{"BGC0000765.1|Exopolysaccharide_1 # 1 # 72 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.319": {"gnl|BL_ORD_ID|939|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 1, "orf_end": 72, "orf_from": "BGC0000765.1|Exopolysaccharide_1 ", "model_name": "APH(3')-IIc", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "1018", "ARO_accession": "3002646", "ARO_name": "APH(3')-IIc", "ARO_category": {"36265": {"category_aro_accession": "3000126", "category_aro_cvterm_id": "36265", "category_aro_name": "APH(3')", "category_aro_description": "A category of aminoglycoside O-phosphotransferase enzymes with modification regiospecificity based at the 3'-hydroxyl group of the respective antibiotic. These enzymes inactivate aminoglycoside antibiotics, specifically kanamycin and neomycin, by the ATP-dependent phosphorylation of the 3'-hydroxyl group of the compound.", "category_aro_class_name": "AMR Gene Family"}, "35924": {"category_aro_accession": "0000005", "category_aro_cvterm_id": "35924", "category_aro_name": "neomycin", "category_aro_description": "Neomycin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Neomycin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35940": {"category_aro_accession": "0000021", "category_aro_cvterm_id": "35940", "category_aro_name": "ribostamycin", "category_aro_description": "Ribostamycin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Ribostamycin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35943": {"category_aro_accession": "0000024", "category_aro_cvterm_id": "35943", "category_aro_name": "butirosin", "category_aro_description": "Butirosin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Butirosin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35966": {"category_aro_accession": "0000049", "category_aro_cvterm_id": "35966", "category_aro_name": "kanamycin A", "category_aro_description": "Kanamycin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Kanamycin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "36999": {"category_aro_accession": "3000655", "category_aro_cvterm_id": "36999", "category_aro_name": "gentamicin B", "category_aro_description": "Gentamicin B is a semisynthetic aminoglycoside antibacterial.", "category_aro_class_name": "Antibiotic"}, "37001": {"category_aro_accession": "3000657", "category_aro_cvterm_id": "37001", "category_aro_name": "paromomycin", "category_aro_description": "An aminoglycoside antibiotic used for the treatment of parasitic infections. It is similar to neomycin sharing a similar spectrum of activity, but its hydroxyl group at the 6'-position instead of an amino group makes it resistant to AAC(6') modifying enzymes.", "category_aro_class_name": "Antibiotic"}, "46133": {"category_aro_accession": "3007382", "category_aro_cvterm_id": "46133", "category_aro_name": "gentamicin", "category_aro_description": "Gentamicin is a commonly used aminoglycoside antibiotic derived from members of the Micromonospora genus of bacteria. It acts by binding the 30S ribosomal subunit, thus inhibiting protein synthesis. Gentamicin is typically used to treat Gram-negative infections of the repiratory and urinary tract, as well as infections of the bone and soft tissue. It also exhibits considerable nephrotoxicity and ototoxicity. Gentamicin is administered as a mixture of gentamicin type C (which makes about around 80% of the complex) and types A, B, and X (distributed in the remaining 20% of the complex).", "category_aro_class_name": "Antibiotic"}, "35935": {"category_aro_accession": "0000016", "category_aro_cvterm_id": "35935", "category_aro_name": "aminoglycoside antibiotic", "category_aro_description": "Aminoglycosides are a group of antibiotics that are mostly effective against Gram-negative bacteria. These molecules consist of aminated sugars attached to a dibasic cyclitol. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit (some work by binding to the 50S subunit), inhibiting the translocation of the peptidyl-tRNA from the A-site to the P-site and also causing misreading of mRNA, leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.59211, "max_identities": 6, "bit_score": 20.4014, "cvterm_id": "37076", "query": "PNLAPKKIIDLVA", "match": "P LAP+++ +L+A", "sequence_from_db": "PELAPRRVAELLA", "sequence_from_broadstreet": "MEASNPFTDGLRLPRAWQEALADAHIERQSIGVSRADVARVHRPGQTDAFLKSEVIDAFSELGDEIARLRWLQAQGQSAPTVIATTEEGGRRWLLMSALPGRDLASSPELAPRRVAELLADALRGLHAVPVANCPFDQQLASRLQAAQARVEAGLVDADDFDDERLGQSPQQVFAELRATRPAHEDLVVSQGDACLPNLTVTDGRFTGFIDCGRLGVADRYQDLALAARSLVHNFGESRCVAALFQRYGAVPDERRLAFYRLLDEFF", "dna_sequence_from_broadstreet": "ATGGAAGCTTCCAATCCCTTCACTGATGGCCTGCGGCTGCCGCGCGCATGGCAGGAAGCGTTGGCCGATGCGCACATCGAGCGGCAGTCGATCGGCGTGTCGCGCGCGGATGTCGCGCGGGTGCATCGTCCCGGGCAGACCGACGCCTTCCTGAAATCGGAAGTGATCGATGCCTTCAGTGAACTGGGTGATGAGATCGCCCGGCTGCGTTGGCTGCAGGCGCAGGGGCAGTCGGCGCCGACGGTGATTGCCACGACCGAGGAGGGCGGTCGGCGCTGGTTGTTGATGAGCGCGTTGCCCGGCCGCGACTTGGCCTCCTCGCCGGAGCTCGCGCCGAGACGGGTGGCAGAACTGCTGGCTGACGCACTGCGTGGCCTGCATGCCGTGCCTGTAGCCAACTGCCCGTTCGACCAGCAGTTGGCATCGCGCCTGCAGGCCGCACAGGCACGCGTCGAGGCGGGGCTGGTCGATGCCGATGACTTCGACGACGAGCGGCTGGGCCAGAGCCCGCAGCAGGTTTTCGCCGAGCTGCGCGCTACCCGGCCCGCTCATGAAGACCTGGTGGTCAGTCAGGGCGATGCCTGCCTGCCCAACCTGACGGTGACCGATGGGCGGTTCACTGGCTTCATCGATTGTGGCCGGTTGGGCGTGGCCGACCGCTATCAGGACCTGGCCCTGGCCGCGCGCAGCCTGGTCCACAATTTCGGGGAGAGCCGCTGTGTCGCCGCGCTGTTCCAGCGCTACGGTGCGGTCCCTGATGAGCGGCGGCTTGCATTCTATCGGTTGCTTGACGAGTTTTTCTGA", "partial": "0", "query_start": 1, "query_end": 39, "hit_start": 321, "hit_end": 360, "orf_dna_sequence": "CCAAATCTAGCACCAAAGAAAATAATTGACTTAGTTGCAACTAAAGAAGACTTAAAAGGTAAGCGAAAATAG", "orf_prot_sequence": "PNLAPKKIIDLVATKEDLKGKRK", "perc_identity": 46.15}}, "BGC0000765.1|Exopolysaccharide_2 # 458 # 1462 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=6bp;gc_cont=0.389": {"gnl|BL_ORD_ID|1772|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 458, "orf_end": 1462, "orf_from": "BGC0000765.1|Exopolysaccharide_2 ", "model_name": "marA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "230", "model_id": "1922", "ARO_accession": "3000263", "ARO_name": "marA", "ARO_category": {"36005": {"category_aro_accession": "0010004", "category_aro_cvterm_id": "36005", "category_aro_name": "resistance-nodulation-cell division (RND) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.", "category_aro_class_name": "AMR Gene Family"}, "41445": {"category_aro_accession": "3004281", "category_aro_cvterm_id": "41445", "category_aro_name": "General Bacterial Porin with reduced permeability to beta-lactams", "category_aro_description": "These are GBPs that are associated with decreased susceptibility to beta-lactams either through mutations in the porin protein, absence of the porin protein, or expression of the porin protein.", "category_aro_class_name": "AMR Gene Family"}, "35949": {"category_aro_accession": "0000030", "category_aro_cvterm_id": "35949", "category_aro_name": "tigecycline", "category_aro_description": "Tigecycline is an glycylcycline antibiotic. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "36308": {"category_aro_accession": "3000169", "category_aro_cvterm_id": "36308", "category_aro_name": "rifampin", "category_aro_description": "Rifampin is a semi-synthetic rifamycin, and inhibits RNA synthesis by binding to RNA polymerase. Rifampin is the mainstay agent for the treatment of tuberculosis, leprosy and complicated Gram-positive infections.", "category_aro_class_name": "Antibiotic"}, "36524": {"category_aro_accession": "3000385", "category_aro_cvterm_id": "36524", "category_aro_name": "chloramphenicol", "category_aro_description": "Chloramphenicol is a bacteriostatic antimicrobial originally derived from the bacterium Streptomyces venezuelae. It was the first antibiotic to be manufactured synthetically on a large scale. It functions by inhibiting peptidyl transferase activity of the bacterial ribosome, binding to A2451 and A2452 residues in the 23S rRNA of the 50S ribosomal subunit and preventing peptide bond formation.", "category_aro_class_name": "Antibiotic"}, "36981": {"category_aro_accession": "3000637", "category_aro_cvterm_id": "36981", "category_aro_name": "ampicillin", "category_aro_description": "Ampicillin is a penicillin derivative that is highly acid stable, with its activity similar to benzylpenicillin.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "37250": {"category_aro_accession": "3000870", "category_aro_cvterm_id": "37250", "category_aro_name": "triclosan", "category_aro_description": "Triclosan is a common antibacterial agent added to many consumer products as a biocide.  It is an inhibitor of fatty acid biosynthesis by blocking enoyl-carrier protein reductase (FabI).", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35923": {"category_aro_accession": "0000004", "category_aro_cvterm_id": "35923", "category_aro_name": "monobactam", "category_aro_description": "Monobactams are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Unlike penams and cephems, monobactams do not have any ring fused to its four-member lactam structure. Monobactam antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35960": {"category_aro_accession": "0000042", "category_aro_cvterm_id": "35960", "category_aro_name": "glycylcycline", "category_aro_description": "Glycylcyclines are a new class of antibiotics derived from tetracycline. These tetracycline analogues are specifically designed to overcome two common mechanisms of tetracycline resistance. Presently, there is only one glycylcycline antibiotic for clinical use: tigecycline. It works by inhibiting action of the prokaryotic 30S ribosome, preventing the binding of aminoacyl-tRNA.", "category_aro_class_name": "Drug Class"}, "35962": {"category_aro_accession": "0000044", "category_aro_cvterm_id": "35962", "category_aro_name": "cephamycin", "category_aro_description": "Cephamycins are a group of beta-lactam antibiotics, very similar to cephalosporins. Together with cephalosporins, they form a sub-group of antibiotics known as cephems. Cephamycins are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. The 7-alpha-methoxy group increases resistance to beta-lactamases.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36296": {"category_aro_accession": "3000157", "category_aro_cvterm_id": "36296", "category_aro_name": "rifamycin antibiotic", "category_aro_description": "Rifamycin antibiotics are a group of broad-spectrum ansamycin antibiotics that inhibit bacterial RNA polymerase by binding to a highly conserved region, blocking the oligonucleotide exit tunnel, and preventing the extension of nascent mRNAs.", "category_aro_class_name": "Drug Class"}, "36526": {"category_aro_accession": "3000387", "category_aro_cvterm_id": "36526", "category_aro_name": "phenicol antibiotic", "category_aro_description": "Phenicols are broad spectrum bacteriostatic antibiotics acting on bacterial protein synthesis. More specifically, the phenicols block peptide elongation by binding to the peptidyltansferase centre of the 70S ribosome.", "category_aro_class_name": "Drug Class"}, "40360": {"category_aro_accession": "3003706", "category_aro_cvterm_id": "40360", "category_aro_name": "penem", "category_aro_description": "Penems are a class of unsaturated beta-lactam antibiotics with a broad spectrum of antibacterial activity and have a structure which renders them highly resistant to beta-lactamases. All penems are all synthetically made and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. They are structurally similar to carbapenems, however, where carbapenems have a carbon, penems have a sulfur.", "category_aro_class_name": "Drug Class"}, "43746": {"category_aro_accession": "3005386", "category_aro_cvterm_id": "43746", "category_aro_name": "disinfecting agents and antiseptics", "category_aro_description": "Disinfectants that can also interact with antimicrobial resistance mechanisms, e.g. molecule efflux, and thus are the targets of disinfectant resistance.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36590": {"category_aro_accession": "3000451", "category_aro_cvterm_id": "36590", "category_aro_name": "protein(s) and two-component regulatory system modulating antibiotic efflux", "category_aro_description": "Protein(s) and two component regulatory systems that directly or indirectly change rates of antibiotic efflux.", "category_aro_class_name": "Efflux Regulator"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}, "36383": {"category_aro_accession": "3000244", "category_aro_cvterm_id": "36383", "category_aro_name": "reduced permeability to antibiotic", "category_aro_description": "Reduction in permeability to antibiotic, generally through reduced production of porins, can provide resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.175321, "max_identities": 12, "bit_score": 29.6462, "cvterm_id": "36839", "query": "YTYGGVDETVKTIKKYFNVPTDSYVMVNMGG", "match": "Y +       +T K YF+VP   Y M NM G", "sequence_from_db": "YGFESQQTLTRTFKNYFDVPPHKYRMTNMQG", "sequence_from_broadstreet": "MSRRNTDAITIHSILDWIEDNLESPLSLEKVSERSGYSKWHLQRMFKKETGHSLGQYIRSRKMTEIAQKLKESNEPILYLAERYGFESQQTLTRTFKNYFDVPPHKYRMTNMQGESRFLHPLNHYNS", "dna_sequence_from_broadstreet": "ATGTCCAGACGCAATACTGACGCTATTACCATTCATAGCATTTTGGACTGGATCGAGGACAACCTGGAATCGCCACTGTCACTGGAGAAAGTGTCAGAGCGTTCGGGTTACTCCAAATGGCACCTGCAACGGATGTTTAAAAAAGAAACCGGTCATTCATTAGGCCAATACATCCGCAGCCGTAAGATGACGGAAATCGCGCAAAAGCTGAAGGAAAGTAACGAGCCGATACTCTATCTGGCAGAACGATATGGCTTCGAGTCGCAACAAACTCTGACCCGAACCTTCAAAAATTACTTTGATGTTCCGCCGCATAAATACCGGATGACCAATATGCAGGGCGAATCGCGCTTTTTACATCCATTAAATCATTACAACAGCTAG", "partial": "0", "query_start": 887, "query_end": 979, "hit_start": 249, "hit_end": 342, "orf_dna_sequence": "ATGGATCATAAGAATAGTGATAATGAATTAAGACATCGCTCACATCATCACCGGCATCATCGACGTAAAAAGTTTTGGCGTATCTTTTGGATTGTATTAGGTGTCTTCCTAGCAGTAGACATCATTGCGGTTATTATCGCTTGGCACAATATCCATGTTGCCACTAACAATATGTATAATCCGATGAGTAATGAAATTAGTGATCGGAAGGTTAGCGACAAACTGAAAGATAAGAAGCCAATGAGCCTGCTTTTATTGGGAACAGATACAGGTGAATTTGGACGTTCTTACAAGGGGAGAACAGATACCATTATGATGATGGTTATCAATCCTAAGACCAATAAGACAACAGTTGTCAGCTTGCCTCGAGATATGAAAGTTAACTTACCGGATTATCCAGACTATTCACCAGCTAAGATTAATGCAGCCTATACTTATGGTGGTGTAGATGAAACTGTTAAAACGATCAAGAAGTACTTTAATGTTCCAACTGATTCTTATGTCATGGTAAACATGGGAGGGCTCGAGAAGGCAATTGATCAAGTTGGAGGAGTGACAGTTAAGTCGCCATTAACGTTTGATTATGAAGGCTATCACTTCACTAAGGGCGTAACTTATCACATGAATGGGAAGAAAGCTTTAGCATTCAGTAGAATGCGTTATGATGACCCAAAAGGAGATTATGGGCGTCAAGAGAGACAAAGACTTGTAATTATGGCATTATTAAAGAGTTCCATTTCTTACAAGACAGTCGTTAACCAAGCATTCTTGAATTCAATCTCTAAGCAAACTATGACTAACTTAACGTTTGATAATATGGTTGCGTTAGCTCAGAATTATCGTCATGCAACTGATAATATCACAAGTGATCACGCTCAAGGACAAGGCGATTGGGAGAATGGCGTTGCCTATGAGTCAGTTAGTCAAGCAGAATGTCAAAGAATTAGTAATAAGTTACGTGCTGCCTTAGGGCTTAAGCCGGAAACCTTAAAGACAGGAGAATAG", "orf_prot_sequence": "MDHKNSDNELRHRSHHHRHHRRKKFWRIFWIVLGVFLAVDIIAVIIAWHNIHVATNNMYNPMSNEISDRKVSDKLKDKKPMSLLLLGTDTGEFGRSYKGRTDTIMMMVINPKTNKTTVVSLPRDMKVNLPDYPDYSPAKINAAYTYGGVDETVKTIKKYFNVPTDSYVMVNMGGLEKAIDQVGGVTVKSPLTFDYEGYHFTKGVTYHMNGKKALAFSRMRYDDPKGDYGRQERQRLVIMALLKSSISYKTVVNQAFLNSISKQTMTNLTFDNMVALAQNYRHATDNITSDHAQGQGDWENGVAYESVSQAECQRISNKLRAALGLKPETLKTGE", "perc_identity": 38.71}}, "BGC0000765.1|Exopolysaccharide_3 # 1469 # 2332 # 1 # ID=1_3;partial=00;start_type=GTG;rbs_motif=TAGG;rbs_spacer=5bp;gc_cont=0.360": {"gnl|BL_ORD_ID|2790|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 1469, "orf_end": 2332, "orf_from": "BGC0000765.1|Exopolysaccharide_3 ", "model_name": "ParS", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "800", "model_id": "3805", "ARO_accession": "3005067", "ARO_name": "ParS", "ARO_category": {"36005": {"category_aro_accession": "0010004", "category_aro_cvterm_id": "36005", "category_aro_name": "resistance-nodulation-cell division (RND) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.", "category_aro_class_name": "AMR Gene Family"}, "41442": {"category_aro_accession": "3004278", "category_aro_cvterm_id": "41442", "category_aro_name": "Outer Membrane Porin (Opr)", "category_aro_description": "The Opr family consists of porins in Pseudomonas species, and other Gram-negative bacteria, that exhibit a variety of substrate selectivities.", "category_aro_class_name": "AMR Gene Family"}, "35925": {"category_aro_accession": "0000006", "category_aro_cvterm_id": "35925", "category_aro_name": "erythromycin", "category_aro_description": "Erythromycin is a macrolide antibiotic with a 14-carbon ring that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people that have an allergy to penicillins. Erythromycin may possess bacteriocidal activity, particularly at higher concentrations by binding to the 50S subunit of the bacterial 70S rRNA complex, inhibiting peptidyl-tRNA translocation. Thus, protein synthesis and subsequently structure/function processes critical for life or replication are inhibited.", "category_aro_class_name": "Antibiotic"}, "35932": {"category_aro_accession": "0000013", "category_aro_cvterm_id": "35932", "category_aro_name": "amikacin", "category_aro_description": "Amikacin is an aminoglycoside antibiotic that works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35933": {"category_aro_accession": "0000014", "category_aro_cvterm_id": "35933", "category_aro_name": "gentamicin C", "category_aro_description": "Gentamicin C is a mixture of gentamicin C1, gentamicin C1a, and gentamicin C2 (these differ in substituents at position C6'). Gentamicin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35963": {"category_aro_accession": "0000045", "category_aro_cvterm_id": "35963", "category_aro_name": "acriflavine", "category_aro_description": "Acriflavine is a topical antiseptic. It has the form of an orange or brown powder. It may be harmful in the eyes or if inhaled. Acriflavine is also used as treatment for external fungal infections of aquarium fish.", "category_aro_class_name": "Antibiotic"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35969": {"category_aro_accession": "0000052", "category_aro_cvterm_id": "35969", "category_aro_name": "tobramycin", "category_aro_description": "Tobramycin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Tobramycin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35990": {"category_aro_accession": "0000073", "category_aro_cvterm_id": "35990", "category_aro_name": "meropenem", "category_aro_description": "Meropenem is an ultra-broad spectrum injectable antibiotic used to treat a wide variety of infections, including meningitis and pneumonia. It is a beta-lactam and belongs to the subgroup of carbapenem, similar to imipenem and ertapenem.", "category_aro_class_name": "Antibiotic"}, "36309": {"category_aro_accession": "3000170", "category_aro_cvterm_id": "36309", "category_aro_name": "imipenem", "category_aro_description": "Imipenem is a broad-spectrum antibiotic and is usually taken with cilastatin, which prevents hydrolysis of imipenem by renal dehydropeptidase-I. It is resistant to hydrolysis by most other beta-lactamases. Notable exceptions are the KPC beta-lactamases and Ambler Class B enzymes.", "category_aro_class_name": "Antibiotic"}, "36524": {"category_aro_accession": "3000385", "category_aro_cvterm_id": "36524", "category_aro_name": "chloramphenicol", "category_aro_description": "Chloramphenicol is a bacteriostatic antimicrobial originally derived from the bacterium Streptomyces venezuelae. It was the first antibiotic to be manufactured synthetically on a large scale. It functions by inhibiting peptidyl transferase activity of the bacterial ribosome, binding to A2451 and A2452 residues in the 23S rRNA of the 50S ribosomal subunit and preventing peptide bond formation.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37007": {"category_aro_accession": "3000663", "category_aro_cvterm_id": "37007", "category_aro_name": "ofloxacin", "category_aro_description": "Ofloxacin is a 6-fluoro, 7-piperazinyl quinolone with a methyl-substituted oxazine ring. It has a broad spectrum of activity including many enterobacteria and mycoplasma but most anaerobes are resistant.", "category_aro_class_name": "Antibiotic"}, "46133": {"category_aro_accession": "3007382", "category_aro_cvterm_id": "46133", "category_aro_name": "gentamicin", "category_aro_description": "Gentamicin is a commonly used aminoglycoside antibiotic derived from members of the Micromonospora genus of bacteria. It acts by binding the 30S ribosomal subunit, thus inhibiting protein synthesis. Gentamicin is typically used to treat Gram-negative infections of the repiratory and urinary tract, as well as infections of the bone and soft tissue. It also exhibits considerable nephrotoxicity and ototoxicity. Gentamicin is administered as a mixture of gentamicin type C (which makes about around 80% of the complex) and types A, B, and X (distributed in the remaining 20% of the complex).", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35923": {"category_aro_accession": "0000004", "category_aro_cvterm_id": "35923", "category_aro_name": "monobactam", "category_aro_description": "Monobactams are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Unlike penams and cephems, monobactams do not have any ring fused to its four-member lactam structure. Monobactam antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35935": {"category_aro_accession": "0000016", "category_aro_cvterm_id": "35935", "category_aro_name": "aminoglycoside antibiotic", "category_aro_description": "Aminoglycosides are a group of antibiotics that are mostly effective against Gram-negative bacteria. These molecules consist of aminated sugars attached to a dibasic cyclitol. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit (some work by binding to the 50S subunit), inhibiting the translocation of the peptidyl-tRNA from the A-site to the P-site and also causing misreading of mRNA, leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Drug Class"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35962": {"category_aro_accession": "0000044", "category_aro_cvterm_id": "35962", "category_aro_name": "cephamycin", "category_aro_description": "Cephamycins are a group of beta-lactam antibiotics, very similar to cephalosporins. Together with cephalosporins, they form a sub-group of antibiotics known as cephems. Cephamycins are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. The 7-alpha-methoxy group increases resistance to beta-lactamases.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36526": {"category_aro_accession": "3000387", "category_aro_cvterm_id": "36526", "category_aro_name": "phenicol antibiotic", "category_aro_description": "Phenicols are broad spectrum bacteriostatic antibiotics acting on bacterial protein synthesis. More specifically, the phenicols block peptide elongation by binding to the peptidyltansferase centre of the 70S ribosome.", "category_aro_class_name": "Drug Class"}, "40360": {"category_aro_accession": "3003706", "category_aro_cvterm_id": "40360", "category_aro_name": "penem", "category_aro_description": "Penems are a class of unsaturated beta-lactam antibiotics with a broad spectrum of antibacterial activity and have a structure which renders them highly resistant to beta-lactamases. All penems are all synthetically made and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. They are structurally similar to carbapenems, however, where carbapenems have a carbon, penems have a sulfur.", "category_aro_class_name": "Drug Class"}, "43746": {"category_aro_accession": "3005386", "category_aro_cvterm_id": "43746", "category_aro_name": "disinfecting agents and antiseptics", "category_aro_description": "Disinfectants that can also interact with antimicrobial resistance mechanisms, e.g. molecule efflux, and thus are the targets of disinfectant resistance.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36590": {"category_aro_accession": "3000451", "category_aro_cvterm_id": "36590", "category_aro_name": "protein(s) and two-component regulatory system modulating antibiotic efflux", "category_aro_description": "Protein(s) and two component regulatory systems that directly or indirectly change rates of antibiotic efflux.", "category_aro_class_name": "Efflux Regulator"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}, "36383": {"category_aro_accession": "3000244", "category_aro_cvterm_id": "36383", "category_aro_name": "reduced permeability to antibiotic", "category_aro_description": "Reduction in permeability to antibiotic, generally through reduced production of porins, can provide resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.15889, "max_identities": 16, "bit_score": 25.7942, "cvterm_id": "36804", "query": "SPAARGIKTFPK---TTLFT-LAGIVLGLIISVALIV", "match": " P    IK  P+   T LFT LA I+LG+++ +AL+V", "sequence_from_db": "GPQLLDIKLPPEPSLTPLFTVLAYILLGVLVGIALLV", "sequence_from_broadstreet": "MLRLFLRLYLLLALGFAAAIFVVDHVIDAFYDSIVENYHRDAVRGQAYSLVEKLAPLDQAGRQRQLEDWRPHYGLELSLTDARQAKLTQEEQALLDKNLLVVREDFTEFISRIDAGPQLLDIKLPPEPSLTPLFTVLAYILLGVLVGIALLVWVRPHWRDLETLRLAAQRFGDGDLSSRTRIFRRSDIRTLAQHFNQMADRIESLISNQRELTNAVSHELRTPISRLSFELEQLNKQVDAEVRHDLIEDMRADLGELEEMVSELLTYARLEHGNVGSHREIVDAASWLDSVVADVALEAEAAGVTCEISACQVEQIRIEPRFMARAVINLLRNAIRHAHSRVEIALLDQGDSCQIRVNDDGPGIPADARQKIFEPFSRLDDSRDRSTGGFGLGLAIVHRVAQWHGGYAEALETPQGGASFRLTWERPR", "dna_sequence_from_broadstreet": "ATGCTGCGCCTGTTCCTGCGCCTCTACCTGCTGCTGGCCCTGGGGTTCGCCGCCGCGATCTTCGTGGTCGACCATGTCATCGACGCGTTCTACGACAGCATCGTCGAGAACTATCACCGCGACGCCGTTCGCGGCCAGGCCTATTCGCTGGTGGAAAAGCTGGCCCCGCTGGACCAGGCCGGACGCCAGCGACAGCTCGAAGACTGGCGTCCCCACTACGGGCTCGAGCTGAGCCTGACGGATGCCAGGCAGGCGAAGCTGACGCAGGAAGAGCAGGCCCTCCTCGACAAGAACCTGCTGGTGGTACGCGAGGACTTCACGGAATTCATCAGCCGCATCGACGCGGGCCCGCAACTGCTCGACATCAAGCTGCCGCCGGAACCCTCGCTGACCCCACTATTCACCGTGCTGGCCTACATCCTGCTCGGCGTGCTGGTCGGCATCGCCCTGCTGGTATGGGTCCGCCCGCACTGGCGCGACCTCGAGACCCTGCGCCTGGCCGCGCAACGCTTCGGCGACGGCGACCTGTCATCGCGCACGCGCATTTTCCGACGCTCCGACATCCGCACCCTGGCCCAGCACTTCAACCAGATGGCCGACCGCATCGAAAGCCTGATCAGCAACCAGCGTGAACTGACCAACGCGGTATCCCACGAATTGCGCACGCCGATCTCCCGCCTGTCCTTCGAACTCGAGCAATTGAACAAGCAGGTCGACGCCGAAGTACGCCACGACCTGATAGAGGACATGCGCGCCGATCTCGGCGAACTGGAGGAAATGGTCTCCGAACTGCTGACCTACGCCCGCCTGGAGCACGGCAACGTCGGGAGCCACCGGGAAATCGTCGACGCCGCGAGCTGGCTGGATAGCGTCGTCGCCGACGTCGCCCTGGAAGCCGAAGCCGCCGGAGTCACCTGCGAGATCAGCGCCTGCCAGGTCGAACAGATCCGCATCGAGCCTCGCTTCATGGCGCGCGCAGTGATCAACCTGCTGCGCAACGCCATTCGCCACGCACACTCGCGCGTCGAAATCGCCCTCCTCGATCAAGGCGACAGCTGTCAGATACGGGTCAACGACGACGGCCCCGGGATACCGGCGGACGCCCGGCAGAAGATCTTCGAACCCTTTTCGCGCCTGGACGACAGCCGCGATCGCAGCACCGGCGGCTTCGGCCTGGGCCTGGCGATCGTCCACCGGGTCGCGCAATGGCACGGCGGCTATGCGGAAGCGCTGGAAACGCCGCAGGGAGGCGCCTCCTTCCGCCTGACCTGGGAGCGACCCCGTTGA", "partial": "0", "query_start": 2078, "query_end": 2176, "hit_start": 345, "hit_end": 456, "orf_dna_sequence": "GTGGAAAACAGTACAAAAACTGAAAATACAATCGATTTACGTAGATTATGGATGCTTCTTCGAGCACATATTTGGGCAATTATCGCCTGGGCCGTTGGTTTAGGAGCAGTTGGATTTGTCTTAGCTGCTTTTGTCGTTGAGCCAAAGTATACTTCAACAACTCAGATTTTGGTTAACCAAAAAAGAAATACGACGGATGCTGGTCAAGCATTCAATGCTCAACAAGCTGATGTCCAGTTAATTAATACTTATAAGGATATTGTTACTAGTCCAGTTATTTTAAAAGATGCTTCTAAGTGGCTAAAAAATCCTACTGAAGTTGTAAAGCCAGCTAAAAAAGCTCAGTACAAGACTTTAGCTGATGGTACTAAAAAACTTGTTAGTCCAGCTGAACCAGCTGTTGTAAGAAGAGCGGGACGTGGCTACAACGTTAGTGCTAAAGAAATGCAAAAAGCAGTGTCAGTAAGTACACAACAACAATCTCAAGTATTTACAATTAGTGCTAAGAGTAATGATCCAGAAAAAGCGCAAGCAATTGCAAATGCGGTTGCTAAAACTTTTAAGAATAAAATTAAGAGCATTATGAATGTTAATAATGTAACAATTGTGTCACCAGCTGCTCGTGGTATTAAGACATTCCCTAAGACTACACTATTTACTCTCGCGGGTATTGTGCTTGGATTAATTATTAGCGTTGCTTTAATTGTCTTACGTGATTCATTTAATACTACAGTCAGAGATGATGACTACTTGACGAAGGAATTAGGTTTAACCAATTTAGGTCATGTATCTCACTTCCACTTATCTAATGATTTTAGTATCAATAAGAAGAACAATGATTCTGGTAAAAAGAAGCGTGTATAG", "orf_prot_sequence": "MENSTKTENTIDLRRLWMLLRAHIWAIIAWAVGLGAVGFVLAAFVVEPKYTSTTQILVNQKRNTTDAGQAFNAQQADVQLINTYKDIVTSPVILKDASKWLKNPTEVVKPAKKAQYKTLADGTKKLVSPAEPAVVRRAGRGYNVSAKEMQKAVSVSTQQQSQVFTISAKSNDPEKAQAIANAVAKTFKNKIKSIMNVNNVTIVSPAARGIKTFPKTTLFTLAGIVLGLIISVALIVLRDSFNTTVRDDDYLTKELGLTNLGHVSHFHLSNDFSINKKNNDSGKKKRV", "perc_identity": 43.24}, "gnl|BL_ORD_ID|4729|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 1469, "orf_end": 2332, "orf_from": "BGC0000765.1|Exopolysaccharide_3 ", "model_name": "vanTm gene in vanL cluster", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "175", "model_id": "229", "ARO_accession": "3002973", "ARO_name": "vanTm gene in vanL cluster", "ARO_category": {"36373": {"category_aro_accession": "3000234", "category_aro_cvterm_id": "36373", "category_aro_name": "glycopeptide resistance gene cluster", "category_aro_description": "Genes that when expressed confer resistance to vancomycin and teicoplanin type antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "36511": {"category_aro_accession": "3000372", "category_aro_cvterm_id": "36511", "category_aro_name": "vanT", "category_aro_description": "VanT is a membrane bound serine racemase, converting L-serine to D-serine. It is associated with VanC, which incorporated D-serine into D-Ala-D-Ser terminal end of peptidoglycan subunits that have a decreased binding affinity with vancomycin. It was isolated from Enterococcus gallinarum.", "category_aro_class_name": "AMR Gene Family"}, "35947": {"category_aro_accession": "0000028", "category_aro_cvterm_id": "35947", "category_aro_name": "vancomycin", "category_aro_description": "Vancomycin is a glycopeptide antibiotic used in the prophylaxis and treatment of infections caused by Gram-positive bacteria. Vancomycin inhibits the synthesis of peptidoglycan, the major component of the cell wall of gram-positive bacteria. Its mechanism of action is unusual in that it acts by binding precursors of peptidoglycan, rather than by interacting with an enzyme.", "category_aro_class_name": "Antibiotic"}, "36220": {"category_aro_accession": "3000081", "category_aro_cvterm_id": "36220", "category_aro_name": "glycopeptide antibiotic", "category_aro_description": "Glycopeptide antibiotics are natural products produced non-ribosomally by Actinomycetales bacteria. With the exception of bleomycins, they act by binding the terminal D-Ala-D-Ala in peptidoglycan precursors of the growing bacterial cell wall and are generally active against Gram-positive bacteria.  This inhibits transglycosylation leading to cell death due to osmotic stress.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.23674, "max_identities": 9, "bit_score": 25.0238, "cvterm_id": "35918", "query": "HIWAIIAWAVGLGAVGFVL", "match": "H+W   AW +GL  V F+L", "sequence_from_db": "HLWFFPAWVLGLLIVQFLL", "sequence_from_broadstreet": "MKKQNTGVNNFRLIAAAMVVAIHCFPFQTISKELDTLVTLTVFRIAVPFFFMVSGYYLLGPIPSSATNTYQINNYIKKQLKVYTFAIVLYLPLAFYSQSITLDMSIISFIKQLLFNGFFYHLWFFPAWVLGLLIVQFLLKRMNIQTVLFITFVAYLIGLGGDSWWGIVKQVPFFFRFYNAIFQLFGYTRNGLFYAPLFFALGAYLYKMNIKNFNSARNNYLLLLFSIEMILESYFLHLFNIPKHDSMYLFLPFVMTLVFIKIYNWSPKNNLLNSSQLSLGVYLIHPYIIAVIHSISIYVSIFTNSIINYLSVLLISYLTIRLILKRKEW", "dna_sequence_from_broadstreet": "ATGAAAAAACAAAATACGGGTGTAAATAATTTCCGTTTAATCGCTGCTGCCATGGTAGTAGCGATTCATTGCTTTCCATTTCAAACAATCAGTAAAGAACTAGATACATTGGTTACGCTAACTGTCTTTCGTATTGCCGTTCCTTTTTTCTTCATGGTTTCTGGGTACTACCTACTAGGTCCAATTCCAAGTTCAGCCACAAATACTTATCAAATTAATAACTATATAAAGAAACAGCTTAAAGTTTATACTTTCGCTATAGTTCTGTATCTACCTTTAGCGTTTTATAGTCAATCTATCACTTTGGATATGTCAATTATTAGTTTTATAAAACAACTACTTTTTAACGGTTTTTTTTACCATCTTTGGTTTTTCCCTGCATGGGTATTAGGATTATTAATTGTTCAATTTTTATTAAAAAGAATGAATATACAGACTGTATTGTTTATAACATTTGTGGCTTATTTAATAGGACTAGGAGGGGATAGTTGGTGGGGAATAGTTAAACAAGTTCCCTTTTTTTTCAGATTTTACAATGCTATATTTCAATTATTTGGTTATACACGAAATGGTCTATTTTATGCGCCGTTATTCTTTGCACTGGGAGCATATCTATACAAGATGAATATTAAAAACTTTAATTCCGCAAGAAATAACTATCTTTTACTGCTTTTTAGTATAGAAATGATTTTAGAAAGTTATTTCTTACATCTCTTTAACATTCCTAAACATGACAGTATGTATTTGTTTTTACCGTTTGTAATGACTTTGGTGTTTATCAAAATATACAATTGGTCACCAAAAAATAATTTATTGAACAGCTCTCAGCTATCTCTAGGAGTATATCTTATACATCCATATATCATCGCAGTAATTCACTCTATCTCAATTTACGTTTCTATTTTTACTAATAGCATAATTAATTATTTAAGTGTGCTATTGATAAGTTACCTAACTATAAGACTAATACTAAAAAGGAAGGAATGGTAG", "partial": "0", "query_start": 1535, "query_end": 1591, "hit_start": 360, "hit_end": 417, "orf_dna_sequence": "GTGGAAAACAGTACAAAAACTGAAAATACAATCGATTTACGTAGATTATGGATGCTTCTTCGAGCACATATTTGGGCAATTATCGCCTGGGCCGTTGGTTTAGGAGCAGTTGGATTTGTCTTAGCTGCTTTTGTCGTTGAGCCAAAGTATACTTCAACAACTCAGATTTTGGTTAACCAAAAAAGAAATACGACGGATGCTGGTCAAGCATTCAATGCTCAACAAGCTGATGTCCAGTTAATTAATACTTATAAGGATATTGTTACTAGTCCAGTTATTTTAAAAGATGCTTCTAAGTGGCTAAAAAATCCTACTGAAGTTGTAAAGCCAGCTAAAAAAGCTCAGTACAAGACTTTAGCTGATGGTACTAAAAAACTTGTTAGTCCAGCTGAACCAGCTGTTGTAAGAAGAGCGGGACGTGGCTACAACGTTAGTGCTAAAGAAATGCAAAAAGCAGTGTCAGTAAGTACACAACAACAATCTCAAGTATTTACAATTAGTGCTAAGAGTAATGATCCAGAAAAAGCGCAAGCAATTGCAAATGCGGTTGCTAAAACTTTTAAGAATAAAATTAAGAGCATTATGAATGTTAATAATGTAACAATTGTGTCACCAGCTGCTCGTGGTATTAAGACATTCCCTAAGACTACACTATTTACTCTCGCGGGTATTGTGCTTGGATTAATTATTAGCGTTGCTTTAATTGTCTTACGTGATTCATTTAATACTACAGTCAGAGATGATGACTACTTGACGAAGGAATTAGGTTTAACCAATTTAGGTCATGTATCTCACTTCCACTTATCTAATGATTTTAGTATCAATAAGAAGAACAATGATTCTGGTAAAAAGAAGCGTGTATAG", "orf_prot_sequence": "MENSTKTENTIDLRRLWMLLRAHIWAIIAWAVGLGAVGFVLAAFVVEPKYTSTTQILVNQKRNTTDAGQAFNAQQADVQLINTYKDIVTSPVILKDASKWLKNPTEVVKPAKKAQYKTLADGTKKLVSPAEPAVVRRAGRGYNVSAKEMQKAVSVSTQQQSQVFTISAKSNDPEKAQAIANAVAKTFKNKIKSIMNVNNVTIVSPAARGIKTFPKTTLFTLAGIVLGLIISVALIVLRDSFNTTVRDDDYLTKELGLTNLGHVSHFHLSNDFSINKKNNDSGKKKRV", "perc_identity": 47.37}}, "BGC0000765.1|Exopolysaccharide_4 # 2343 # 3098 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=TAGG;rbs_spacer=9bp;gc_cont=0.368": {"gnl|BL_ORD_ID|574|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2343, "orf_end": 3098, "orf_from": "BGC0000765.1|Exopolysaccharide_4 ", "model_name": "adeJ", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "2000", "model_id": "630", "ARO_accession": "3000781", "ARO_name": "adeJ", "ARO_category": {"36005": {"category_aro_accession": "0010004", "category_aro_cvterm_id": "36005", "category_aro_name": "resistance-nodulation-cell division (RND) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "36308": {"category_aro_accession": "3000169", "category_aro_cvterm_id": "36308", "category_aro_name": "rifampin", "category_aro_description": "Rifampin is a semi-synthetic rifamycin, and inhibits RNA synthesis by binding to RNA polymerase. Rifampin is the mainstay agent for the treatment of tuberculosis, leprosy and complicated Gram-positive infections.", "category_aro_class_name": "Antibiotic"}, "36309": {"category_aro_accession": "3000170", "category_aro_cvterm_id": "36309", "category_aro_name": "imipenem", "category_aro_description": "Imipenem is a broad-spectrum antibiotic and is usually taken with cilastatin, which prevents hydrolysis of imipenem by renal dehydropeptidase-I. It is resistant to hydrolysis by most other beta-lactamases. Notable exceptions are the KPC beta-lactamases and Ambler Class B enzymes.", "category_aro_class_name": "Antibiotic"}, "36327": {"category_aro_accession": "3000188", "category_aro_cvterm_id": "36327", "category_aro_name": "trimethoprim", "category_aro_description": "Trimethoprim is a synthetic 5-(3,4,5- trimethoxybenzyl) pyrimidine inhibitor of dihydrofolate reductase, inhibiting synthesis of tetrahydrofolic acid. Tetrahydrofolic acid is an essential precursor in the de novo synthesis of the DNA nucleotide thymidine. Trimethoprim is a bacteriostatic antibiotic mainly used in the prophylaxis and treatment of urinary tract infections in combination with sulfamethoxazole, a sulfonamide antibiotic.", "category_aro_class_name": "Antibiotic"}, "36524": {"category_aro_accession": "3000385", "category_aro_cvterm_id": "36524", "category_aro_name": "chloramphenicol", "category_aro_description": "Chloramphenicol is a bacteriostatic antimicrobial originally derived from the bacterium Streptomyces venezuelae. It was the first antibiotic to be manufactured synthetically on a large scale. It functions by inhibiting peptidyl transferase activity of the bacterial ribosome, binding to A2451 and A2452 residues in the 23S rRNA of the 50S ribosomal subunit and preventing peptide bond formation.", "category_aro_class_name": "Antibiotic"}, "40523": {"category_aro_accession": "3003832", "category_aro_cvterm_id": "40523", "category_aro_name": "ticarcillin", "category_aro_description": "Ticarcillin is a carboxypenicillin used for the treatment of Gram-negative bacteria, particularly P. aeruginosa. Ticarcillin's antibiotic properties arise from its ability to prevent cross-linking of peptidoglycan during cell wall synthesis, when the bacteria try to divide, causing cell death.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36296": {"category_aro_accession": "3000157", "category_aro_cvterm_id": "36296", "category_aro_name": "rifamycin antibiotic", "category_aro_description": "Rifamycin antibiotics are a group of broad-spectrum ansamycin antibiotics that inhibit bacterial RNA polymerase by binding to a highly conserved region, blocking the oligonucleotide exit tunnel, and preventing the extension of nascent mRNAs.", "category_aro_class_name": "Drug Class"}, "36310": {"category_aro_accession": "3000171", "category_aro_cvterm_id": "36310", "category_aro_name": "diaminopyrimidine antibiotic", "category_aro_description": "Diaminopyrimidines are a class of organic compounds containing a pyrimidine ring substituted by two amine groups.  They are inhibitors of dihydrofolate reductase, an enzyme critical for DNA synthesis.", "category_aro_class_name": "Drug Class"}, "36526": {"category_aro_accession": "3000387", "category_aro_cvterm_id": "36526", "category_aro_name": "phenicol antibiotic", "category_aro_description": "Phenicols are broad spectrum bacteriostatic antibiotics acting on bacterial protein synthesis. More specifically, the phenicols block peptide elongation by binding to the peptidyltansferase centre of the 70S ribosome.", "category_aro_class_name": "Drug Class"}, "40360": {"category_aro_accession": "3003706", "category_aro_cvterm_id": "40360", "category_aro_name": "penem", "category_aro_description": "Penems are a class of unsaturated beta-lactam antibiotics with a broad spectrum of antibacterial activity and have a structure which renders them highly resistant to beta-lactamases. All penems are all synthetically made and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. They are structurally similar to carbapenems, however, where carbapenems have a carbon, penems have a sulfur.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.19914, "max_identities": 14, "bit_score": 26.9498, "cvterm_id": "35507", "query": "GSNRMRAFLNMVK-EHYDLVILDLAPVLEVSDTQILAGEMDG", "match": "GS  MR +L+  K   Y L   D+A  L+  ++Q+  G++ G", "sequence_from_db": "GSYAMRIWLDPAKLTSYQLTPSDIATALQAQNSQVAVGQLGG", "sequence_from_broadstreet": "MAQFFIHRPIFAWVIALVIMLAGILTLTKMPIAQYPTIAPPTVTIAATYPGASAETVENTVTQIIEQQMNGLDGLRYISSNSAGNGQASIQLNFEQGVDPDIAQVQVQNKLQSATALLPEDVQRQGVTVTKSGASFLQVIAFYSPDNNLSDSDIKDYVNSSIKEPLSRVAGVGEVQVFGGSYAMRIWLDPAKLTSYQLTPSDIATALQAQNSQVAVGQLGGAPAVQGQVLNATVNAQSLLQTPEQFKNIFLKNTASGAEVRLKDVARVELGSDNYQFDSKFNGKPAAGLAIKIATGANALDTAEAVEQRLSELRKNYPTGLADKLAYDTTPFIRLSIESVVHTLIEAVILVFIVMFLFLQNWRATIIPTLAVPVVVLGTFAVINIFGFSINTLTMFAMVLAIGLLVDDAIVVVENVERVMSEDHTDPVTATSRSMQQISGALVGITSVLTAVFVPMAFFGGTTGVIYRQFSITLVTAMVLSLIVALTFTPALCATILKQHDPNKEPSNNIFARFFRSFNNGFDRMSHSYQNGVSRMLKGKIFSGVLYAVVVALLVFLFQKLPSSFLPEEDQGVVMTLVQLPPNATLDRTGKVIDTMTNFFMNEKDTVESIFTVSGFSFTGVGQNAGIGFVKLKDWSKRTTPETQIGSLIQRGMALNMIIKDASYVMPLQLPAMPELGVTAGFNLQLKDSSGQGHEKLIAARNTILGLASQDKRLVGVRPNGQEDTPQYQINVDQAQAGAMGVSIAEINNTMRIAWGGSYINDFVDRGRVKKVYVQGDAGSRMMPEDLNKWYVRNNKGEMVPFSAFATGEWTYGSPRLERYNGVSSVNIQGTPAPGVSSGDAMKAMEEIIGKLPSMGLQGFDYEWTGLSLEERESGAQAPFLYALSLLIVFLCLAALYESWSIPFSVLLVVPLGVIGAIVLTYLGMIIKGDPNLSNNIYFQVAIIAVIGLSAKNAILIVEFAKELQEKGEDLLDATLHAAKMRLRPIIMTTLAFGFGVLPLALSTGAGAGSQHSVGFGVLGGVLSATFLGIFFIPVFYVWIRSMFKYKPKTINTQEHKS", "dna_sequence_from_broadstreet": "ATGGCACAATTTTTTATTCATCGCCCCATATTTGCGTGGGTGATTGCATTAGTCATTATGTTGGCGGGTATTCTTACGCTAACAAAAATGCCTATTGCACAATATCCAACGATTGCACCACCAACCGTAACGATTGCTGCGACTTATCCTGGTGCATCGGCTGAAACAGTTGAAAATACTGTAACCCAGATCATTGAACAACAAATGAATGGTCTTGATGGCTTACGTTATATTTCATCTAACAGTGCTGGTAATGGTCAGGCATCTATTCAATTAAACTTTGAACAAGGTGTTGACCCTGATATTGCACAGGTTCAAGTTCAAAACAAATTGCAATCTGCAACTGCGCTTTTACCTGAAGATGTACAACGTCAAGGTGTAACAGTTACTAAATCTGGTGCGAGCTTCTTGCAAGTTATTGCATTCTATTCACCAGATAACAACCTGTCAGACTCTGACATTAAAGACTACGTAAACTCGTCAATTAAAGAACCGCTTAGCCGTGTTGCCGGTGTTGGTGAGGTACAGGTCTTCGGTGGCTCATACGCAATGCGTATCTGGCTTGATCCAGCTAAATTAACAAGCTATCAACTTACTCCTAGTGATATTGCAACTGCCTTACAAGCGCAGAACTCGCAAGTTGCCGTAGGTCAGTTAGGTGGTGCTCCGGCTGTACAAGGTCAAGTTCTTAACGCAACAGTAAATGCACAAAGCTTATTGCAGACTCCTGAACAGTTTAAAAATATCTTCTTAAAGAACACAGCATCAGGTGCTGAGGTTCGATTAAAAGATGTTGCTCGCGTAGAATTAGGTTCGGATAACTATCAATTCGACTCGAAGTTTAACGGTAAACCGGCAGCTGGTCTTGCAATTAAAATTGCAACAGGTGCTAACGCACTCGACACAGCCGAAGCAGTTGAACAACGTTTATCTGAACTACGTAAGAACTATCCAACAGGTCTTGCAGATAAACTGGCTTATGACACGACTCCATTTATCCGTCTTTCAATTGAAAGTGTAGTACACACATTAATTGAAGCCGTGATTTTGGTATTCATTGTCATGTTCCTATTCTTACAAAACTGGCGTGCAACGATTATTCCAACGCTTGCAGTTCCAGTAGTTGTATTAGGTACATTTGCGGTCATTAATATCTTTGGCTTCTCAATTAACACCTTAACCATGTTCGCTATGGTATTGGCAATCGGTCTTCTGGTCGACGACGCCATTGTTGTAGTCGAAAACGTTGAACGTGTGATGAGTGAAGACCATACCGATCCGGTTACGGCCACTTCTCGCTCAATGCAGCAGATTTCTGGTGCGTTAGTAGGTATTACCAGCGTATTGACAGCGGTATTCGTACCAATGGCTTTCTTTGGTGGTACAACAGGTGTAATTTACCGCCAGTTCTCGATTACCCTTGTAACTGCAATGGTTCTGTCGTTAATTGTAGCGTTGACGTTCACACCGGCACTTTGTGCAACTATCTTGAAACAGCATGATCCTAATAAAGAACCAAGCAATAATATCTTTGCGCGTTTCTTTAGAAGCTTTAACAATGGTTTTGACCGCATGTCGCATAGCTACCAAAATGGTGTTAGCCGCATGCTTAAAGGCAAAATCTTCTCTGGCGTGCTCTATGCTGTTGTAGTTGCCCTTTTAGTCTTCTTGTTCCAAAAACTCCCGTCTTCATTCTTACCAGAAGAAGATCAGGGTGTGGTCATGACACTTGTACAATTACCACCAAATGCAACGCTTGACCGTACCGGTAAAGTGATTGATACCATGACTAACTTCTTTATGAATGAAAAAGATACCGTGGAATCTATTTTCACTGTTTCTGGTTTCTCATTCACAGGTGTTGGTCAAAACGCGGGTATTGGCTTCGTTAAGTTGAAAGACTGGAGCAAACGTACGACACCAGAAACTCAAATTGGTTCATTGATTCAGCGTGGTATGGCATTAAATATGATCATTAAAGATGCATCATACGTTATGCCGTTACAGCTTCCAGCAATGCCTGAACTTGGTGTAACTGCCGGATTTAACTTGCAGCTTAAAGATTCAAGTGGTCAAGGCCATGAGAAACTGATTGCAGCTCGTAACACGATTTTAGGTTTGGCATCACAAGATAAACGTCTTGTAGGTGTGCGTCCAAATGGTCAGGAAGATACTCCTCAGTATCAAATTAATGTAGATCAGGCTCAAGCTGGTGCTATGGGCGTTAGTATTGCCGAAATCAACAATACAATGCGTATTGCATGGGGTGGCTCATACATTAACGATTTCGTTGACCGTGGTCGTGTGAAAAAAGTTTATGTTCAAGGTGATGCGGGCAGCCGTATGATGCCTGAAGACTTAAACAAATGGTATGTACGTAATAACAAAGGTGAGATGGTTCCATTCTCGGCATTTGCTACAGGCGAATGGACGTATGGTTCTCCACGTCTCGAACGTTATAACGGCGTGTCATCGGTTAACATTCAAGGTACACCTGCACCTGGCGTGAGCTCTGGTGATGCCATGAAAGCAATGGAAGAAATTATTGGTAAGTTACCATCTATGGGCTTACAAGGTTTCGACTATGAGTGGACAGGCTTATCACTTGAAGAACGTGAGTCTGGTGCTCAAGCGCCGTTCTTATACGCACTTTCATTGTTAATCGTATTCCTTTGCTTGGCTGCACTATATGAAAGCTGGTCAATTCCGTTCTCGGTTTTACTTGTGGTACCACTTGGTGTCATTGGTGCAATCGTATTGACCTACTTGGGCATGATTATTAAAGGAGATCCAAATCTCTCAAATAACATTTACTTCCAGGTAGCGATTATTGCGGTTATCGGTCTTTCTGCAAAAAATGCGATCTTGATTGTTGAATTCGCAAAAGAATTGCAGGAAAAAGGTGAAGATCTACTTGATGCAACCTTACATGCTGCAAAAATGCGTTTACGTCCAATTATCATGACCACCCTTGCCTTCGGTTTCGGTGTACTTCCACTTGCACTTTCAACAGGTGCCGGTGCAGGAAGTCAGCACTCTGTAGGCTTTGGTGTACTTGGTGGCGTACTCAGCGCGACGTTCTTAGGAATCTTCTTTATCCCTGTATTCTATGTGTGGATTCGTAGTATGTTTAAGTACAAACCAAAAACCATAAACACTCAGGAGCATAAATCGTGA", "partial": "0", "query_start": 2790, "query_end": 2912, "hit_start": 537, "hit_end": 663, "orf_dna_sequence": "ATGGGATTGTTTAATAGACGTAGAAAACGTGGTACAGATGAAACCATGCAATATGGTGCTAAGTTAATTACTGTAGCAAAACCGCAAAATCCAGTAAGTGAACAGTTTAGAACAGTGAAGACTAATATTGACTTTACTAGTGTTGATCATCAAATCAAAGCTTTAGCTTTTACATCAGCTAATATTAGTGAAGGAAAGTCAACTGTAACAGTGAATGTGGCGGTTACAATGGCTCAAGCAGGTAAAAAAGTATTATTGATTGATGCCGATTTGCACAGACCAACATTACACCAAACATTCGACATTCCAAATCGAGTAGGATTGACTACAATTTTAACTTCACATTCTAATGAAGTTGATATGGCAAATATTGTTAAAGAAGATATTATTCCTAATCTTTCAGTAATGCCTGCTGGTCCTATTCCACCTAATCCAGCTCAATTATTGGGTTCTAATAGAATGCGTGCCTTTCTAAACATGGTTAAGGAACACTATGATTTGGTAATTTTGGATTTAGCGCCGGTCTTAGAAGTTTCAGATACCCAAATTTTAGCTGGTGAAATGGATGGAGTAGTTTTAGTTGTACGTCAAGGAGTTACGCAGAAGGCTGGAGTTGAGCGTGCTATTGAAATGCTTAACTTAACTAAGACACATGTTTTAGGGTATGTAATGAATGACGTGAAAACTGGTCCAGATGGCTATGGATACGGCTATGGCTATGGATACAGTCAAGAAAAAGATGGAGAAACGAAGTAA", "orf_prot_sequence": "MGLFNRRRKRGTDETMQYGAKLITVAKPQNPVSEQFRTVKTNIDFTSVDHQIKALAFTSANISEGKSTVTVNVAVTMAQAGKKVLLIDADLHRPTLHQTFDIPNRVGLTTILTSHSNEVDMANIVKEDIIPNLSVMPAGPIPPNPAQLLGSNRMRAFLNMVKEHYDLVILDLAPVLEVSDTQILAGEMDGVVLVVRQGVTQKAGVERAIEMLNLTKTHVLGYVMNDVKTGPDGYGYGYGYGYSQEKDGETK", "perc_identity": 33.33}, "gnl|BL_ORD_ID|4808|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 2343, "orf_end": 3098, "orf_from": "BGC0000765.1|Exopolysaccharide_4 ", "model_name": "Streptomyces lividans otr(A)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "450", "model_id": "5797", "ARO_accession": "3007127", "ARO_name": "Streptomyces lividans otr(A)", "ARO_category": {"35921": {"category_aro_accession": "0000002", "category_aro_cvterm_id": "35921", "category_aro_name": "tetracycline-resistant ribosomal protection protein", "category_aro_description": "A family of proteins known to bind to the 30S ribosomal subunit. This interaction prevents tetracycline and tetracycline derivatives from inhibiting ribosomal function. Thus, these proteins confer elevated resistance to tetracycline derivatives as a ribosomal protection protein.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.94184, "max_identities": 13, "bit_score": 25.7942, "cvterm_id": "39551", "query": "ERAIEMLNLTKTHVLGYVMNDVKTGPDGYGYGYGY", "match": "E A EM  L +T     +   V+ GP G G  +GY", "sequence_from_db": "EAAEEMPWLDRTRYFATIGLRVEPGPRGSGGAFGY", "sequence_from_broadstreet": "MRTLNIGILAHVDAGKTSLTERLLFDHGAVDRLGSVDAGDTRTVDGGIERRRGITIRSAVAAFTVGDTRVNLIDTPGHSDFVAEVERALEVLDGAVLLLSAVEGVQARTRVLMRALRRLRLPTIVFVNKIDRAGARTDGLLGDVRRLLTPHVAPLTEVADAGTPRARVTRRPPDGRTAEALAEVDTEVLAALVDGPEPTGEDVARALAARTADGSFHPLYHGSALGGQGVAELVEGLLGLIPAATPGTSGGTSGGTEPRGTVFAVRPGPAGERTAYLRLYGGEVHPRRRLTFLRRESDGRTTEVSGRVTRLDVVGGDATLTAGNIAALTVPGGLRVGDRLGGPTDRAPQFAPPTLQTLVRARHPEQAAPLRSALLALADQDPLLHARPAASGATALLLYGEVQMEVLAATLAEDFGIEAEFTPGRVRFLERPAGTDEAAEEMPWLDRTRYFATIGLRVEPGPRGSGGAFGYETELGALPRAFHQAVEETVHDTLRTGLTGAAVTDYRVTLIRSGFSSPLSTAADFRGLTPLVLRRALARAGTVLHEPYQAFEAEVPADTLAAVTALLASLGADFTGTTGGDPAWIVTGELPARRVREAELRLPGLTHGEAVWSSRPCEDRPLKAGNSGPGTGVGGHSGE", "dna_sequence_from_broadstreet": "ATGCGCACCCTGAACATCGGCATTCTGGCCCACGTCGACGCGGGTAAGACCAGCCTGACCGAACGGCTCCTGTTCGACCACGGCGCCGTCGACCGGCTCGGCAGCGTCGACGCCGGCGACACCCGTACGGTCGACGGCGGTATCGAGCGCCGCCGCGGCATCACCATCCGCTCCGCCGTCGCCGCCTTCACCGTCGGCGACACGCGCGTCAACCTGATCGACACCCCGGGACACTCCGACTTCGTCGCGGAGGTCGAGCGGGCCCTGGAAGTGCTCGACGGGGCGGTGCTGCTGCTGTCCGCCGTCGAGGGCGTCCAGGCGCGGACCCGCGTCCTGATGCGCGCGCTGCGGCGGCTGCGGCTGCCCACGATCGTGTTCGTCAACAAGATCGACCGGGCCGGCGCGCGCACCGACGGCCTCCTCGGTGACGTCCGGCGCCTGCTGACGCCGCACGTCGCGCCGCTGACCGAGGTGGCGGACGCCGGTACCCCGCGCGCCCGGGTCACCCGCCGCCCGCCGGACGGGCGGACCGCGGAGGCCCTCGCCGAGGTCGACACGGAGGTCCTGGCCGCGCTGGTCGACGGCCCCGAGCCGACCGGGGAGGACGTGGCCCGCGCCCTCGCCGCCCGTACCGCCGACGGCTCGTTCCACCCGCTGTACCACGGCTCCGCGCTCGGCGGACAGGGCGTCGCGGAGCTGGTCGAGGGCCTGCTCGGCCTGATCCCGGCCGCCACGCCGGGCACGTCCGGCGGCACGTCCGGCGGCACGGAACCGCGCGGCACGGTCTTCGCCGTGCGCCCCGGACCCGCCGGCGAGCGCACCGCGTACCTCAGGCTGTACGGCGGCGAGGTGCACCCGCGCCGGCGGCTCACCTTCCTGCGGCGCGAGTCCGACGGGCGGACCACCGAGGTCTCCGGCCGGGTGACCCGCCTCGACGTCGTCGGCGGCGACGCCACGCTCACCGCCGGGAACATCGCCGCGCTCACCGTTCCCGGGGGCCTGCGCGTCGGCGACCGGCTCGGCGGACCGACCGACCGTGCACCGCAGTTCGCGCCACCGACCCTGCAGACGCTGGTCCGGGCCCGGCACCCGGAGCAGGCGGCGCCGCTGCGCTCCGCCCTGCTGGCGCTGGCCGACCAGGACCCGCTGCTGCACGCCCGACCGGCGGCGTCCGGCGCCACCGCCCTGCTCCTGTACGGCGAGGTCCAGATGGAGGTGCTCGCGGCGACACTGGCCGAGGACTTCGGGATCGAGGCGGAGTTCACGCCGGGCCGCGTCCGGTTCCTGGAGCGTCCGGCGGGCACCGACGAGGCCGCGGAGGAGATGCCGTGGCTCGACCGCACCCGGTACTTCGCGACGATCGGGCTGCGCGTCGAACCGGGTCCGCGCGGCTCCGGCGGGGCCTTCGGGTACGAGACGGAGCTCGGCGCGCTCCCCCGGGCCTTCCACCAGGCCGTCGAGGAGACCGTCCACGACACGCTGCGGACCGGGCTCACCGGTGCGGCGGTCACCGACTACCGGGTCACGCTGATCCGCTCCGGCTTCAGCTCGCCGCTCAGCACGGCCGCCGACTTCCGCGGGCTGACACCGCTCGTGCTGCGCCGTGCCCTCGCCCGCGCGGGGACCGTGCTCCACGAGCCGTACCAGGCCTTCGAGGCGGAGGTCCCGGCGGACACGCTGGCCGCCGTGACGGCCCTGCTGGCCTCGCTGGGCGCGGACTTCACCGGAACGACGGGGGGCGACCCGGCCTGGATCGTCACCGGCGAGCTGCCGGCCCGGCGGGTGCGGGAGGCCGAGCTGCGGCTGCCGGGGCTGACGCACGGGGAGGCGGTCTGGTCCTCCCGCCCTTGCGAGGACCGACCGCTGAAGGCCGGAAACTCTGGGCCTGGCACGGGAGTTGGCGGGCATTCGGGTGAGTAG", "partial": "0", "query_start": 2958, "query_end": 3062, "hit_start": 1308, "hit_end": 1413, "orf_dna_sequence": "ATGGGATTGTTTAATAGACGTAGAAAACGTGGTACAGATGAAACCATGCAATATGGTGCTAAGTTAATTACTGTAGCAAAACCGCAAAATCCAGTAAGTGAACAGTTTAGAACAGTGAAGACTAATATTGACTTTACTAGTGTTGATCATCAAATCAAAGCTTTAGCTTTTACATCAGCTAATATTAGTGAAGGAAAGTCAACTGTAACAGTGAATGTGGCGGTTACAATGGCTCAAGCAGGTAAAAAAGTATTATTGATTGATGCCGATTTGCACAGACCAACATTACACCAAACATTCGACATTCCAAATCGAGTAGGATTGACTACAATTTTAACTTCACATTCTAATGAAGTTGATATGGCAAATATTGTTAAAGAAGATATTATTCCTAATCTTTCAGTAATGCCTGCTGGTCCTATTCCACCTAATCCAGCTCAATTATTGGGTTCTAATAGAATGCGTGCCTTTCTAAACATGGTTAAGGAACACTATGATTTGGTAATTTTGGATTTAGCGCCGGTCTTAGAAGTTTCAGATACCCAAATTTTAGCTGGTGAAATGGATGGAGTAGTTTTAGTTGTACGTCAAGGAGTTACGCAGAAGGCTGGAGTTGAGCGTGCTATTGAAATGCTTAACTTAACTAAGACACATGTTTTAGGGTATGTAATGAATGACGTGAAAACTGGTCCAGATGGCTATGGATACGGCTATGGCTATGGATACAGTCAAGAAAAAGATGGAGAAACGAAGTAA", "orf_prot_sequence": "MGLFNRRRKRGTDETMQYGAKLITVAKPQNPVSEQFRTVKTNIDFTSVDHQIKALAFTSANISEGKSTVTVNVAVTMAQAGKKVLLIDADLHRPTLHQTFDIPNRVGLTTILTSHSNEVDMANIVKEDIIPNLSVMPAGPIPPNPAQLLGSNRMRAFLNMVKEHYDLVILDLAPVLEVSDTQILAGEMDGVVLVVRQGVTQKAGVERAIEMLNLTKTHVLGYVMNDVKTGPDGYGYGYGYGYSQEKDGETK", "perc_identity": 37.14}}, "BGC0000765.1|Exopolysaccharide_5 # 3105 # 3875 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.354": {"gnl|BL_ORD_ID|73|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 3105, "orf_end": 3875, "orf_from": "BGC0000765.1|Exopolysaccharide_5 ", "model_name": "GIM-1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "84", "ARO_accession": "3000845", "ARO_name": "GIM-1", "ARO_category": {"39772": {"category_aro_accession": "3003195", "category_aro_cvterm_id": "39772", "category_aro_name": "GIM beta-lactamase", "category_aro_description": "GIM beta-lactamase enzymes isolated from Pseudomonas aeruginosa, and found to confer broad-spectrum resistance to beta-lactam antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35923": {"category_aro_accession": "0000004", "category_aro_cvterm_id": "35923", "category_aro_name": "monobactam", "category_aro_description": "Monobactams are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Unlike penams and cephems, monobactams do not have any ring fused to its four-member lactam structure. Monobactam antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35962": {"category_aro_accession": "0000044", "category_aro_cvterm_id": "35962", "category_aro_name": "cephamycin", "category_aro_description": "Cephamycins are a group of beta-lactam antibiotics, very similar to cephalosporins. Together with cephalosporins, they form a sub-group of antibiotics known as cephems. Cephamycins are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. The 7-alpha-methoxy group increases resistance to beta-lactamases.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "40360": {"category_aro_accession": "3003706", "category_aro_cvterm_id": "40360", "category_aro_name": "penem", "category_aro_description": "Penems are a class of unsaturated beta-lactam antibiotics with a broad spectrum of antibacterial activity and have a structure which renders them highly resistant to beta-lactamases. All penems are all synthetically made and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. They are structurally similar to carbapenems, however, where carbapenems have a carbon, penems have a sulfur.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.58229, "max_identities": 11, "bit_score": 26.9498, "cvterm_id": "36752", "query": "SEDVPTYAKDMTFKLLGRGITPIIVH", "match": "S+ +PTY  ++T KLL R   P+  H", "sequence_from_db": "SKSIPTYTSELTKKLLAREGKPVPTH", "sequence_from_broadstreet": "MKNVLVFLILLVALPALAQGHKPLEVIKIEDGVYLHTSFKNIEGYGLVDSNGLVVLDNNQAYIIDTPWSEEDTKLLLSWATDRGYQVMASISTHSHEDRTAGIKLLNSKSIPTYTSELTKKLLAREGKPVPTHYFKDDEFTLGNGLIELYYPGAGHTEDNIVAWLPKSKILFGGCLVRSHEWEGLGYVGDASISSWADSIKNIVSKKYPIQMVVPGHGKVGSSDILDHTIDLAESASNKLMQPTAEASAD", "dna_sequence_from_broadstreet": "ATGAAAAATGTATTAGTGTTTTTAATATTACTTGTAGCGTTGCCAGCTTTAGCTCAGGGTCATAAACCGCTAGAAGTTATAAAAATTGAAGATGGAGTATATCTTCATACCTCCTTTAAGAATATTGAAGGCTATGGGTTAGTTGATTCGAATGGGTTGGTAGTTCTGGATAATAATCAAGCCTATATTATCGACACACCTTGGTCTGAAGAAGACACGAAGTTGTTATTATCCTGGGCGACTGACAGGGGATACCAGGTTATGGCTAGCATCTCAACTCATTCTCATGAAGATCGCACTGCTGGTATCAAGTTGCTAAATTCAAAGTCAATTCCTACATACACATCAGAGTTAACTAAAAAGCTTCTTGCCCGTGAAGGAAAGCCGGTTCCTACCCACTACTTTAAAGACGACGAATTCACACTGGGAAATGGGCTTATAGAGCTCTACTATCCAGGTGCTGGGCATACAGAGGATAATATTGTTGCTTGGTTACCCAAAAGCAAAATACTATTTGGTGGCTGCCTCGTGAGGAGTCATGAGTGGGAAGGCTTAGGTTACGTAGGCGACGCCTCAATTAGCTCTTGGGCTGACTCAATTAAAAATATTGTATCGAAAAAATATCCCATTCAAATGGTCGTTCCGGGGCATGGCAAAGTTGGAAGTTCAGATATATTAGATCACACCATTGATCTTGCTGAATCAGCTTCTAACAAATTAATGCAACCGACCGCTGAAGCGTCGGCTGATTAA", "partial": "0", "query_start": 3444, "query_end": 3521, "hit_start": 321, "hit_end": 399, "orf_dna_sequence": "ATGGTATTAGTTGACATTCACGCACATATATTGCCAGGAATTGATGATGGTTCTCCTGATTTGGAATCTTCATTAGGTCTAGCAGAAGCTGCAGTAGCCGATGGAATTACTCATGCATTAATGACCCCACATACTTTAAATGGAAAATATTTAAATCATAAAGAGGATATCATTAAAGAGACAGCTAGTTTTCAAAAGGAATTAGAACAGCACAATATTCCTTTGACTGTCTTTCCAAGTCAAGAAGTTCGTCTAAATGGTAATTTACCGCAAGCTTTAGATGATGATGATATCTTATTTTGTGATGAAGATGGCAGATATATGCTATTAGAATTTCCAAGTGAAGATGTACCAACTTATGCCAAAGATATGACTTTTAAATTGTTAGGACGGGGGATTACCCCAATCATTGTTCATCCAGAAAGGAATTCTGGTATCTTGGCTCATCCAGAAAAATTACAAGAGTTTATTGAGCAAGGCTGTTTAACGCACATAACTGCTAGTTCGTATGTGGGAGTCTTTGGAAAAGAGATCGAAAAATTAGCTGATCAATTTGTAGAAGCGGGTCAAGTAGCCACTTTTGCTTCAGATGCACATACGTTGCCAAAACGTGAAAGTCGAATGCATGACGCTTATGAGAAGTTAGAAAAAACGCAAGGATTGGATGTTGCTAATAGCTTTAAGCAGAATGCACGAAACATTATTAATTCTGATAATGTTAATTTAAATTGGAAACCTTTAAAGAAAAAGAAACGGTTTTGGATATTTTAA", "orf_prot_sequence": "MVLVDIHAHILPGIDDGSPDLESSLGLAEAAVADGITHALMTPHTLNGKYLNHKEDIIKETASFQKELEQHNIPLTVFPSQEVRLNGNLPQALDDDDILFCDEDGRYMLLEFPSEDVPTYAKDMTFKLLGRGITPIIVHPERNSGILAHPEKLQEFIEQGCLTHITASSYVGVFGKEIEKLADQFVEAGQVATFASDAHTLPKRESRMHDAYEKLEKTQGLDVANSFKQNARNIINSDNVNLNWKPLKKKKRFWIF", "perc_identity": 42.31}, "gnl|BL_ORD_ID|1487|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 3105, "orf_end": 3875, "orf_from": "BGC0000765.1|Exopolysaccharide_5 ", "model_name": "GIM-2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1623", "ARO_accession": "3003194", "ARO_name": "GIM-2", "ARO_category": {"39772": {"category_aro_accession": "3003195", "category_aro_cvterm_id": "39772", "category_aro_name": "GIM beta-lactamase", "category_aro_description": "GIM beta-lactamase enzymes isolated from Pseudomonas aeruginosa, and found to confer broad-spectrum resistance to beta-lactam antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35923": {"category_aro_accession": "0000004", "category_aro_cvterm_id": "35923", "category_aro_name": "monobactam", "category_aro_description": "Monobactams are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Unlike penams and cephems, monobactams do not have any ring fused to its four-member lactam structure. Monobactam antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35962": {"category_aro_accession": "0000044", "category_aro_cvterm_id": "35962", "category_aro_name": "cephamycin", "category_aro_description": "Cephamycins are a group of beta-lactam antibiotics, very similar to cephalosporins. Together with cephalosporins, they form a sub-group of antibiotics known as cephems. Cephamycins are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. The 7-alpha-methoxy group increases resistance to beta-lactamases.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "40360": {"category_aro_accession": "3003706", "category_aro_cvterm_id": "40360", "category_aro_name": "penem", "category_aro_description": "Penems are a class of unsaturated beta-lactam antibiotics with a broad spectrum of antibacterial activity and have a structure which renders them highly resistant to beta-lactamases. All penems are all synthetically made and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. They are structurally similar to carbapenems, however, where carbapenems have a carbon, penems have a sulfur.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.64003, "max_identities": 11, "bit_score": 26.9498, "cvterm_id": "36884", "query": "SEDVPTYAKDMTFKLLGRGITPIIVH", "match": "S+ +PTY  ++T KLL R   P+  H", "sequence_from_db": "SKSIPTYTSELTKKLLAREGKPVPTH", "sequence_from_broadstreet": "MKNVLVFLILLVALPALAQGHKPLEVIKIEDGVYLHTSFKNIEGYGLVDSNGLVVLDNNQAYIIDTPWSEEDTKLLLSWATDRGYQVMASISTHSHGDRTAGIKLLNSKSIPTYTSELTKKLLAREGKPVPTHYFKDDEFTLGNGLIELYYPGAGHTEDNIVAWLPKSKILFGGCLVRSHEWEGLGYVGDASISSWADSIKNIVSKKYPIQMVVPGHGKVGSSDILDHTIDLAESASNKLMQPTAEASAD", "dna_sequence_from_broadstreet": "ATGAAAAATGTATTAGTGTTTTTAATATTACTTGTAGCGTTGCCAGCTTTAGCTCAGGGTCATAAACCGCTAGAAGTTATAAAAATTGAAGATGGAGTATATCTTCATACCTCCTTTAAGAATATTGAAGGCTATGGGTTAGTTGATTCGAATGGGTTGGTAGTTCTGGATAATAATCAAGCCTATATTATCGACACACCTTGGTCTGAAGAAGACACGAAGTTGTTATTATCCTGGGCGACTGACAGGGGATACCAGGTTATGGCTAGCATCTCAACTCATTCTCATGGAGATCGCACTGCTGGTATCAAGTTGCTAAATTCAAAGTCAATTCCTACATACACATCAGAGTTAACTAAAAAGCTTCTTGCCCGTGAAGGAAAGCCGGTTCCTACCCACTACTTTAAAGACGACGAATTCACACTGGGAAATGGGCTTATAGAGCTCTACTATCCAGGTGCTGGGCATACAGAGGATAATATTGTTGCTTGGTTACCCAAAAGCAAAATACTATTTGGTGGCTGCCTCGTGAGGAGTCATGAGTGGGAAGGCTTAGGTTACGTAGGCGACGCCTCAATTAGCTCTTGGGCTGACTCAATTAAAAATATTGTATCGAAAAAATATCCCATTCAAATGGTCGTTCCGGGGCATGGCAAAGTTGGAAGTTCAGATATATTAGATCACACCATTGATCTTGCTGAATCAGCTTCTAACAAATTAATGCAACCGACCGCTGAAGCGTCGGCTGATTAA", "partial": "0", "query_start": 3444, "query_end": 3521, "hit_start": 321, "hit_end": 399, "orf_dna_sequence": "ATGGTATTAGTTGACATTCACGCACATATATTGCCAGGAATTGATGATGGTTCTCCTGATTTGGAATCTTCATTAGGTCTAGCAGAAGCTGCAGTAGCCGATGGAATTACTCATGCATTAATGACCCCACATACTTTAAATGGAAAATATTTAAATCATAAAGAGGATATCATTAAAGAGACAGCTAGTTTTCAAAAGGAATTAGAACAGCACAATATTCCTTTGACTGTCTTTCCAAGTCAAGAAGTTCGTCTAAATGGTAATTTACCGCAAGCTTTAGATGATGATGATATCTTATTTTGTGATGAAGATGGCAGATATATGCTATTAGAATTTCCAAGTGAAGATGTACCAACTTATGCCAAAGATATGACTTTTAAATTGTTAGGACGGGGGATTACCCCAATCATTGTTCATCCAGAAAGGAATTCTGGTATCTTGGCTCATCCAGAAAAATTACAAGAGTTTATTGAGCAAGGCTGTTTAACGCACATAACTGCTAGTTCGTATGTGGGAGTCTTTGGAAAAGAGATCGAAAAATTAGCTGATCAATTTGTAGAAGCGGGTCAAGTAGCCACTTTTGCTTCAGATGCACATACGTTGCCAAAACGTGAAAGTCGAATGCATGACGCTTATGAGAAGTTAGAAAAAACGCAAGGATTGGATGTTGCTAATAGCTTTAAGCAGAATGCACGAAACATTATTAATTCTGATAATGTTAATTTAAATTGGAAACCTTTAAAGAAAAAGAAACGGTTTTGGATATTTTAA", "orf_prot_sequence": "MVLVDIHAHILPGIDDGSPDLESSLGLAEAAVADGITHALMTPHTLNGKYLNHKEDIIKETASFQKELEQHNIPLTVFPSQEVRLNGNLPQALDDDDILFCDEDGRYMLLEFPSEDVPTYAKDMTFKLLGRGITPIIVHPERNSGILAHPEKLQEFIEQGCLTHITASSYVGVFGKEIEKLADQFVEAGQVATFASDAHTLPKRESRMHDAYEKLEKTQGLDVANSFKQNARNIINSDNVNLNWKPLKKKKRFWIF", "perc_identity": 42.31}, "gnl|BL_ORD_ID|41|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 3105, "orf_end": 3875, "orf_from": "BGC0000765.1|Exopolysaccharide_5 ", "model_name": "AAC(3)-IIIc", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "51", "ARO_accession": "3002538", "ARO_name": "AAC(3)-IIIc", "ARO_category": {"36461": {"category_aro_accession": "3000322", "category_aro_cvterm_id": "36461", "category_aro_name": "AAC(3)", "category_aro_description": "A category of aminoglycoside N-acetyltransferase enzymes with modification regiospecificity based at the 3-amino group of the respective antibiotic. These enzymes inactivate aminoglycoside antibiotics through acetylation of the 3-amino group of the compound.", "category_aro_class_name": "AMR Gene Family"}, "40942": {"category_aro_accession": "3004015", "category_aro_cvterm_id": "40942", "category_aro_name": "gentamicin A", "category_aro_description": "Gentamicin A is part of a complex of broad spectrum aminoglycoside antibiotics. Gentamicin inhibits protein synthesis, resulting in bacterial cell death.", "category_aro_class_name": "Antibiotic"}, "46133": {"category_aro_accession": "3007382", "category_aro_cvterm_id": "46133", "category_aro_name": "gentamicin", "category_aro_description": "Gentamicin is a commonly used aminoglycoside antibiotic derived from members of the Micromonospora genus of bacteria. It acts by binding the 30S ribosomal subunit, thus inhibiting protein synthesis. Gentamicin is typically used to treat Gram-negative infections of the repiratory and urinary tract, as well as infections of the bone and soft tissue. It also exhibits considerable nephrotoxicity and ototoxicity. Gentamicin is administered as a mixture of gentamicin type C (which makes about around 80% of the complex) and types A, B, and X (distributed in the remaining 20% of the complex).", "category_aro_class_name": "Antibiotic"}, "35935": {"category_aro_accession": "0000016", "category_aro_cvterm_id": "35935", "category_aro_name": "aminoglycoside antibiotic", "category_aro_description": "Aminoglycosides are a group of antibiotics that are mostly effective against Gram-negative bacteria. These molecules consist of aminated sugars attached to a dibasic cyclitol. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit (some work by binding to the 50S subunit), inhibiting the translocation of the peptidyl-tRNA from the A-site to the P-site and also causing misreading of mRNA, leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.82203, "max_identities": 13, "bit_score": 26.9498, "cvterm_id": "36752", "query": "EDIIKETASFQKELEQHNIPLTVFPSQEVRLNGNLPQAL", "match": "ED++ E     +E  +H  P     S+ +R NG LP+ L", "sequence_from_db": "EDLVDEDGRVPQEWREHIPPFDPRRSRAIRDNGVLPEFL", "sequence_from_broadstreet": "MFSRWSKPLVLAAVTRASLAADLAALGLAAGDAVMVHAAVSKVGRLLDGPDTIIAALSDAGRPAGTILAYADWEARYEDLVDEDGRVPQEWREHIPPFDPRRSRAIRDNGVLPEFLRTTPGALRSGNPGASMVGLGARAEWFTADHPLDYGYGEGSPLARLVEAGGKVLMLGAPLDTLTLLHHAEHLADIPGKRIRRIEVPLATPTGTQWRMIEEFDTGDPIVEGLAEDYFAEIVTAFLAGGRGRQGLIGTAPSVLVDAAAITAFGVAWLESRFGSPSS", "dna_sequence_from_broadstreet": "ATGTTCTCTCGTTGGTCGAAACCTCTCGTGCTTGCCGCCGTGACCCGCGCCTCGCTCGCCGCTGATCTCGCCGCGCTTGGCCTTGCCGCGGGCGATGCGGTCATGGTCCATGCCGCCGTCAGCAAGGTCGGCCGCCTGCTCGACGGTCCCGACACGATCATCGCCGCTCTGTCCGACGCCGGTCGGCCTGCCGGCACCATCCTCGCCTATGCCGATTGGGAAGCGCGCTACGAGGACCTCGTGGACGAGGACGGCCGCGTGCCGCAGGAATGGCGCGAGCACATCCCACCCTTCGATCCGCGGCGCTCACGCGCGATCCGCGACAATGGCGTGCTTCCGGAATTCCTGCGGACGACACCGGGTGCGTTGCGCAGCGGCAATCCCGGCGCCTCGATGGTCGGGCTCGGCGCCAGAGCGGAATGGTTCACCGCAGACCATCCCCTCGACTACGGCTATGGCGAGGGTTCGCCGCTGGCCAGGCTGGTCGAAGCCGGCGGCAAGGTGCTGATGCTCGGGGCGCCGCTCGACACGCTGACCCTGCTGCACCATGCCGAGCATCTGGCCGACATCCCCGGCAAGCGCATCCGGCGGATCGAGGTGCCGCTGGCGACGCCGACCGGCACGCAATGGCGCATGATCGAGGAATTCGATACCGGCGATCCGATCGTCGAAGGTTTGGCCGAGGACTACTTCGCCGAGATCGTGACGGCGTTCCTTGCCGGCGGCCGAGGACGGCAGGGCTTGATCGGCACCGCGCCATCCGTGCTGGTCGATGCTGCCGCAATCACGGCTTTCGGCGTCGCCTGGCTGGAATCGCGCTTCGGCTCGCCCTCATCCTGA", "partial": "0", "query_start": 3267, "query_end": 3383, "hit_start": 231, "hit_end": 348, "orf_dna_sequence": "ATGGTATTAGTTGACATTCACGCACATATATTGCCAGGAATTGATGATGGTTCTCCTGATTTGGAATCTTCATTAGGTCTAGCAGAAGCTGCAGTAGCCGATGGAATTACTCATGCATTAATGACCCCACATACTTTAAATGGAAAATATTTAAATCATAAAGAGGATATCATTAAAGAGACAGCTAGTTTTCAAAAGGAATTAGAACAGCACAATATTCCTTTGACTGTCTTTCCAAGTCAAGAAGTTCGTCTAAATGGTAATTTACCGCAAGCTTTAGATGATGATGATATCTTATTTTGTGATGAAGATGGCAGATATATGCTATTAGAATTTCCAAGTGAAGATGTACCAACTTATGCCAAAGATATGACTTTTAAATTGTTAGGACGGGGGATTACCCCAATCATTGTTCATCCAGAAAGGAATTCTGGTATCTTGGCTCATCCAGAAAAATTACAAGAGTTTATTGAGCAAGGCTGTTTAACGCACATAACTGCTAGTTCGTATGTGGGAGTCTTTGGAAAAGAGATCGAAAAATTAGCTGATCAATTTGTAGAAGCGGGTCAAGTAGCCACTTTTGCTTCAGATGCACATACGTTGCCAAAACGTGAAAGTCGAATGCATGACGCTTATGAGAAGTTAGAAAAAACGCAAGGATTGGATGTTGCTAATAGCTTTAAGCAGAATGCACGAAACATTATTAATTCTGATAATGTTAATTTAAATTGGAAACCTTTAAAGAAAAAGAAACGGTTTTGGATATTTTAA", "orf_prot_sequence": "MVLVDIHAHILPGIDDGSPDLESSLGLAEAAVADGITHALMTPHTLNGKYLNHKEDIIKETASFQKELEQHNIPLTVFPSQEVRLNGNLPQALDDDDILFCDEDGRYMLLEFPSEDVPTYAKDMTFKLLGRGITPIIVHPERNSGILAHPEKLQEFIEQGCLTHITASSYVGVFGKEIEKLADQFVEAGQVATFASDAHTLPKRESRMHDAYEKLEKTQGLDVANSFKQNARNIINSDNVNLNWKPLKKKKRFWIF", "perc_identity": 33.33}, "gnl|BL_ORD_ID|431|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 3105, "orf_end": 3875, "orf_from": "BGC0000765.1|Exopolysaccharide_5 ", "model_name": "IMP-29", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "479", "ARO_accession": "3002220", "ARO_name": "IMP-29", "ARO_category": {"36029": {"category_aro_accession": "3000020", "category_aro_cvterm_id": "36029", "category_aro_name": "IMP beta-lactamase", "category_aro_description": "Plasmid mediated IMP-type carbapenemases, of which at least 26 varieties are currently known, became established in Japan in the 1990s in enteric gram-negative organisms, Pseudomonas and Acinetobacter species. Integron-associated, sometimes within plasmids. Hydrolyses all beta-lactams except monobactams, and evades all beta-lactam inhibitors.", "category_aro_class_name": "AMR Gene Family"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35962": {"category_aro_accession": "0000044", "category_aro_cvterm_id": "35962", "category_aro_name": "cephamycin", "category_aro_description": "Cephamycins are a group of beta-lactam antibiotics, very similar to cephalosporins. Together with cephalosporins, they form a sub-group of antibiotics known as cephems. Cephamycins are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. The 7-alpha-methoxy group increases resistance to beta-lactamases.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "40360": {"category_aro_accession": "3003706", "category_aro_cvterm_id": "40360", "category_aro_name": "penem", "category_aro_description": "Penems are a class of unsaturated beta-lactam antibiotics with a broad spectrum of antibacterial activity and have a structure which renders them highly resistant to beta-lactamases. All penems are all synthetically made and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. They are structurally similar to carbapenems, however, where carbapenems have a carbon, penems have a sulfur.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.26604, "max_identities": 9, "bit_score": 25.0238, "cvterm_id": "36752", "query": "SEDVPTYAKDMTFKLLGRG", "match": "S+ +PTYA ++T +LL +G", "sequence_from_db": "SQSIPTYASELTNELLKKG", "sequence_from_broadstreet": "MSKLFVFLIFLFCSITAAAESLPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNTEAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASELTNELLKKGGKVQAKNSFSGVSYWLVKKKIEVFYPGPGHTPDNVVVWLPENRVLFGGCFVKPYGLGNLDDANVEAWPHSAEILMSRYGNAKLVVPSHSDIGNASLLKLTWEQAVKGLKESKKPSQPSN", "dna_sequence_from_broadstreet": "ATGAGCAAGTTATTTGTATTCCTTATTTTTTTGTTTTGTAGCATTACTGCCGCAGCAGAGTCTTTGCCAGATTTAAAAATTGAGAAGCTCGACGAAGGCGTTTATGTTCATACTTCGTTTGAAGAAGTTAACGGTTGGGGTGTTGTTCCTAAACATGGCTTGGTGGTTCTTGTAAATACTGAGGCCTATCTGATTGACACTCCATTTACGGCTAAAGATACTGAAAAGTTAGTCACTTGGTTTGTGGAACGCGGCTATAAAATAAAAGGCAGTATTTCCTCTCATTTTCATAGCGACAGCACAGGCGGAATAGAGTGGCTTAATTCTCAATCTATCCCCACGTATGCATCTGAATTAACAAATGAACTTCTTAAAAAAGGCGGTAAAGTACAAGCTAAAAATTCATTTAGCGGAGTTAGCTATTGGCTAGTTAAGAAAAAGATTGAAGTTTTTTATCCTGGTCCAGGGCACACTCCAGATAACGTAGTGGTTTGGCTACCTGAAAATAGAGTTTTGTTCGGTGGTTGTTTTGTTAAACCGTACGGTCTTGGAAATCTCGATGACGCAAATGTTGAAGCATGGCCACATTCTGCTGAAATATTAATGTCTAGGTATGGTAATGCAAAACTGGTTGTTCCAAGCCATAGTGACATCGGAAATGCGTCGCTCTTGAAGCTTACATGGGAGCAGGCTGTTAAAGGGCTAAAAGAAAGTAAAAAACCATCACAGCCAAGTAACTAA", "partial": "0", "query_start": 3444, "query_end": 3500, "hit_start": 324, "hit_end": 381, "orf_dna_sequence": "ATGGTATTAGTTGACATTCACGCACATATATTGCCAGGAATTGATGATGGTTCTCCTGATTTGGAATCTTCATTAGGTCTAGCAGAAGCTGCAGTAGCCGATGGAATTACTCATGCATTAATGACCCCACATACTTTAAATGGAAAATATTTAAATCATAAAGAGGATATCATTAAAGAGACAGCTAGTTTTCAAAAGGAATTAGAACAGCACAATATTCCTTTGACTGTCTTTCCAAGTCAAGAAGTTCGTCTAAATGGTAATTTACCGCAAGCTTTAGATGATGATGATATCTTATTTTGTGATGAAGATGGCAGATATATGCTATTAGAATTTCCAAGTGAAGATGTACCAACTTATGCCAAAGATATGACTTTTAAATTGTTAGGACGGGGGATTACCCCAATCATTGTTCATCCAGAAAGGAATTCTGGTATCTTGGCTCATCCAGAAAAATTACAAGAGTTTATTGAGCAAGGCTGTTTAACGCACATAACTGCTAGTTCGTATGTGGGAGTCTTTGGAAAAGAGATCGAAAAATTAGCTGATCAATTTGTAGAAGCGGGTCAAGTAGCCACTTTTGCTTCAGATGCACATACGTTGCCAAAACGTGAAAGTCGAATGCATGACGCTTATGAGAAGTTAGAAAAAACGCAAGGATTGGATGTTGCTAATAGCTTTAAGCAGAATGCACGAAACATTATTAATTCTGATAATGTTAATTTAAATTGGAAACCTTTAAAGAAAAAGAAACGGTTTTGGATATTTTAA", "orf_prot_sequence": "MVLVDIHAHILPGIDDGSPDLESSLGLAEAAVADGITHALMTPHTLNGKYLNHKEDIIKETASFQKELEQHNIPLTVFPSQEVRLNGNLPQALDDDDILFCDEDGRYMLLEFPSEDVPTYAKDMTFKLLGRGITPIIVHPERNSGILAHPEKLQEFIEQGCLTHITASSYVGVFGKEIEKLADQFVEAGQVATFASDAHTLPKRESRMHDAYEKLEKTQGLDVANSFKQNARNIINSDNVNLNWKPLKKKKRFWIF", "perc_identity": 47.37}, "gnl|BL_ORD_ID|4680|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 3105, "orf_end": 3875, "orf_from": "BGC0000765.1|Exopolysaccharide_5 ", "model_name": "vanT gene in vanE cluster", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "200", "model_id": "1308", "ARO_accession": "3002971", "ARO_name": "vanT gene in vanE cluster", "ARO_category": {"36373": {"category_aro_accession": "3000234", "category_aro_cvterm_id": "36373", "category_aro_name": "glycopeptide resistance gene cluster", "category_aro_description": "Genes that when expressed confer resistance to vancomycin and teicoplanin type antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "36511": {"category_aro_accession": "3000372", "category_aro_cvterm_id": "36511", "category_aro_name": "vanT", "category_aro_description": "VanT is a membrane bound serine racemase, converting L-serine to D-serine. It is associated with VanC, which incorporated D-serine into D-Ala-D-Ser terminal end of peptidoglycan subunits that have a decreased binding affinity with vancomycin. It was isolated from Enterococcus gallinarum.", "category_aro_class_name": "AMR Gene Family"}, "35947": {"category_aro_accession": "0000028", "category_aro_cvterm_id": "35947", "category_aro_name": "vancomycin", "category_aro_description": "Vancomycin is a glycopeptide antibiotic used in the prophylaxis and treatment of infections caused by Gram-positive bacteria. Vancomycin inhibits the synthesis of peptidoglycan, the major component of the cell wall of gram-positive bacteria. Its mechanism of action is unusual in that it acts by binding precursors of peptidoglycan, rather than by interacting with an enzyme.", "category_aro_class_name": "Antibiotic"}, "36220": {"category_aro_accession": "3000081", "category_aro_cvterm_id": "36220", "category_aro_name": "glycopeptide antibiotic", "category_aro_description": "Glycopeptide antibiotics are natural products produced non-ribosomally by Actinomycetales bacteria. With the exception of bleomycins, they act by binding the terminal D-Ala-D-Ala in peptidoglycan precursors of the growing bacterial cell wall and are generally active against Gram-positive bacteria.  This inhibits transglycosylation leading to cell death due to osmotic stress.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.47504, "max_identities": 13, "bit_score": 24.6386, "cvterm_id": "35918", "query": "GITPIIVHPERNSGILAHPEKLQEFIEQGCLTHITASSY", "match": "GI+    H + + GIL +PE   +F+  G L +   S Y", "sequence_from_db": "GISYGYTHIQSSYGILNYPELSFDFVRIGILCYGFLSDY", "sequence_from_broadstreet": "MKHRANGIDLFRIFAATMVVAIHTFPFQSIAPFLDEVITLTVFRVAVPFFFMITGYFLLGRLSLNFSYNNNQRVKKYLYKIGMIYLYSILLYFPLSLLNGTISLKMNILLLLKVFIFDGTFYHLWYFPASIIGTILVTLLLRSIGFKLTVAFSTCLYLVGLGGDSWYGITNQVPLLNKLYTFIFSWSDYTRSGVFFTPVFLCLGIFAYRVSKKLTASKILNLLFYVFIIGMTFESIFLHRFTNVKHDSMYLLLPSCALILFLMLLNWQPKLKVKESADLTLLVYILHPLVIVIVHSISKYIPILKNSLLNFLLVVVCSFILAQLLLNLKRKLRVSKQKIPFERASKEISASAIHHNINEIRKIIPKNTNIMGVVKANAYGCGMVEVAYELEKIGISFFCVATIEEAIALRKSGNQGDILILGYTHPNRINDIKKYNLIQSIVSEEHGKVLNLKKIPIRCHLQVDTGMHRLGVTPNVTIIQQMYLFSNLKIEGIYSHLGSSDSLEQESIARTNTQIFLFNNILSDLEQMGISYGYTHIQSSYGILNYPELSFDFVRIGILCYGFLSDYNSPTKIPIDLQPIVKVKASLITERIVEAGEYVGYGLGAKVEKRTRIGVVSIGYADGIPRALSNAKLTLEFKGQSIKQIGNICMDMMLVDLSEVEDISLNDELIVLPNISKIADEEQTITNELLSRLGSRLGTELN", "dna_sequence_from_broadstreet": "ATGAAGCATAGAGCTAACGGCATTGATCTATTTCGAATATTCGCTGCTACTATGGTTGTTGCTATCCATACATTCCCTTTTCAATCAATAGCACCTTTTTTAGACGAAGTCATAACGTTAACTGTGTTTCGGGTAGCTGTCCCTTTTTTCTTTATGATTACAGGATATTTTTTGTTAGGAAGATTGTCATTAAATTTTTCGTATAATAATAATCAGAGAGTGAAAAAATATCTATACAAAATTGGAATGATTTATTTATATTCTATTTTATTGTATTTCCCATTATCTTTACTAAATGGCACTATTTCATTAAAAATGAACATACTTTTACTTTTAAAGGTTTTCATTTTTGACGGTACCTTTTATCACCTATGGTACTTTCCAGCTAGTATAATTGGAACGATTTTAGTAACCCTACTGTTACGTAGTATAGGATTTAAATTAACAGTCGCATTTTCTACATGTCTATATCTAGTTGGACTTGGTGGAGACAGCTGGTACGGGATAACCAATCAAGTTCCATTGCTAAATAAACTGTATACATTTATTTTTAGTTGGTCGGACTATACGCGTTCAGGTGTTTTCTTTACGCCTGTGTTTCTTTGCCTAGGAATATTTGCCTATAGAGTATCTAAAAAGTTAACTGCATCAAAGATATTAAACTTGCTTTTTTATGTGTTTATCATAGGTATGACTTTTGAGAGTATATTTCTACACCGATTTACGAACGTCAAACACGATAGTATGTATCTCTTATTGCCTTCATGTGCATTAATTTTGTTTTTAATGTTATTAAACTGGCAACCAAAACTAAAGGTAAAAGAATCAGCCGATTTAACGTTACTGGTTTATATTCTCCATCCATTAGTTATTGTAATTGTCCATTCTATAAGTAAGTATATTCCGATATTAAAAAACAGTTTGCTAAATTTCTTGTTAGTAGTCGTGTGCAGCTTTATACTAGCTCAGCTTCTGTTAAACTTAAAAAGAAAGCTAAGAGTTAGTAAGCAAAAAATACCATTTGAACGTGCTAGTAAAGAAATATCAGCTAGTGCAATACACCATAATATTAATGAAATACGAAAGATAATTCCCAAAAATACAAATATTATGGGTGTTGTGAAGGCAAATGCGTATGGCTGTGGCATGGTAGAGGTAGCTTATGAATTAGAAAAAATCGGTATTTCATTTTTCTGCGTAGCTACTATAGAAGAAGCAATTGCTTTAAGGAAATCAGGAAACCAAGGGGATATTTTAATTTTAGGGTATACACATCCCAATCGCATTAATGATATAAAAAAATATAATTTGATTCAATCGATTGTAAGTGAAGAACATGGGAAAGTGTTGAATCTAAAAAAAATACCTATTCGTTGTCATTTACAGGTTGATACTGGGATGCATCGTTTAGGTGTTACACCGAACGTAACAATTATTCAGCAGATGTATCTTTTTTCCAATCTTAAGATTGAGGGGATATACTCACACTTAGGTTCTTCAGACTCATTAGAGCAAGAATCAATCGCTCGAACAAATACTCAAATTTTTTTATTCAATAATATACTAAGTGATTTGGAACAAATGGGTATTTCCTACGGTTATACTCATATCCAAAGCAGCTATGGTATTTTAAATTACCCAGAATTAAGCTTTGATTTTGTGAGAATAGGAATTCTCTGTTATGGATTTTTAAGTGACTATAATAGTCCGACTAAAATCCCTATAGATTTACAACCTATAGTAAAAGTAAAAGCCTCTTTGATTACAGAAAGAATTGTGGAGGCAGGTGAATATGTTGGCTATGGATTAGGCGCTAAAGTTGAAAAAAGAACAAGAATAGGTGTCGTTAGTATTGGGTATGCGGACGGTATACCAAGGGCATTATCCAATGCTAAACTTACGTTAGAGTTTAAAGGTCAATCAATAAAACAGATTGGGAATATTTGTATGGATATGATGCTTGTTGATCTGTCCGAAGTGGAAGATATTTCCTTGAATGATGAACTAATCGTGTTACCTAATATTAGTAAAATCGCTGATGAAGAACAAACAATTACCAATGAGCTATTGAGTCGATTAGGTTCGAGGTTAGGTACAGAGTTAAATTGA", "partial": "0", "query_start": 3498, "query_end": 3614, "hit_start": 1584, "hit_end": 1701, "orf_dna_sequence": "ATGGTATTAGTTGACATTCACGCACATATATTGCCAGGAATTGATGATGGTTCTCCTGATTTGGAATCTTCATTAGGTCTAGCAGAAGCTGCAGTAGCCGATGGAATTACTCATGCATTAATGACCCCACATACTTTAAATGGAAAATATTTAAATCATAAAGAGGATATCATTAAAGAGACAGCTAGTTTTCAAAAGGAATTAGAACAGCACAATATTCCTTTGACTGTCTTTCCAAGTCAAGAAGTTCGTCTAAATGGTAATTTACCGCAAGCTTTAGATGATGATGATATCTTATTTTGTGATGAAGATGGCAGATATATGCTATTAGAATTTCCAAGTGAAGATGTACCAACTTATGCCAAAGATATGACTTTTAAATTGTTAGGACGGGGGATTACCCCAATCATTGTTCATCCAGAAAGGAATTCTGGTATCTTGGCTCATCCAGAAAAATTACAAGAGTTTATTGAGCAAGGCTGTTTAACGCACATAACTGCTAGTTCGTATGTGGGAGTCTTTGGAAAAGAGATCGAAAAATTAGCTGATCAATTTGTAGAAGCGGGTCAAGTAGCCACTTTTGCTTCAGATGCACATACGTTGCCAAAACGTGAAAGTCGAATGCATGACGCTTATGAGAAGTTAGAAAAAACGCAAGGATTGGATGTTGCTAATAGCTTTAAGCAGAATGCACGAAACATTATTAATTCTGATAATGTTAATTTAAATTGGAAACCTTTAAAGAAAAAGAAACGGTTTTGGATATTTTAA", "orf_prot_sequence": "MVLVDIHAHILPGIDDGSPDLESSLGLAEAAVADGITHALMTPHTLNGKYLNHKEDIIKETASFQKELEQHNIPLTVFPSQEVRLNGNLPQALDDDDILFCDEDGRYMLLEFPSEDVPTYAKDMTFKLLGRGITPIIVHPERNSGILAHPEKLQEFIEQGCLTHITASSYVGVFGKEIEKLADQFVEAGQVATFASDAHTLPKRESRMHDAYEKLEKTQGLDVANSFKQNARNIINSDNVNLNWKPLKKKKRFWIF", "perc_identity": 33.33}}, "BGC0000765.1|Exopolysaccharide_6 # 3903 # 4562 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=TAG;rbs_spacer=8bp;gc_cont=0.345": {"gnl|BL_ORD_ID|913|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 3903, "orf_end": 4562, "orf_from": "BGC0000765.1|Exopolysaccharide_6 ", "model_name": "baeS", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "850", "model_id": "986", "ARO_accession": "3000829", "ARO_name": "baeS", "ARO_category": {"36005": {"category_aro_accession": "0010004", "category_aro_cvterm_id": "36005", "category_aro_name": "resistance-nodulation-cell division (RND) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.", "category_aro_class_name": "AMR Gene Family"}, "36250": {"category_aro_accession": "3000111", "category_aro_cvterm_id": "36250", "category_aro_name": "novobiocin", "category_aro_description": "Novobiocin is an aminocoumarin antibiotic produced by Streptomyces spheroides and Streptomyces niveus, and binds DNA gyrase subunit B inhibiting ATP-dependent DNA supercoiling.", "category_aro_class_name": "Antibiotic"}, "35935": {"category_aro_accession": "0000016", "category_aro_cvterm_id": "35935", "category_aro_name": "aminoglycoside antibiotic", "category_aro_description": "Aminoglycosides are a group of antibiotics that are mostly effective against Gram-negative bacteria. These molecules consist of aminated sugars attached to a dibasic cyclitol. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit (some work by binding to the 50S subunit), inhibiting the translocation of the peptidyl-tRNA from the A-site to the P-site and also causing misreading of mRNA, leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Drug Class"}, "36242": {"category_aro_accession": "3000103", "category_aro_cvterm_id": "36242", "category_aro_name": "aminocoumarin antibiotic", "category_aro_description": "Aminocoumarin antibiotics bind DNA gyrase subunit B to inhibit ATP-dependent DNA supercoiling.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36590": {"category_aro_accession": "3000451", "category_aro_cvterm_id": "36590", "category_aro_name": "protein(s) and two-component regulatory system modulating antibiotic efflux", "category_aro_description": "Protein(s) and two component regulatory systems that directly or indirectly change rates of antibiotic efflux.", "category_aro_class_name": "Efflux Regulator"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.32329, "max_identities": 23, "bit_score": 26.9498, "cvterm_id": "36839", "query": "IGKNEKPFKMWKFRSMIVNADKMVKQLEEQNEIDGAMFKIKDDPRVTKIGHVIRKYSLDELPQLWNVLKGDMSLVGPRPPLP", "match": "+G+       W+F   + N D+ V Q+    E D +    +D P      H  R        Q W V + +  LVGPR P+P", "sequence_from_db": "LGEQYAQHGNWRF---LRNNDRFVFQILRSFEHDNS----EDKPGPGMPPHGWRT-------QFWVVDQNNKVLVGPRAPIP", "sequence_from_broadstreet": "MKFWRPGITGKLFLAIFATCIVLLISMHWAVRISFERGFIDYIKHGNEQRLQLLSDALGEQYAQHGNWRFLRNNDRFVFQILRSFEHDNSEDKPGPGMPPHGWRTQFWVVDQNNKVLVGPRAPIPPDGTRRPILVNGAEVGAVIASPVERLTRNTDINFDKQQRQTSWLIVALATLLAALATFLLARGLLAPVKRLVDGTHKLAAGDFTTRVTPTSEDELGKLAQDFNQLASTLEKNQQMRRDFMADISHELRTPLAVLRGELEAIQDGVRKFTPETVASLQAEVGTLTKLVDDLHQLSMSDEGALAYQKAPVDLIPLLEVAGGAFRERFASRGLKLQFSLPDSITVFGDRDRLMQLFNNLLENSLRYTDSGGSLQISAGQRDKTVRLTFADSAPGVSDDQLQKLFERFYRTEGSRNRASGGSGLGLAICLNIVEAHNGRIIAAHSPFGGVSITVELPLERDLQREV", "dna_sequence_from_broadstreet": "ATGAAGTTCTGGCGACCCGGTATTACCGGCAAACTGTTTCTGGCGATTTTCGCCACCTGCATTGTCTTGCTGATCAGTATGCACTGGGCGGTGCGTATCAGTTTTGAGCGTGGCTTTATTGATTACATCAAGCATGGTAATGAACAGCGATTACAACTGTTAAGTGATGCGCTTGGCGAGCAGTATGCGCAGCATGGCAACTGGCGCTTCCTGCGCAACAATGATCGCTTTGTCTTTCAGATCCTGCGTTCATTTGAACACGATAATTCGGAAGATAAACCCGGCCCGGGTATGCCACCGCACGGCTGGCGTACCCAGTTCTGGGTGGTTGATCAAAACAACAAAGTGCTGGTTGGTCCGCGAGCGCCGATTCCACCTGACGGTACACGGCGACCCATTCTGGTCAACGGTGCGGAAGTTGGCGCGGTGATCGCCTCCCCCGTTGAGCGGTTAACGCGCAATACTGATATCAATTTCGATAAACAACAGCGGCAAACCAGCTGGTTGATTGTCGCCCTGGCAACGTTACTCGCGGCACTTGCCACTTTTCTGCTGGCGCGCGGTTTACTGGCACCGGTAAAACGACTTGTCGATGGCACGCACAAACTGGCGGCGGGCGATTTCACTACCCGCGTAACGCCCACCAGTGAAGATGAACTGGGCAAACTGGCGCAAGACTTCAACCAGCTTGCCAGCACACTGGAGAAAAACCAGCAAATGCGGCGCGATTTTATGGCCGATATTTCTCACGAACTGCGTACGCCATTAGCGGTGCTGCGCGGTGAACTGGAAGCCATTCAGGATGGCGTGCGTAAATTCACGCCGGAGACGGTGGCGTCTTTACAGGCGGAGGTCGGTACACTGACCAAACTGGTTGACGATCTCCATCAGTTGTCGATGTCTGATGAAGGCGCTCTCGCCTATCAAAAAGCACCGGTAGATTTGATCCCACTGCTGGAAGTGGCGGGCGGCGCATTTCGCGAACGATTCGCCAGTCGTGGCCTGAAACTGCAATTTTCCCTGCCAGACAGTATTACCGTATTTGGCGATCGCGACCGTTTAATGCAGTTATTCAATAACTTACTGGAAAACAGCCTGCGCTACACTGACAGCGGCGGCAGCCTGCAAATCTCTGCCGGGCAGCGCGACAAAACGGTGCGCCTGACCTTTGCCGACAGTGCGCCAGGTGTCAGTGACGATCAGCTACAAAAATTGTTTGAACGTTTTTATCGCACCGAAGGTTCCCGCAACCGTGCCAGCGGCGGTTCCGGGCTGGGGCTGGCGATTTGCCTGAACATTGTTGAAGCACATAATGGTCGCATTATTGCTGCCCATTCGCCTTTTGGCGGGGTAAGCATTACAGTAGAGTTACCGCTGGAACGGGATTTACAGAGAGAAGTATGA", "partial": "0", "query_start": 4101, "query_end": 4346, "hit_start": 171, "hit_end": 375, "orf_dna_sequence": "ATGATGGCACAAGAGGTTAAAAGGGTAAAACTAGATCCGTCAAAAGTTAAGGGACGTGTAGGATACCGTGCTGTAAAACGTGGCTTTGATATTTTAGCTAGTGGATTGGCTCTGATATTATTGTCTCCATTATTTTTAGTTTTAATTGTCTTAATTAAAAAGGAAGATGGTGGACCAGCTTTCTATTCACAAGAACGAATCGGTAAAAATGAGAAACCATTTAAAATGTGGAAGTTTCGTTCAATGATTGTGAATGCCGATAAAATGGTAAAACAGTTAGAAGAACAAAATGAAATTGACGGGGCAATGTTTAAGATTAAAGATGATCCTCGTGTAACTAAAATTGGTCATGTAATTAGAAAATATAGTCTTGATGAATTACCTCAGCTTTGGAACGTGTTAAAAGGTGATATGTCTTTAGTAGGTCCACGTCCACCTCTACCAATGGAAGTGGCTGATTATACTGACTATGATAAATTGCGTTTAACTGTTACACCAGGTTGTACAGGACTTTGGCAGGTAACAAAACGTAATGATGCAGACTTTGATGAAATGGTAGAATTAGACCTTGAATATATCAATAAGAGTAGTTTGTGGTTTGATTTTAAGATTTTATTAAAGACTGTTGGTGTTGTTATTCATCCGAATAGTGCGTATTAA", "orf_prot_sequence": "MMAQEVKRVKLDPSKVKGRVGYRAVKRGFDILASGLALILLSPLFLVLIVLIKKEDGGPAFYSQERIGKNEKPFKMWKFRSMIVNADKMVKQLEEQNEIDGAMFKIKDDPRVTKIGHVIRKYSLDELPQLWNVLKGDMSLVGPRPPLPMEVADYTDYDKLRLTVTPGCTGLWQVTKRNDADFDEMVELDLEYINKSSLWFDFKILLKTVGVVIHPNSAY", "perc_identity": 28.05}}, "BGC0000765.1|Exopolysaccharide_7 # 4581 # 5030 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.322": {"gnl|BL_ORD_ID|4678|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 4581, "orf_end": 5030, "orf_from": "BGC0000765.1|Exopolysaccharide_7 ", "model_name": "vanW gene in vanB cluster", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "50", "model_id": "1036", "ARO_accession": "3002964", "ARO_name": "vanW gene in vanB cluster", "ARO_category": {"36011": {"category_aro_accession": "3000002", "category_aro_cvterm_id": "36011", "category_aro_name": "vanW", "category_aro_description": "vanW is an accessory gene, with unknown function, found on vancomycin resistance operons.", "category_aro_class_name": "AMR Gene Family"}, "36373": {"category_aro_accession": "3000234", "category_aro_cvterm_id": "36373", "category_aro_name": "glycopeptide resistance gene cluster", "category_aro_description": "Genes that when expressed confer resistance to vancomycin and teicoplanin type antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35947": {"category_aro_accession": "0000028", "category_aro_cvterm_id": "35947", "category_aro_name": "vancomycin", "category_aro_description": "Vancomycin is a glycopeptide antibiotic used in the prophylaxis and treatment of infections caused by Gram-positive bacteria. Vancomycin inhibits the synthesis of peptidoglycan, the major component of the cell wall of gram-positive bacteria. Its mechanism of action is unusual in that it acts by binding precursors of peptidoglycan, rather than by interacting with an enzyme.", "category_aro_class_name": "Antibiotic"}, "36220": {"category_aro_accession": "3000081", "category_aro_cvterm_id": "36220", "category_aro_name": "glycopeptide antibiotic", "category_aro_description": "Glycopeptide antibiotics are natural products produced non-ribosomally by Actinomycetales bacteria. With the exception of bleomycins, they act by binding the terminal D-Ala-D-Ala in peptidoglycan precursors of the growing bacterial cell wall and are generally active against Gram-positive bacteria.  This inhibits transglycosylation leading to cell death due to osmotic stress.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.45483, "max_identities": 14, "bit_score": 23.8682, "cvterm_id": "35918", "query": "RFWVTFDKEDARSKLKSEKMYGCYYPTNRNLKNLIRNTFLAIKVLRKERPDVIISSGAAVAVPFFYIGK", "match": "+ WVT D E    ++ ++K     Y         +R +    +  + ER  V + +G  +     Y  K", "sequence_from_db": "QIWVTLDDEKIIGQVFADKQPQALYKIANGSIQYVRESGGIYEYAKVERMQVALGTGEIIDCKLLYTNK", "sequence_from_broadstreet": "MNRKRLTQRFPFLLPMRQAQRKICFYAGMRFDGCCYAQTIGEKTLPYLLFETDCALYNHNTGFDMIYQENKVFNLKLAAKTLNGLLIKPGETFSFWRLVRHADKDTPYKDGLTVANGKLTTMSGGGMCQMSNLLFWVFLHTPLTIIQRSGHVVKEFPEPNSDEIKGVDATISEGWIDLKVRNDTDCTYQIWVTLDDEKIIGQVFADKQPQALYKIANGSIQYVRESGGIYEYAKVERMQVALGTGEIIDCKLLYTNKCKICYPLPESVDIQEANQ", "dna_sequence_from_broadstreet": "ATGAACAGAAAAAGATTGACACAGCGCTTCCCGTTCCTGCTTCCAATGAGACAAGCGCAGAGAAAAATATGCTTTTATGCGGGAATGAGATTTGACGGCTGTTGCTATGCACAGACGATAGGAGAAAAAACGCTTCCCTATTTGCTCTTTGAAACGGATTGTGCGTTATACAACCACAATACCGGATTTGACATGATATACCAAGAAAACAAGGTGTTCAACTTAAAGCTGGCGGCAAAGACCTTAAACGGCCTATTGATAAAACCGGGGGAAACCTTTTCTTTCTGGCGGCTGGTACGCCATGCGGACAAAGATACCCCCTATAAAGACGGCCTTACGGTGGCCAATGGTAAGCTCACCACCATGTCGGGCGGCGGTATGTGCCAGATGAGCAATTTACTATTTTGGGTGTTCCTGCATACGCCATTGACAATTATCCAGCGCAGCGGTCACGTAGTAAAGGAGTTTCCAGAGCCAAACAGTGACGAGATCAAAGGGGTGGATGCAACCATCTCAGAGGGCTGGATTGATTTAAAAGTGCGAAACGATACCGACTGCACCTACCAAATATGGGTGACCCTAGATGATGAGAAAATCATCGGTCAGGTGTTCGCCGACAAACAGCCTCAAGCATTATACAAAATTGCAAACGGCAGTATTCAGTATGTCCGTGAAAGTGGCGGGATTTATGAATATGCCAAGGTTGAACGGATGCAAGTTGCCTTAGGTACCGGGGAAATAATAGATTGCAAGCTGCTTTATACAAACAAATGCAAAATCTGCTATCCCCTCCCGGAAAGTGTGGATATTCAGGAGGCGAACCAATGA", "partial": "0", "query_start": 4662, "query_end": 4868, "hit_start": 564, "hit_end": 771, "orf_dna_sequence": "ATGAAAGTTTGTTTAGTTGGTTCTAGCGGTGGTCACTTAACTCATCTTTATATGTTAAAGCCATTTTGGCAAAATAAGGATAGATTCTGGGTTACTTTTGATAAAGAAGATGCAAGAAGTAAGCTGAAATCTGAAAAGATGTATGGATGTTACTATCCCACTAACCGTAATCTAAAAAACTTGATTCGTAATACTTTTTTAGCAATTAAAGTGCTCCGTAAAGAACGTCCTGATGTAATTATTTCTAGTGGGGCTGCAGTAGCAGTTCCATTTTTTTATATCGGAAAATTAATGGGTGCTAAGACTGTTTACATTGAAGTATTTGATCGCTATGATAAACCTACAATTACTGGTAAATTGGTATATCCAATAACAGATAAGTTTATCGTTGAATGGGAAGAAATGAAGAAAGTTTATCCTAAGGCAATTAATTTAGGAAGTATTTTTTAG", "orf_prot_sequence": "MKVCLVGSSGGHLTHLYMLKPFWQNKDRFWVTFDKEDARSKLKSEKMYGCYYPTNRNLKNLIRNTFLAIKVLRKERPDVIISSGAAVAVPFFYIGKLMGAKTVYIEVFDRYDKPTITGKLVYPITDKFIVEWEEMKKVYPKAINLGSIF", "perc_identity": 20.29}, "gnl|BL_ORD_ID|2723|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 4581, "orf_end": 5030, "orf_from": "BGC0000765.1|Exopolysaccharide_7 ", "model_name": "tet(51)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "3288", "ARO_accession": "3004586", "ARO_name": "tet(51)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.31161, "max_identities": 17, "bit_score": 23.483, "cvterm_id": "36791", "query": "SSGAAVAVPFFYIGKLMGAKTVYIEVFDRYD---KPTITG--KLVYPITDKFIVEWEEMKKVYPKAIN", "match": " S  A+   + + G+L  A+  Y   F+RY+   +P +    K    + + F+V  E  K+V  +  N", "sequence_from_db": "GSNQALVGAYIFAGELKQAEGNYHRAFNRYNELLQPFVEANQKFGVLVNESFLVRDEVSKEVAEERSN", "sequence_from_broadstreet": "MPIINKILVIGAGIAGPAVCYWLRRFGFSPILVERCANLRKGGHAVDIRGVAIDLAKSMGIYKKICNMRTQVELGRYVDAEGNILHEEKGERFGFREGDDIEILRGDLVQILIDAMGDVPCHFNQWVESIKQRDNDVEVQFKDGRTELYDLVIGADGLHSTTRRMVFDKDEYKLTNLGAYFSAFSIPNYLNLNHTDVQFEANQKLISMASDKNPKIAITGFCFRAQNVLNNLRDENEQRRFLRDTFQDFGWETSKILELMSDSNDFYFDSFTQVKMKSWTKGRVALVGDAGYCASPFPGQGSNQALVGAYIFAGELKQAEGNYHRAFNRYNELLQPFVEANQKFGVLVNESFLVRDEVSKEVAEERSNKIMQEIKIVSNMISLPNYE", "dna_sequence_from_broadstreet": "ATGCCTATCATAAATAAAATTCTGGTAATAGGAGCCGGCATTGCTGGACCCGCGGTTTGTTATTGGTTAAGAAGATTTGGCTTTTCTCCCATTTTAGTTGAAAGGTGTGCCAATTTACGAAAAGGAGGGCATGCTGTGGATATTCGAGGTGTTGCTATCGATCTTGCTAAAAGCATGGGTATTTATAAAAAAATATGCAATATGCGCACCCAGGTGGAATTAGGAAGGTATGTTGACGCCGAAGGTAATATCTTGCATGAAGAAAAAGGCGAAAGATTTGGCTTTAGGGAGGGTGATGATATTGAAATTCTCCGCGGTGATTTAGTTCAAATACTGATAGATGCCATGGGAGATGTTCCCTGTCATTTCAATCAATGGGTTGAGAGCATTAAGCAGAGGGATAATGATGTAGAGGTTCAATTTAAAGATGGTAGAACGGAACTTTACGATTTGGTTATCGGTGCTGATGGCTTGCATTCAACCACCAGAAGGATGGTTTTTGATAAGGATGAATATAAATTAACTAACCTTGGTGCATACTTTAGTGCTTTTAGTATTCCAAATTATCTTAATTTGAATCACACCGATGTGCAATTCGAGGCTAATCAAAAACTTATATCTATGGCTAGCGATAAGAACCCTAAAATTGCTATAACAGGATTCTGTTTCCGTGCACAGAATGTCTTGAATAATTTGCGCGATGAAAACGAGCAACGGAGATTTCTACGCGATACTTTTCAAGATTTTGGCTGGGAGACATCCAAAATACTTGAACTGATGTCAGATAGTAATGATTTTTATTTTGATTCATTCACTCAAGTGAAAATGAAGTCATGGACAAAAGGACGAGTTGCTTTGGTGGGCGATGCAGGTTACTGCGCATCCCCATTCCCTGGTCAAGGTAGTAATCAGGCACTGGTAGGTGCTTATATTTTTGCAGGAGAACTAAAACAGGCAGAAGGCAATTATCATCGAGCATTTAACCGTTATAATGAATTATTACAACCATTTGTTGAAGCCAATCAAAAATTTGGCGTCTTGGTTAACGAATCGTTTCTCGTTCGTGATGAAGTCTCTAAGGAGGTGGCAGAAGAAAGATCGAATAAGATTATGCAAGAGATAAAAATTGTATCGAATATGATTTCGTTGCCGAATTATGAATGA", "partial": "0", "query_start": 4824, "query_end": 5012, "hit_start": 900, "hit_end": 1104, "orf_dna_sequence": "ATGAAAGTTTGTTTAGTTGGTTCTAGCGGTGGTCACTTAACTCATCTTTATATGTTAAAGCCATTTTGGCAAAATAAGGATAGATTCTGGGTTACTTTTGATAAAGAAGATGCAAGAAGTAAGCTGAAATCTGAAAAGATGTATGGATGTTACTATCCCACTAACCGTAATCTAAAAAACTTGATTCGTAATACTTTTTTAGCAATTAAAGTGCTCCGTAAAGAACGTCCTGATGTAATTATTTCTAGTGGGGCTGCAGTAGCAGTTCCATTTTTTTATATCGGAAAATTAATGGGTGCTAAGACTGTTTACATTGAAGTATTTGATCGCTATGATAAACCTACAATTACTGGTAAATTGGTATATCCAATAACAGATAAGTTTATCGTTGAATGGGAAGAAATGAAGAAAGTTTATCCTAAGGCAATTAATTTAGGAAGTATTTTTTAG", "orf_prot_sequence": "MKVCLVGSSGGHLTHLYMLKPFWQNKDRFWVTFDKEDARSKLKSEKMYGCYYPTNRNLKNLIRNTFLAIKVLRKERPDVIISSGAAVAVPFFYIGKLMGAKTVYIEVFDRYDKPTITGKLVYPITDKFIVEWEEMKKVYPKAINLGSIF", "perc_identity": 25.0}}, "BGC0000765.1|Exopolysaccharide_8 # 5040 # 5540 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=TAGG;rbs_spacer=8bp;gc_cont=0.309": {"gnl|BL_ORD_ID|2205|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5040, "orf_end": 5540, "orf_from": "BGC0000765.1|Exopolysaccharide_8 ", "model_name": "FusF", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "3364", "ARO_accession": "3004663", "ARO_name": "FusF", "ARO_category": {"43297": {"category_aro_accession": "3005086", "category_aro_cvterm_id": "43297", "category_aro_name": "Target protecting FusB-type protein conferring resistance to Fusidic acid", "category_aro_description": "Fusidic acid resistance determinants through the mediation of target protection. These protein drive the dissociation of EF-G from the ribosome thus counteracting the action of Fusidic acid.", "category_aro_class_name": "AMR Gene Family"}, "37139": {"category_aro_accession": "3000759", "category_aro_cvterm_id": "37139", "category_aro_name": "fusidic acid", "category_aro_description": "Fusidic acid is the only commercially available fusidane, a group of steroid-like antibiotics. It is most active against Gram-positive bacteria, and acts by inhibiting elongation factor G to  block protein synthesis.", "category_aro_class_name": "Antibiotic"}, "45735": {"category_aro_accession": "3007153", "category_aro_cvterm_id": "45735", "category_aro_name": "fusidane antibiotic", "category_aro_description": "A group of antibiotics possessing steroid rings or steroid-like structures.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.404031, "max_identities": 16, "bit_score": 27.7202, "cvterm_id": "36766", "query": "HQVD--FTELIEKRMNNIIPVYDVNKLAETIKNY", "match": "HQ+D   TE IEK MN  I    V+K+ ET++ Y", "sequence_from_db": "HQIDDTLTEAIEKLMNIRITKVQVDKILETLQTY", "sequence_from_broadstreet": "MEKQIYPYQFNYIKERIAHLLNAYKSVNDLNTIASIKETTKIDIYQQFHQIDDTLTEAIEKLMNIRITKVQVDKILETLQTYVIPFEHPSKKQVEKTFRKIKKLKSPLISDEILLESTYIGWNDIASNRKFIIYYNEQGTLTGFYGDIANQTVKGYCAICNKESNVALFMRKTRTSGDGQYTKKGDYICFDSIKCNQQLSDITQFYQFVDKIHS", "dna_sequence_from_broadstreet": "TTGGAAAAACAAATTTATCCATATCAATTTAACTATATTAAAGAACGAATCGCACATTTACTTAATGCTTATAAATCAGTAAATGACTTAAATACAATTGCTTCTATAAAAGAAACAACTAAAATAGACATTTATCAGCAGTTTCATCAAATAGATGATACGTTGACTGAAGCGATTGAAAAATTAATGAACATACGTATTACTAAAGTACAAGTAGATAAAATATTAGAAACTTTACAGACATACGTTATACCCTTTGAACACCCTTCAAAAAAACAAGTCGAAAAAACTTTTCGTAAAATTAAAAAGCTTAAATCACCGCTTATTAGTGATGAAATCCTTTTGGAAAGTACTTATATCGGATGGAACGATATCGCTTCAAACAGAAAATTTATCATCTATTATAACGAGCAAGGAACTTTAACAGGTTTTTATGGCGACATTGCTAACCAAACCGTTAAGGGCTATTGCGCAATTTGTAATAAAGAATCTAATGTCGCTCTATTTATGCGTAAAACACGTACTTCTGGTGATGGACAATATACCAAAAAAGGTGACTATATTTGTTTTGACAGTATCAAATGTAATCAACAATTGTCGGATATTACACAATTTTATCAATTTGTCGATAAAATCCACTCATAA", "partial": "0", "query_start": 5346, "query_end": 5441, "hit_start": 144, "hit_end": 246, "orf_dna_sequence": "ATGATTTTTGTTACTGTAGGTACTCATGAGCAGCCTTTTAACCGTTTGGTGAAAAAAATAGATGATTTGGTTGCTGAAGGTACAATTAAGGAAAAAGTGGTTATTCAGACTGGTTTTAGTACATATAAACCAGTACATTGCGAAGGCCACAAAATGATGTCTTTTGAAGAAATGCAAAATACTTTGAAAGATGCGCGTATTGTTATTACGCATGGTGGACCTTCAAGTTTTATTGAAGCATTACAATTTGGAAAAGTTCCAATTGTGGTTCCTAGACAAGAAAAATATCATGAGCATGTTAACAATCACCAAGTTGACTTCACCGAATTAATTGAAAAAAGAATGAATAATATAATTCCTGTTTATGATGTAAATAAACTTGCTGAAACAATTAAAAACTATGATGAAATTGTCAAAACAAAAAATGTTGGCGAAAGTAGTAATAATAGGAAATTTAATCAAAGCTTGGAACATATTATTAATGAATTAGTGGGGAAGTAA", "orf_prot_sequence": "MIFVTVGTHEQPFNRLVKKIDDLVAEGTIKEKVVIQTGFSTYKPVHCEGHKMMSFEEMQNTLKDARIVITHGGPSSFIEALQFGKVPIVVPRQEKYHEHVNNHQVDFTELIEKRMNNIIPVYDVNKLAETIKNYDEIVKTKNVGESSNNRKFNQSLEHIINELVGK", "perc_identity": 47.06}, "gnl|BL_ORD_ID|4863|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5040, "orf_end": 5540, "orf_from": "BGC0000765.1|Exopolysaccharide_8 ", "model_name": "MCR-1.24", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1000", "model_id": "5848", "ARO_accession": "3007243", "ARO_name": "MCR-1.24", "ARO_category": {"41432": {"category_aro_accession": "3004268", "category_aro_cvterm_id": "41432", "category_aro_name": "MCR phosphoethanolamine transferase", "category_aro_description": "A group of mobile colistin resistance genes encode the MCR family of phosphoethanolamine transferases, which catalyze the addition of phosphoethanolamine onto lipid A, thus interfering with the binding of colistin to the cell membrane.", "category_aro_class_name": "AMR Gene Family"}, "36966": {"category_aro_accession": "3000622", "category_aro_cvterm_id": "36966", "category_aro_name": "colistin A", "category_aro_description": "Colistin A, or polymyxin E1, has a 6-octanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36968": {"category_aro_accession": "3000624", "category_aro_cvterm_id": "36968", "category_aro_name": "colistin B", "category_aro_description": "Colistin B, or polymyxin E2, has a 6-heptanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36192": {"category_aro_accession": "3000053", "category_aro_cvterm_id": "36192", "category_aro_name": "peptide antibiotic", "category_aro_description": "Peptide antibiotics have a wide range of antibacterial mechanisms, depending on the amino acids that make up the antibiotic, although most act to disrupt the cell membrane in some manner. Subclasses of peptide antibiotics can include additional sidechains of other types, such as lipids in the case of the lipopeptide antibiotics.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.81699, "max_identities": 9, "bit_score": 23.8682, "cvterm_id": "35914", "query": "MNNIIPVYDVNKLAET", "match": "+N I+P+Y V KLA T", "sequence_from_db": "VNPIMPIYSVGKLAST", "sequence_from_broadstreet": "MMQHTSVWYRRSVSPFVLVASVAVFLTATANLTFFDKISQTYPIADNLGFVLTIAVVLFGAMLLITTLLSSYRYVLKPVLILLLIMGAVTSYFTDTYGTVYDTTMLQNALQTDQAETKDLLNAAFIMRIIGLGVLPSLLVAFVKVDYPTWGKGLMRRLGLIVASLAPILLPVVAFSSQYSSFFRVHKPPCSYVNPIMPIYSVGKLASTEYKKASAPKDSIYHAKDAVQATKPDMCKPRVVVFVVGETARADHVSFNGYERDTFPQLAKIDGVTNFSNVTSCGTSTAYFVPCMFSYLGADEYDVDTAKYQENVLDTLDRLGVSILWRDNNSDSKGVMDKLPKAQFADYKSATNNAICNTNPYNECRDVGMLVGLDDFVAANNGKDMLIMLHQMGNHGPAYFKRYDEKFAKFTPVCEGNELAKCEHQSLINAYDNALLATDDFIAQSIQWLQTHSNAYDVSMLYVSDHGESLGENGVYLHGMPNAFAPKEQRSVPAFFWTDKQTGITPMATDTVLTHDAITPTLLKLFDVTADKVKDRTAFIR", "dna_sequence_from_broadstreet": "ATGATGCAGCATACTTCTGTGTGGTACCGACGCTCGGTCAGTCCGTTTGTTCTTGTGGCGAGTGTTGCCGTTTTCTTGACCGCGACCGCCAATCTTACCTTTTTTGATAAAATCAGCCAAACCTATCCCATCGCGGACAATCTCGGCTTTGTGCTGACGATCGCTGTCGTGCTCTTTGGCGCGATGCTACTGATCACCACGCTGTTATCATCGTATCGCTATGTGCTAAAGCCTGTGTTGATTTTGCTATTAATCATGGGCGCGGTGACCAGTTATTTTACTGACACTTATGGCACGGTCTATGATACGACCATGCTCCAAAATGCCCTACAGACCGACCAAGCCGAGACCAAGGATCTATTAAACGCAGCGTTTATCATGCGTATCATTGGTTTGGGTGTGCTACCAAGTTTGCTTGTGGCTTTTGTTAAGGTGGATTATCCGACTTGGGGCAAGGGTTTGATGCGCCGATTGGGCTTGATCGTGGCAAGTCTTGCGCCGATTTTACTGCCTGTGGTGGCGTTCAGCAGTCAGTATTCCAGTTTCTTTCGCGTGCATAAGCCGCCATGTAGCTATGTCAATCCGATCATGCCAATCTACTCGGTGGGTAAGCTGGCCAGTACTGAGTATAAAAAAGCCAGTGCGCCAAAAGATTCCATTTATCACGCCAAAGACGCGGTACAAGCAACCAAGCCTGATATGTGTAAGCCACGCGTAGTGGTGTTCGTCGTCGGTGAGACGGCACGCGCCGATCACGTCAGCTTCAATGGCTATGAGCGCGATACTTTCCCACAGCTTGCCAAGATCGATGGCGTGACCAATTTTAGCAATGTCACATCGTGCGGCACATCGACGGCGTATTTTGTGCCGTGTATGTTCAGCTATCTGGGCGCGGATGAGTATGATGTCGATACCGCCAAATACCAAGAAAATGTGCTGGATACGCTGGATCGCTTGGGCGTAAGTATCTTGTGGCGTGATAATAATTCGGACTCAAAAGGCGTGATGGATAAGCTGCCAAAAGCGCAATTTGCCGATTATAAATCCGCGACCAACAACGCCATCTGCAACACCAATCCTTATAACGAATGCCGCGATGTCGGTATGCTCGTTGGCTTAGATGACTTTGTCGCTGCCAATAACGGCAAAGATATGCTGATCATGCTGCACCAAATGGGCAATCACGGGCCTGCGTATTTTAAGCGATATGATGAAAAGTTTGCCAAATTCACGCCAGTGTGTGAAGGTAATGAGCTTGCCAAGTGCGAACATCAGTCCTTGATCAATGCTTATGACAATGCCTTGCTTGCCACCGATGATTTCATCGCTCAAAGTATCCAGTGGCTGCAGACGCACAGCAATGCCTATGATGTCTCAATGCTGTATGTCAGCGATCATGGCGAAAGTCTGGGTGAGAACGGTGTCTATCTACATGGTATGCCAAATGCCTTTGCACCAAAAGAACAGCGCAGTGTGCCTGCATTTTTCTGGACGGATAAGCAAACTGGCATCACGCCAATGGCAACCGATACCGTCCTGACCCATGACGCGATCACGCCGACATTATTAAAGCTGTTTGATGTCACCGCGGACAAAGTCAAAGACCGCACCGCATTCATCCGCTGA", "partial": "0", "query_start": 5382, "query_end": 5429, "hit_start": 576, "hit_end": 624, "orf_dna_sequence": "ATGATTTTTGTTACTGTAGGTACTCATGAGCAGCCTTTTAACCGTTTGGTGAAAAAAATAGATGATTTGGTTGCTGAAGGTACAATTAAGGAAAAAGTGGTTATTCAGACTGGTTTTAGTACATATAAACCAGTACATTGCGAAGGCCACAAAATGATGTCTTTTGAAGAAATGCAAAATACTTTGAAAGATGCGCGTATTGTTATTACGCATGGTGGACCTTCAAGTTTTATTGAAGCATTACAATTTGGAAAAGTTCCAATTGTGGTTCCTAGACAAGAAAAATATCATGAGCATGTTAACAATCACCAAGTTGACTTCACCGAATTAATTGAAAAAAGAATGAATAATATAATTCCTGTTTATGATGTAAATAAACTTGCTGAAACAATTAAAAACTATGATGAAATTGTCAAAACAAAAAATGTTGGCGAAAGTAGTAATAATAGGAAATTTAATCAAAGCTTGGAACATATTATTAATGAATTAGTGGGGAAGTAA", "orf_prot_sequence": "MIFVTVGTHEQPFNRLVKKIDDLVAEGTIKEKVVIQTGFSTYKPVHCEGHKMMSFEEMQNTLKDARIVITHGGPSSFIEALQFGKVPIVVPRQEKYHEHVNNHQVDFTELIEKRMNNIIPVYDVNKLAETIKNYDEIVKTKNVGESSNNRKFNQSLEHIINELVGK", "perc_identity": 56.25}}, "BGC0000765.1|Exopolysaccharide_9 # 5541 # 6266 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=TAG;rbs_spacer=11bp;gc_cont=0.277": {"gnl|BL_ORD_ID|1453|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB50", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1588", "ARO_accession": "3002765", "ARO_name": "QnrB50", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.33909, "max_identities": 17, "bit_score": 26.9498, "cvterm_id": "36915", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+D KR   ++VEN T +  D+      GTE I       G   Y     KG   S+ +", "sequence_from_db": "IDRKRFTGEKVENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRAM", "sequence_from_broadstreet": "MTLALVGEKIDRKRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAAGCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 6024, "query_end": 6197, "hit_start": 27, "hit_end": 180, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 29.31}, "gnl|BL_ORD_ID|1229|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB8", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1335", "ARO_accession": "3002722", "ARO_name": "QnrB8", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.10514, "max_identities": 17, "bit_score": 26.1794, "cvterm_id": "36915", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+D  R   ++VEN T +  D+      GTE I       G   Y     KG   S+ I", "sequence_from_db": "IDRNRFTGEKVENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRAI", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGCGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGGTACTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAACTATCAGGCCGCATTGCTCATGGAACGTCTTGGCATCGCTGTGATTGGCTAG", "partial": "0", "query_start": 6024, "query_end": 6197, "hit_start": 27, "hit_end": 180, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 29.31}, "gnl|BL_ORD_ID|4918|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB75", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5909", "ARO_accession": "3003187", "ARO_name": "QnrB75", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.14356, "max_identities": 16, "bit_score": 26.1794, "cvterm_id": "36915", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+D  R   +++EN T +  D+      GTE I       G   Y     KG K S+ +", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGGKFSRAM", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGGKFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGGGCAAATTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCGGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGCTAG", "partial": "0", "query_start": 6024, "query_end": 6197, "hit_start": 27, "hit_end": 180, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 27.59}, "gnl|BL_ORD_ID|1255|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB69", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1369", "ARO_accession": "3002781", "ARO_name": "QnrB69", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.22251, "max_identities": 17, "bit_score": 26.1794, "cvterm_id": "36915", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+D  R   ++VEN T +  D+      GTE I       G   Y     KG   S+ I", "sequence_from_db": "IDRNRFTGEKVENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRAI", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQGVKLDSYQASLILERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAGAAAGTCGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAGTTTATTGGCTGCCAATTTTATGATCGAGAGAGCCAGAAAGGGTGTAATTTTAGCCGCGCTATCCTGAAAGATGCCATTTTCAAAAGTTGCGATCTCTCCATGGCGGATTTCAGAAATGTGAGTGCGCTGGGAATCGAAATTCGCCACTGCCGCGCACAAGGTTCAGATTTTCGCGGCGCAAGCTTTATGAATATGATTACCACACGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGTACTCAGGTACTTGGCGCAACGTTCAGTGGATCGGACCTCTCTGGCGGCGAGTTTTCATCGTTCGACTGGCGGGCAGCAAACTTTACGCACTGTGATTTGACCAATTCAGAACTGGGCGATCTCGATGTCCGGGGTGTTGATTTGCAAGGCGTTAAACTGGACAGCTACCAGGCATCGTTGATCCTGGAACGTCTTGGCATCGCTGTCATTGGTTAA", "partial": "0", "query_start": 6024, "query_end": 6197, "hit_start": 27, "hit_end": 180, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 29.31}, "gnl|BL_ORD_ID|821|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB37", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "891", "ARO_accession": "3002752", "ARO_name": "QnrB37", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.22251, "max_identities": 17, "bit_score": 26.1794, "cvterm_id": "36915", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+D  R   ++VEN T +  D+      GTE I       G   Y     KG   S+ I", "sequence_from_db": "IDRNRFTGEKVENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRAI", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDVRGVDLQGVKLDSYQASLILERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTTGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAGAAAGTCGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAGTTTATTGGCTGCCAATTTTATGATCGAGAGAGCCAGAAAGGGTGTAATTTTAGCCGCGCTATCCTGAAAGATGCCATTTTCAAAAGTTGCGATCTCTCCATGGCGGATTTCAGGAATGTGAGTGCGCTGGGAATCGAAATTCGCCACTGCCGCGCACAAGGTTCAGATTTTCGCGGCGCAAGCTTTATGAATATGATTACCACACGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGAACTCAGGTACTGGGGGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGTGAGTTTTCGTCGTTCGACTGGCGAGCCGCAAACGTTACGCACTGTGATTTGACCAATTCAGAACTGGGCGATCTCGATGTCCGGGGTGTTGATTTGCAAGGAGTCAAACTGGACAGCTACCAGGCATCGTTGATCCTGGAACGTCTTGGCATCGCTGTCATTGGTTAA", "partial": "0", "query_start": 6024, "query_end": 6197, "hit_start": 27, "hit_end": 180, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 29.31}, "gnl|BL_ORD_ID|682|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB21", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "740", "ARO_accession": "3002736", "ARO_name": "QnrB21", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.2427, "max_identities": 17, "bit_score": 26.1794, "cvterm_id": "35914", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+D  R   ++VEN T +  D+      GTE I       G   Y     KG   S+ I", "sequence_from_db": "IDRNRFTGEKVENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRAI", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGCGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGGTACTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAGCTATCAGGCCGCATTGCTCATGGAACGTCTTGGCATCGCTGTGATTGGCTAG", "partial": "0", "query_start": 6024, "query_end": 6197, "hit_start": 27, "hit_end": 180, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 29.31}, "gnl|BL_ORD_ID|1853|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB60", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "2011", "ARO_accession": "3002773", "ARO_name": "QnrB60", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.28362, "max_identities": 17, "bit_score": 26.1794, "cvterm_id": "36915", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+D  R   ++VEN T +  D+      GTE I       G   Y     KG   S+ I", "sequence_from_db": "IDRNRFTGEKVENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRAI", "sequence_from_broadstreet": "MALALIGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAVLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCATTAATTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGCGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGGTGCTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAGCTATCAGGCCGTATTGCTCATGGAACGTCTTGGCATCGCTGTCATTGGCTAA", "partial": "0", "query_start": 6024, "query_end": 6197, "hit_start": 27, "hit_end": 180, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 29.31}, "gnl|BL_ORD_ID|764|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB55", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "827", "ARO_accession": "3002768", "ARO_name": "QnrB55", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.32529, "max_identities": 17, "bit_score": 26.1794, "cvterm_id": "39585", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKK", "match": "+D  R   ++VEN T +  D+      GTE I       G  LY     KG   S+ ", "sequence_from_db": "IDRNRFTGEKVENSTFFNCDFSGADLSGTEFI-------GCQLYDRESQKGCNFSRA", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQLYDRESQKGCNFSRANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLLERLGIAVMG", "dna_sequence_from_broadstreet": "ATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAAAAAGTTGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTGAGCGGCACTGAATTTATTGGCTGCCAGTTATATGATCGAGAAAGTCAGAAAGGATGTAATTTTAGTCGCGCTAACCTGAAAGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCTGATTTCAGGAATATCAATGCGCTGGGAATCGAAATTCGCCACTGCCGGGCACAAGGGTCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACCACCCGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGTACTCAGGTGCTGGGCGCAACGTTCAGTGGATCAGACCTCTCTGGCGGCGAGTTTTCATCCTTCGACTGGCGAGCAGCAAACGTTACGCACTGTGATTTGACCAATTCGGAACTGGGCGATTTAGATATCCGCGGGGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGCTCCTGGAACGTCTTGGTATCGCTGTCATGGGTTAA", "partial": "0", "query_start": 6024, "query_end": 6194, "hit_start": 27, "hit_end": 177, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 29.82}, "gnl|BL_ORD_ID|85|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB38", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "99", "ARO_accession": "3002753", "ARO_name": "QnrB38", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.34641, "max_identities": 17, "bit_score": 26.1794, "cvterm_id": "36915", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+D  R   ++VEN T +  D+      GTE I       G   Y     KG   S+ I", "sequence_from_db": "IDRNRFTGEKVENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRAI", "sequence_from_broadstreet": "MALALIGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCATTAATTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGCGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGGTACTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAGCTATCAGGCCGCATTGCTCATGGAACGTCTTGGCATCGCTGTCATTGGCTAA", "partial": "0", "query_start": 6024, "query_end": 6197, "hit_start": 27, "hit_end": 180, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 29.31}, "gnl|BL_ORD_ID|499|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB3", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "548", "ARO_accession": "3002716", "ARO_name": "QnrB3", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.40756, "max_identities": 16, "bit_score": 26.1794, "cvterm_id": "35914", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+D  R   +++EN T +  D+      GTE I       G   Y     KG K S+ +", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCKFSRAM", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCKFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAAATTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCGGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 6024, "query_end": 6197, "hit_start": 63, "hit_end": 216, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 27.59}, "gnl|BL_ORD_ID|717|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB25", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "781", "ARO_accession": "3002740", "ARO_name": "QnrB25", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.43282, "max_identities": 17, "bit_score": 26.1794, "cvterm_id": "36915", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+D  R   ++VEN T +  D+      GTE I       G   Y     KG   S+ I", "sequence_from_db": "IDRNRFTGEKVENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRAI", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITSTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGCGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAGTACCAATCTAAGCTACGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGGTGCTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAGCTATCAGGCCGCATTGCTCATGGAACGTCTTGGCATCGCTATCATTGGCTAA", "partial": "0", "query_start": 6024, "query_end": 6197, "hit_start": 27, "hit_end": 180, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 29.31}, "gnl|BL_ORD_ID|863|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB70", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "938", "ARO_accession": "3002782", "ARO_name": "QnrB70", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.76101, "max_identities": 18, "bit_score": 25.7942, "cvterm_id": "39584", "query": "TQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "T +L    +D  R   ++VEN T +  D+      GTE I       G   Y     KG   S+ +", "sequence_from_db": "TLVLVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRAM", "sequence_from_broadstreet": "MTLVLVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGTATTAGTAGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTTAGTGGTTCAGATCTCTCCGGTGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 6000, "query_end": 6197, "hit_start": 3, "hit_end": 180, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 27.27}, "gnl|BL_ORD_ID|1072|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB34", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1160", "ARO_accession": "3002749", "ARO_name": "QnrB34", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.19753, "max_identities": 19, "bit_score": 25.7942, "cvterm_id": "39583", "query": "ITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+ T  L    +D  R    +VEN T +  D+      GTE I       G   Y     KG   S+ I", "sequence_from_db": "MMTLALVGEKIDRNRFTGAKVENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRAI", "sequence_from_broadstreet": "MMTLALVGEKIDRNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMAGFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQGVKLDSYQASLILERLGIAVIG", "dna_sequence_from_broadstreet": "ATGATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGATTCACTGGTGCGAAAGTTGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTCAGCGGTACTGAGTTTATTGGCTGCCAGTTCTATGATCGAGAGAGCCAGAAAGGGTGTAATTTTAGTCGCGCTATCCTGAAAGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCGGGTTTCAGGAATGTGAGCGCGCTGGGAATCGAAATTCGCCACTGCCGCGCACAAGGTTCAGATTTTCGCGGCGCAAGCTTTATGAATATGATTACCACACGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGTTGGATGGGTACTCAGGTACTGGGGGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGTGAGTTTTCGTCGTTCGACTGGCGGGCCGCAAACTTTACGCACTGTGATTTGACCAATTCAGAACTGGGCGATCTCGATGTCCGGGGTGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGATCCTGGAACGTCTTGGCATCGCTGTCATTGGTTAA", "partial": "0", "query_start": 5994, "query_end": 6197, "hit_start": 0, "hit_end": 183, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 27.94}, "gnl|BL_ORD_ID|371|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB11", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "411", "ARO_accession": "3002725", "ARO_name": "QnrB11", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.19753, "max_identities": 19, "bit_score": 25.7942, "cvterm_id": "36915", "query": "ITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+ T  L    +D  R    +VEN T +  D+      GTE I       G   Y     KG   S+ I", "sequence_from_db": "MMTLALVGEKIDRNRFTGAKVENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRAI", "sequence_from_broadstreet": "MMTLALVGEKIDRNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQGVKLDSYQASLILERLGIAVMG", "dna_sequence_from_broadstreet": "ATGATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGATTCACTGGTGCGAAAGTTGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGCGCCGACCTCAGCGGCACTGAGTTTATTGGCTGCCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCTATCCTGAAAGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCGGATTTCAGGAATGTGAGCGCGCTGGGAATCGAAATTCGCCACTGCCGCGCACAAGGTTCAGATTTTCGCGGCGCAAGCTTTATGAATATGATTACCACACGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGTTGGATGGGTACTCAGGTACTGGGGGCGACGTTCAGTGGTTCGGATCTTTCCGGCGGTGAGTTTTCGTCGTTCGACTGGCGGGCCGCAAACTTTACGCACTGTGATTTGACCAATTCAGAACTGGGCGATCTCGATGTCCGGGGTGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGATCCTGGAACGTCTTGGTATCGCTGTCATGGGTTAA", "partial": "0", "query_start": 5994, "query_end": 6197, "hit_start": 0, "hit_end": 183, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 27.94}, "gnl|BL_ORD_ID|1175|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB12", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1280", "ARO_accession": "3002726", "ARO_name": "QnrB12", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.22655, "max_identities": 19, "bit_score": 25.7942, "cvterm_id": "39583", "query": "ITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+ T  L    +D  R    +VEN T +  D+      GTE I       G   Y     KG   S+ I", "sequence_from_db": "MMTLALVGEKIDRNRFTGAKVENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRAI", "sequence_from_broadstreet": "MMTLALVGEKIDRNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQGVKLDSYQASLILERLGIAVIG", "dna_sequence_from_broadstreet": "ATGATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAACAGATTCACTGGTGCGAAAGTTGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTCAGCGGCACTGAGTTTATTGGCTGTCAGTTCTATGATCGAGAGAGCCAGAAAGGGTGTAATTTTAGTCGCGCTATCCTGAAAGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCGGATTTCAGGAATGTGAGCGCGCTGGGAATCGAAATTCGCCACTGCCGCGCACAAGGTTCAGATTTTCGCGGCGCAAGCTTTATGAATATGATTACCACACGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGTTGGATGGGTACTCAGGTACTGGGGGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGTGAGTTTTCGTCGTTCGACTGGCGGGCCGCAAACTTTACGCACTGTGATTTGACCAATTCAGAACTGGGCGATCTCGATGTCCGGGGTGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGATCCTGGAACGTCTTGGCATCGCTGTCATTGGTTAA", "partial": "0", "query_start": 5994, "query_end": 6197, "hit_start": 0, "hit_end": 183, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 27.94}, "gnl|BL_ORD_ID|349|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB61", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "382", "ARO_accession": "3002774", "ARO_name": "QnrB61", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.39878, "max_identities": 16, "bit_score": 25.7942, "cvterm_id": "39584", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+D  R   ++VEN T +  D+      GTE I       G   Y     KG   S+ +", "sequence_from_db": "IDRNRFTSEKVENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRAM", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTSEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCAGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 6024, "query_end": 6197, "hit_start": 27, "hit_end": 180, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 27.59}, "gnl|BL_ORD_ID|1084|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB22", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1174", "ARO_accession": "3002737", "ARO_name": "QnrB22", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.79607, "max_identities": 18, "bit_score": 25.409, "cvterm_id": "39583", "query": "ITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKK", "match": "+ T  L    +D  R   ++VEN T +  D+      GTE I       G   Y     KG   S+ ", "sequence_from_db": "MMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLCGTEFI-------GCQFYDRESQKGCNFSRA", "sequence_from_broadstreet": "MMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLCGTEFIGCQFYDRESQKGCNFSRANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDIRVVDLQGVKLDSYQASLLLERLGIAVMG", "dna_sequence_from_broadstreet": "ATGATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAAAAAGTCGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTTTGCGGTACTGAATTTATTGGCTGCCAGTTTTATGATCGAGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCTAACCTGAAGGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCGGATTTCAGAAATATCAATGCGCTGGGAATCGAAATTCGCCACTGCCGGGCACAAGGGTCAGATTTTCGCGGCGCAAGCTTTATGAATATGATCACCACCCGCACCTGGTTTTGTAGCGCTTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCTAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAGAACCGCTGGATGGGTACTCAGGTGCTGGGCGCAACGTTCAGTGGATCAGACCTCTCTGGCGGCGAGTTTTCATCCTTCGACTGGCGAGCAGCAAACGTAACGCACTGTGATTTGACCAATTCGGAACTGGGCGATTTAGATATCCGGGTAGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGCTCCTGGAACGTCTTGGTATCGCTGTCATGGGTTAA", "partial": "0", "query_start": 5994, "query_end": 6194, "hit_start": 0, "hit_end": 180, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 26.87}, "gnl|BL_ORD_ID|490|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB59", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "539", "ARO_accession": "3002772", "ARO_name": "QnrB59", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.8814, "max_identities": 16, "bit_score": 25.409, "cvterm_id": "36915", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+D  R   ++VEN T +  D+      GTE I       G   Y     KG   S+ +", "sequence_from_db": "IDRNRFTSEKVENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRAM", "sequence_from_broadstreet": "MLSLLYKNTGIDMTLALVGEKIDRNRFTSEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGTTGTCATTACTGTATAAAAACACAGGCATAGATATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCAGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACACGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 6024, "query_end": 6197, "hit_start": 63, "hit_end": 216, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 27.59}, "gnl|BL_ORD_ID|1613|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB35", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1760", "ARO_accession": "3002750", "ARO_name": "QnrB35", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.1086, "max_identities": 17, "bit_score": 25.409, "cvterm_id": "36915", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+D  R    +VEN T +  D+      GTE I       G   Y     KG   S+ I", "sequence_from_db": "IDRNRFTGAKVENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRAI", "sequence_from_broadstreet": "MALALIGEKIDRNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQMLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCATTAATTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGCAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGCGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGAGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTATGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGATGCTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAGCTATCAGGCCGCGTTGCTCATGGAACGTCTTGGCATCGCTGTCATTGGCTAA", "partial": "0", "query_start": 6024, "query_end": 6197, "hit_start": 27, "hit_end": 180, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 29.31}, "gnl|BL_ORD_ID|503|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB28", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "552", "ARO_accession": "3002743", "ARO_name": "QnrB28", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.41635, "max_identities": 18, "bit_score": 25.409, "cvterm_id": "36915", "query": "TQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "T  L    +D  R   ++VEN T +  D+      GTE I       G   Y     KG   S+ +", "sequence_from_db": "TLALVSEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRAM", "sequence_from_broadstreet": "MTLALVSEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVAGATFSGSDLSGGEFSAFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTAGCGAAAAAATTGACAGAAACCGCTTCACCGGGGAAAAAGTTGAAAACAGTACTTTTTTTAACTGTGATTTTTCAGGGGCCGATCTTAGCGGCACTGAATTTATCGGCTGTCAGTTTTATGATCGCGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTTAAAAGTTGCGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCCCTGGGAATTGAAATTCGCCACTGCCGCGCGCAGGGTTCAGATTTTCGCGGCGCGAGTTTTATGAACATGATCACCACGCGGACCTGGTTTTGCAGCGCATACATCACGAATACCAATCTAAGCTACGCCAACTTTTCGAAGGTTGTCCTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGAACTCAGGTAGCGGGTGCAACGTTCAGTGGATCAGATCTCTCGGGAGGTGAATTTTCAGCGTTCGACTGGCGGGCCGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGTGTAGATTTACAAGGCGTCAAATTGGATAGCTATCAGGCAGCGTTGCTGATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 6000, "query_end": 6197, "hit_start": 3, "hit_end": 180, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 27.27}, "gnl|BL_ORD_ID|1549|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB67", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1683", "ARO_accession": "3002779", "ARO_name": "QnrB67", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.5376, "max_identities": 16, "bit_score": 25.409, "cvterm_id": "39584", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+D  R   ++VEN T +  D+      GTE I       G   Y     KG   S+ +", "sequence_from_db": "IDRNRFTGEKVENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRAM", "sequence_from_broadstreet": "MTLALVCEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTTGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAACTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACTAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 6024, "query_end": 6197, "hit_start": 27, "hit_end": 180, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 27.59}, "gnl|BL_ORD_ID|1886|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB72", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "2049", "ARO_accession": "3002784", "ARO_name": "QnrB72", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.57875, "max_identities": 16, "bit_score": 25.409, "cvterm_id": "39586", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+D  R   ++VEN T +  D+      GTE I       G   Y     KG   S+ +", "sequence_from_db": "IDRNRFTGEKVENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRAM", "sequence_from_broadstreet": "MTLALVCEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITMRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTTGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCATGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTTAGTGGTTCAGATCTCTCCGGTGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 6024, "query_end": 6197, "hit_start": 27, "hit_end": 180, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 27.59}, "gnl|BL_ORD_ID|1455|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB27", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1590", "ARO_accession": "3002742", "ARO_name": "QnrB27", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.57875, "max_identities": 18, "bit_score": 25.409, "cvterm_id": "39584", "query": "TQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "T  L    +D  R   ++VEN T +  D+      GTE I       G   Y     KG   S+ +", "sequence_from_db": "TLALVSEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRAM", "sequence_from_broadstreet": "MTLALVSEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVAGATFSGSDLSGGEFSAFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTAGCGAAAAAATTGACAGAAACCGCTTCACCGGGGAAAAAGTTGAAAACAGTACTTTTTTTAACTGTGATTTTTCAGGGGCCGATCTTAGCGGCACTGAATTTATCGGCTGTCAGTTTTATGATCGCGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTTAAAAGTTGCGATTTATCCATGGCGGATTTTCGCAACGCCAGTGCCCTGGGAATTGAAATTCGCCACTGCCGCGCGCAGGGTTCAGATTTTCGCGGCGCGAGTTTTATGAACATGATCACCACGCGGACCTGGTTTTGCAGCGCATACATCACGAATACCAATCTAAGCTACGCCAACTTTTCGAAGGTTGTCCTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGAACTCAGGTAGCGGGTGCAACGTTCAGTGGATCAGATCTCTCGGGCGGTGAATTTTCAGCGTTCGACTGGCGGGCCGCAAACTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGTGTAGATTTACAAGGCGTCAAATTGGATAGCTATCAGGCAGCGTTGCTGATGGAGCGGCTTGGCATCGCGGTGATTGGCTAG", "partial": "0", "query_start": 6000, "query_end": 6197, "hit_start": 3, "hit_end": 180, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 27.27}, "gnl|BL_ORD_ID|244|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB36", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "272", "ARO_accession": "3002751", "ARO_name": "QnrB36", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.79015, "max_identities": 16, "bit_score": 25.409, "cvterm_id": "36915", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+D  R   ++VEN T +  D+      GTE I       G   Y     KG   S+ +", "sequence_from_db": "IDRNRFTGEKVENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRAM", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDTIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATACCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 6024, "query_end": 6197, "hit_start": 27, "hit_end": 180, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 27.59}, "gnl|BL_ORD_ID|1163|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB40", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1267", "ARO_accession": "3002755", "ARO_name": "QnrB40", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.92163, "max_identities": 16, "bit_score": 25.0238, "cvterm_id": "39584", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+D  R   ++VEN T +  D+      GTE I       G   Y     KG   S+ +", "sequence_from_db": "IDRNRFTGEKVENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRAM", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLRDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGTTFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACTGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAGAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTACGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 6024, "query_end": 6197, "hit_start": 27, "hit_end": 180, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 27.59}, "gnl|BL_ORD_ID|1153|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB68", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1257", "ARO_accession": "3002780", "ARO_name": "QnrB68", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.92163, "max_identities": 16, "bit_score": 25.0238, "cvterm_id": "39584", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+D  R   ++VEN T +  D+      GTE I       G   Y     KG   S+ +", "sequence_from_db": "IDRNRFTGEKVENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRAM", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVMGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTAATGGGTGCGACGTTTAGTGGTTCAGATCTCTCCGGTGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 6024, "query_end": 6197, "hit_start": 27, "hit_end": 180, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 27.59}, "gnl|BL_ORD_ID|48|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB47", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "58", "ARO_accession": "3002762", "ARO_name": "QnrB47", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.96626, "max_identities": 16, "bit_score": 25.0238, "cvterm_id": "36915", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+D  R   ++VEN T +  D+      GTE I       G   Y     KG   S+ +", "sequence_from_db": "IDRNRFTGEKVENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRAM", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLRDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAGAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGTGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 6024, "query_end": 6197, "hit_start": 27, "hit_end": 180, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 27.59}, "gnl|BL_ORD_ID|120|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB10", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "139", "ARO_accession": "3002724", "ARO_name": "QnrB10", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.08509, "max_identities": 16, "bit_score": 25.0238, "cvterm_id": "36915", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+D  R   ++VEN T +  D+      GTE I       G   Y     KG   S+ +", "sequence_from_db": "IDRNRFTGEKVENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRAM", "sequence_from_broadstreet": "MLSLLYKNTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGTTGTCATTACTGTATAAAAACACAGGCATAGATATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGGTGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGTCGCGCACAAGGCGCAGATTTTCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCCGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGACTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 6024, "query_end": 6197, "hit_start": 63, "hit_end": 216, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 27.59}, "gnl|BL_ORD_ID|529|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB19", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "581", "ARO_accession": "3002734", "ARO_name": "QnrB19", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.29014, "max_identities": 16, "bit_score": 25.0238, "cvterm_id": "35914", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+D  R   ++VEN T +  D+      GTE I       G   Y     KG   S+ +", "sequence_from_db": "IDRNRFTGEKVENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRAM", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGGTGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGTGCCTTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACTAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAGCTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 6024, "query_end": 6197, "hit_start": 27, "hit_end": 180, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 27.59}, "gnl|BL_ORD_ID|787|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB62", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "852", "ARO_accession": "3002775", "ARO_name": "QnrB62", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.41579, "max_identities": 16, "bit_score": 25.0238, "cvterm_id": "36915", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+D  R   ++VEN T +  D+      GTE I       G   Y     KG   S+ +", "sequence_from_db": "IDRNRFTGEKVENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRAM", "sequence_from_broadstreet": "MTPLLYKNTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAACACAGGCATAGATATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAAAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTTAGTGGTTCAGATCTCTCCGGTGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGACTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 6024, "query_end": 6197, "hit_start": 63, "hit_end": 216, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 27.59}, "gnl|BL_ORD_ID|973|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB73", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1063", "ARO_accession": "3002785", "ARO_name": "QnrB73", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.5343, "max_identities": 16, "bit_score": 25.0238, "cvterm_id": "36915", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+D  R   ++VEN T +  D+      GTE I       G   Y     KG   S+ +", "sequence_from_db": "IDRNRFTGEKVENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRAM", "sequence_from_broadstreet": "MSLALVSEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVAGATFSGSDLSGGEFSAFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGAGTCTGGCACTAGTTAGCGAAAAAATTGACAGAAACCGCTTCACCGGGGAAAAAGTTGAAAACAGTACTTTTTTTAACTGTGATTTTTCAGGGGCCGATCTTAGCGGCACTGAATTTATCGGCTGTCAGTTTTATGATCGCGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTTAAAAGTTGCGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCTCTGGGAATTGAAATTCGCCACTGCCGCGCGCAGGGTTCAGATTTTCGCGGCGCGAGTTTTATGAACATGATCACCACGCGGACCTGGTTTTGCAGCGCATACATCACGAATACCAATCTAAGCTACGCCAACTTTTCGAAGGTTGTCCTGGAAAAGTGCGAGCTGTGGGAAAATCGCTGGATGGGAACTCAGGTAGCGGGTGCAACGTTCAGTGGATCAGATCTCTCGGGCGGTGAATTTTCAGCGTTCGACTGGCGGGCCGCAAACTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGTGTAGATTTACAAGGCGTCAAATTGGATAGCTATCAGGCAGCGTTGCTGATGGAGCGGCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 6024, "query_end": 6197, "hit_start": 27, "hit_end": 180, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 27.59}, "gnl|BL_ORD_ID|1668|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB5", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1809", "ARO_accession": "3002719", "ARO_name": "QnrB5", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.61431, "max_identities": 16, "bit_score": 25.0238, "cvterm_id": "35665", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+D  R   ++VEN T +  D+      GTE I       G   Y     KG   S+ +", "sequence_from_db": "IDRNRFTGEKVENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRAM", "sequence_from_broadstreet": "MTPLLYKNTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAACACAGGCATAGATATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGGTGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGTGCCTTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACTAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAGCTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 6024, "query_end": 6197, "hit_start": 63, "hit_end": 216, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 27.59}, "gnl|BL_ORD_ID|1159|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB56", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1263", "ARO_accession": "3002769", "ARO_name": "QnrB56", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.82008, "max_identities": 16, "bit_score": 25.0238, "cvterm_id": "36915", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+D  R   ++VEN T +  D+      GTE I       G   Y     KG   S+ +", "sequence_from_db": "IDRNRFTGEKVENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRAM", "sequence_from_broadstreet": "MTPLLYKNTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAGNFTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAACACAGGCATAGATATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGGTGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTTCGCGGTGCAAGCTTTATGAATATGATCACCACGCGTACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGGAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAGCTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 6024, "query_end": 6197, "hit_start": 63, "hit_end": 216, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 27.59}, "gnl|BL_ORD_ID|323|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB24", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "354", "ARO_accession": "3002739", "ARO_name": "QnrB24", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.2545, "max_identities": 15, "bit_score": 25.0238, "cvterm_id": "36915", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+D  R   +++EN T +  D+      GTE I       G   Y     KG   S+ +", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADMSGTEFI-------GCQFYDRESQKGCNFSRAM", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADMSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMVDFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCACTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACATGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGTGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTGATTGGCTAG", "partial": "0", "query_start": 6024, "query_end": 6197, "hit_start": 63, "hit_end": 216, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 25.86}, "gnl|BL_ORD_ID|1839|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB74", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1993", "ARO_accession": "3002786", "ARO_name": "QnrB74", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.5208, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "35914", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+D  R   +++EN T +  D+      GTE I       G   Y     KG   S+ +", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRAM", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMIITRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWIGAQVLGATFSGSDFFGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACTTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGTTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGTATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATTATCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATAGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATTTCTTCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACTAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 6024, "query_end": 6197, "hit_start": 27, "hit_end": 180, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 25.86}, "gnl|BL_ORD_ID|4921|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB80", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5912", "ARO_accession": "3003192", "ARO_name": "QnrB80", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.58893, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "36915", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+D  R   +++EN T +  D+      GTE I       G   Y     KG   S+ +", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRAM", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALDIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGACATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTACCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGGGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 6024, "query_end": 6197, "hit_start": 27, "hit_end": 180, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 25.86}, "gnl|BL_ORD_ID|901|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "975", "ARO_accession": "3002714", "ARO_name": "QnrB1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.79703, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "35915", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+D  R   +++EN T +  D+      GTE I       G   Y     KG   S+ +", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRAM", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWIGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATAGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAGCGACTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 6024, "query_end": 6197, "hit_start": 27, "hit_end": 180, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 25.86}, "gnl|BL_ORD_ID|4919|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB77", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5910", "ARO_accession": "3003189", "ARO_name": "QnrB77", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.86765, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "36915", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+D  R   +++EN T +  D+      GTE I       G   Y     KG   S+ +", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRAM", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGTDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCACAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCGAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGCTAG", "partial": "0", "query_start": 6024, "query_end": 6197, "hit_start": 27, "hit_end": 180, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 25.86}, "gnl|BL_ORD_ID|1643|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB44", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1789", "ARO_accession": "3002759", "ARO_name": "QnrB44", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.86765, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "35914", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+D  R   +++EN T +  D+      GTE I       G   Y     KG   S+ +", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRAM", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFTTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTAAGTGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGTGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTACGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTCATTGGTTAA", "partial": "0", "query_start": 6024, "query_end": 6197, "hit_start": 27, "hit_end": 180, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 25.86}, "gnl|BL_ORD_ID|703|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB7", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "765", "ARO_accession": "3002721", "ARO_name": "QnrB7", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.86765, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "36884", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+D  R   +++EN T +  D+      GTE I       G   Y     KG   S+ +", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRAM", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFTTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTAAGTGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTACGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 6024, "query_end": 6197, "hit_start": 27, "hit_end": 180, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 25.86}, "gnl|BL_ORD_ID|1445|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB9", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1579", "ARO_accession": "3002723", "ARO_name": "QnrB9", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.93891, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "36915", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+D  R   +++EN T +  D+      GTE I       G   Y     KG   S+ +", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRAM", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTAAGTGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 6024, "query_end": 6197, "hit_start": 27, "hit_end": 180, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 25.86}, "gnl|BL_ORD_ID|1392|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB64", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1513", "ARO_accession": "3002776", "ARO_name": "QnrB64", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.93891, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "36915", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+D  R   +++EN T +  D+      GTE I       G   Y     KG   S+ +", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRAM", "sequence_from_broadstreet": "MALALVGDKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGATAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGTCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTATGCCAATTTTTCGAAAGTCGTGCTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 6024, "query_end": 6197, "hit_start": 27, "hit_end": 180, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 25.86}, "gnl|BL_ORD_ID|1868|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB43", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "2028", "ARO_accession": "3002758", "ARO_name": "QnrB43", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.01082, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "35914", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+D  R   +++EN T +  D+      GTE I       G   Y     KG   S+ +", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRAM", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLAGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTGCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGCTGCTCATGGAACGTCTTGGCATCGCGGTAATTGGTTAA", "partial": "0", "query_start": 6024, "query_end": 6197, "hit_start": 27, "hit_end": 180, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 25.86}, "gnl|BL_ORD_ID|1568|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB4", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1707", "ARO_accession": "3002718", "ARO_name": "QnrB4", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.08337, "max_identities": 16, "bit_score": 24.6386, "cvterm_id": "35914", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKK", "match": "+D  R   ++VEN T +  D+      GTE I       G   Y     KG   S+ ", "sequence_from_db": "IDRNRFTGEKVENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRA", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLLERLGIAVMG", "dna_sequence_from_broadstreet": "ATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAAAAAGTTGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTTAGCGGCACTGAATTTATTGGCTGCCAGTTTTATGATCGAGAAAGTCAGAAAGGATGTAATTTTAGTCGCGCTAACCTGAAAGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCTGATTTCAGGAATATCAATGCGCTGGGAATCGAAATTCGCCACTGCCGGGCACAAGGGTCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACCACCCGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGTACTCAGGTGCTGGGCGCAACGTTCAGTGGATCAGACCTCTCTGGCGGCGAGTTTTCATCCTTCGACTGGCGAGCAGCAAACGTTACGCACTGTGATTTGACCAATTCGGAACTGGGCGATTTAGATATCCGCGGGGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGCTCCTGGAACGTCTTGGTATCGCTGTCATGGGTTAA", "partial": "0", "query_start": 6024, "query_end": 6194, "hit_start": 27, "hit_end": 177, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 28.07}, "gnl|BL_ORD_ID|661|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB32", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "716", "ARO_accession": "3002747", "ARO_name": "QnrB32", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.23046, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "36915", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+D  R   +++EN T +  D+      GTE I       G   Y     KG   S+ +", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRAM", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNSNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTAAGTGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTAAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACTCAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 6024, "query_end": 6197, "hit_start": 27, "hit_end": 180, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 25.86}, "gnl|BL_ORD_ID|525|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB65", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "577", "ARO_accession": "3002777", "ARO_name": "QnrB65", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.305, "max_identities": 16, "bit_score": 24.6386, "cvterm_id": "36915", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKK", "match": "+D  R   ++VEN T +  D+      GTE I       G   Y     KG   S+ ", "sequence_from_db": "IDRNRFTGEKVENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRA", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLLERLGIAVMG", "dna_sequence_from_broadstreet": "ATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAGAAAGTCGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATTGGCTGCCAGTTTTATGATCGAGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCTAACCTGAAGGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCGGATTTCAGAAATATCAATGCGCTGGGAATCGAAATTCGCCACTGCCGGGCACAAGGGGCAGATTTTCGCGGCGCAAGCTTTATGAATATGATCACCACCCGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCTAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGTACTCAGGTGCTGGGCGCAACGTTCAGTGGATCAGACCTCTCTGGCGGCGAGTTTTCATCCTTCGACTGGCGAGCAGCAAACGTTACGCACTGTGATTTGACCAATTCGGAACTGGGCGATTTAGATATCCGTGGGGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGCTCCTGGAACGTCTTGGCATCGCTGTCATGGGTTAA", "partial": "0", "query_start": 6024, "query_end": 6194, "hit_start": 27, "hit_end": 177, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 28.07}, "gnl|BL_ORD_ID|1346|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB26", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1470", "ARO_accession": "3002741", "ARO_name": "QnrB26", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.34061, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "36943", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+D  R   +++EN T +  D+      GTE I       G   Y     KG   S+ +", "sequence_from_db": "IDRNRFTGEKIENGTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRAM", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGVKIDRNRFTGEKIENGTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGTAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATGGTACATTTTTTAATTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCGAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 6024, "query_end": 6197, "hit_start": 63, "hit_end": 216, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 25.86}, "gnl|BL_ORD_ID|291|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB54", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "324", "ARO_accession": "3002767", "ARO_name": "QnrB54", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.38021, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "36915", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+D  R   +++EN T +  D+      GTE I       G   Y     KG   S+ +", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRAM", "sequence_from_broadstreet": "MALALVSEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCACTGGCACTCGTTAGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTACCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 6024, "query_end": 6197, "hit_start": 27, "hit_end": 180, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 25.86}, "gnl|BL_ORD_ID|1435|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB16", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1564", "ARO_accession": "3002731", "ARO_name": "QnrB16", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.41595, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "36915", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+D  R   +++EN T +  D+      GTE I       G   Y     KG   S+ +", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRAM", "sequence_from_broadstreet": "MTPLLYIKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATATAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTACCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGGGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 6024, "query_end": 6197, "hit_start": 63, "hit_end": 216, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 25.86}, "gnl|BL_ORD_ID|4920|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB78", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5911", "ARO_accession": "3003190", "ARO_name": "QnrB78", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.53269, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "36915", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+D  R   +++EN T +  D+      GTE I       G   Y     KG   S+ +", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRAM", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRSVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTAAGTGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGAGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 6024, "query_end": 6197, "hit_start": 27, "hit_end": 180, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 25.86}, "gnl|BL_ORD_ID|571|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB46", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "625", "ARO_accession": "3002761", "ARO_name": "QnrB46", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.64606, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "35915", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+D  R   +++EN T +  D+      GTE I       G   Y     KG   S+ +", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRAM", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAGAAAACAGGAACAAATATGGCTCTAGCGCTCGTGGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAAAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGAGCGGACCTGAGCGGCACTGAGTTTATCGGCTGCCAATTTTATGATCGTGAAAGCCAGAAAGGCTGTAATTTTAGCCGTGCGATGTTAAAGGATGCTATTTTTAAAAGCTGCGATTTATCCATGGCCGATTTTCGCAATGCAAGCGCCCTGGGTATTGAGATTCGTCATTGTAGGGCTCAGGGTGCAGATTTTCGCGGCGCAAGCTTTATGAACATGATTACCACGCGAACTTGGTTCTGCAGCGCGTATATCACGAATACGAATCTGTCTTATGCCAATTTTTCGAAAGCAGTGTTGGAGAAGTGTGAATTATGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCAACTTTCGACTGGCGAGCAGCAAACTTTACACATTGCGATCTCACAAATTCGGAGTTGGGTGACTTAGATATTCGTCGGGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCTTCGTTGCTCATGGAGCGACTTGGCATCGCGATAATTGGATGA", "partial": "0", "query_start": 6024, "query_end": 6197, "hit_start": 63, "hit_end": 216, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 25.86}, "gnl|BL_ORD_ID|238|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB13", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "266", "ARO_accession": "3002727", "ARO_name": "QnrB13", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.64606, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "36915", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+D  R   +++EN T +  D+      GTE I       G   Y     KG   S+ +", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRAM", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 6024, "query_end": 6197, "hit_start": 63, "hit_end": 216, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 25.86}, "gnl|BL_ORD_ID|542|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB41", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "594", "ARO_accession": "3002756", "ARO_name": "QnrB41", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.66098, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "36915", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+D  R   +++EN T +  D+      GTE I       G   Y     KG   S+ +", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRAM", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGDKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIGS", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGATAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGACTTGGCATCGCGGTGATTGGTAGC", "partial": "1", "query_start": 6024, "query_end": 6197, "hit_start": 63, "hit_end": 216, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 25.86}, "gnl|BL_ORD_ID|1009|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB29", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1102", "ARO_accession": "3002744", "ARO_name": "QnrB29", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.72415, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "36915", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+D  R   +++EN T +  D+      GTE I       G   Y     KG   S+ +", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRAM", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMVDFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCACTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGTGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTGATTGGCTAG", "partial": "0", "query_start": 6024, "query_end": 6197, "hit_start": 63, "hit_end": 216, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 25.86}, "gnl|BL_ORD_ID|377|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB6", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "417", "ARO_accession": "3002720", "ARO_name": "QnrB6", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.72415, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "36950", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+D  R   +++EN T +  D+      GTE I       G   Y     KG   S+ +", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRAM", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 6024, "query_end": 6197, "hit_start": 63, "hit_end": 216, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 25.86}, "gnl|BL_ORD_ID|869|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB48", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "946", "ARO_accession": "3002763", "ARO_name": "QnrB48", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.7666, "max_identities": 15, "bit_score": 24.2534, "cvterm_id": "36915", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+D  R   +++EN T +  D+      GTE I       G   Y     KG   S+ +", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRAM", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGGLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGGAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTTCGCGGCGCAAGCTTTATGAATATGATCACCACACGCACCTGGTTTTGCAGCGCATATATAACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGGCTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 6024, "query_end": 6197, "hit_start": 27, "hit_end": 180, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 25.86}, "gnl|BL_ORD_ID|459|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB17", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "498", "ARO_accession": "3002732", "ARO_name": "QnrB17", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.80295, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "36915", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+D  R   +++EN T +  D+      GTE I       G   Y     KG   S+ +", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRAM", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCGAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 6024, "query_end": 6197, "hit_start": 63, "hit_end": 216, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 25.86}, "gnl|BL_ORD_ID|436|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB49", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "484", "ARO_accession": "3002764", "ARO_name": "QnrB49", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.80295, "max_identities": 15, "bit_score": 24.6386, "cvterm_id": "36915", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+D  R   +++EN T +  D+      GTE I       G   Y     KG   S+ +", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRAM", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCACTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTAGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGGACCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 6024, "query_end": 6197, "hit_start": 63, "hit_end": 216, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 25.86}, "gnl|BL_ORD_ID|1506|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB57", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1636", "ARO_accession": "3002770", "ARO_name": "QnrB57", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.88245, "max_identities": 15, "bit_score": 24.2534, "cvterm_id": "36915", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+D  R   +++EN T +  D+      GTE I       G   Y     KG   S+ +", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRAM", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGNLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTAACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGCTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 6024, "query_end": 6197, "hit_start": 63, "hit_end": 216, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 25.86}, "gnl|BL_ORD_ID|4925|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB76", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5919", "ARO_accession": "3003188", "ARO_name": "QnrB76", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.96268, "max_identities": 15, "bit_score": 24.2534, "cvterm_id": "43754", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+D  R   +++EN T +  D+      GTE I       G   Y     KG   S+ +", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRAM", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGTGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 6024, "query_end": 6197, "hit_start": 63, "hit_end": 216, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 25.86}, "gnl|BL_ORD_ID|4917|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB39", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5908", "ARO_accession": "3002754", "ARO_name": "QnrB39", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.33759, "max_identities": 17, "bit_score": 24.2534, "cvterm_id": "39643", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+D  R    +VEN T +  D+      GTE I       G   Y     KG   S+ I", "sequence_from_db": "IDRNRFTGVKVENSTFFNCDFSGTDLSGTEFI-------GCQFYDRESQKGCNFSRAI", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGVKVENSTFFNCDFSGTDLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNASALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQGVKLDSYQASLILERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCGTTGGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGTGAAAGTTGAAAATAGCACGTTTTTCAACTGTGATTTTTCGGGTACCGACCTTAGCGGCACTGAATTTATTGGCTGCCAGTTTTATGATCGAGAGAGCCAGAAAGGGTGTAATTTTAGTCGCGCTATCCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCCATGGCGGATTTCAGAAATGCCAGCGCGCTGGGAATCGAGATTCGCCACTGCCGCGCGCAAGGTTCGGATTTTCGCGGTGCCAGTTTTATGAATATGATCACCACCCGCACCTGGTTTTGCAGCGCTTATATCACCAATACAAACTTAAGCTACGCCAACTTTTCGAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGTTGGATGGGTACTCAGGTACTGGGGGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGTCGTTCGACTGGCGGGCCGCGAACTTTACGCACTGTGACCTGACCAACTCGGAGCTGGGTGATTTAGACGTCCGTGGGGTGGATTTACAAGGCGTTAAACTGGACAGCTACCAGGCGTCTTTGATCCTGGAGCGTCTTGGCATCGCTGTCATTGGTTAA", "partial": "0", "query_start": 6024, "query_end": 6197, "hit_start": 27, "hit_end": 180, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 29.31}, "gnl|BL_ORD_ID|1882|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB31", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "2044", "ARO_accession": "3002746", "ARO_name": "QnrB31", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.37476, "max_identities": 15, "bit_score": 24.2534, "cvterm_id": "35915", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+D  R   +++EN T +  D+      GTE I       G   Y     KG   S+ +", "sequence_from_db": "IDRNRFTGEKIENSTFFLCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRAM", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFLCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEISHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAGAAAACAGGTACAAATATGGCTCTGGCGCTCGTGGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTTTATGTGATTTTTCAGGAGCCGACCTGAGCGGCACTGAGTTTATCGGCTGTCAATTCTATGATCGTGAAAGCCAGAAAGGCTGCAATTTTAGTCGTGCGATGTTAAAGGATGCCATTTTTAAAAGCTGCGATTTATCCATGGCGGATTTTCGCAATGCAAGCGCCCTGGGTATTGAGATTTCTCATTGTAGGGCTCAGGGTGCAGATTTTCGCGGCGCAAGCTTTATGAACATGATTACCACGCGCACTTGGTTCTGCAGCGCGTATATCACGAATACGAATCTGTCTTATGCCAATTTTTCGAAAGTCGTGTTGGAGAAGTGTGAGTTATGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCAACTTTCGACTGGCGAGCAGCAAACTTTACACATTGCGATCTCACAAATTCGGAGTTGGGTGACTTAGATATTCGTCGGGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCTTCGTTGCTCATGGAGCGACTTGGCATCGCGATAATTGGTTGA", "partial": "0", "query_start": 6024, "query_end": 6197, "hit_start": 63, "hit_end": 216, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 25.86}, "gnl|BL_ORD_ID|1111|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB45", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1209", "ARO_accession": "3002760", "ARO_name": "QnrB45", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.50745, "max_identities": 15, "bit_score": 24.2534, "cvterm_id": "35914", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+D  R   +++EN T +  D+      GTE I       G   Y     KG   S+ +", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRTM", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRTMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTACGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTGATTGGTTAA", "partial": "0", "query_start": 6024, "query_end": 6197, "hit_start": 27, "hit_end": 180, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 25.86}, "gnl|BL_ORD_ID|1788|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5541, "orf_end": 6266, "orf_from": "BGC0000765.1|Exopolysaccharide_9 ", "model_name": "QnrB30", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1940", "ARO_accession": "3002745", "ARO_name": "QnrB30", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.80576, "max_identities": 15, "bit_score": 24.2534, "cvterm_id": "39584", "query": "LDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKI", "match": "+D  R   +++EN T +  D+      GTE I       G   Y     KG   S+ +", "sequence_from_db": "IDRNRFTGEKIENSTFFNCDFSGADLSGTEFI-------GCQFYDRESQKGCNFSRAM", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSSDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCACTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTAAAAGATGCCATTTTTAAAAGCAGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGGGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 6024, "query_end": 6197, "hit_start": 63, "hit_end": 216, "orf_dna_sequence": "ATGACTATACCAAAAGTAATACATTATTGTTGGTTTGGAAATAATCCAAAACCTAAAGTAATTCAAGATTGTATAGAATCTTGGAAAAAATATTGTCCCGATTACGAGATAAAAGAATGGAACGAATCAAATTATGATGTAAATAAAACTAAGTATACTCAGTTAGCTTATAAAAGTAAAAAGTATGCTTTCTTAACCGATTATGTTCGTTTAGATGCCCTTTATAATGAGGGTGGTGTCTATATGGATACCGATGTGAAATTGATTAAGTCAATTGATGATCTTGTTAAAAAGGGTAATTTCATGTCTTTTGAAAAAGTAGGTCGGGTTAATACAGGTGTGGGATTTGCTAGTGAAAAAGGCACATCTATCCTTAAAGAAAATTTAGATTATTATAATACACATACATTTGTGGATAAAAATAATAATTTTGATCCTGAAATTTGTGTAAAAATAACTACACAATTGTTGGAAAAACATGGACTAGATTATAAGCGTAATGAACAGCAAGAAGTAGAGAATTTTACTATTTACCCATCAGATTATTTCTCTCCTAAAAAAATGGGAACAGAAAAAATTACAATTACTTCAAATACTTACGGTATACATTTGTATGCTTCTAGTTGGTATAAAGGATCAAAATTGTCCAAAAAAATTAAGTATCATCTAATTCCGCTTAAAGAATTTGTGAAATATAAAATTTTGAAAAGAAAATTATATGAATAA", "orf_prot_sequence": "MTIPKVIHYCWFGNNPKPKVIQDCIESWKKYCPDYEIKEWNESNYDVNKTKYTQLAYKSKKYAFLTDYVRLDALYNEGGVYMDTDVKLIKSIDDLVKKGNFMSFEKVGRVNTGVGFASEKGTSILKENLDYYNTHTFVDKNNNFDPEICVKITTQLLEKHGLDYKRNEQQEVENFTIYPSDYFSPKKMGTEKITITSNTYGIHLYASSWYKGSKLSKKIKYHLIPLKEFVKYKILKRKLYE", "perc_identity": 25.86}}, "BGC0000765.1|Exopolysaccharide_10 # 6259 # 7164 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.266": {"gnl|BL_ORD_ID|1937|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 6259, "orf_end": 7164, "orf_from": "BGC0000765.1|Exopolysaccharide_10 ", "model_name": "PmrF", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "550", "model_id": "2014", "ARO_accession": "3003578", "ARO_name": "PmrF", "ARO_category": {"41433": {"category_aro_accession": "3004269", "category_aro_cvterm_id": "41433", "category_aro_name": "pmr phosphoethanolamine transferase", "category_aro_description": "This family of phosphoethanolamine transferase catalyze the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine to lipid A, which impedes the binding of colistin to the cell membrane.", "category_aro_class_name": "AMR Gene Family"}, "36593": {"category_aro_accession": "3000454", "category_aro_cvterm_id": "36593", "category_aro_name": "polymyxin B", "category_aro_description": "Polymyxin B is mixture of mostly polymyxins B1 and B2, mainly used for resistant gram-negative infections. They are polypeptides with cationic detergent action on cell membranes.", "category_aro_class_name": "Antibiotic"}, "36192": {"category_aro_accession": "3000053", "category_aro_cvterm_id": "36192", "category_aro_name": "peptide antibiotic", "category_aro_description": "Peptide antibiotics have a wide range of antibacterial mechanisms, depending on the amino acids that make up the antibiotic, although most act to disrupt the cell membrane in some manner. Subclasses of peptide antibiotics can include additional sidechains of other types, such as lipids in the case of the lipopeptide antibiotics.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0363123, "max_identities": 19, "bit_score": 32.3426, "cvterm_id": "36849", "query": "EQISIITPVFNR---LKELTRLYKSLRTQNNNNFIWIIVDDGS-EKTINEIVDIWKKESKFKIDLIVQSNQGKMHAYKNAMKRLNTPWSLVVDSD", "match": "+++S++ PV+N    L EL R   +        +  +++DDGS + + + +V+  + E+   + +++  N G+  A       +     + +D+D", "sequence_from_db": "KKVSVVIPVYNEQESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVEASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDAD", "sequence_from_broadstreet": "MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVEASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEGYDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHERSTFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLGSIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYTDVRARPRYFVQQVIRPSSKENE", "dna_sequence_from_broadstreet": "ATGTTTGAAATCCACCCTGTTAAGAAAGTCTCGGTGGTTATTCCCGTTTATAACGAGCAGGAAAGCTTACCGGAATTAATCAGGCGCACCACCACAGCCTGTGAATCGTTGGGGAAAGAGTATGAGATCCTGCTGATTGATGACGGCAGTAGCGATAATTCCGCGCATATGCTGGTCGAAGCCTCACAAGCGGAGAACAGCCATATTGTGTCTATTTTGCTTAACCGCAATTACGGGCAACATTCAGCGATTATGGCGGGATTCAGTCACGTTACTGGCGACTTAATTATTACCCTTGATGCCGATCTCCAGAATCCGCCAGAAGAAATCCCCCGCCTGGTGGCAAAAGCCGATGAAGGTTACGACGTGGTAGGGACTGTACGCCAGAACCGCCAGGACAGCTGGTTTCGTAAAACCGCTTCGAAGATGATTAACCGGCTTATTCAGCGCACCACTGGCAAAGCGATGGGTGATTACGGTTGTATGCTGCGCGCCTATCGCCGTCATATTGTCGATGCGATGTTGCACTGCCATGAACGCAGCACCTTTATCCCGATTCTGGCGAATATCTTCGCCCGCCGTGCCATTGAAATTCCAGTACATCATGCCGAGCGTGAGTTTGGTGAATCCAAATACAGTTTTATGCGCCTGATTAATTTGATGTACGACCTGGTGACCTGCCTTACCACAACGCCGCTACGTATGCTGAGTCTGCTCGGCAGCATTATTGCGATTGGAGGTTTTAGCATTGCGGTGCTGCTGGTGATTTTACGCCTGACCTTCGGACCACAATGGGCGGCAGAAGGCGTCTTTATGCTATTTGCCGTGCTGTTTACTTTTATTGGCGCTCAGTTTATCGGCATGGGATTACTCGGTGAATATATCGGCAGGATCTACACCGATGTCCGCGCCCGCCCCCGCTATTTTGTTCAGCAAGTTATCCGTCCATCCAGCAAGGAAAATGAATAA", "partial": "0", "query_start": 6280, "query_end": 6552, "hit_start": 21, "hit_end": 306, "orf_dna_sequence": "ATGAATAAGGTAGCATATAAAGAACAAATATCTATTATTACCCCTGTTTTTAATAGATTAAAAGAATTAACTAGACTATATAAATCGTTACGCACGCAAAATAATAATAATTTTATATGGATTATTGTAGATGATGGTTCTGAGAAAACTATTAATGAGATTGTAGATATTTGGAAAAAAGAATCAAAATTTAAGATTGATTTGATCGTCCAGTCTAATCAAGGAAAAATGCATGCCTATAAAAATGCAATGAAACGTTTGAATACACCATGGTCGTTAGTCGTAGATAGTGATGATACTGTATCAGAAGAAATGATAGATATTTTATATAAAACAATATTATCTATTAATTCTGATAATGATTGTGGTGTAGTTTTCCCAAGAAAATTAGGTGCTGATTCGAATGGAACATCTCTTTGGAAACAATTACCAAATAAAGTTAATATTATAGATTTGAGATATCAATATAATATTCCCGAATCTACTATTTTTATAAAAACTAATGAATTAAAAAAGGCATTTAACTCCTTACAATTACCTGATGAAAAATTTATTAGTGAAGAAATACTTTACAATAAATTAATGGAACAAGGTAAATTTGTTGTAAGAGATGAACTATTTTATTTTGGTGATTATCAAGAGGATGGACTAACAAAACATCTTTTTGAATTATGGTTAAAAAATCCTAAAAGTACCATTATGTTGTTGAATTCAAGATATCGCGCAATGAATTCATTTCCTTGGAAAAAGCGATTGATAGGTCAATGGAAAACAAATATTAATTTAACTGCTTTTGCACTTGCAACTAACAGATCAATTAAAAGTGTTTCACCAGATTTAATAGAAAGTATTTTTTTATTTTTACCAGCGTTGGTTTTGAAGGAAAAGAGATTCAAAATTGAATAA", "orf_prot_sequence": "MNKVAYKEQISIITPVFNRLKELTRLYKSLRTQNNNNFIWIIVDDGSEKTINEIVDIWKKESKFKIDLIVQSNQGKMHAYKNAMKRLNTPWSLVVDSDDTVSEEMIDILYKTILSINSDNDCGVVFPRKLGADSNGTSLWKQLPNKVNIIDLRYQYNIPESTIFIKTNELKKAFNSLQLPDEKFISEEILYNKLMEQGKFVVRDELFYFGDYQEDGLTKHLFELWLKNPKSTIMLLNSRYRAMNSFPWKKRLIGQWKTNINLTAFALATNRSIKSVSPDLIESIFLFLPALVLKEKRFKIE", "perc_identity": 20.0}, "gnl|BL_ORD_ID|2651|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 6259, "orf_end": 7164, "orf_from": "BGC0000765.1|Exopolysaccharide_10 ", "model_name": "dfrB4", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "150", "model_id": "3076", "ARO_accession": "3004498", "ARO_name": "dfrB4", "ARO_category": {"37617": {"category_aro_accession": "3001218", "category_aro_cvterm_id": "37617", "category_aro_name": "trimethoprim resistant dihydrofolate reductase dfr", "category_aro_description": "Alternative dihydropteroate synthase dfr present on plasmids produces alternate proteins that are less sensitive to trimethoprim from inhibiting its role in folate synthesis, thus conferring trimethoprim resistance.", "category_aro_class_name": "AMR Gene Family"}, "36327": {"category_aro_accession": "3000188", "category_aro_cvterm_id": "36327", "category_aro_name": "trimethoprim", "category_aro_description": "Trimethoprim is a synthetic 5-(3,4,5- trimethoxybenzyl) pyrimidine inhibitor of dihydrofolate reductase, inhibiting synthesis of tetrahydrofolic acid. Tetrahydrofolic acid is an essential precursor in the de novo synthesis of the DNA nucleotide thymidine. Trimethoprim is a bacteriostatic antibiotic mainly used in the prophylaxis and treatment of urinary tract infections in combination with sulfamethoxazole, a sulfonamide antibiotic.", "category_aro_class_name": "Antibiotic"}, "36310": {"category_aro_accession": "3000171", "category_aro_cvterm_id": "36310", "category_aro_name": "diaminopyrimidine antibiotic", "category_aro_description": "Diaminopyrimidines are a class of organic compounds containing a pyrimidine ring substituted by two amine groups.  They are inhibitors of dihydrofolate reductase, an enzyme critical for DNA synthesis.", "category_aro_class_name": "Drug Class"}, "35998": {"category_aro_accession": "0001002", "category_aro_cvterm_id": "35998", "category_aro_name": "antibiotic target replacement", "category_aro_description": "Replacement or substitution of antibiotic action target, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.39945, "max_identities": 11, "bit_score": 25.409, "cvterm_id": "35914", "query": "PKSTIMLLNSRYRAMNSFPWKKRLIGQWKTNINLTAFALATNRSIKSV", "match": "P +    L  R R  +   W+ R++G + T +    +A+ +     SV", "sequence_from_db": "PSNATFALGDRVRKKSGAAWQGRIVGWYCTTLTPEGYAVESESHPDSV", "sequence_from_broadstreet": "MNEGKNEVSTSAAGRFAFPSNATFALGDRVRKKSGAAWQGRIVGWYCTTLTPEGYAVESESHPDSVQIYPMTALERVA", "dna_sequence_from_broadstreet": "ATGAATGAAGGAAAAAATGAGGTCAGTACTTCAGCTGCTGGCCGGTTCGCATTCCCATCAAACGCCACGTTTGCCTTGGGGGATCGCGTACGCAAGAAGTCTGGCGCTGCTTGGCAGGGGCGCATTGTCGGGTGGTACTGCACAACACTTACCCCTGAAGGCTACGCCGTCGAGTCCGAATCTCACCCAGACTCAGTCCAGATTTATCCCATGACTGCGCTTGAACGGGTGGCCTGA", "partial": "0", "query_start": 6943, "query_end": 7086, "hit_start": 54, "hit_end": 198, "orf_dna_sequence": "ATGAATAAGGTAGCATATAAAGAACAAATATCTATTATTACCCCTGTTTTTAATAGATTAAAAGAATTAACTAGACTATATAAATCGTTACGCACGCAAAATAATAATAATTTTATATGGATTATTGTAGATGATGGTTCTGAGAAAACTATTAATGAGATTGTAGATATTTGGAAAAAAGAATCAAAATTTAAGATTGATTTGATCGTCCAGTCTAATCAAGGAAAAATGCATGCCTATAAAAATGCAATGAAACGTTTGAATACACCATGGTCGTTAGTCGTAGATAGTGATGATACTGTATCAGAAGAAATGATAGATATTTTATATAAAACAATATTATCTATTAATTCTGATAATGATTGTGGTGTAGTTTTCCCAAGAAAATTAGGTGCTGATTCGAATGGAACATCTCTTTGGAAACAATTACCAAATAAAGTTAATATTATAGATTTGAGATATCAATATAATATTCCCGAATCTACTATTTTTATAAAAACTAATGAATTAAAAAAGGCATTTAACTCCTTACAATTACCTGATGAAAAATTTATTAGTGAAGAAATACTTTACAATAAATTAATGGAACAAGGTAAATTTGTTGTAAGAGATGAACTATTTTATTTTGGTGATTATCAAGAGGATGGACTAACAAAACATCTTTTTGAATTATGGTTAAAAAATCCTAAAAGTACCATTATGTTGTTGAATTCAAGATATCGCGCAATGAATTCATTTCCTTGGAAAAAGCGATTGATAGGTCAATGGAAAACAAATATTAATTTAACTGCTTTTGCACTTGCAACTAACAGATCAATTAAAAGTGTTTCACCAGATTTAATAGAAAGTATTTTTTTATTTTTACCAGCGTTGGTTTTGAAGGAAAAGAGATTCAAAATTGAATAA", "orf_prot_sequence": "MNKVAYKEQISIITPVFNRLKELTRLYKSLRTQNNNNFIWIIVDDGSEKTINEIVDIWKKESKFKIDLIVQSNQGKMHAYKNAMKRLNTPWSLVVDSDDTVSEEMIDILYKTILSINSDNDCGVVFPRKLGADSNGTSLWKQLPNKVNIIDLRYQYNIPESTIFIKTNELKKAFNSLQLPDEKFISEEILYNKLMEQGKFVVRDELFYFGDYQEDGLTKHLFELWLKNPKSTIMLLNSRYRAMNSFPWKKRLIGQWKTNINLTAFALATNRSIKSVSPDLIESIFLFLPALVLKEKRFKIE", "perc_identity": 22.92}, "gnl|BL_ORD_ID|2493|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 6259, "orf_end": 7164, "orf_from": "BGC0000765.1|Exopolysaccharide_10 ", "model_name": "RSA-1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "2884", "ARO_accession": "3004444", "ARO_name": "RSA-1", "ARO_category": {"41636": {"category_aro_accession": "3004443", "category_aro_cvterm_id": "41636", "category_aro_name": "RSA beta-lactamase", "category_aro_description": "A family of class A beta-lactamase enzymes, RSA beta-lactamases show carbapenemase and cephalosporinase activity.", "category_aro_class_name": "AMR Gene Family"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.03537, "max_identities": 21, "bit_score": 26.1794, "cvterm_id": "36791", "query": "NQGKMHAYKNAMKRLNTPWSLVVDSDDTVSEEMIDILYKTILSINSDNDCGVVFPRKLGADSNGTSLWKQLPNKVNIIDLR", "match": "+ G++ AY  A KR      + V   +  S ++            SDN    +   KLG  S  TS+++ L + V+ +D R", "sequence_from_db": "SAGQLDAYAPAAKRYLPTGYITVAEANQASVQL------------SDNTAANLLLDKLGGPSQLTSMFRSLGDSVSRLDRR", "sequence_from_broadstreet": "MGMQLARSTILTVLLCLPIAVTATTKEEIQKIERQRNLTVGIALVDDGGTLLFGHRETQRFAMCSTFKLPLAAATLKQIESGKWSAAERLSYSAGQLDAYAPAAKRYLPTGYITVAEANQASVQLSDNTAANLLLDKLGGPSQLTSMFRSLGDSVSRLDRREPDLNTNVSGDPRDTTTPGAMARIVAKLVYGNYLSTAGREQLQRLLIGNNTGDSRIRAGIASGWTTGDKTGSCPNGGRNDAAFLVSPDGRRFALTVYLNAPSLDDKARNEVVATVARLAVESIR", "dna_sequence_from_broadstreet": "ATGGGAATGCAACTAGCTAGGTCGACGATCCTCACTGTTTTGCTCTGTCTGCCGATTGCTGTAACGGCTACGACTAAGGAGGAGATCCAAAAGATTGAGCGTCAGCGCAACCTCACGGTTGGCATCGCTCTTGTAGACGACGGGGGAACACTCCTGTTCGGTCATCGCGAAACGCAGCGCTTCGCCATGTGCTCGACATTTAAGTTGCCGCTGGCGGCTGCAACGCTTAAGCAAATCGAGAGCGGAAAGTGGTCTGCCGCCGAGCGGCTGAGCTATAGCGCTGGCCAATTAGATGCCTACGCGCCAGCTGCCAAGAGATATCTACCTACAGGCTACATCACGGTAGCTGAGGCTAACCAAGCCTCGGTCCAGCTCAGCGATAATACTGCTGCCAACTTGCTGCTTGACAAACTCGGAGGGCCATCGCAGCTCACATCCATGTTTCGCTCCCTCGGCGATTCCGTGAGTCGCCTGGATAGAAGAGAACCCGATTTGAACACCAACGTTTCGGGTGACCCGCGCGACACGACTACGCCGGGCGCGATGGCACGCATTGTCGCAAAGCTGGTATATGGAAACTATCTAAGTACAGCAGGCCGAGAGCAATTGCAGCGGCTTCTCATTGGCAATAACACAGGCGACTCGAGGATTCGCGCTGGAATCGCATCTGGCTGGACGACTGGCGACAAAACGGGTTCCTGCCCCAATGGCGGACGAAATGACGCTGCGTTCCTGGTAAGCCCTGATGGCCGCAGATTTGCGCTGACAGTGTACCTGAACGCCCCATCGCTTGACGACAAGGCACGGAACGAGGTGGTCGCTACGGTAGCTCGCTTGGCGGTTGAGAGTATCCGCTAG", "partial": "0", "query_start": 6475, "query_end": 6717, "hit_start": 276, "hit_end": 483, "orf_dna_sequence": "ATGAATAAGGTAGCATATAAAGAACAAATATCTATTATTACCCCTGTTTTTAATAGATTAAAAGAATTAACTAGACTATATAAATCGTTACGCACGCAAAATAATAATAATTTTATATGGATTATTGTAGATGATGGTTCTGAGAAAACTATTAATGAGATTGTAGATATTTGGAAAAAAGAATCAAAATTTAAGATTGATTTGATCGTCCAGTCTAATCAAGGAAAAATGCATGCCTATAAAAATGCAATGAAACGTTTGAATACACCATGGTCGTTAGTCGTAGATAGTGATGATACTGTATCAGAAGAAATGATAGATATTTTATATAAAACAATATTATCTATTAATTCTGATAATGATTGTGGTGTAGTTTTCCCAAGAAAATTAGGTGCTGATTCGAATGGAACATCTCTTTGGAAACAATTACCAAATAAAGTTAATATTATAGATTTGAGATATCAATATAATATTCCCGAATCTACTATTTTTATAAAAACTAATGAATTAAAAAAGGCATTTAACTCCTTACAATTACCTGATGAAAAATTTATTAGTGAAGAAATACTTTACAATAAATTAATGGAACAAGGTAAATTTGTTGTAAGAGATGAACTATTTTATTTTGGTGATTATCAAGAGGATGGACTAACAAAACATCTTTTTGAATTATGGTTAAAAAATCCTAAAAGTACCATTATGTTGTTGAATTCAAGATATCGCGCAATGAATTCATTTCCTTGGAAAAAGCGATTGATAGGTCAATGGAAAACAAATATTAATTTAACTGCTTTTGCACTTGCAACTAACAGATCAATTAAAAGTGTTTCACCAGATTTAATAGAAAGTATTTTTTTATTTTTACCAGCGTTGGTTTTGAAGGAAAAGAGATTCAAAATTGAATAA", "orf_prot_sequence": "MNKVAYKEQISIITPVFNRLKELTRLYKSLRTQNNNNFIWIIVDDGSEKTINEIVDIWKKESKFKIDLIVQSNQGKMHAYKNAMKRLNTPWSLVVDSDDTVSEEMIDILYKTILSINSDNDCGVVFPRKLGADSNGTSLWKQLPNKVNIIDLRYQYNIPESTIFIKTNELKKAFNSLQLPDEKFISEEILYNKLMEQGKFVVRDELFYFGDYQEDGLTKHLFELWLKNPKSTIMLLNSRYRAMNSFPWKKRLIGQWKTNINLTAFALATNRSIKSVSPDLIESIFLFLPALVLKEKRFKIE", "perc_identity": 25.93}, "gnl|BL_ORD_ID|4560|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 6259, "orf_end": 7164, "orf_from": "BGC0000765.1|Exopolysaccharide_10 ", "model_name": "PME-1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "600", "model_id": "5630", "ARO_accession": "3006973", "ARO_name": "PME-1", "ARO_category": {"43895": {"category_aro_accession": "3005435", "category_aro_cvterm_id": "43895", "category_aro_name": "PME beta-lactamase", "category_aro_description": "PME beta-lactamases are class A beta-lactamases found in Gammaproteobacteria.", "category_aro_class_name": "AMR Gene Family"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.69084, "max_identities": 12, "bit_score": 25.409, "cvterm_id": "36752", "query": "INSDNDCGVVFPRKLGADSNGTSLWKQLPNKVNIID", "match": "+ SDN    +  RKLG     T+LW+   ++V+ +D", "sequence_from_db": "LTSDNAAANLLIRKLGGPEAVTALWRASGDEVSRLD", "sequence_from_broadstreet": "MFLYFTQIRAWPLAALLLFMLAACAGAPRAPDDATDTASDALAALELRNGGRLGVFALDAGSGRSLGWREDERFGMCSTFKLLLAATVLDAARQGRLDGTAPIHFSDDDLVPHSPVLREHLALGSSTLTAPELARATQLTSDNAAANLLIRKLGGPEAVTALWRASGDEVSRLDRLEPDMNLLPPGDLRDSTSPRAMAQHVARLFTSEMLVPEDRERLREWMVETGTGLARLRAATPPHWQAGDKTGSAIAPLMPNKTHDVAVFWPPGRAPVIVAAYYESDAHHAGRIRAQDEAVLAQVGRIAVAWAGD", "dna_sequence_from_broadstreet": "ATGTTCCTTTACTTCACACAGATCCGCGCATGGCCGCTGGCCGCATTGCTGCTGTTTATGCTGGCCGCATGCGCTGGCGCGCCGCGCGCTCCCGATGACGCAACCGATACCGCAAGCGATGCGCTGGCGGCACTGGAACTGCGCAACGGCGGGCGTCTGGGCGTGTTCGCGCTGGATGCCGGCAGTGGCCGCAGTCTGGGCTGGCGCGAAGACGAGCGCTTCGGCATGTGCTCGACATTCAAGCTGCTGCTGGCGGCCACGGTGCTGGATGCGGCACGGCAGGGCCGGCTCGACGGCACCGCACCGATCCACTTCAGCGATGACGATCTGGTGCCGCATTCACCGGTGCTGCGCGAACACTTGGCCCTCGGCAGCAGCACGCTGACCGCACCCGAACTGGCCCGCGCCACCCAGCTGACCAGCGACAACGCCGCCGCCAATCTGCTGATCCGCAAGTTGGGCGGGCCGGAAGCCGTCACCGCACTCTGGCGCGCCAGTGGCGATGAAGTGAGCCGGCTGGACCGGCTGGAGCCAGACATGAATCTGCTGCCGCCCGGCGACCTGCGCGACAGCACCTCGCCGCGCGCGATGGCGCAGCACGTGGCCCGTCTGTTCACCTCCGAGATGCTCGTACCCGAAGACCGTGAACGCCTGCGCGAATGGATGGTTGAAACCGGCACCGGCCTTGCCCGCCTGCGCGCCGCCACGCCACCGCACTGGCAGGCCGGCGACAAGACCGGTTCTGCAATCGCGCCGCTGATGCCGAACAAGACCCACGATGTCGCGGTGTTCTGGCCGCCGGGCCGGGCGCCGGTCATCGTCGCCGCGTATTACGAATCCGATGCCCACCATGCCGGCAGGATCCGCGCGCAGGACGAGGCCGTGCTGGCGCAGGTCGGGCGTATTGCGGTGGCCTGGGCGGGCGATTGA", "partial": "0", "query_start": 6604, "query_end": 6711, "hit_start": 414, "hit_end": 522, "orf_dna_sequence": "ATGAATAAGGTAGCATATAAAGAACAAATATCTATTATTACCCCTGTTTTTAATAGATTAAAAGAATTAACTAGACTATATAAATCGTTACGCACGCAAAATAATAATAATTTTATATGGATTATTGTAGATGATGGTTCTGAGAAAACTATTAATGAGATTGTAGATATTTGGAAAAAAGAATCAAAATTTAAGATTGATTTGATCGTCCAGTCTAATCAAGGAAAAATGCATGCCTATAAAAATGCAATGAAACGTTTGAATACACCATGGTCGTTAGTCGTAGATAGTGATGATACTGTATCAGAAGAAATGATAGATATTTTATATAAAACAATATTATCTATTAATTCTGATAATGATTGTGGTGTAGTTTTCCCAAGAAAATTAGGTGCTGATTCGAATGGAACATCTCTTTGGAAACAATTACCAAATAAAGTTAATATTATAGATTTGAGATATCAATATAATATTCCCGAATCTACTATTTTTATAAAAACTAATGAATTAAAAAAGGCATTTAACTCCTTACAATTACCTGATGAAAAATTTATTAGTGAAGAAATACTTTACAATAAATTAATGGAACAAGGTAAATTTGTTGTAAGAGATGAACTATTTTATTTTGGTGATTATCAAGAGGATGGACTAACAAAACATCTTTTTGAATTATGGTTAAAAAATCCTAAAAGTACCATTATGTTGTTGAATTCAAGATATCGCGCAATGAATTCATTTCCTTGGAAAAAGCGATTGATAGGTCAATGGAAAACAAATATTAATTTAACTGCTTTTGCACTTGCAACTAACAGATCAATTAAAAGTGTTTCACCAGATTTAATAGAAAGTATTTTTTTATTTTTACCAGCGTTGGTTTTGAAGGAAAAGAGATTCAAAATTGAATAA", "orf_prot_sequence": "MNKVAYKEQISIITPVFNRLKELTRLYKSLRTQNNNNFIWIIVDDGSEKTINEIVDIWKKESKFKIDLIVQSNQGKMHAYKNAMKRLNTPWSLVVDSDDTVSEEMIDILYKTILSINSDNDCGVVFPRKLGADSNGTSLWKQLPNKVNIIDLRYQYNIPESTIFIKTNELKKAFNSLQLPDEKFISEEILYNKLMEQGKFVVRDELFYFGDYQEDGLTKHLFELWLKNPKSTIMLLNSRYRAMNSFPWKKRLIGQWKTNINLTAFALATNRSIKSVSPDLIESIFLFLPALVLKEKRFKIE", "perc_identity": 33.33}}, "BGC0000765.1|Exopolysaccharide_11 # 7157 # 8200 # 1 # ID=1_11;partial=00;start_type=TTG;rbs_motif=AGG;rbs_spacer=15bp;gc_cont=0.252": {"gnl|BL_ORD_ID|1937|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 7157, "orf_end": 8200, "orf_from": "BGC0000765.1|Exopolysaccharide_11 ", "model_name": "PmrF", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "550", "model_id": "2014", "ARO_accession": "3003578", "ARO_name": "PmrF", "ARO_category": {"41433": {"category_aro_accession": "3004269", "category_aro_cvterm_id": "41433", "category_aro_name": "pmr phosphoethanolamine transferase", "category_aro_description": "This family of phosphoethanolamine transferase catalyze the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine to lipid A, which impedes the binding of colistin to the cell membrane.", "category_aro_class_name": "AMR Gene Family"}, "36593": {"category_aro_accession": "3000454", "category_aro_cvterm_id": "36593", "category_aro_name": "polymyxin B", "category_aro_description": "Polymyxin B is mixture of mostly polymyxins B1 and B2, mainly used for resistant gram-negative infections. They are polypeptides with cationic detergent action on cell membranes.", "category_aro_class_name": "Antibiotic"}, "36192": {"category_aro_accession": "3000053", "category_aro_cvterm_id": "36192", "category_aro_name": "peptide antibiotic", "category_aro_description": "Peptide antibiotics have a wide range of antibacterial mechanisms, depending on the amino acids that make up the antibiotic, although most act to disrupt the cell membrane in some manner. Subclasses of peptide antibiotics can include additional sidechains of other types, such as lipids in the case of the lipopeptide antibiotics.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.108699, "max_identities": 25, "bit_score": 31.187, "cvterm_id": "36849", "query": "EISLIIPVHNSSNFVDTIYNNISSQIYT---NFEVLIIDDHSRDNTKEELKE--KFKNAKFKYRILSSNGNGVSAARNMGIEKSQGRYVAFIDDDDEIVPD", "match": "++S++IPV+N    +  +    ++   +    +E+L+IDD S DN+   L E  + +N+     +L+ N  G  +A   G     G  +  +D D +  P+", "sequence_from_db": "KVSVVIPVYNEQESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVEASQAENSHIVSILLNRN-YGQHSAIMAGFSHVTGDLIITLDADLQNPPE", "sequence_from_broadstreet": "MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVEASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEGYDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHERSTFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLGSIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYTDVRARPRYFVQQVIRPSSKENE", "dna_sequence_from_broadstreet": "ATGTTTGAAATCCACCCTGTTAAGAAAGTCTCGGTGGTTATTCCCGTTTATAACGAGCAGGAAAGCTTACCGGAATTAATCAGGCGCACCACCACAGCCTGTGAATCGTTGGGGAAAGAGTATGAGATCCTGCTGATTGATGACGGCAGTAGCGATAATTCCGCGCATATGCTGGTCGAAGCCTCACAAGCGGAGAACAGCCATATTGTGTCTATTTTGCTTAACCGCAATTACGGGCAACATTCAGCGATTATGGCGGGATTCAGTCACGTTACTGGCGACTTAATTATTACCCTTGATGCCGATCTCCAGAATCCGCCAGAAGAAATCCCCCGCCTGGTGGCAAAAGCCGATGAAGGTTACGACGTGGTAGGGACTGTACGCCAGAACCGCCAGGACAGCTGGTTTCGTAAAACCGCTTCGAAGATGATTAACCGGCTTATTCAGCGCACCACTGGCAAAGCGATGGGTGATTACGGTTGTATGCTGCGCGCCTATCGCCGTCATATTGTCGATGCGATGTTGCACTGCCATGAACGCAGCACCTTTATCCCGATTCTGGCGAATATCTTCGCCCGCCGTGCCATTGAAATTCCAGTACATCATGCCGAGCGTGAGTTTGGTGAATCCAAATACAGTTTTATGCGCCTGATTAATTTGATGTACGACCTGGTGACCTGCCTTACCACAACGCCGCTACGTATGCTGAGTCTGCTCGGCAGCATTATTGCGATTGGAGGTTTTAGCATTGCGGTGCTGCTGGTGATTTTACGCCTGACCTTCGGACCACAATGGGCGGCAGAAGGCGTCTTTATGCTATTTGCCGTGCTGTTTACTTTTATTGGCGCTCAGTTTATCGGCATGGGATTACTCGGTGAATATATCGGCAGGATCTACACCGATGTCCGCGCCCGCCCCCGCTATTTTGTTCAGCAAGTTATCCGTCCATCCAGCAAGGAAAATGAATAA", "partial": "0", "query_start": 7169, "query_end": 7456, "hit_start": 24, "hit_end": 324, "orf_dna_sequence": "TTGAATAACTATGAGATTAGTTTGATAATCCCAGTTCATAATTCATCTAACTTTGTTGATACAATCTACAATAATATTTCTTCGCAAATATACACAAATTTCGAAGTACTTATAATAGATGATCATTCGCGGGATAATACGAAAGAAGAATTAAAAGAGAAATTTAAAAATGCAAAATTTAAATATAGAATTTTATCGTCAAATGGTAATGGAGTTTCTGCAGCAAGAAATATGGGAATAGAAAAATCTCAAGGAAGATACGTTGCTTTTATAGATGATGATGATGAAATTGTTCCCGATTATTTAGAAATTTTGCATAATCATGTAGCTAATGATAATATTCCGATTGCACTAGGTAATTATAGTGAAATTACACAAGATAAAGAAACACCTTTTAAATTTAAAAATGCTGGTATTTTTGATAATGAATGGGTTATAAATAAATTAATACCACAAACCATATTTCCGTTAGAAGGAGAACAATCTATTTGGTTACCGGTATGGCGTACCATAATCAAACGAGATATTATTATAAGTAATAATATAAAATTTGATGAGAAGATATCACAAGCAGAAGATTTCTTATTTATGATTGAGCTTTTATTAAAAGCTGAACGTATATCAATAATTTCAGGGAAATCTATATATTTTTATAATAGAAGACAATCATCTGCTATGAATAAATATATTGAAAATGATATTGAAAAACAAAAATATTTCCATAAGCGATTTTATGAATTGTTAAATAAGAATGATCTATATAATTTATATAGAAAGCGTTATTTAAGTAATCGTGTAAAAATGTACTCTACGTTAATTTCTAATGCTACTCGTGCATCAAATAAAAAAGTTGGAATACAAGAAATTAAGAAAAGTAGAGAATTATTTTTAAAAGATGATTATGTAAATTCTACTTCACTGAAATCTCTCTATAATTCTAAGTCCATTCAATTTGCTATCTATTTATTACGGCATAATAAAGTTGTTTTATTATATTCTATTTACAGACTTAAGGAAAAAAAGAGATTAAATCAATTTAACTAA", "orf_prot_sequence": "MNNYEISLIIPVHNSSNFVDTIYNNISSQIYTNFEVLIIDDHSRDNTKEELKEKFKNAKFKYRILSSNGNGVSAARNMGIEKSQGRYVAFIDDDDEIVPDYLEILHNHVANDNIPIALGNYSEITQDKETPFKFKNAGIFDNEWVINKLIPQTIFPLEGEQSIWLPVWRTIIKRDIIISNNIKFDEKISQAEDFLFMIELLLKAERISIISGKSIYFYNRRQSSAMNKYIENDIEKQKYFHKRFYELLNKNDLYNLYRKRYLSNRVKMYSTLISNATRASNKKVGIQEIKKSRELFLKDDYVNSTSLKSLYNSKSIQFAIYLLRHNKVVLLYSIYRLKEKKRLNQFN", "perc_identity": 24.75}, "gnl|BL_ORD_ID|350|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 7157, "orf_end": 8200, "orf_from": "BGC0000765.1|Exopolysaccharide_11 ", "model_name": "APH(2'')-IVa", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "550", "model_id": "384", "ARO_accession": "3002637", "ARO_name": "APH(2'')-IVa", "ARO_category": {"36267": {"category_aro_accession": "3000128", "category_aro_cvterm_id": "36267", "category_aro_name": "APH(2'')", "category_aro_description": "A category of aminoglycoside O-phosphotransferase enzymes with modification regiospecificity based at the 2''-hydroxyl group of the respective antibiotic. These enzymes inactivate aminoglycoside antibiotics, specifically kanamycin, tobramycin and amikacin, by the ATP-dependent phosphorylation of the 3'-hydroxyl group of the compound.", "category_aro_class_name": "AMR Gene Family"}, "35932": {"category_aro_accession": "0000013", "category_aro_cvterm_id": "35932", "category_aro_name": "amikacin", "category_aro_description": "Amikacin is an aminoglycoside antibiotic that works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35966": {"category_aro_accession": "0000049", "category_aro_cvterm_id": "35966", "category_aro_name": "kanamycin A", "category_aro_description": "Kanamycin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Kanamycin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35969": {"category_aro_accession": "0000052", "category_aro_cvterm_id": "35969", "category_aro_name": "tobramycin", "category_aro_description": "Tobramycin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Tobramycin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "40942": {"category_aro_accession": "3004015", "category_aro_cvterm_id": "40942", "category_aro_name": "gentamicin A", "category_aro_description": "Gentamicin A is part of a complex of broad spectrum aminoglycoside antibiotics. Gentamicin inhibits protein synthesis, resulting in bacterial cell death.", "category_aro_class_name": "Antibiotic"}, "46133": {"category_aro_accession": "3007382", "category_aro_cvterm_id": "46133", "category_aro_name": "gentamicin", "category_aro_description": "Gentamicin is a commonly used aminoglycoside antibiotic derived from members of the Micromonospora genus of bacteria. It acts by binding the 30S ribosomal subunit, thus inhibiting protein synthesis. Gentamicin is typically used to treat Gram-negative infections of the repiratory and urinary tract, as well as infections of the bone and soft tissue. It also exhibits considerable nephrotoxicity and ototoxicity. Gentamicin is administered as a mixture of gentamicin type C (which makes about around 80% of the complex) and types A, B, and X (distributed in the remaining 20% of the complex).", "category_aro_class_name": "Antibiotic"}, "35935": {"category_aro_accession": "0000016", "category_aro_cvterm_id": "35935", "category_aro_name": "aminoglycoside antibiotic", "category_aro_description": "Aminoglycosides are a group of antibiotics that are mostly effective against Gram-negative bacteria. These molecules consist of aminated sugars attached to a dibasic cyclitol. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit (some work by binding to the 50S subunit), inhibiting the translocation of the peptidyl-tRNA from the A-site to the P-site and also causing misreading of mRNA, leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.33695, "max_identities": 11, "bit_score": 25.7942, "cvterm_id": "36767", "query": "GVSAARNMGIEKSQGRYVAFIDDDDEIVPDYLEILHNHVANDNIPIALGNY", "match": "G+    +  I      +++ ++DD+E   +++  + NH  + +IP  L  Y", "sequence_from_db": "GIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKY", "sequence_from_broadstreet": "MRTYTFDQVEKAIEQLYPDFTINTIEISGEGNDCIAYEINRDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLLNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWYEEGLNEIRSIKIK", "dna_sequence_from_broadstreet": "ATGAGAACTTATACTTTCGACCAGGTAGAAAAGGCAATAGAGCAGTTATATCCTGATTTTACTATCAATACAATAGAGATTTCAGGAGAAGGCAATGACTGTATTGCATATGAAATAAACAGGGATTTCATTTTTAAATTTCCAAAGCATTCAAGAGGATCTACTAATCTTTTTAATGAAGTAAATATACTCAAAAGAATCCACAATAAATTACCCCTCCCCATTCCGGAGGTGGTTTTTACAGGAATGCCATCAGAAACGTACCAAATGTCTTTCGCAGGTTTTACAAAAATTAAAGGAGTACCATTGACACCTCTTCTACTCAATAATCTGCCGAAGCAATCTCAAAATCAGGCAGCTAAGGACCTGGCCCGATTTCTAAGTGAACTTCACAGCATAAACATCTCTGGATTCAAAAGTAATCTGGTATTAGATTTTCGAGAGAAGATAAATGAAGATAATAAAAAAATCAAAAAGTTACTATCCAGGGAATTAAAGGGTCCCCAGATGAAGAAAGTGGATGATTTTTACAGGGATATTCTAGAGAACGAAATCTACTTCAAATACTATCCTTGTCTTATTCATAACGATTTTAGCAGTGATCATATTTTATTTGATACCGAAAAAAATACTATTTGTGGAATAATCGATTTTGGAGATGCAGCTATTTCTGATCCCGACAATGATTTTATAAGTTTGATGGAAGATGATGAAGAATACGGCATGGAATTTGTATCAAAAATATTGAACCATTACAAACATAAGGATATACCGACAGTTTTGGAAAAATATAGGATGAAAGAAAAATACTGGTCGTTCGAAAAGATTATCTATGGAAAGGAATATGGTTATATGGATTGGTATGAAGAGGGATTAAATGAAATCAGAAGCATTAAAATTAAATAG", "partial": "0", "query_start": 7367, "query_end": 7519, "hit_start": 639, "hit_end": 792, "orf_dna_sequence": "TTGAATAACTATGAGATTAGTTTGATAATCCCAGTTCATAATTCATCTAACTTTGTTGATACAATCTACAATAATATTTCTTCGCAAATATACACAAATTTCGAAGTACTTATAATAGATGATCATTCGCGGGATAATACGAAAGAAGAATTAAAAGAGAAATTTAAAAATGCAAAATTTAAATATAGAATTTTATCGTCAAATGGTAATGGAGTTTCTGCAGCAAGAAATATGGGAATAGAAAAATCTCAAGGAAGATACGTTGCTTTTATAGATGATGATGATGAAATTGTTCCCGATTATTTAGAAATTTTGCATAATCATGTAGCTAATGATAATATTCCGATTGCACTAGGTAATTATAGTGAAATTACACAAGATAAAGAAACACCTTTTAAATTTAAAAATGCTGGTATTTTTGATAATGAATGGGTTATAAATAAATTAATACCACAAACCATATTTCCGTTAGAAGGAGAACAATCTATTTGGTTACCGGTATGGCGTACCATAATCAAACGAGATATTATTATAAGTAATAATATAAAATTTGATGAGAAGATATCACAAGCAGAAGATTTCTTATTTATGATTGAGCTTTTATTAAAAGCTGAACGTATATCAATAATTTCAGGGAAATCTATATATTTTTATAATAGAAGACAATCATCTGCTATGAATAAATATATTGAAAATGATATTGAAAAACAAAAATATTTCCATAAGCGATTTTATGAATTGTTAAATAAGAATGATCTATATAATTTATATAGAAAGCGTTATTTAAGTAATCGTGTAAAAATGTACTCTACGTTAATTTCTAATGCTACTCGTGCATCAAATAAAAAAGTTGGAATACAAGAAATTAAGAAAAGTAGAGAATTATTTTTAAAAGATGATTATGTAAATTCTACTTCACTGAAATCTCTCTATAATTCTAAGTCCATTCAATTTGCTATCTATTTATTACGGCATAATAAAGTTGTTTTATTATATTCTATTTACAGACTTAAGGAAAAAAAGAGATTAAATCAATTTAACTAA", "orf_prot_sequence": "MNNYEISLIIPVHNSSNFVDTIYNNISSQIYTNFEVLIIDDHSRDNTKEELKEKFKNAKFKYRILSSNGNGVSAARNMGIEKSQGRYVAFIDDDDEIVPDYLEILHNHVANDNIPIALGNYSEITQDKETPFKFKNAGIFDNEWVINKLIPQTIFPLEGEQSIWLPVWRTIIKRDIIISNNIKFDEKISQAEDFLFMIELLLKAERISIISGKSIYFYNRRQSSAMNKYIENDIEKQKYFHKRFYELLNKNDLYNLYRKRYLSNRVKMYSTLISNATRASNKKVGIQEIKKSRELFLKDDYVNSTSLKSLYNSKSIQFAIYLLRHNKVVLLYSIYRLKEKKRLNQFN", "perc_identity": 21.57}, "gnl|BL_ORD_ID|1635|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 7157, "orf_end": 8200, "orf_from": "BGC0000765.1|Exopolysaccharide_11 ", "model_name": "AAC(2')-Ia", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "300", "model_id": "1781", "ARO_accession": "3002523", "ARO_name": "AAC(2')-Ia", "ARO_category": {"36480": {"category_aro_accession": "3000341", "category_aro_cvterm_id": "36480", "category_aro_name": "AAC(2')", "category_aro_description": "A category of aminoglycoside N-acetyltransferase enzymes with modification regiospecificity based at the 2'-amino group of the respective antibiotic. These enzymes inactivate aminoglycoside antibiotics through acetylation of the 2-amino group of the compound.", "category_aro_class_name": "AMR Gene Family"}, "35926": {"category_aro_accession": "0000007", "category_aro_cvterm_id": "35926", "category_aro_name": "dibekacin", "category_aro_description": "Dibekacin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Dibekacin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35956": {"category_aro_accession": "0000038", "category_aro_cvterm_id": "35956", "category_aro_name": "netilmicin", "category_aro_description": "Netilmicin is a member of the aminoglycoside family of antibiotics. These antibiotics have the ability to kill a wide variety of bacteria by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth. Netilmicin is not absorbed from the gut and is therefore only given by injection or infusion. It is only used in the treatment of serious infections particularly those resistant to gentamicin.", "category_aro_class_name": "Antibiotic"}, "35969": {"category_aro_accession": "0000052", "category_aro_cvterm_id": "35969", "category_aro_name": "tobramycin", "category_aro_description": "Tobramycin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Tobramycin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "46127": {"category_aro_accession": "3007377", "category_aro_cvterm_id": "46127", "category_aro_name": "6'-N-ethylnetilmicin", "category_aro_description": "6'-N-ethylnetilmicin is an aminoglycoside antibiotic and a derivative of netilmicin.", "category_aro_class_name": "Antibiotic"}, "46133": {"category_aro_accession": "3007382", "category_aro_cvterm_id": "46133", "category_aro_name": "gentamicin", "category_aro_description": "Gentamicin is a commonly used aminoglycoside antibiotic derived from members of the Micromonospora genus of bacteria. It acts by binding the 30S ribosomal subunit, thus inhibiting protein synthesis. Gentamicin is typically used to treat Gram-negative infections of the repiratory and urinary tract, as well as infections of the bone and soft tissue. It also exhibits considerable nephrotoxicity and ototoxicity. Gentamicin is administered as a mixture of gentamicin type C (which makes about around 80% of the complex) and types A, B, and X (distributed in the remaining 20% of the complex).", "category_aro_class_name": "Antibiotic"}, "35935": {"category_aro_accession": "0000016", "category_aro_cvterm_id": "35935", "category_aro_name": "aminoglycoside antibiotic", "category_aro_description": "Aminoglycosides are a group of antibiotics that are mostly effective against Gram-negative bacteria. These molecules consist of aminated sugars attached to a dibasic cyclitol. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit (some work by binding to the 50S subunit), inhibiting the translocation of the peptidyl-tRNA from the A-site to the P-site and also causing misreading of mRNA, leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.78338, "max_identities": 9, "bit_score": 25.409, "cvterm_id": "36946", "query": "DDEIVPDYLEILHNHVANDNIPIALG", "match": "D + +  ++ I+  H+A DN PI++G", "sequence_from_db": "DQQKLVGHVAIIQRHMALDNTPISVG", "sequence_from_broadstreet": "MGIEYRSLHTSQLTLSEKEALYDLLIEGFEGDFSHDDFAHTLGGMHVMAFDQQKLVGHVAIIQRHMALDNTPISVGYVEAMVVEQSYRRQGIGRQLMLQTNKIIASCYQLGLLSASDDGQKLYHSVGWQIWKGKLFELKQGSYIRSIEEEGGVMGWKADGEVDFTASLYCDFRGGDQW", "dna_sequence_from_broadstreet": "ATGGGCATAGAATACCGCAGTCTGCATACCAGCCAATTGACACTGAGTGAAAAAGAAGCGCTTTACGATTTATTAATTGAAGGTTTTGAAGGCGATTTTTCGCATGACGATTTCGCGCACACTTTAGGTGGAATGCACGTCATGGCTTTTGATCAACAAAAATTGGTTGGTCATGTTGCAATTATTCAACGCCATATGGCCCTAGATAATACGCCTATCTCTGTAGGGTATGTTGAAGCGATGGTAGTTGAACAAAGTTATCGTCGCCAAGGTATTGGGCGGCAATTGATGCTGCAAACCAATAAAATTATAGCTTCGTGTTATCAATTAGGGCTGCTGTCGGCTTCAGATGATGGACAAAAATTGTATCATTCGGTTGGATGGCAAATCTGGAAAGGTAAGTTGTTTGAATTGAAACAAGGGAGCTATATCCGTTCTATTGAAGAAGAAGGCGGAGTCATGGGCTGGAAAGCGGATGGTGAGGTTGATTTTACCGCTTCGCTTTACTGTGATTTTCGTGGCGGTGATCAGTGGTAA", "partial": "0", "query_start": 7436, "query_end": 7513, "hit_start": 150, "hit_end": 228, "orf_dna_sequence": "TTGAATAACTATGAGATTAGTTTGATAATCCCAGTTCATAATTCATCTAACTTTGTTGATACAATCTACAATAATATTTCTTCGCAAATATACACAAATTTCGAAGTACTTATAATAGATGATCATTCGCGGGATAATACGAAAGAAGAATTAAAAGAGAAATTTAAAAATGCAAAATTTAAATATAGAATTTTATCGTCAAATGGTAATGGAGTTTCTGCAGCAAGAAATATGGGAATAGAAAAATCTCAAGGAAGATACGTTGCTTTTATAGATGATGATGATGAAATTGTTCCCGATTATTTAGAAATTTTGCATAATCATGTAGCTAATGATAATATTCCGATTGCACTAGGTAATTATAGTGAAATTACACAAGATAAAGAAACACCTTTTAAATTTAAAAATGCTGGTATTTTTGATAATGAATGGGTTATAAATAAATTAATACCACAAACCATATTTCCGTTAGAAGGAGAACAATCTATTTGGTTACCGGTATGGCGTACCATAATCAAACGAGATATTATTATAAGTAATAATATAAAATTTGATGAGAAGATATCACAAGCAGAAGATTTCTTATTTATGATTGAGCTTTTATTAAAAGCTGAACGTATATCAATAATTTCAGGGAAATCTATATATTTTTATAATAGAAGACAATCATCTGCTATGAATAAATATATTGAAAATGATATTGAAAAACAAAAATATTTCCATAAGCGATTTTATGAATTGTTAAATAAGAATGATCTATATAATTTATATAGAAAGCGTTATTTAAGTAATCGTGTAAAAATGTACTCTACGTTAATTTCTAATGCTACTCGTGCATCAAATAAAAAAGTTGGAATACAAGAAATTAAGAAAAGTAGAGAATTATTTTTAAAAGATGATTATGTAAATTCTACTTCACTGAAATCTCTCTATAATTCTAAGTCCATTCAATTTGCTATCTATTTATTACGGCATAATAAAGTTGTTTTATTATATTCTATTTACAGACTTAAGGAAAAAAAGAGATTAAATCAATTTAACTAA", "orf_prot_sequence": "MNNYEISLIIPVHNSSNFVDTIYNNISSQIYTNFEVLIIDDHSRDNTKEELKEKFKNAKFKYRILSSNGNGVSAARNMGIEKSQGRYVAFIDDDDEIVPDYLEILHNHVANDNIPIALGNYSEITQDKETPFKFKNAGIFDNEWVINKLIPQTIFPLEGEQSIWLPVWRTIIKRDIIISNNIKFDEKISQAEDFLFMIELLLKAERISIISGKSIYFYNRRQSSAMNKYIENDIEKQKYFHKRFYELLNKNDLYNLYRKRYLSNRVKMYSTLISNATRASNKKVGIQEIKKSRELFLKDDYVNSTSLKSLYNSKSIQFAIYLLRHNKVVLLYSIYRLKEKKRLNQFN", "perc_identity": 34.62}, "gnl|BL_ORD_ID|119|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 7157, "orf_end": 8200, "orf_from": "BGC0000765.1|Exopolysaccharide_11 ", "model_name": "APH(2'')-Ie", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "550", "model_id": "137", "ARO_accession": "3002634", "ARO_name": "APH(2'')-Ie", "ARO_category": {"36267": {"category_aro_accession": "3000128", "category_aro_cvterm_id": "36267", "category_aro_name": "APH(2'')", "category_aro_description": "A category of aminoglycoside O-phosphotransferase enzymes with modification regiospecificity based at the 2''-hydroxyl group of the respective antibiotic. These enzymes inactivate aminoglycoside antibiotics, specifically kanamycin, tobramycin and amikacin, by the ATP-dependent phosphorylation of the 3'-hydroxyl group of the compound.", "category_aro_class_name": "AMR Gene Family"}, "35932": {"category_aro_accession": "0000013", "category_aro_cvterm_id": "35932", "category_aro_name": "amikacin", "category_aro_description": "Amikacin is an aminoglycoside antibiotic that works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35966": {"category_aro_accession": "0000049", "category_aro_cvterm_id": "35966", "category_aro_name": "kanamycin A", "category_aro_description": "Kanamycin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Kanamycin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35969": {"category_aro_accession": "0000052", "category_aro_cvterm_id": "35969", "category_aro_name": "tobramycin", "category_aro_description": "Tobramycin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Tobramycin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "40942": {"category_aro_accession": "3004015", "category_aro_cvterm_id": "40942", "category_aro_name": "gentamicin A", "category_aro_description": "Gentamicin A is part of a complex of broad spectrum aminoglycoside antibiotics. Gentamicin inhibits protein synthesis, resulting in bacterial cell death.", "category_aro_class_name": "Antibiotic"}, "46133": {"category_aro_accession": "3007382", "category_aro_cvterm_id": "46133", "category_aro_name": "gentamicin", "category_aro_description": "Gentamicin is a commonly used aminoglycoside antibiotic derived from members of the Micromonospora genus of bacteria. It acts by binding the 30S ribosomal subunit, thus inhibiting protein synthesis. Gentamicin is typically used to treat Gram-negative infections of the repiratory and urinary tract, as well as infections of the bone and soft tissue. It also exhibits considerable nephrotoxicity and ototoxicity. Gentamicin is administered as a mixture of gentamicin type C (which makes about around 80% of the complex) and types A, B, and X (distributed in the remaining 20% of the complex).", "category_aro_class_name": "Antibiotic"}, "35935": {"category_aro_accession": "0000016", "category_aro_cvterm_id": "35935", "category_aro_name": "aminoglycoside antibiotic", "category_aro_description": "Aminoglycosides are a group of antibiotics that are mostly effective against Gram-negative bacteria. These molecules consist of aminated sugars attached to a dibasic cyclitol. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit (some work by binding to the 50S subunit), inhibiting the translocation of the peptidyl-tRNA from the A-site to the P-site and also causing misreading of mRNA, leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.8273, "max_identities": 11, "bit_score": 25.409, "cvterm_id": "36767", "query": "GVSAARNMGIEKSQGRYVAFIDDDDEIVPDYLEILHNHVANDNIPIALGNY", "match": "G+    +  I      +++ ++DD+E   +++  + NH  + +IP  L  Y", "sequence_from_db": "GIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKY", "sequence_from_broadstreet": "MTTYTFDQVEEAIEQLYPDFTINTIEISGEGNDCIAYEINGNFIFKFPKHSRASINLLNEVTVLKTIHNELSLPIPEVVFTGMPSEMCQMSFAGFTKIKGVPLTPLLLKNLPKQSQDQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGHQMKKVDDFYRDILDNEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYMMKEKYWSFEKIIYGKEYGYMDWYEEGLNEIRSIKIK", "dna_sequence_from_broadstreet": "ATGACAACTTATACTTTCGACCAGGTAGAAGAGGCAATAGAGCAGTTATATCCTGATTTTACTATCAATACAATAGAGATTTCAGGAGAAGGCAATGACTGTATTGCATATGAAATAAACGGGAATTTTATTTTTAAATTTCCAAAGCATTCAAGAGCTTCGATTAATCTCTTGAATGAAGTAACCGTACTCAAAACAATCCACAATGAATTATCACTACCCATTCCCGAGGTGGTTTTTACAGGAATGCCATCAGAAATGTGCCAAATGTCTTTCGCAGGTTTTACAAAAATTAAAGGAGTACCTTTGACACCTCTTCTACTCAAAAATCTGCCGAAGCAATCTCAAGATCAGGCAGCTAAGGACCTGGCCCGATTTTTAAGTGAACTTCACAGCATAAATATCTCTGGATTCAAAAGTAATCTGGTATTAGATTTTCGAGAGAAGATAAATGAAGATAATAAAAAAATCAAAAAGTTACTATCCAGGGAATTAAAGGGTCACCAGATGAAGAAAGTGGATGATTTTTACAGGGATATTCTAGACAACGAAATCTACTTCAAATACTATCCTTGTCTTATTCATAACGATTTCAGCAGCGATCATATTTTATTTGATACCGAAAAAAATACCATTTGTGGAATAATCGATTTTGGAGATGCAGCTATTTCTGATCCCGACAATGATTTTATAAGTTTGATGGAAGATGATGAAGAGTACGGCATGGAATTCGTATCAAAAATATTGAACCATTACAAACATAAGGATATACCGACAGTTTTGGAAAAATATATGATGAAAGAAAAATACTGGTCGTTCGAAAAGATTATCTATGGAAAGGAATATGGTTATATGGATTGGTATGAAGAGGGATTAAATGAAATCAGAAGCATTAAAATTAAATAG", "partial": "0", "query_start": 7367, "query_end": 7519, "hit_start": 639, "hit_end": 792, "orf_dna_sequence": "TTGAATAACTATGAGATTAGTTTGATAATCCCAGTTCATAATTCATCTAACTTTGTTGATACAATCTACAATAATATTTCTTCGCAAATATACACAAATTTCGAAGTACTTATAATAGATGATCATTCGCGGGATAATACGAAAGAAGAATTAAAAGAGAAATTTAAAAATGCAAAATTTAAATATAGAATTTTATCGTCAAATGGTAATGGAGTTTCTGCAGCAAGAAATATGGGAATAGAAAAATCTCAAGGAAGATACGTTGCTTTTATAGATGATGATGATGAAATTGTTCCCGATTATTTAGAAATTTTGCATAATCATGTAGCTAATGATAATATTCCGATTGCACTAGGTAATTATAGTGAAATTACACAAGATAAAGAAACACCTTTTAAATTTAAAAATGCTGGTATTTTTGATAATGAATGGGTTATAAATAAATTAATACCACAAACCATATTTCCGTTAGAAGGAGAACAATCTATTTGGTTACCGGTATGGCGTACCATAATCAAACGAGATATTATTATAAGTAATAATATAAAATTTGATGAGAAGATATCACAAGCAGAAGATTTCTTATTTATGATTGAGCTTTTATTAAAAGCTGAACGTATATCAATAATTTCAGGGAAATCTATATATTTTTATAATAGAAGACAATCATCTGCTATGAATAAATATATTGAAAATGATATTGAAAAACAAAAATATTTCCATAAGCGATTTTATGAATTGTTAAATAAGAATGATCTATATAATTTATATAGAAAGCGTTATTTAAGTAATCGTGTAAAAATGTACTCTACGTTAATTTCTAATGCTACTCGTGCATCAAATAAAAAAGTTGGAATACAAGAAATTAAGAAAAGTAGAGAATTATTTTTAAAAGATGATTATGTAAATTCTACTTCACTGAAATCTCTCTATAATTCTAAGTCCATTCAATTTGCTATCTATTTATTACGGCATAATAAAGTTGTTTTATTATATTCTATTTACAGACTTAAGGAAAAAAAGAGATTAAATCAATTTAACTAA", "orf_prot_sequence": "MNNYEISLIIPVHNSSNFVDTIYNNISSQIYTNFEVLIIDDHSRDNTKEELKEKFKNAKFKYRILSSNGNGVSAARNMGIEKSQGRYVAFIDDDDEIVPDYLEILHNHVANDNIPIALGNYSEITQDKETPFKFKNAGIFDNEWVINKLIPQTIFPLEGEQSIWLPVWRTIIKRDIIISNNIKFDEKISQAEDFLFMIELLLKAERISIISGKSIYFYNRRQSSAMNKYIENDIEKQKYFHKRFYELLNKNDLYNLYRKRYLSNRVKMYSTLISNATRASNKKVGIQEIKKSRELFLKDDYVNSTSLKSLYNSKSIQFAIYLLRHNKVVLLYSIYRLKEKKRLNQFN", "perc_identity": 21.57}, "gnl|BL_ORD_ID|556|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 7157, "orf_end": 8200, "orf_from": "BGC0000765.1|Exopolysaccharide_11 ", "model_name": "emrK", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "600", "model_id": "609", "ARO_accession": "3000206", "ARO_name": "emrK", "ARO_category": {"36003": {"category_aro_accession": "0010002", "category_aro_cvterm_id": "36003", "category_aro_name": "major facilitator superfamily (MFS) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Major facilitator superfamily (MFS) transporters and ABC transporters comprise the two largest and most functionally diverse of the transporter superfamilies. However, MFS transporters are distinct from ABC transporters in both their primary sequence and structure and in the mechanism of energy coupling. As secondary transporters they are, like RND and SMR transporters, energized by the electrochemical proton gradient.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.88465, "max_identities": 11, "bit_score": 25.7942, "cvterm_id": "35914", "query": "PQTIFPLEGEQSIWLPVWRTIIKRDI---IISNNIKFDEKISQAEDFLFMI", "match": "PQ +   +  +  WL + RT IK  +   I   +++  E +S  +  + ++", "sequence_from_db": "PQVVEAADATKEAWLALKRTDIKSPVTGYIAQRSVQVGETVSPGQSLMAVV", "sequence_from_broadstreet": "MELEDMISTDDAYVTGNADPISAQVSGSVTVVNHKDTNYVRQGDILVSLDKTDATIALNKAKNNLANIVRQTNKLYLQDKQYSAEVASARIQYQQSLEDYNRRVPLAKQGVISKETLEHTKDTLISSKAALNAAIQAYKANKALVMNTPLNRQPQVVEAADATKEAWLALKRTDIKSPVTGYIAQRSVQVGETVSPGQSLMAVVPARQMWVNANFKETQLTDVRIGQSVNIISDLYGENVVFHGRVTGINMGTGNAFSLLPAQNATGNWIKIVQRVPVEVSLDPKELMEHPLRIGLSMTATIDTKNEDIAEMPELASTVTSMPAYTSKALVIDTSPIEKEISNIISHNGQL", "dna_sequence_from_broadstreet": "ATGGAATTAGAAGACATGATTAGTACAGATGACGCCTATGTCACGGGGAATGCAGATCCAATTTCTGCACAAGTCTCAGGTAGTGTCACTGTCGTTAATCATAAAGATACGAACTACGTTCGACAAGGTGACATTTTAGTTTCACTGGATAAAACTGATGCCACTATCGCACTCAATAAAGCTAAAAATAATCTGGCAAATATTGTTCGGCAAACGAATAAACTATACTTACAGGATAAACAATACAGTGCCGAAGTCGCTTCAGCACGTATTCAGTATCAACAATCTTTAGAAGATTATAACCGTCGAGTGCCGTTAGCGAAGCAGGGGGTTATTTCAAAAGAAACGCTGGAGCATACCAAAGATACGTTAATAAGTAGCAAAGCGGCATTGAATGCCGCTATCCAGGCTTATAAAGCGAATAAAGCTTTAGTAATGAACACACCATTAAACCGTCAGCCACAAGTCGTTGAAGCGGCGGATGCAACTAAAGAAGCCTGGTTGGCGCTTAAACGTACGGATATTAAGAGTCCGGTTACCGGCTATATTGCCCAGAGAAGTGTTCAGGTCGGCGAAACAGTGAGCCCCGGACAATCGTTAATGGCTGTCGTACCGGCACGTCAAATGTGGGTTAATGCCAACTTTAAAGAAACACAACTCACGGATGTACGGATTGGTCAATCGGTCAATATTATCAGCGATCTTTATGGTGAAAATGTTGTGTTTCATGGTCGGGTGACAGGGATCAATATGGGAACCGGCAATGCGTTCTCCTTATTACCTGCACAAAATGCGACAGGGAACTGGATCAAAATCGTTCAGCGTGTACCGGTTGAAGTTTCTCTTGATCCAAAAGAACTCATGGAACACCCCTTGCGTATTGGTTTATCGATGACAGCAACTATTGATACGAAGAACGAAGACATTGCCGAGATGCCTGAGCTGGCTTCAACCGTGACCTCCATGCCGGCTTATACCAGTAAGGCTTTAGTTATCGATACCAGTCCGATAGAAAAAGAAATTAGCAACATTATTTCGCATAATGGACAACTTTAA", "partial": "0", "query_start": 7607, "query_end": 7750, "hit_start": 459, "hit_end": 612, "orf_dna_sequence": "TTGAATAACTATGAGATTAGTTTGATAATCCCAGTTCATAATTCATCTAACTTTGTTGATACAATCTACAATAATATTTCTTCGCAAATATACACAAATTTCGAAGTACTTATAATAGATGATCATTCGCGGGATAATACGAAAGAAGAATTAAAAGAGAAATTTAAAAATGCAAAATTTAAATATAGAATTTTATCGTCAAATGGTAATGGAGTTTCTGCAGCAAGAAATATGGGAATAGAAAAATCTCAAGGAAGATACGTTGCTTTTATAGATGATGATGATGAAATTGTTCCCGATTATTTAGAAATTTTGCATAATCATGTAGCTAATGATAATATTCCGATTGCACTAGGTAATTATAGTGAAATTACACAAGATAAAGAAACACCTTTTAAATTTAAAAATGCTGGTATTTTTGATAATGAATGGGTTATAAATAAATTAATACCACAAACCATATTTCCGTTAGAAGGAGAACAATCTATTTGGTTACCGGTATGGCGTACCATAATCAAACGAGATATTATTATAAGTAATAATATAAAATTTGATGAGAAGATATCACAAGCAGAAGATTTCTTATTTATGATTGAGCTTTTATTAAAAGCTGAACGTATATCAATAATTTCAGGGAAATCTATATATTTTTATAATAGAAGACAATCATCTGCTATGAATAAATATATTGAAAATGATATTGAAAAACAAAAATATTTCCATAAGCGATTTTATGAATTGTTAAATAAGAATGATCTATATAATTTATATAGAAAGCGTTATTTAAGTAATCGTGTAAAAATGTACTCTACGTTAATTTCTAATGCTACTCGTGCATCAAATAAAAAAGTTGGAATACAAGAAATTAAGAAAAGTAGAGAATTATTTTTAAAAGATGATTATGTAAATTCTACTTCACTGAAATCTCTCTATAATTCTAAGTCCATTCAATTTGCTATCTATTTATTACGGCATAATAAAGTTGTTTTATTATATTCTATTTACAGACTTAAGGAAAAAAAGAGATTAAATCAATTTAACTAA", "orf_prot_sequence": "MNNYEISLIIPVHNSSNFVDTIYNNISSQIYTNFEVLIIDDHSRDNTKEELKEKFKNAKFKYRILSSNGNGVSAARNMGIEKSQGRYVAFIDDDDEIVPDYLEILHNHVANDNIPIALGNYSEITQDKETPFKFKNAGIFDNEWVINKLIPQTIFPLEGEQSIWLPVWRTIIKRDIIISNNIKFDEKISQAEDFLFMIELLLKAERISIISGKSIYFYNRRQSSAMNKYIENDIEKQKYFHKRFYELLNKNDLYNLYRKRYLSNRVKMYSTLISNATRASNKKVGIQEIKKSRELFLKDDYVNSTSLKSLYNSKSIQFAIYLLRHNKVVLLYSIYRLKEKKRLNQFN", "perc_identity": 21.57}}, "BGC0000765.1|Exopolysaccharide_12 # 8223 # 9251 # 1 # ID=1_12;partial=00;start_type=GTG;rbs_motif=TAGG;rbs_spacer=12bp;gc_cont=0.277": {"gnl|BL_ORD_ID|1937|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 8223, "orf_end": 9251, "orf_from": "BGC0000765.1|Exopolysaccharide_12 ", "model_name": "PmrF", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "550", "model_id": "2014", "ARO_accession": "3003578", "ARO_name": "PmrF", "ARO_category": {"41433": {"category_aro_accession": "3004269", "category_aro_cvterm_id": "41433", "category_aro_name": "pmr phosphoethanolamine transferase", "category_aro_description": "This family of phosphoethanolamine transferase catalyze the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine to lipid A, which impedes the binding of colistin to the cell membrane.", "category_aro_class_name": "AMR Gene Family"}, "36593": {"category_aro_accession": "3000454", "category_aro_cvterm_id": "36593", "category_aro_name": "polymyxin B", "category_aro_description": "Polymyxin B is mixture of mostly polymyxins B1 and B2, mainly used for resistant gram-negative infections. They are polypeptides with cationic detergent action on cell membranes.", "category_aro_class_name": "Antibiotic"}, "36192": {"category_aro_accession": "3000053", "category_aro_cvterm_id": "36192", "category_aro_name": "peptide antibiotic", "category_aro_description": "Peptide antibiotics have a wide range of antibacterial mechanisms, depending on the amino acids that make up the antibiotic, although most act to disrupt the cell membrane in some manner. Subclasses of peptide antibiotics can include additional sidechains of other types, such as lipids in the case of the lipopeptide antibiotics.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000530739, "max_identities": 25, "bit_score": 38.5058, "cvterm_id": "36849", "query": "ITVIVPIYN----VEKYIRKCLDSLKRQTYKNFEVWAIDDGSPDNSKKIVQE--YADKDPRFKSILKENGGYGSVLEYGIKNTKTKYFLVCDPD", "match": "++V++P+YN    + + IR+   + +    K +E+  IDDGS DNS  ++ E   A+       +L  N G  S +  G  +      +  D D", "sequence_from_db": "VSVVIPVYNEQESLPELIRRTTTACE-SLGKEYEILLIDDGSSDNSAHMLVEASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDAD", "sequence_from_broadstreet": "MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVEASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEGYDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHERSTFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLGSIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYTDVRARPRYFVQQVIRPSSKENE", "dna_sequence_from_broadstreet": "ATGTTTGAAATCCACCCTGTTAAGAAAGTCTCGGTGGTTATTCCCGTTTATAACGAGCAGGAAAGCTTACCGGAATTAATCAGGCGCACCACCACAGCCTGTGAATCGTTGGGGAAAGAGTATGAGATCCTGCTGATTGATGACGGCAGTAGCGATAATTCCGCGCATATGCTGGTCGAAGCCTCACAAGCGGAGAACAGCCATATTGTGTCTATTTTGCTTAACCGCAATTACGGGCAACATTCAGCGATTATGGCGGGATTCAGTCACGTTACTGGCGACTTAATTATTACCCTTGATGCCGATCTCCAGAATCCGCCAGAAGAAATCCCCCGCCTGGTGGCAAAAGCCGATGAAGGTTACGACGTGGTAGGGACTGTACGCCAGAACCGCCAGGACAGCTGGTTTCGTAAAACCGCTTCGAAGATGATTAACCGGCTTATTCAGCGCACCACTGGCAAAGCGATGGGTGATTACGGTTGTATGCTGCGCGCCTATCGCCGTCATATTGTCGATGCGATGTTGCACTGCCATGAACGCAGCACCTTTATCCCGATTCTGGCGAATATCTTCGCCCGCCGTGCCATTGAAATTCCAGTACATCATGCCGAGCGTGAGTTTGGTGAATCCAAATACAGTTTTATGCGCCTGATTAATTTGATGTACGACCTGGTGACCTGCCTTACCACAACGCCGCTACGTATGCTGAGTCTGCTCGGCAGCATTATTGCGATTGGAGGTTTTAGCATTGCGGTGCTGCTGGTGATTTTACGCCTGACCTTCGGACCACAATGGGCGGCAGAAGGCGTCTTTATGCTATTTGCCGTGCTGTTTACTTTTATTGGCGCTCAGTTTATCGGCATGGGATTACTCGGTGAATATATCGGCAGGATCTACACCGATGTCCGCGCCCGCCCCCGCTATTTTGTTCAGCAAGTTATCCGTCCATCCAGCAAGGAAAATGAATAA", "partial": "0", "query_start": 8235, "query_end": 8498, "hit_start": 27, "hit_end": 306, "orf_dna_sequence": "GTGAATCCAGATATTACTGTTATAGTTCCAATTTATAATGTTGAAAAATATATTAGAAAGTGCTTAGACAGTCTGAAAAGACAGACATACAAGAACTTTGAAGTTTGGGCAATAGATGATGGCTCTCCTGATAATTCTAAAAAGATTGTTCAAGAATATGCTGATAAAGATCCAAGATTTAAATCTATTTTAAAAGAAAATGGTGGCTATGGGTCAGTTTTAGAATATGGAATTAAGAATACAAAAACAAAATATTTTTTAGTTTGTGATCCTGATGATTGGCTAACAGATGATGCATTGGAAAAATTACATAATTTTGCAAAAAATAGTAATTTAGATGTAACTGTTGGTGATAAATATAATATTTATTCAGAAGATAATAAAAAAGTATACATTCCTAGTTTTAAAAAAGAGTTAAATGTAAAACCACGTGTTGCATATGATACGGCTGAAAAAAAGGATAGATTTATTTTTAGTGAAGTATCACCACATGCAAAATTATTTAAAACATCAATTGCAAAAAATATAGATTTTCCTCATAAGATTAGCTATACGGACACTATTTTGTATGTGTTGTCGATTGCTAATGCAAAGAGAGTAGGATATCTGGATGAAGCTCTTGCATACTACTTGATAGATCGTCCTGGTAATACTATGACAGCAAAGACTGAAGCTAAAATTAGGGATACCATTAAAATATGGCATTCCATTTATAATCAGTTGATAAATGGATTTGAGCTAAATCAAATTGAAACATATATATATTTCTTATATTATGAAATGAAAATAATACTTATTACAGAATCTCAGCTACCTTCTATGAGTAAGTATCATACTGAGATTTTAAAAATTATGAGAATAATGCAAAGATATAATAAGATATTAGCTAAATATGTGAATAATAAGGTTGTTCCATATAATACAAATTCTATGACTGGACGCTTAATATTCAAAGGATTTATGAATAAAGCAACATATAAATGGGTAGAGAGATTATATGTTAAATTAGAGAGGAAACGTGAAGCTTAA", "orf_prot_sequence": "MNPDITVIVPIYNVEKYIRKCLDSLKRQTYKNFEVWAIDDGSPDNSKKIVQEYADKDPRFKSILKENGGYGSVLEYGIKNTKTKYFLVCDPDDWLTDDALEKLHNFAKNSNLDVTVGDKYNIYSEDNKKVYIPSFKKELNVKPRVAYDTAEKKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTEAKIRDTIKIWHSIYNQLINGFELNQIETYIYFLYYEMKIILITESQLPSMSKYHTEILKIMRIMQRYNKILAKYVNNKVVPYNTNSMTGRLIFKGFMNKATYKWVERLYVKLERKREA", "perc_identity": 26.6}, "gnl|BL_ORD_ID|632|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 8223, "orf_end": 9251, "orf_from": "BGC0000765.1|Exopolysaccharide_12 ", "model_name": "OXA-239", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "685", "ARO_accession": "3001498", "ARO_name": "OXA-239", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.499159, "max_identities": 26, "bit_score": 28.8758, "cvterm_id": "39095", "query": "DVTVGDKYN-----IYSEDNKKVYIPSFKKELNVKPRVAYDTAE---KKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTE", "match": "D+T+G+        +Y E  +++ +   +KE+    R+ +  AE   + D F    V P     K +  + ++F  ++++T         AN K +  L+E+  Y +  + G  M  K++", "sequence_from_db": "DMTLGEAMKLSAVPVYQELARRIGLDLMQKEVK---RIGFGNAEIGQQVDNFWL--VGP----LKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMNIKSQ", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRLFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMNIKSQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTTATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGACCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCCCAATTAGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGAATATAAAATCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 8559, "query_end": 8894, "hit_start": 345, "hit_end": 678, "orf_dna_sequence": "GTGAATCCAGATATTACTGTTATAGTTCCAATTTATAATGTTGAAAAATATATTAGAAAGTGCTTAGACAGTCTGAAAAGACAGACATACAAGAACTTTGAAGTTTGGGCAATAGATGATGGCTCTCCTGATAATTCTAAAAAGATTGTTCAAGAATATGCTGATAAAGATCCAAGATTTAAATCTATTTTAAAAGAAAATGGTGGCTATGGGTCAGTTTTAGAATATGGAATTAAGAATACAAAAACAAAATATTTTTTAGTTTGTGATCCTGATGATTGGCTAACAGATGATGCATTGGAAAAATTACATAATTTTGCAAAAAATAGTAATTTAGATGTAACTGTTGGTGATAAATATAATATTTATTCAGAAGATAATAAAAAAGTATACATTCCTAGTTTTAAAAAAGAGTTAAATGTAAAACCACGTGTTGCATATGATACGGCTGAAAAAAAGGATAGATTTATTTTTAGTGAAGTATCACCACATGCAAAATTATTTAAAACATCAATTGCAAAAAATATAGATTTTCCTCATAAGATTAGCTATACGGACACTATTTTGTATGTGTTGTCGATTGCTAATGCAAAGAGAGTAGGATATCTGGATGAAGCTCTTGCATACTACTTGATAGATCGTCCTGGTAATACTATGACAGCAAAGACTGAAGCTAAAATTAGGGATACCATTAAAATATGGCATTCCATTTATAATCAGTTGATAAATGGATTTGAGCTAAATCAAATTGAAACATATATATATTTCTTATATTATGAAATGAAAATAATACTTATTACAGAATCTCAGCTACCTTCTATGAGTAAGTATCATACTGAGATTTTAAAAATTATGAGAATAATGCAAAGATATAATAAGATATTAGCTAAATATGTGAATAATAAGGTTGTTCCATATAATACAAATTCTATGACTGGACGCTTAATATTCAAAGGATTTATGAATAAAGCAACATATAAATGGGTAGAGAGATTATATGTTAAATTAGAGAGGAAACGTGAAGCTTAA", "orf_prot_sequence": "MNPDITVIVPIYNVEKYIRKCLDSLKRQTYKNFEVWAIDDGSPDNSKKIVQEYADKDPRFKSILKENGGYGSVLEYGIKNTKTKYFLVCDPDDWLTDDALEKLHNFAKNSNLDVTVGDKYNIYSEDNKKVYIPSFKKELNVKPRVAYDTAEKKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTEAKIRDTIKIWHSIYNQLINGFELNQIETYIYFLYYEMKIILITESQLPSMSKYHTEILKIMRIMQRYNKILAKYVNNKVVPYNTNSMTGRLIFKGFMNKATYKWVERLYVKLERKREA", "perc_identity": 21.67}, "gnl|BL_ORD_ID|295|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 8223, "orf_end": 9251, "orf_from": "BGC0000765.1|Exopolysaccharide_12 ", "model_name": "OXA-225", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "326", "ARO_accession": "3001493", "ARO_name": "OXA-225", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.777338, "max_identities": 26, "bit_score": 28.4906, "cvterm_id": "35507", "query": "DVTVGDKYN-----IYSEDNKKVYIPSFKKELNVKPRVAYDTAE---KKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTE", "match": "D+T+G+        +Y E  +++ +   +KE+    R+ +  AE   + D F    V P     K +  + ++F  ++++T         AN K +  L+E+  Y +  + G  M  K++", "sequence_from_db": "DMTLGEAMKLSAVPVYQELARRIGLDLMQKEVK---RIGFGNAEIGQQVDNFWL--VGP----LKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKSQ", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKSQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGACCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCCCAATTAGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGGATATAAAATCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 8559, "query_end": 8894, "hit_start": 345, "hit_end": 678, "orf_dna_sequence": "GTGAATCCAGATATTACTGTTATAGTTCCAATTTATAATGTTGAAAAATATATTAGAAAGTGCTTAGACAGTCTGAAAAGACAGACATACAAGAACTTTGAAGTTTGGGCAATAGATGATGGCTCTCCTGATAATTCTAAAAAGATTGTTCAAGAATATGCTGATAAAGATCCAAGATTTAAATCTATTTTAAAAGAAAATGGTGGCTATGGGTCAGTTTTAGAATATGGAATTAAGAATACAAAAACAAAATATTTTTTAGTTTGTGATCCTGATGATTGGCTAACAGATGATGCATTGGAAAAATTACATAATTTTGCAAAAAATAGTAATTTAGATGTAACTGTTGGTGATAAATATAATATTTATTCAGAAGATAATAAAAAAGTATACATTCCTAGTTTTAAAAAAGAGTTAAATGTAAAACCACGTGTTGCATATGATACGGCTGAAAAAAAGGATAGATTTATTTTTAGTGAAGTATCACCACATGCAAAATTATTTAAAACATCAATTGCAAAAAATATAGATTTTCCTCATAAGATTAGCTATACGGACACTATTTTGTATGTGTTGTCGATTGCTAATGCAAAGAGAGTAGGATATCTGGATGAAGCTCTTGCATACTACTTGATAGATCGTCCTGGTAATACTATGACAGCAAAGACTGAAGCTAAAATTAGGGATACCATTAAAATATGGCATTCCATTTATAATCAGTTGATAAATGGATTTGAGCTAAATCAAATTGAAACATATATATATTTCTTATATTATGAAATGAAAATAATACTTATTACAGAATCTCAGCTACCTTCTATGAGTAAGTATCATACTGAGATTTTAAAAATTATGAGAATAATGCAAAGATATAATAAGATATTAGCTAAATATGTGAATAATAAGGTTGTTCCATATAATACAAATTCTATGACTGGACGCTTAATATTCAAAGGATTTATGAATAAAGCAACATATAAATGGGTAGAGAGATTATATGTTAAATTAGAGAGGAAACGTGAAGCTTAA", "orf_prot_sequence": "MNPDITVIVPIYNVEKYIRKCLDSLKRQTYKNFEVWAIDDGSPDNSKKIVQEYADKDPRFKSILKENGGYGSVLEYGIKNTKTKYFLVCDPDDWLTDDALEKLHNFAKNSNLDVTVGDKYNIYSEDNKKVYIPSFKKELNVKPRVAYDTAEKKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTEAKIRDTIKIWHSIYNQLINGFELNQIETYIYFLYYEMKIILITESQLPSMSKYHTEILKIMRIMQRYNKILAKYVNNKVVPYNTNSMTGRLIFKGFMNKATYKWVERLYVKLERKREA", "perc_identity": 21.67}, "gnl|BL_ORD_ID|1718|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 8223, "orf_end": 9251, "orf_from": "BGC0000765.1|Exopolysaccharide_12 ", "model_name": "OXA-165", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "1860", "ARO_accession": "3001465", "ARO_name": "OXA-165", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.17849, "max_identities": 26, "bit_score": 27.7202, "cvterm_id": "35507", "query": "DVTVGDKYN-----IYSEDNKKVYIPSFKKELNVKPRVAYDTAE---KKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTE", "match": "D+T+G+        +Y E  +++ +   +KE+    R+ +  AE   + D F    V P     K +  + ++F  ++++T         AN K +  L+E+  Y +  + G  M  K +", "sequence_from_db": "DMTLGEAMKLSAVPVYQELARRIGLDLMQKEVK---RIGFGNAEIGQQVDNFWL--VGP----LKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDVKPQ", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDVKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGACCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCCCAATTAGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGGATGTAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 8559, "query_end": 8894, "hit_start": 345, "hit_end": 678, "orf_dna_sequence": "GTGAATCCAGATATTACTGTTATAGTTCCAATTTATAATGTTGAAAAATATATTAGAAAGTGCTTAGACAGTCTGAAAAGACAGACATACAAGAACTTTGAAGTTTGGGCAATAGATGATGGCTCTCCTGATAATTCTAAAAAGATTGTTCAAGAATATGCTGATAAAGATCCAAGATTTAAATCTATTTTAAAAGAAAATGGTGGCTATGGGTCAGTTTTAGAATATGGAATTAAGAATACAAAAACAAAATATTTTTTAGTTTGTGATCCTGATGATTGGCTAACAGATGATGCATTGGAAAAATTACATAATTTTGCAAAAAATAGTAATTTAGATGTAACTGTTGGTGATAAATATAATATTTATTCAGAAGATAATAAAAAAGTATACATTCCTAGTTTTAAAAAAGAGTTAAATGTAAAACCACGTGTTGCATATGATACGGCTGAAAAAAAGGATAGATTTATTTTTAGTGAAGTATCACCACATGCAAAATTATTTAAAACATCAATTGCAAAAAATATAGATTTTCCTCATAAGATTAGCTATACGGACACTATTTTGTATGTGTTGTCGATTGCTAATGCAAAGAGAGTAGGATATCTGGATGAAGCTCTTGCATACTACTTGATAGATCGTCCTGGTAATACTATGACAGCAAAGACTGAAGCTAAAATTAGGGATACCATTAAAATATGGCATTCCATTTATAATCAGTTGATAAATGGATTTGAGCTAAATCAAATTGAAACATATATATATTTCTTATATTATGAAATGAAAATAATACTTATTACAGAATCTCAGCTACCTTCTATGAGTAAGTATCATACTGAGATTTTAAAAATTATGAGAATAATGCAAAGATATAATAAGATATTAGCTAAATATGTGAATAATAAGGTTGTTCCATATAATACAAATTCTATGACTGGACGCTTAATATTCAAAGGATTTATGAATAAAGCAACATATAAATGGGTAGAGAGATTATATGTTAAATTAGAGAGGAAACGTGAAGCTTAA", "orf_prot_sequence": "MNPDITVIVPIYNVEKYIRKCLDSLKRQTYKNFEVWAIDDGSPDNSKKIVQEYADKDPRFKSILKENGGYGSVLEYGIKNTKTKYFLVCDPDDWLTDDALEKLHNFAKNSNLDVTVGDKYNIYSEDNKKVYIPSFKKELNVKPRVAYDTAEKKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTEAKIRDTIKIWHSIYNQLINGFELNQIETYIYFLYYEMKIILITESQLPSMSKYHTEILKIMRIMQRYNKILAKYVNNKVVPYNTNSMTGRLIFKGFMNKATYKWVERLYVKLERKREA", "perc_identity": 21.67}, "gnl|BL_ORD_ID|3907|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 8223, "orf_end": 9251, "orf_from": "BGC0000765.1|Exopolysaccharide_12 ", "model_name": "OXA-657", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4977", "ARO_accession": "3005872", "ARO_name": "OXA-657", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.22095, "max_identities": 26, "bit_score": 27.7202, "cvterm_id": "35507", "query": "DVTVGDKYN-----IYSEDNKKVYIPSFKKELNVKPRVAYDTAE---KKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTE", "match": "D+T+G+        +Y E  +++ +   +KE+    R+ +  AE   + D F    V P     K +  + ++F  ++++T         AN K +  L+E+  Y +  + G  M  K +", "sequence_from_db": "DMTLGEAMKLSAVPVYQELARRIGLDLMQKEVK---RIGFGNAEIGQQVDNFWL--VGP----LKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMGIKPQ", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMGIKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGACCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCCCAATTAGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGGGTATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 8559, "query_end": 8894, "hit_start": 345, "hit_end": 678, "orf_dna_sequence": "GTGAATCCAGATATTACTGTTATAGTTCCAATTTATAATGTTGAAAAATATATTAGAAAGTGCTTAGACAGTCTGAAAAGACAGACATACAAGAACTTTGAAGTTTGGGCAATAGATGATGGCTCTCCTGATAATTCTAAAAAGATTGTTCAAGAATATGCTGATAAAGATCCAAGATTTAAATCTATTTTAAAAGAAAATGGTGGCTATGGGTCAGTTTTAGAATATGGAATTAAGAATACAAAAACAAAATATTTTTTAGTTTGTGATCCTGATGATTGGCTAACAGATGATGCATTGGAAAAATTACATAATTTTGCAAAAAATAGTAATTTAGATGTAACTGTTGGTGATAAATATAATATTTATTCAGAAGATAATAAAAAAGTATACATTCCTAGTTTTAAAAAAGAGTTAAATGTAAAACCACGTGTTGCATATGATACGGCTGAAAAAAAGGATAGATTTATTTTTAGTGAAGTATCACCACATGCAAAATTATTTAAAACATCAATTGCAAAAAATATAGATTTTCCTCATAAGATTAGCTATACGGACACTATTTTGTATGTGTTGTCGATTGCTAATGCAAAGAGAGTAGGATATCTGGATGAAGCTCTTGCATACTACTTGATAGATCGTCCTGGTAATACTATGACAGCAAAGACTGAAGCTAAAATTAGGGATACCATTAAAATATGGCATTCCATTTATAATCAGTTGATAAATGGATTTGAGCTAAATCAAATTGAAACATATATATATTTCTTATATTATGAAATGAAAATAATACTTATTACAGAATCTCAGCTACCTTCTATGAGTAAGTATCATACTGAGATTTTAAAAATTATGAGAATAATGCAAAGATATAATAAGATATTAGCTAAATATGTGAATAATAAGGTTGTTCCATATAATACAAATTCTATGACTGGACGCTTAATATTCAAAGGATTTATGAATAAAGCAACATATAAATGGGTAGAGAGATTATATGTTAAATTAGAGAGGAAACGTGAAGCTTAA", "orf_prot_sequence": "MNPDITVIVPIYNVEKYIRKCLDSLKRQTYKNFEVWAIDDGSPDNSKKIVQEYADKDPRFKSILKENGGYGSVLEYGIKNTKTKYFLVCDPDDWLTDDALEKLHNFAKNSNLDVTVGDKYNIYSEDNKKVYIPSFKKELNVKPRVAYDTAEKKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTEAKIRDTIKIWHSIYNQLINGFELNQIETYIYFLYYEMKIILITESQLPSMSKYHTEILKIMRIMQRYNKILAKYVNNKVVPYNTNSMTGRLIFKGFMNKATYKWVERLYVKLERKREA", "perc_identity": 21.67}, "gnl|BL_ORD_ID|1574|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 8223, "orf_end": 9251, "orf_from": "BGC0000765.1|Exopolysaccharide_12 ", "model_name": "OXA-398", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "1716", "ARO_accession": "3001584", "ARO_name": "OXA-398", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.34579, "max_identities": 26, "bit_score": 27.7202, "cvterm_id": "35507", "query": "DVTVGDKYN-----IYSEDNKKVYIPSFKKELNVKPRVAYDTAE---KKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTE", "match": "D+T+G+        +Y E  +++ +   +KE+    R+ +  AE   + D F    V P     K +  + ++F  ++++T         AN K +  L+E+  Y +  + G  M  K +", "sequence_from_db": "DMTLGEAMKLSAVPVYQELARRIGLDLMQKEVK---RIGFGNAEIGQQVDNFWL--VGP----LKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKQQ", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKQQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGACCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCCCAATTAGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGGATATAAAACAACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 8559, "query_end": 8894, "hit_start": 345, "hit_end": 678, "orf_dna_sequence": "GTGAATCCAGATATTACTGTTATAGTTCCAATTTATAATGTTGAAAAATATATTAGAAAGTGCTTAGACAGTCTGAAAAGACAGACATACAAGAACTTTGAAGTTTGGGCAATAGATGATGGCTCTCCTGATAATTCTAAAAAGATTGTTCAAGAATATGCTGATAAAGATCCAAGATTTAAATCTATTTTAAAAGAAAATGGTGGCTATGGGTCAGTTTTAGAATATGGAATTAAGAATACAAAAACAAAATATTTTTTAGTTTGTGATCCTGATGATTGGCTAACAGATGATGCATTGGAAAAATTACATAATTTTGCAAAAAATAGTAATTTAGATGTAACTGTTGGTGATAAATATAATATTTATTCAGAAGATAATAAAAAAGTATACATTCCTAGTTTTAAAAAAGAGTTAAATGTAAAACCACGTGTTGCATATGATACGGCTGAAAAAAAGGATAGATTTATTTTTAGTGAAGTATCACCACATGCAAAATTATTTAAAACATCAATTGCAAAAAATATAGATTTTCCTCATAAGATTAGCTATACGGACACTATTTTGTATGTGTTGTCGATTGCTAATGCAAAGAGAGTAGGATATCTGGATGAAGCTCTTGCATACTACTTGATAGATCGTCCTGGTAATACTATGACAGCAAAGACTGAAGCTAAAATTAGGGATACCATTAAAATATGGCATTCCATTTATAATCAGTTGATAAATGGATTTGAGCTAAATCAAATTGAAACATATATATATTTCTTATATTATGAAATGAAAATAATACTTATTACAGAATCTCAGCTACCTTCTATGAGTAAGTATCATACTGAGATTTTAAAAATTATGAGAATAATGCAAAGATATAATAAGATATTAGCTAAATATGTGAATAATAAGGTTGTTCCATATAATACAAATTCTATGACTGGACGCTTAATATTCAAAGGATTTATGAATAAAGCAACATATAAATGGGTAGAGAGATTATATGTTAAATTAGAGAGGAAACGTGAAGCTTAA", "orf_prot_sequence": "MNPDITVIVPIYNVEKYIRKCLDSLKRQTYKNFEVWAIDDGSPDNSKKIVQEYADKDPRFKSILKENGGYGSVLEYGIKNTKTKYFLVCDPDDWLTDDALEKLHNFAKNSNLDVTVGDKYNIYSEDNKKVYIPSFKKELNVKPRVAYDTAEKKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTEAKIRDTIKIWHSIYNQLINGFELNQIETYIYFLYYEMKIILITESQLPSMSKYHTEILKIMRIMQRYNKILAKYVNNKVVPYNTNSMTGRLIFKGFMNKATYKWVERLYVKLERKREA", "perc_identity": 21.67}, "gnl|BL_ORD_ID|4042|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 8223, "orf_end": 9251, "orf_from": "BGC0000765.1|Exopolysaccharide_12 ", "model_name": "OXA-807", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "5112", "ARO_accession": "3006007", "ARO_name": "OXA-807", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.43178, "max_identities": 26, "bit_score": 27.7202, "cvterm_id": "39672", "query": "DVTVGDKYN-----IYSEDNKKVYIPSFKKELNVKPRVAYDTAE---KKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTE", "match": "D+T+G+        +Y E  +++ +   +KE+    R+ +  AE   + D F    V P     K +  + ++F  ++++T         AN K +  L+E+  Y +  + G  M  K +", "sequence_from_db": "DMTLGEAMKLSAVPVYQELARRIGLDLMQKEVK---RIGFGNAEIGQQVDNFWL--VGP----LKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQ", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINKTQSQIVQGHNQVIHQYFDEKNTSGVLVIQADKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTGWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVTFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATAAAACCCAGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAGCAGATAAAAAAATTAATCTGTATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGGTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCCGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGGCCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCTCAATTGGCGCATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACCGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCACTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCTGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 8559, "query_end": 8894, "hit_start": 345, "hit_end": 678, "orf_dna_sequence": "GTGAATCCAGATATTACTGTTATAGTTCCAATTTATAATGTTGAAAAATATATTAGAAAGTGCTTAGACAGTCTGAAAAGACAGACATACAAGAACTTTGAAGTTTGGGCAATAGATGATGGCTCTCCTGATAATTCTAAAAAGATTGTTCAAGAATATGCTGATAAAGATCCAAGATTTAAATCTATTTTAAAAGAAAATGGTGGCTATGGGTCAGTTTTAGAATATGGAATTAAGAATACAAAAACAAAATATTTTTTAGTTTGTGATCCTGATGATTGGCTAACAGATGATGCATTGGAAAAATTACATAATTTTGCAAAAAATAGTAATTTAGATGTAACTGTTGGTGATAAATATAATATTTATTCAGAAGATAATAAAAAAGTATACATTCCTAGTTTTAAAAAAGAGTTAAATGTAAAACCACGTGTTGCATATGATACGGCTGAAAAAAAGGATAGATTTATTTTTAGTGAAGTATCACCACATGCAAAATTATTTAAAACATCAATTGCAAAAAATATAGATTTTCCTCATAAGATTAGCTATACGGACACTATTTTGTATGTGTTGTCGATTGCTAATGCAAAGAGAGTAGGATATCTGGATGAAGCTCTTGCATACTACTTGATAGATCGTCCTGGTAATACTATGACAGCAAAGACTGAAGCTAAAATTAGGGATACCATTAAAATATGGCATTCCATTTATAATCAGTTGATAAATGGATTTGAGCTAAATCAAATTGAAACATATATATATTTCTTATATTATGAAATGAAAATAATACTTATTACAGAATCTCAGCTACCTTCTATGAGTAAGTATCATACTGAGATTTTAAAAATTATGAGAATAATGCAAAGATATAATAAGATATTAGCTAAATATGTGAATAATAAGGTTGTTCCATATAATACAAATTCTATGACTGGACGCTTAATATTCAAAGGATTTATGAATAAAGCAACATATAAATGGGTAGAGAGATTATATGTTAAATTAGAGAGGAAACGTGAAGCTTAA", "orf_prot_sequence": "MNPDITVIVPIYNVEKYIRKCLDSLKRQTYKNFEVWAIDDGSPDNSKKIVQEYADKDPRFKSILKENGGYGSVLEYGIKNTKTKYFLVCDPDDWLTDDALEKLHNFAKNSNLDVTVGDKYNIYSEDNKKVYIPSFKKELNVKPRVAYDTAEKKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTEAKIRDTIKIWHSIYNQLINGFELNQIETYIYFLYYEMKIILITESQLPSMSKYHTEILKIMRIMQRYNKILAKYVNNKVVPYNTNSMTGRLIFKGFMNKATYKWVERLYVKLERKREA", "perc_identity": 21.67}, "gnl|BL_ORD_ID|4048|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 8223, "orf_end": 9251, "orf_from": "BGC0000765.1|Exopolysaccharide_12 ", "model_name": "OXA-814", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "5118", "ARO_accession": "3006013", "ARO_name": "OXA-814", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.50985, "max_identities": 26, "bit_score": 27.7202, "cvterm_id": "39672", "query": "DVTVGDKYN-----IYSEDNKKVYIPSFKKELNVKPRVAYDTAE---KKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTE", "match": "D+T+G+        +Y E  +++ +   +KE+    R+ +  AE   + D F    V P     K +  + ++F  ++++T         AN K +  L+E+  Y +  + G  M  K +", "sequence_from_db": "DMTLGEAMKLSAVPVYQELARRIGLDLMQKEVK---RIGFGNAEIGQQVDNFWL--VGP----LKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQ", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETQSQIVQGHNQVIHQYFDEKNTSGVLVIQADKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTGWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVTFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCAGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAGCAGATAAAAAAATTAATCTGTATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGGTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCCGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGGCCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCTCAATTGGCGCATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACCGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCACTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCTGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 8559, "query_end": 8894, "hit_start": 345, "hit_end": 678, "orf_dna_sequence": "GTGAATCCAGATATTACTGTTATAGTTCCAATTTATAATGTTGAAAAATATATTAGAAAGTGCTTAGACAGTCTGAAAAGACAGACATACAAGAACTTTGAAGTTTGGGCAATAGATGATGGCTCTCCTGATAATTCTAAAAAGATTGTTCAAGAATATGCTGATAAAGATCCAAGATTTAAATCTATTTTAAAAGAAAATGGTGGCTATGGGTCAGTTTTAGAATATGGAATTAAGAATACAAAAACAAAATATTTTTTAGTTTGTGATCCTGATGATTGGCTAACAGATGATGCATTGGAAAAATTACATAATTTTGCAAAAAATAGTAATTTAGATGTAACTGTTGGTGATAAATATAATATTTATTCAGAAGATAATAAAAAAGTATACATTCCTAGTTTTAAAAAAGAGTTAAATGTAAAACCACGTGTTGCATATGATACGGCTGAAAAAAAGGATAGATTTATTTTTAGTGAAGTATCACCACATGCAAAATTATTTAAAACATCAATTGCAAAAAATATAGATTTTCCTCATAAGATTAGCTATACGGACACTATTTTGTATGTGTTGTCGATTGCTAATGCAAAGAGAGTAGGATATCTGGATGAAGCTCTTGCATACTACTTGATAGATCGTCCTGGTAATACTATGACAGCAAAGACTGAAGCTAAAATTAGGGATACCATTAAAATATGGCATTCCATTTATAATCAGTTGATAAATGGATTTGAGCTAAATCAAATTGAAACATATATATATTTCTTATATTATGAAATGAAAATAATACTTATTACAGAATCTCAGCTACCTTCTATGAGTAAGTATCATACTGAGATTTTAAAAATTATGAGAATAATGCAAAGATATAATAAGATATTAGCTAAATATGTGAATAATAAGGTTGTTCCATATAATACAAATTCTATGACTGGACGCTTAATATTCAAAGGATTTATGAATAAAGCAACATATAAATGGGTAGAGAGATTATATGTTAAATTAGAGAGGAAACGTGAAGCTTAA", "orf_prot_sequence": "MNPDITVIVPIYNVEKYIRKCLDSLKRQTYKNFEVWAIDDGSPDNSKKIVQEYADKDPRFKSILKENGGYGSVLEYGIKNTKTKYFLVCDPDDWLTDDALEKLHNFAKNSNLDVTVGDKYNIYSEDNKKVYIPSFKKELNVKPRVAYDTAEKKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTEAKIRDTIKIWHSIYNQLINGFELNQIETYIYFLYYEMKIILITESQLPSMSKYHTEILKIMRIMQRYNKILAKYVNNKVVPYNTNSMTGRLIFKGFMNKATYKWVERLYVKLERKREA", "perc_identity": 21.67}, "gnl|BL_ORD_ID|2091|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 8223, "orf_end": 9251, "orf_from": "BGC0000765.1|Exopolysaccharide_12 ", "model_name": "OXA-440", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "3510", "ARO_accession": "3003596", "ARO_name": "OXA-440", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.52326, "max_identities": 26, "bit_score": 27.7202, "cvterm_id": "35507", "query": "DVTVGDKYN-----IYSEDNKKVYIPSFKKELNVKPRVAYDTAE---KKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTE", "match": "D+T+G+        +Y E  +++ +   +KE+    R+ +  AE   + D F    V P     K +  + ++F  ++++T         AN K +  L+E+  Y +  + G  M  K +", "sequence_from_db": "DMTLGEAMKLSAVPVYQELARRIGLDLMQKEVK---RIGFGNAEIGQQVDNFWL--VGP----LKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDKKPQ", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDKKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGACCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCCCAATTAGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGGATAAAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 8559, "query_end": 8894, "hit_start": 345, "hit_end": 678, "orf_dna_sequence": "GTGAATCCAGATATTACTGTTATAGTTCCAATTTATAATGTTGAAAAATATATTAGAAAGTGCTTAGACAGTCTGAAAAGACAGACATACAAGAACTTTGAAGTTTGGGCAATAGATGATGGCTCTCCTGATAATTCTAAAAAGATTGTTCAAGAATATGCTGATAAAGATCCAAGATTTAAATCTATTTTAAAAGAAAATGGTGGCTATGGGTCAGTTTTAGAATATGGAATTAAGAATACAAAAACAAAATATTTTTTAGTTTGTGATCCTGATGATTGGCTAACAGATGATGCATTGGAAAAATTACATAATTTTGCAAAAAATAGTAATTTAGATGTAACTGTTGGTGATAAATATAATATTTATTCAGAAGATAATAAAAAAGTATACATTCCTAGTTTTAAAAAAGAGTTAAATGTAAAACCACGTGTTGCATATGATACGGCTGAAAAAAAGGATAGATTTATTTTTAGTGAAGTATCACCACATGCAAAATTATTTAAAACATCAATTGCAAAAAATATAGATTTTCCTCATAAGATTAGCTATACGGACACTATTTTGTATGTGTTGTCGATTGCTAATGCAAAGAGAGTAGGATATCTGGATGAAGCTCTTGCATACTACTTGATAGATCGTCCTGGTAATACTATGACAGCAAAGACTGAAGCTAAAATTAGGGATACCATTAAAATATGGCATTCCATTTATAATCAGTTGATAAATGGATTTGAGCTAAATCAAATTGAAACATATATATATTTCTTATATTATGAAATGAAAATAATACTTATTACAGAATCTCAGCTACCTTCTATGAGTAAGTATCATACTGAGATTTTAAAAATTATGAGAATAATGCAAAGATATAATAAGATATTAGCTAAATATGTGAATAATAAGGTTGTTCCATATAATACAAATTCTATGACTGGACGCTTAATATTCAAAGGATTTATGAATAAAGCAACATATAAATGGGTAGAGAGATTATATGTTAAATTAGAGAGGAAACGTGAAGCTTAA", "orf_prot_sequence": "MNPDITVIVPIYNVEKYIRKCLDSLKRQTYKNFEVWAIDDGSPDNSKKIVQEYADKDPRFKSILKENGGYGSVLEYGIKNTKTKYFLVCDPDDWLTDDALEKLHNFAKNSNLDVTVGDKYNIYSEDNKKVYIPSFKKELNVKPRVAYDTAEKKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTEAKIRDTIKIWHSIYNQLINGFELNQIETYIYFLYYEMKIILITESQLPSMSKYHTEILKIMRIMQRYNKILAKYVNNKVVPYNTNSMTGRLIFKGFMNKATYKWVERLYVKLERKREA", "perc_identity": 21.67}, "gnl|BL_ORD_ID|4043|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 8223, "orf_end": 9251, "orf_from": "BGC0000765.1|Exopolysaccharide_12 ", "model_name": "OXA-808", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "5113", "ARO_accession": "3006008", "ARO_name": "OXA-808", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.56424, "max_identities": 26, "bit_score": 27.335, "cvterm_id": "39672", "query": "DVTVGDKYN-----IYSEDNKKVYIPSFKKELNVKPRVAYDTAE---KKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTE", "match": "D+T+G+        +Y E  +++ +   +KE+    R+ +  AE   + D F    V P     K +  + ++F  ++++T         AN K +  L+E+  Y +  + G  M  K +", "sequence_from_db": "DMTLGEAMKLSAVPVYQELARRIGLDLMQKEVK---RIGFGNAEIGQQVDNFWL--VGP----LKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQ", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETQSQIVQGHNQVIHQYFDEKNTSGVLVIQADKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTGWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVTFALNMEMRSEMPASILNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCAGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAGCAGATAAAAAAATTAATCTGTATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGGTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCCGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGGCCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCTCAATTGGCGCATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACCGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCACTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCTGCATCTATACTTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 8559, "query_end": 8894, "hit_start": 345, "hit_end": 678, "orf_dna_sequence": "GTGAATCCAGATATTACTGTTATAGTTCCAATTTATAATGTTGAAAAATATATTAGAAAGTGCTTAGACAGTCTGAAAAGACAGACATACAAGAACTTTGAAGTTTGGGCAATAGATGATGGCTCTCCTGATAATTCTAAAAAGATTGTTCAAGAATATGCTGATAAAGATCCAAGATTTAAATCTATTTTAAAAGAAAATGGTGGCTATGGGTCAGTTTTAGAATATGGAATTAAGAATACAAAAACAAAATATTTTTTAGTTTGTGATCCTGATGATTGGCTAACAGATGATGCATTGGAAAAATTACATAATTTTGCAAAAAATAGTAATTTAGATGTAACTGTTGGTGATAAATATAATATTTATTCAGAAGATAATAAAAAAGTATACATTCCTAGTTTTAAAAAAGAGTTAAATGTAAAACCACGTGTTGCATATGATACGGCTGAAAAAAAGGATAGATTTATTTTTAGTGAAGTATCACCACATGCAAAATTATTTAAAACATCAATTGCAAAAAATATAGATTTTCCTCATAAGATTAGCTATACGGACACTATTTTGTATGTGTTGTCGATTGCTAATGCAAAGAGAGTAGGATATCTGGATGAAGCTCTTGCATACTACTTGATAGATCGTCCTGGTAATACTATGACAGCAAAGACTGAAGCTAAAATTAGGGATACCATTAAAATATGGCATTCCATTTATAATCAGTTGATAAATGGATTTGAGCTAAATCAAATTGAAACATATATATATTTCTTATATTATGAAATGAAAATAATACTTATTACAGAATCTCAGCTACCTTCTATGAGTAAGTATCATACTGAGATTTTAAAAATTATGAGAATAATGCAAAGATATAATAAGATATTAGCTAAATATGTGAATAATAAGGTTGTTCCATATAATACAAATTCTATGACTGGACGCTTAATATTCAAAGGATTTATGAATAAAGCAACATATAAATGGGTAGAGAGATTATATGTTAAATTAGAGAGGAAACGTGAAGCTTAA", "orf_prot_sequence": "MNPDITVIVPIYNVEKYIRKCLDSLKRQTYKNFEVWAIDDGSPDNSKKIVQEYADKDPRFKSILKENGGYGSVLEYGIKNTKTKYFLVCDPDDWLTDDALEKLHNFAKNSNLDVTVGDKYNIYSEDNKKVYIPSFKKELNVKPRVAYDTAEKKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTEAKIRDTIKIWHSIYNQLINGFELNQIETYIYFLYYEMKIILITESQLPSMSKYHTEILKIMRIMQRYNKILAKYVNNKVVPYNTNSMTGRLIFKGFMNKATYKWVERLYVKLERKREA", "perc_identity": 21.67}, "gnl|BL_ORD_ID|2866|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 8223, "orf_end": 9251, "orf_from": "BGC0000765.1|Exopolysaccharide_12 ", "model_name": "OXA-818", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "560", "model_id": "3884", "ARO_accession": "3005159", "ARO_name": "OXA-818", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.56424, "max_identities": 26, "bit_score": 27.335, "cvterm_id": "39672", "query": "DVTVGDKYN-----IYSEDNKKVYIPSFKKELNVKPRVAYDTAE---KKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTE", "match": "D+T+G+        +Y E  +++ +   +KE+    R+ +  AE   + D F    V P     K +  + ++F  ++++T         AN K +  L+E+  Y +  + G  M  K +", "sequence_from_db": "DMTLGEAMKLSAVPVYQELARRIGLDLMQKEVK---RIGFGNAEIGQQVDNFWL--VGP----LKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQ", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETQSQIVQGHNQVIHQYFDEKNTSGVLVIQADKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTGWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCAGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAGCAGATAAAAAAATTAATCTGTATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGGTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCCGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGGCCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCTCAATTGGCGCATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACCGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCTGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 8559, "query_end": 8894, "hit_start": 345, "hit_end": 678, "orf_dna_sequence": "GTGAATCCAGATATTACTGTTATAGTTCCAATTTATAATGTTGAAAAATATATTAGAAAGTGCTTAGACAGTCTGAAAAGACAGACATACAAGAACTTTGAAGTTTGGGCAATAGATGATGGCTCTCCTGATAATTCTAAAAAGATTGTTCAAGAATATGCTGATAAAGATCCAAGATTTAAATCTATTTTAAAAGAAAATGGTGGCTATGGGTCAGTTTTAGAATATGGAATTAAGAATACAAAAACAAAATATTTTTTAGTTTGTGATCCTGATGATTGGCTAACAGATGATGCATTGGAAAAATTACATAATTTTGCAAAAAATAGTAATTTAGATGTAACTGTTGGTGATAAATATAATATTTATTCAGAAGATAATAAAAAAGTATACATTCCTAGTTTTAAAAAAGAGTTAAATGTAAAACCACGTGTTGCATATGATACGGCTGAAAAAAAGGATAGATTTATTTTTAGTGAAGTATCACCACATGCAAAATTATTTAAAACATCAATTGCAAAAAATATAGATTTTCCTCATAAGATTAGCTATACGGACACTATTTTGTATGTGTTGTCGATTGCTAATGCAAAGAGAGTAGGATATCTGGATGAAGCTCTTGCATACTACTTGATAGATCGTCCTGGTAATACTATGACAGCAAAGACTGAAGCTAAAATTAGGGATACCATTAAAATATGGCATTCCATTTATAATCAGTTGATAAATGGATTTGAGCTAAATCAAATTGAAACATATATATATTTCTTATATTATGAAATGAAAATAATACTTATTACAGAATCTCAGCTACCTTCTATGAGTAAGTATCATACTGAGATTTTAAAAATTATGAGAATAATGCAAAGATATAATAAGATATTAGCTAAATATGTGAATAATAAGGTTGTTCCATATAATACAAATTCTATGACTGGACGCTTAATATTCAAAGGATTTATGAATAAAGCAACATATAAATGGGTAGAGAGATTATATGTTAAATTAGAGAGGAAACGTGAAGCTTAA", "orf_prot_sequence": "MNPDITVIVPIYNVEKYIRKCLDSLKRQTYKNFEVWAIDDGSPDNSKKIVQEYADKDPRFKSILKENGGYGSVLEYGIKNTKTKYFLVCDPDDWLTDDALEKLHNFAKNSNLDVTVGDKYNIYSEDNKKVYIPSFKKELNVKPRVAYDTAEKKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTEAKIRDTIKIWHSIYNQLINGFELNQIETYIYFLYYEMKIILITESQLPSMSKYHTEILKIMRIMQRYNKILAKYVNNKVVPYNTNSMTGRLIFKGFMNKATYKWVERLYVKLERKREA", "perc_identity": 21.67}, "gnl|BL_ORD_ID|126|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 8223, "orf_end": 9251, "orf_from": "BGC0000765.1|Exopolysaccharide_12 ", "model_name": "OXA-27", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "147", "ARO_accession": "3001422", "ARO_name": "OXA-27", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.62058, "max_identities": 26, "bit_score": 27.335, "cvterm_id": "35507", "query": "DVTVGDKYN-----IYSEDNKKVYIPSFKKELNVKPRVAYDTAE---KKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTE", "match": "D+T+G+        +Y E  +++ +   +KE+    R+ +  AE   + D F    V P     K +  + ++F  ++++T         AN K +  L+E+  Y +  + G  M  K +", "sequence_from_db": "DMTLGEAMKLSAVPVYQELARRIGLDLMQKEVK---RIGFGNAEIGQQVDNFWL--VGP----LKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQ", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKADINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVAFALKMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTCATTCAAACAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAGCGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGACCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCCCAATTAGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAAAATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 8559, "query_end": 8894, "hit_start": 345, "hit_end": 678, "orf_dna_sequence": "GTGAATCCAGATATTACTGTTATAGTTCCAATTTATAATGTTGAAAAATATATTAGAAAGTGCTTAGACAGTCTGAAAAGACAGACATACAAGAACTTTGAAGTTTGGGCAATAGATGATGGCTCTCCTGATAATTCTAAAAAGATTGTTCAAGAATATGCTGATAAAGATCCAAGATTTAAATCTATTTTAAAAGAAAATGGTGGCTATGGGTCAGTTTTAGAATATGGAATTAAGAATACAAAAACAAAATATTTTTTAGTTTGTGATCCTGATGATTGGCTAACAGATGATGCATTGGAAAAATTACATAATTTTGCAAAAAATAGTAATTTAGATGTAACTGTTGGTGATAAATATAATATTTATTCAGAAGATAATAAAAAAGTATACATTCCTAGTTTTAAAAAAGAGTTAAATGTAAAACCACGTGTTGCATATGATACGGCTGAAAAAAAGGATAGATTTATTTTTAGTGAAGTATCACCACATGCAAAATTATTTAAAACATCAATTGCAAAAAATATAGATTTTCCTCATAAGATTAGCTATACGGACACTATTTTGTATGTGTTGTCGATTGCTAATGCAAAGAGAGTAGGATATCTGGATGAAGCTCTTGCATACTACTTGATAGATCGTCCTGGTAATACTATGACAGCAAAGACTGAAGCTAAAATTAGGGATACCATTAAAATATGGCATTCCATTTATAATCAGTTGATAAATGGATTTGAGCTAAATCAAATTGAAACATATATATATTTCTTATATTATGAAATGAAAATAATACTTATTACAGAATCTCAGCTACCTTCTATGAGTAAGTATCATACTGAGATTTTAAAAATTATGAGAATAATGCAAAGATATAATAAGATATTAGCTAAATATGTGAATAATAAGGTTGTTCCATATAATACAAATTCTATGACTGGACGCTTAATATTCAAAGGATTTATGAATAAAGCAACATATAAATGGGTAGAGAGATTATATGTTAAATTAGAGAGGAAACGTGAAGCTTAA", "orf_prot_sequence": "MNPDITVIVPIYNVEKYIRKCLDSLKRQTYKNFEVWAIDDGSPDNSKKIVQEYADKDPRFKSILKENGGYGSVLEYGIKNTKTKYFLVCDPDDWLTDDALEKLHNFAKNSNLDVTVGDKYNIYSEDNKKVYIPSFKKELNVKPRVAYDTAEKKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTEAKIRDTIKIWHSIYNQLINGFELNQIETYIYFLYYEMKIILITESQLPSMSKYHTEILKIMRIMQRYNKILAKYVNNKVVPYNTNSMTGRLIFKGFMNKATYKWVERLYVKLERKREA", "perc_identity": 21.67}, "gnl|BL_ORD_ID|3824|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 8223, "orf_end": 9251, "orf_from": "BGC0000765.1|Exopolysaccharide_12 ", "model_name": "OXA-565", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4894", "ARO_accession": "3005789", "ARO_name": "OXA-565", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.63498, "max_identities": 26, "bit_score": 27.335, "cvterm_id": "35507", "query": "DVTVGDKYN-----IYSEDNKKVYIPSFKKELNVKPRVAYDTAE---KKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTE", "match": "D+T+G+        +Y E  +++ +   +KE+    R+ +  AE   + D F    V P     K +  + ++F  ++++T         AN K +  L+E+  Y +  + G  M  K +", "sequence_from_db": "DMTLGEAMKLSAVPVYQELARRIGLDLMQKEVK---RIGFGNAEIGQQVDNFWL--VGP----LKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQ", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINKTQSQIVQGHNQVIHQYFDEKNTSGVLVIQADKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVTFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATAAAACCCAGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAGCAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCCGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGGCCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCTCAATTGGCGCATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACCGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCACTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCTGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 8559, "query_end": 8894, "hit_start": 345, "hit_end": 678, "orf_dna_sequence": "GTGAATCCAGATATTACTGTTATAGTTCCAATTTATAATGTTGAAAAATATATTAGAAAGTGCTTAGACAGTCTGAAAAGACAGACATACAAGAACTTTGAAGTTTGGGCAATAGATGATGGCTCTCCTGATAATTCTAAAAAGATTGTTCAAGAATATGCTGATAAAGATCCAAGATTTAAATCTATTTTAAAAGAAAATGGTGGCTATGGGTCAGTTTTAGAATATGGAATTAAGAATACAAAAACAAAATATTTTTTAGTTTGTGATCCTGATGATTGGCTAACAGATGATGCATTGGAAAAATTACATAATTTTGCAAAAAATAGTAATTTAGATGTAACTGTTGGTGATAAATATAATATTTATTCAGAAGATAATAAAAAAGTATACATTCCTAGTTTTAAAAAAGAGTTAAATGTAAAACCACGTGTTGCATATGATACGGCTGAAAAAAAGGATAGATTTATTTTTAGTGAAGTATCACCACATGCAAAATTATTTAAAACATCAATTGCAAAAAATATAGATTTTCCTCATAAGATTAGCTATACGGACACTATTTTGTATGTGTTGTCGATTGCTAATGCAAAGAGAGTAGGATATCTGGATGAAGCTCTTGCATACTACTTGATAGATCGTCCTGGTAATACTATGACAGCAAAGACTGAAGCTAAAATTAGGGATACCATTAAAATATGGCATTCCATTTATAATCAGTTGATAAATGGATTTGAGCTAAATCAAATTGAAACATATATATATTTCTTATATTATGAAATGAAAATAATACTTATTACAGAATCTCAGCTACCTTCTATGAGTAAGTATCATACTGAGATTTTAAAAATTATGAGAATAATGCAAAGATATAATAAGATATTAGCTAAATATGTGAATAATAAGGTTGTTCCATATAATACAAATTCTATGACTGGACGCTTAATATTCAAAGGATTTATGAATAAAGCAACATATAAATGGGTAGAGAGATTATATGTTAAATTAGAGAGGAAACGTGAAGCTTAA", "orf_prot_sequence": "MNPDITVIVPIYNVEKYIRKCLDSLKRQTYKNFEVWAIDDGSPDNSKKIVQEYADKDPRFKSILKENGGYGSVLEYGIKNTKTKYFLVCDPDDWLTDDALEKLHNFAKNSNLDVTVGDKYNIYSEDNKKVYIPSFKKELNVKPRVAYDTAEKKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTEAKIRDTIKIWHSIYNQLINGFELNQIETYIYFLYYEMKIILITESQLPSMSKYHTEILKIMRIMQRYNKILAKYVNNKVVPYNTNSMTGRLIFKGFMNKATYKWVERLYVKLERKREA", "perc_identity": 21.67}, "gnl|BL_ORD_ID|2279|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 8223, "orf_end": 9251, "orf_from": "BGC0000765.1|Exopolysaccharide_12 ", "model_name": "OXA-483", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "545", "model_id": "3544", "ARO_accession": "3003640", "ARO_name": "OXA-483", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.64951, "max_identities": 26, "bit_score": 27.335, "cvterm_id": "35507", "query": "DVTVGDKYN-----IYSEDNKKVYIPSFKKELNVKPRVAYDTAE---KKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTE", "match": "D+T+G+        +Y E  +++ +   +KE+    R+ +  AE   + D F    V P     K +  + ++F  ++++T         AN K +  L+E+  Y +  + G  M  K +", "sequence_from_db": "DMTLGEAMKLSAVPVYQELARRIGLDLMQKEVK---RIGFGNAEIGQQVDNFWL--VGP----LKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQ", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVAVALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGACCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCCCAATTAGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTGTTGCATTAAATATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 8559, "query_end": 8894, "hit_start": 345, "hit_end": 678, "orf_dna_sequence": "GTGAATCCAGATATTACTGTTATAGTTCCAATTTATAATGTTGAAAAATATATTAGAAAGTGCTTAGACAGTCTGAAAAGACAGACATACAAGAACTTTGAAGTTTGGGCAATAGATGATGGCTCTCCTGATAATTCTAAAAAGATTGTTCAAGAATATGCTGATAAAGATCCAAGATTTAAATCTATTTTAAAAGAAAATGGTGGCTATGGGTCAGTTTTAGAATATGGAATTAAGAATACAAAAACAAAATATTTTTTAGTTTGTGATCCTGATGATTGGCTAACAGATGATGCATTGGAAAAATTACATAATTTTGCAAAAAATAGTAATTTAGATGTAACTGTTGGTGATAAATATAATATTTATTCAGAAGATAATAAAAAAGTATACATTCCTAGTTTTAAAAAAGAGTTAAATGTAAAACCACGTGTTGCATATGATACGGCTGAAAAAAAGGATAGATTTATTTTTAGTGAAGTATCACCACATGCAAAATTATTTAAAACATCAATTGCAAAAAATATAGATTTTCCTCATAAGATTAGCTATACGGACACTATTTTGTATGTGTTGTCGATTGCTAATGCAAAGAGAGTAGGATATCTGGATGAAGCTCTTGCATACTACTTGATAGATCGTCCTGGTAATACTATGACAGCAAAGACTGAAGCTAAAATTAGGGATACCATTAAAATATGGCATTCCATTTATAATCAGTTGATAAATGGATTTGAGCTAAATCAAATTGAAACATATATATATTTCTTATATTATGAAATGAAAATAATACTTATTACAGAATCTCAGCTACCTTCTATGAGTAAGTATCATACTGAGATTTTAAAAATTATGAGAATAATGCAAAGATATAATAAGATATTAGCTAAATATGTGAATAATAAGGTTGTTCCATATAATACAAATTCTATGACTGGACGCTTAATATTCAAAGGATTTATGAATAAAGCAACATATAAATGGGTAGAGAGATTATATGTTAAATTAGAGAGGAAACGTGAAGCTTAA", "orf_prot_sequence": "MNPDITVIVPIYNVEKYIRKCLDSLKRQTYKNFEVWAIDDGSPDNSKKIVQEYADKDPRFKSILKENGGYGSVLEYGIKNTKTKYFLVCDPDDWLTDDALEKLHNFAKNSNLDVTVGDKYNIYSEDNKKVYIPSFKKELNVKPRVAYDTAEKKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTEAKIRDTIKIWHSIYNQLINGFELNQIETYIYFLYYEMKIILITESQLPSMSKYHTEILKIMRIMQRYNKILAKYVNNKVVPYNTNSMTGRLIFKGFMNKATYKWVERLYVKLERKREA", "perc_identity": 21.67}, "gnl|BL_ORD_ID|1573|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 8223, "orf_end": 9251, "orf_from": "BGC0000765.1|Exopolysaccharide_12 ", "model_name": "OXA-73", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "1715", "ARO_accession": "3001785", "ARO_name": "OXA-73", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.64951, "max_identities": 26, "bit_score": 27.335, "cvterm_id": "35915", "query": "DVTVGDKYN-----IYSEDNKKVYIPSFKKELNVKPRVAYDTAE---KKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTE", "match": "D+T+G+        +Y E  +++ +   +KE+    R+ +  AE   + D F    V P     K +  + ++F  ++++T         AN K +  L+E+  Y +  + G  M  K +", "sequence_from_db": "DMTLGEAMKLSAVPVYQELARRIGLDLMQKEVK---RIGFGNAEIGQQVDNFWL--VGP----LKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQ", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVAFALKMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGACCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCCCAATTAGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAAAATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 8559, "query_end": 8894, "hit_start": 345, "hit_end": 678, "orf_dna_sequence": "GTGAATCCAGATATTACTGTTATAGTTCCAATTTATAATGTTGAAAAATATATTAGAAAGTGCTTAGACAGTCTGAAAAGACAGACATACAAGAACTTTGAAGTTTGGGCAATAGATGATGGCTCTCCTGATAATTCTAAAAAGATTGTTCAAGAATATGCTGATAAAGATCCAAGATTTAAATCTATTTTAAAAGAAAATGGTGGCTATGGGTCAGTTTTAGAATATGGAATTAAGAATACAAAAACAAAATATTTTTTAGTTTGTGATCCTGATGATTGGCTAACAGATGATGCATTGGAAAAATTACATAATTTTGCAAAAAATAGTAATTTAGATGTAACTGTTGGTGATAAATATAATATTTATTCAGAAGATAATAAAAAAGTATACATTCCTAGTTTTAAAAAAGAGTTAAATGTAAAACCACGTGTTGCATATGATACGGCTGAAAAAAAGGATAGATTTATTTTTAGTGAAGTATCACCACATGCAAAATTATTTAAAACATCAATTGCAAAAAATATAGATTTTCCTCATAAGATTAGCTATACGGACACTATTTTGTATGTGTTGTCGATTGCTAATGCAAAGAGAGTAGGATATCTGGATGAAGCTCTTGCATACTACTTGATAGATCGTCCTGGTAATACTATGACAGCAAAGACTGAAGCTAAAATTAGGGATACCATTAAAATATGGCATTCCATTTATAATCAGTTGATAAATGGATTTGAGCTAAATCAAATTGAAACATATATATATTTCTTATATTATGAAATGAAAATAATACTTATTACAGAATCTCAGCTACCTTCTATGAGTAAGTATCATACTGAGATTTTAAAAATTATGAGAATAATGCAAAGATATAATAAGATATTAGCTAAATATGTGAATAATAAGGTTGTTCCATATAATACAAATTCTATGACTGGACGCTTAATATTCAAAGGATTTATGAATAAAGCAACATATAAATGGGTAGAGAGATTATATGTTAAATTAGAGAGGAAACGTGAAGCTTAA", "orf_prot_sequence": "MNPDITVIVPIYNVEKYIRKCLDSLKRQTYKNFEVWAIDDGSPDNSKKIVQEYADKDPRFKSILKENGGYGSVLEYGIKNTKTKYFLVCDPDDWLTDDALEKLHNFAKNSNLDVTVGDKYNIYSEDNKKVYIPSFKKELNVKPRVAYDTAEKKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTEAKIRDTIKIWHSIYNQLINGFELNQIETYIYFLYYEMKIILITESQLPSMSKYHTEILKIMRIMQRYNKILAKYVNNKVVPYNTNSMTGRLIFKGFMNKATYKWVERLYVKLERKREA", "perc_identity": 21.67}, "gnl|BL_ORD_ID|4041|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 8223, "orf_end": 9251, "orf_from": "BGC0000765.1|Exopolysaccharide_12 ", "model_name": "OXA-806", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "5111", "ARO_accession": "3006006", "ARO_name": "OXA-806", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.66417, "max_identities": 26, "bit_score": 27.335, "cvterm_id": "39672", "query": "DVTVGDKYN-----IYSEDNKKVYIPSFKKELNVKPRVAYDTAE---KKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTE", "match": "D+T+G+        +Y E  +++ +   +KE+    R+ +  AE   + D F    V P     K +  + ++F  ++++T         AN K +  L+E+  Y +  + G  M  K +", "sequence_from_db": "DMTLGEAMKLSAVPVYQELARRIGLDLMQKEVK---RIGFGNAEIGQQVDNFWL--VGP----LKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQ", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINKTQSQIVQGHNQVIHQYFDEKNTSGVLVIQADKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVAFALNMEMRSGMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATAAAACCCAGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAGCAGATAAAAAAATTAATCTGTATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCCGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGGCCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCTCAATTGGCGCATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCACTAAATATGGAAATGCGGTCAGGAATGCCTGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 8559, "query_end": 8894, "hit_start": 345, "hit_end": 678, "orf_dna_sequence": "GTGAATCCAGATATTACTGTTATAGTTCCAATTTATAATGTTGAAAAATATATTAGAAAGTGCTTAGACAGTCTGAAAAGACAGACATACAAGAACTTTGAAGTTTGGGCAATAGATGATGGCTCTCCTGATAATTCTAAAAAGATTGTTCAAGAATATGCTGATAAAGATCCAAGATTTAAATCTATTTTAAAAGAAAATGGTGGCTATGGGTCAGTTTTAGAATATGGAATTAAGAATACAAAAACAAAATATTTTTTAGTTTGTGATCCTGATGATTGGCTAACAGATGATGCATTGGAAAAATTACATAATTTTGCAAAAAATAGTAATTTAGATGTAACTGTTGGTGATAAATATAATATTTATTCAGAAGATAATAAAAAAGTATACATTCCTAGTTTTAAAAAAGAGTTAAATGTAAAACCACGTGTTGCATATGATACGGCTGAAAAAAAGGATAGATTTATTTTTAGTGAAGTATCACCACATGCAAAATTATTTAAAACATCAATTGCAAAAAATATAGATTTTCCTCATAAGATTAGCTATACGGACACTATTTTGTATGTGTTGTCGATTGCTAATGCAAAGAGAGTAGGATATCTGGATGAAGCTCTTGCATACTACTTGATAGATCGTCCTGGTAATACTATGACAGCAAAGACTGAAGCTAAAATTAGGGATACCATTAAAATATGGCATTCCATTTATAATCAGTTGATAAATGGATTTGAGCTAAATCAAATTGAAACATATATATATTTCTTATATTATGAAATGAAAATAATACTTATTACAGAATCTCAGCTACCTTCTATGAGTAAGTATCATACTGAGATTTTAAAAATTATGAGAATAATGCAAAGATATAATAAGATATTAGCTAAATATGTGAATAATAAGGTTGTTCCATATAATACAAATTCTATGACTGGACGCTTAATATTCAAAGGATTTATGAATAAAGCAACATATAAATGGGTAGAGAGATTATATGTTAAATTAGAGAGGAAACGTGAAGCTTAA", "orf_prot_sequence": "MNPDITVIVPIYNVEKYIRKCLDSLKRQTYKNFEVWAIDDGSPDNSKKIVQEYADKDPRFKSILKENGGYGSVLEYGIKNTKTKYFLVCDPDDWLTDDALEKLHNFAKNSNLDVTVGDKYNIYSEDNKKVYIPSFKKELNVKPRVAYDTAEKKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTEAKIRDTIKIWHSIYNQLINGFELNQIETYIYFLYYEMKIILITESQLPSMSKYHTEILKIMRIMQRYNKILAKYVNNKVVPYNTNSMTGRLIFKGFMNKATYKWVERLYVKLERKREA", "perc_identity": 21.67}, "gnl|BL_ORD_ID|1020|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 8223, "orf_end": 9251, "orf_from": "BGC0000765.1|Exopolysaccharide_12 ", "model_name": "OXA-435", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "1115", "ARO_accession": "3003162", "ARO_name": "OXA-435", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.66417, "max_identities": 26, "bit_score": 27.335, "cvterm_id": "35507", "query": "DVTVGDKYN-----IYSEDNKKVYIPSFKKELNVKPRVAYDTAE---KKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTE", "match": "D+T+G+        +Y E  +++ +   +KE+    R+ +  AE   + D F    V P     K +  + ++F  ++++T         AN K +  L+E+  Y +  + G  M  K +", "sequence_from_db": "DMTLGEAMKLSAVPVYQELARRIGLDLMQKEVK---RIGFGNAEIGQQVDNFWL--VGP----LKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQ", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLSGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGACCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCCCAATTAGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGTCCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 8559, "query_end": 8894, "hit_start": 345, "hit_end": 678, "orf_dna_sequence": "GTGAATCCAGATATTACTGTTATAGTTCCAATTTATAATGTTGAAAAATATATTAGAAAGTGCTTAGACAGTCTGAAAAGACAGACATACAAGAACTTTGAAGTTTGGGCAATAGATGATGGCTCTCCTGATAATTCTAAAAAGATTGTTCAAGAATATGCTGATAAAGATCCAAGATTTAAATCTATTTTAAAAGAAAATGGTGGCTATGGGTCAGTTTTAGAATATGGAATTAAGAATACAAAAACAAAATATTTTTTAGTTTGTGATCCTGATGATTGGCTAACAGATGATGCATTGGAAAAATTACATAATTTTGCAAAAAATAGTAATTTAGATGTAACTGTTGGTGATAAATATAATATTTATTCAGAAGATAATAAAAAAGTATACATTCCTAGTTTTAAAAAAGAGTTAAATGTAAAACCACGTGTTGCATATGATACGGCTGAAAAAAAGGATAGATTTATTTTTAGTGAAGTATCACCACATGCAAAATTATTTAAAACATCAATTGCAAAAAATATAGATTTTCCTCATAAGATTAGCTATACGGACACTATTTTGTATGTGTTGTCGATTGCTAATGCAAAGAGAGTAGGATATCTGGATGAAGCTCTTGCATACTACTTGATAGATCGTCCTGGTAATACTATGACAGCAAAGACTGAAGCTAAAATTAGGGATACCATTAAAATATGGCATTCCATTTATAATCAGTTGATAAATGGATTTGAGCTAAATCAAATTGAAACATATATATATTTCTTATATTATGAAATGAAAATAATACTTATTACAGAATCTCAGCTACCTTCTATGAGTAAGTATCATACTGAGATTTTAAAAATTATGAGAATAATGCAAAGATATAATAAGATATTAGCTAAATATGTGAATAATAAGGTTGTTCCATATAATACAAATTCTATGACTGGACGCTTAATATTCAAAGGATTTATGAATAAAGCAACATATAAATGGGTAGAGAGATTATATGTTAAATTAGAGAGGAAACGTGAAGCTTAA", "orf_prot_sequence": "MNPDITVIVPIYNVEKYIRKCLDSLKRQTYKNFEVWAIDDGSPDNSKKIVQEYADKDPRFKSILKENGGYGSVLEYGIKNTKTKYFLVCDPDDWLTDDALEKLHNFAKNSNLDVTVGDKYNIYSEDNKKVYIPSFKKELNVKPRVAYDTAEKKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTEAKIRDTIKIWHSIYNQLINGFELNQIETYIYFLYYEMKIILITESQLPSMSKYHTEILKIMRIMQRYNKILAKYVNNKVVPYNTNSMTGRLIFKGFMNKATYKWVERLYVKLERKREA", "perc_identity": 21.67}, "gnl|BL_ORD_ID|281|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 8223, "orf_end": 9251, "orf_from": "BGC0000765.1|Exopolysaccharide_12 ", "model_name": "OXA-167", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "312", "ARO_accession": "3001467", "ARO_name": "OXA-167", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.67896, "max_identities": 26, "bit_score": 27.335, "cvterm_id": "35507", "query": "DVTVGDKYN-----IYSEDNKKVYIPSFKKELNVKPRVAYDTAE---KKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTE", "match": "D+T+G+        +Y E  +++ +   +KE+    R+ +  AE   + D F    V P     K +  + ++F  ++++T         AN K +  L+E+  Y +  + G  M  K +", "sequence_from_db": "DMTLGEAMKLSAVPVYQELARRIGLDLMQKEVK---RIGFGNAEIGQQVDNFWL--VGP----LKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQ", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELMMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGACCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCCCAATTAGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGAATTAATGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 8559, "query_end": 8894, "hit_start": 345, "hit_end": 678, "orf_dna_sequence": "GTGAATCCAGATATTACTGTTATAGTTCCAATTTATAATGTTGAAAAATATATTAGAAAGTGCTTAGACAGTCTGAAAAGACAGACATACAAGAACTTTGAAGTTTGGGCAATAGATGATGGCTCTCCTGATAATTCTAAAAAGATTGTTCAAGAATATGCTGATAAAGATCCAAGATTTAAATCTATTTTAAAAGAAAATGGTGGCTATGGGTCAGTTTTAGAATATGGAATTAAGAATACAAAAACAAAATATTTTTTAGTTTGTGATCCTGATGATTGGCTAACAGATGATGCATTGGAAAAATTACATAATTTTGCAAAAAATAGTAATTTAGATGTAACTGTTGGTGATAAATATAATATTTATTCAGAAGATAATAAAAAAGTATACATTCCTAGTTTTAAAAAAGAGTTAAATGTAAAACCACGTGTTGCATATGATACGGCTGAAAAAAAGGATAGATTTATTTTTAGTGAAGTATCACCACATGCAAAATTATTTAAAACATCAATTGCAAAAAATATAGATTTTCCTCATAAGATTAGCTATACGGACACTATTTTGTATGTGTTGTCGATTGCTAATGCAAAGAGAGTAGGATATCTGGATGAAGCTCTTGCATACTACTTGATAGATCGTCCTGGTAATACTATGACAGCAAAGACTGAAGCTAAAATTAGGGATACCATTAAAATATGGCATTCCATTTATAATCAGTTGATAAATGGATTTGAGCTAAATCAAATTGAAACATATATATATTTCTTATATTATGAAATGAAAATAATACTTATTACAGAATCTCAGCTACCTTCTATGAGTAAGTATCATACTGAGATTTTAAAAATTATGAGAATAATGCAAAGATATAATAAGATATTAGCTAAATATGTGAATAATAAGGTTGTTCCATATAATACAAATTCTATGACTGGACGCTTAATATTCAAAGGATTTATGAATAAAGCAACATATAAATGGGTAGAGAGATTATATGTTAAATTAGAGAGGAAACGTGAAGCTTAA", "orf_prot_sequence": "MNPDITVIVPIYNVEKYIRKCLDSLKRQTYKNFEVWAIDDGSPDNSKKIVQEYADKDPRFKSILKENGGYGSVLEYGIKNTKTKYFLVCDPDDWLTDDALEKLHNFAKNSNLDVTVGDKYNIYSEDNKKVYIPSFKKELNVKPRVAYDTAEKKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTEAKIRDTIKIWHSIYNQLINGFELNQIETYIYFLYYEMKIILITESQLPSMSKYHTEILKIMRIMQRYNKILAKYVNNKVVPYNTNSMTGRLIFKGFMNKATYKWVERLYVKLERKREA", "perc_identity": 21.67}, "gnl|BL_ORD_ID|1662|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 8223, "orf_end": 9251, "orf_from": "BGC0000765.1|Exopolysaccharide_12 ", "model_name": "OXA-168", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "1802", "ARO_accession": "3001468", "ARO_name": "OXA-168", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.69387, "max_identities": 26, "bit_score": 27.335, "cvterm_id": "35507", "query": "DVTVGDKYN-----IYSEDNKKVYIPSFKKELNVKPRVAYDTAE---KKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTE", "match": "D+T+G+        +Y E  +++ +   +KE+    R+ +  AE   + D F    V P     K +  + ++F  ++++T         AN K +  L+E+  Y +  + G  M  K +", "sequence_from_db": "DMTLGEAMKLSAVPVYQELARRIGLDLMQKEVK---RIGFGNAEIGQQVDNFWL--VGP----LKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQ", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLAGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGACCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCCCAATTAGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGGCCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 8559, "query_end": 8894, "hit_start": 345, "hit_end": 678, "orf_dna_sequence": "GTGAATCCAGATATTACTGTTATAGTTCCAATTTATAATGTTGAAAAATATATTAGAAAGTGCTTAGACAGTCTGAAAAGACAGACATACAAGAACTTTGAAGTTTGGGCAATAGATGATGGCTCTCCTGATAATTCTAAAAAGATTGTTCAAGAATATGCTGATAAAGATCCAAGATTTAAATCTATTTTAAAAGAAAATGGTGGCTATGGGTCAGTTTTAGAATATGGAATTAAGAATACAAAAACAAAATATTTTTTAGTTTGTGATCCTGATGATTGGCTAACAGATGATGCATTGGAAAAATTACATAATTTTGCAAAAAATAGTAATTTAGATGTAACTGTTGGTGATAAATATAATATTTATTCAGAAGATAATAAAAAAGTATACATTCCTAGTTTTAAAAAAGAGTTAAATGTAAAACCACGTGTTGCATATGATACGGCTGAAAAAAAGGATAGATTTATTTTTAGTGAAGTATCACCACATGCAAAATTATTTAAAACATCAATTGCAAAAAATATAGATTTTCCTCATAAGATTAGCTATACGGACACTATTTTGTATGTGTTGTCGATTGCTAATGCAAAGAGAGTAGGATATCTGGATGAAGCTCTTGCATACTACTTGATAGATCGTCCTGGTAATACTATGACAGCAAAGACTGAAGCTAAAATTAGGGATACCATTAAAATATGGCATTCCATTTATAATCAGTTGATAAATGGATTTGAGCTAAATCAAATTGAAACATATATATATTTCTTATATTATGAAATGAAAATAATACTTATTACAGAATCTCAGCTACCTTCTATGAGTAAGTATCATACTGAGATTTTAAAAATTATGAGAATAATGCAAAGATATAATAAGATATTAGCTAAATATGTGAATAATAAGGTTGTTCCATATAATACAAATTCTATGACTGGACGCTTAATATTCAAAGGATTTATGAATAAAGCAACATATAAATGGGTAGAGAGATTATATGTTAAATTAGAGAGGAAACGTGAAGCTTAA", "orf_prot_sequence": "MNPDITVIVPIYNVEKYIRKCLDSLKRQTYKNFEVWAIDDGSPDNSKKIVQEYADKDPRFKSILKENGGYGSVLEYGIKNTKTKYFLVCDPDDWLTDDALEKLHNFAKNSNLDVTVGDKYNIYSEDNKKVYIPSFKKELNVKPRVAYDTAEKKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTEAKIRDTIKIWHSIYNQLINGFELNQIETYIYFLYYEMKIILITESQLPSMSKYHTEILKIMRIMQRYNKILAKYVNNKVVPYNTNSMTGRLIFKGFMNKATYKWVERLYVKLERKREA", "perc_identity": 21.67}, "gnl|BL_ORD_ID|1390|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 8223, "orf_end": 9251, "orf_from": "BGC0000765.1|Exopolysaccharide_12 ", "model_name": "OXA-423", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "1511", "ARO_accession": "3003161", "ARO_name": "OXA-423", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.69387, "max_identities": 26, "bit_score": 27.335, "cvterm_id": "35507", "query": "DVTVGDKYN-----IYSEDNKKVYIPSFKKELNVKPRVAYDTAE---KKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTE", "match": "D+T+G+        +Y E  +++ +   +KE+    R+ +  AE   + D F    V P     K +  + ++F  ++++T         AN K +  L+E+  Y +  + G  M  K +", "sequence_from_db": "DMTLGEAMKLSAAPVYQELARRIGLDLMQKEVK---RIGFGNAEIGQQVDNFWL--VGP----LKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQ", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAAPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCGTTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGCCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGACCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCCCAATTAGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 8559, "query_end": 8894, "hit_start": 345, "hit_end": 678, "orf_dna_sequence": "GTGAATCCAGATATTACTGTTATAGTTCCAATTTATAATGTTGAAAAATATATTAGAAAGTGCTTAGACAGTCTGAAAAGACAGACATACAAGAACTTTGAAGTTTGGGCAATAGATGATGGCTCTCCTGATAATTCTAAAAAGATTGTTCAAGAATATGCTGATAAAGATCCAAGATTTAAATCTATTTTAAAAGAAAATGGTGGCTATGGGTCAGTTTTAGAATATGGAATTAAGAATACAAAAACAAAATATTTTTTAGTTTGTGATCCTGATGATTGGCTAACAGATGATGCATTGGAAAAATTACATAATTTTGCAAAAAATAGTAATTTAGATGTAACTGTTGGTGATAAATATAATATTTATTCAGAAGATAATAAAAAAGTATACATTCCTAGTTTTAAAAAAGAGTTAAATGTAAAACCACGTGTTGCATATGATACGGCTGAAAAAAAGGATAGATTTATTTTTAGTGAAGTATCACCACATGCAAAATTATTTAAAACATCAATTGCAAAAAATATAGATTTTCCTCATAAGATTAGCTATACGGACACTATTTTGTATGTGTTGTCGATTGCTAATGCAAAGAGAGTAGGATATCTGGATGAAGCTCTTGCATACTACTTGATAGATCGTCCTGGTAATACTATGACAGCAAAGACTGAAGCTAAAATTAGGGATACCATTAAAATATGGCATTCCATTTATAATCAGTTGATAAATGGATTTGAGCTAAATCAAATTGAAACATATATATATTTCTTATATTATGAAATGAAAATAATACTTATTACAGAATCTCAGCTACCTTCTATGAGTAAGTATCATACTGAGATTTTAAAAATTATGAGAATAATGCAAAGATATAATAAGATATTAGCTAAATATGTGAATAATAAGGTTGTTCCATATAATACAAATTCTATGACTGGACGCTTAATATTCAAAGGATTTATGAATAAAGCAACATATAAATGGGTAGAGAGATTATATGTTAAATTAGAGAGGAAACGTGAAGCTTAA", "orf_prot_sequence": "MNPDITVIVPIYNVEKYIRKCLDSLKRQTYKNFEVWAIDDGSPDNSKKIVQEYADKDPRFKSILKENGGYGSVLEYGIKNTKTKYFLVCDPDDWLTDDALEKLHNFAKNSNLDVTVGDKYNIYSEDNKKVYIPSFKKELNVKPRVAYDTAEKKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTEAKIRDTIKIWHSIYNQLINGFELNQIETYIYFLYYEMKIILITESQLPSMSKYHTEILKIMRIMQRYNKILAKYVNNKVVPYNTNSMTGRLIFKGFMNKATYKWVERLYVKLERKREA", "perc_identity": 21.67}, "gnl|BL_ORD_ID|1234|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 8223, "orf_end": 9251, "orf_from": "BGC0000765.1|Exopolysaccharide_12 ", "model_name": "OXA-166", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "1343", "ARO_accession": "3001466", "ARO_name": "OXA-166", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.69387, "max_identities": 26, "bit_score": 27.335, "cvterm_id": "35507", "query": "DVTVGDKYN-----IYSEDNKKVYIPSFKKELNVKPRVAYDTAE---KKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTE", "match": "D+T+G+        +Y E  +++ +   +KE+    R+ +  AE   + D F    V P     K +  + ++F  ++++T         AN K +  L+E+  Y +  + G  M  K +", "sequence_from_db": "DMTLGEAMKLSAVPVYQELARRIGLDLMQKEVK---RIGFGNAEIGQQVDNFWL--VGP----LKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQ", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGALVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGCGCTGGTTATTCAAACAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGACCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCCCAATTAGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 8559, "query_end": 8894, "hit_start": 345, "hit_end": 678, "orf_dna_sequence": "GTGAATCCAGATATTACTGTTATAGTTCCAATTTATAATGTTGAAAAATATATTAGAAAGTGCTTAGACAGTCTGAAAAGACAGACATACAAGAACTTTGAAGTTTGGGCAATAGATGATGGCTCTCCTGATAATTCTAAAAAGATTGTTCAAGAATATGCTGATAAAGATCCAAGATTTAAATCTATTTTAAAAGAAAATGGTGGCTATGGGTCAGTTTTAGAATATGGAATTAAGAATACAAAAACAAAATATTTTTTAGTTTGTGATCCTGATGATTGGCTAACAGATGATGCATTGGAAAAATTACATAATTTTGCAAAAAATAGTAATTTAGATGTAACTGTTGGTGATAAATATAATATTTATTCAGAAGATAATAAAAAAGTATACATTCCTAGTTTTAAAAAAGAGTTAAATGTAAAACCACGTGTTGCATATGATACGGCTGAAAAAAAGGATAGATTTATTTTTAGTGAAGTATCACCACATGCAAAATTATTTAAAACATCAATTGCAAAAAATATAGATTTTCCTCATAAGATTAGCTATACGGACACTATTTTGTATGTGTTGTCGATTGCTAATGCAAAGAGAGTAGGATATCTGGATGAAGCTCTTGCATACTACTTGATAGATCGTCCTGGTAATACTATGACAGCAAAGACTGAAGCTAAAATTAGGGATACCATTAAAATATGGCATTCCATTTATAATCAGTTGATAAATGGATTTGAGCTAAATCAAATTGAAACATATATATATTTCTTATATTATGAAATGAAAATAATACTTATTACAGAATCTCAGCTACCTTCTATGAGTAAGTATCATACTGAGATTTTAAAAATTATGAGAATAATGCAAAGATATAATAAGATATTAGCTAAATATGTGAATAATAAGGTTGTTCCATATAATACAAATTCTATGACTGGACGCTTAATATTCAAAGGATTTATGAATAAAGCAACATATAAATGGGTAGAGAGATTATATGTTAAATTAGAGAGGAAACGTGAAGCTTAA", "orf_prot_sequence": "MNPDITVIVPIYNVEKYIRKCLDSLKRQTYKNFEVWAIDDGSPDNSKKIVQEYADKDPRFKSILKENGGYGSVLEYGIKNTKTKYFLVCDPDDWLTDDALEKLHNFAKNSNLDVTVGDKYNIYSEDNKKVYIPSFKKELNVKPRVAYDTAEKKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTEAKIRDTIKIWHSIYNQLINGFELNQIETYIYFLYYEMKIILITESQLPSMSKYHTEILKIMRIMQRYNKILAKYVNNKVVPYNTNSMTGRLIFKGFMNKATYKWVERLYVKLERKREA", "perc_identity": 21.67}, "gnl|BL_ORD_ID|288|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 8223, "orf_end": 9251, "orf_from": "BGC0000765.1|Exopolysaccharide_12 ", "model_name": "OXA-366", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "319", "ARO_accession": "3001553", "ARO_name": "OXA-366", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.69387, "max_identities": 26, "bit_score": 27.335, "cvterm_id": "35507", "query": "DVTVGDKYN-----IYSEDNKKVYIPSFKKELNVKPRVAYDTAE---KKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTE", "match": "D+T+G+        +Y E  +++ +   +KE+    R+ +  AE   + D F    V P     K +  + ++F  ++++T         AN K +  L+E+  Y +  + G  M  K +", "sequence_from_db": "DMTLGEAMKLSAVPVYQELARRIGLDLMQKEVK---RIGFGNAEIGQQVDNFWL--VGP----LKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQ", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTAQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGCTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGACCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCCCAATTAGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 8559, "query_end": 8894, "hit_start": 345, "hit_end": 678, "orf_dna_sequence": "GTGAATCCAGATATTACTGTTATAGTTCCAATTTATAATGTTGAAAAATATATTAGAAAGTGCTTAGACAGTCTGAAAAGACAGACATACAAGAACTTTGAAGTTTGGGCAATAGATGATGGCTCTCCTGATAATTCTAAAAAGATTGTTCAAGAATATGCTGATAAAGATCCAAGATTTAAATCTATTTTAAAAGAAAATGGTGGCTATGGGTCAGTTTTAGAATATGGAATTAAGAATACAAAAACAAAATATTTTTTAGTTTGTGATCCTGATGATTGGCTAACAGATGATGCATTGGAAAAATTACATAATTTTGCAAAAAATAGTAATTTAGATGTAACTGTTGGTGATAAATATAATATTTATTCAGAAGATAATAAAAAAGTATACATTCCTAGTTTTAAAAAAGAGTTAAATGTAAAACCACGTGTTGCATATGATACGGCTGAAAAAAAGGATAGATTTATTTTTAGTGAAGTATCACCACATGCAAAATTATTTAAAACATCAATTGCAAAAAATATAGATTTTCCTCATAAGATTAGCTATACGGACACTATTTTGTATGTGTTGTCGATTGCTAATGCAAAGAGAGTAGGATATCTGGATGAAGCTCTTGCATACTACTTGATAGATCGTCCTGGTAATACTATGACAGCAAAGACTGAAGCTAAAATTAGGGATACCATTAAAATATGGCATTCCATTTATAATCAGTTGATAAATGGATTTGAGCTAAATCAAATTGAAACATATATATATTTCTTATATTATGAAATGAAAATAATACTTATTACAGAATCTCAGCTACCTTCTATGAGTAAGTATCATACTGAGATTTTAAAAATTATGAGAATAATGCAAAGATATAATAAGATATTAGCTAAATATGTGAATAATAAGGTTGTTCCATATAATACAAATTCTATGACTGGACGCTTAATATTCAAAGGATTTATGAATAAAGCAACATATAAATGGGTAGAGAGATTATATGTTAAATTAGAGAGGAAACGTGAAGCTTAA", "orf_prot_sequence": "MNPDITVIVPIYNVEKYIRKCLDSLKRQTYKNFEVWAIDDGSPDNSKKIVQEYADKDPRFKSILKENGGYGSVLEYGIKNTKTKYFLVCDPDDWLTDDALEKLHNFAKNSNLDVTVGDKYNIYSEDNKKVYIPSFKKELNVKPRVAYDTAEKKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTEAKIRDTIKIWHSIYNQLINGFELNQIETYIYFLYYEMKIILITESQLPSMSKYHTEILKIMRIMQRYNKILAKYVNNKVVPYNTNSMTGRLIFKGFMNKATYKWVERLYVKLERKREA", "perc_identity": 21.67}, "gnl|BL_ORD_ID|208|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 8223, "orf_end": 9251, "orf_from": "BGC0000765.1|Exopolysaccharide_12 ", "model_name": "OXA-422", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "230", "ARO_accession": "3003160", "ARO_name": "OXA-422", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.70892, "max_identities": 26, "bit_score": 27.335, "cvterm_id": "35507", "query": "DVTVGDKYN-----IYSEDNKKVYIPSFKKELNVKPRVAYDTAE---KKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTE", "match": "D+T+G+        +Y E  +++ +   +KE+    R+ +  AE   + D F    V P     K +  + ++F  ++++T         AN K +  L+E+  Y +  + G  M  K +", "sequence_from_db": "DMTLGEAMKLSAVPVYQELARRIGLDLMQKEVK---RIGFGNAEIGQQVDNFWL--VGP----LKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQ", "sequence_from_broadstreet": "MNKYFTCYVVASPFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCCTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGACCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCCCAATTAGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 8559, "query_end": 8894, "hit_start": 345, "hit_end": 678, "orf_dna_sequence": "GTGAATCCAGATATTACTGTTATAGTTCCAATTTATAATGTTGAAAAATATATTAGAAAGTGCTTAGACAGTCTGAAAAGACAGACATACAAGAACTTTGAAGTTTGGGCAATAGATGATGGCTCTCCTGATAATTCTAAAAAGATTGTTCAAGAATATGCTGATAAAGATCCAAGATTTAAATCTATTTTAAAAGAAAATGGTGGCTATGGGTCAGTTTTAGAATATGGAATTAAGAATACAAAAACAAAATATTTTTTAGTTTGTGATCCTGATGATTGGCTAACAGATGATGCATTGGAAAAATTACATAATTTTGCAAAAAATAGTAATTTAGATGTAACTGTTGGTGATAAATATAATATTTATTCAGAAGATAATAAAAAAGTATACATTCCTAGTTTTAAAAAAGAGTTAAATGTAAAACCACGTGTTGCATATGATACGGCTGAAAAAAAGGATAGATTTATTTTTAGTGAAGTATCACCACATGCAAAATTATTTAAAACATCAATTGCAAAAAATATAGATTTTCCTCATAAGATTAGCTATACGGACACTATTTTGTATGTGTTGTCGATTGCTAATGCAAAGAGAGTAGGATATCTGGATGAAGCTCTTGCATACTACTTGATAGATCGTCCTGGTAATACTATGACAGCAAAGACTGAAGCTAAAATTAGGGATACCATTAAAATATGGCATTCCATTTATAATCAGTTGATAAATGGATTTGAGCTAAATCAAATTGAAACATATATATATTTCTTATATTATGAAATGAAAATAATACTTATTACAGAATCTCAGCTACCTTCTATGAGTAAGTATCATACTGAGATTTTAAAAATTATGAGAATAATGCAAAGATATAATAAGATATTAGCTAAATATGTGAATAATAAGGTTGTTCCATATAATACAAATTCTATGACTGGACGCTTAATATTCAAAGGATTTATGAATAAAGCAACATATAAATGGGTAGAGAGATTATATGTTAAATTAGAGAGGAAACGTGAAGCTTAA", "orf_prot_sequence": "MNPDITVIVPIYNVEKYIRKCLDSLKRQTYKNFEVWAIDDGSPDNSKKIVQEYADKDPRFKSILKENGGYGSVLEYGIKNTKTKYFLVCDPDDWLTDDALEKLHNFAKNSNLDVTVGDKYNIYSEDNKKVYIPSFKKELNVKPRVAYDTAEKKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTEAKIRDTIKIWHSIYNQLINGFELNQIETYIYFLYYEMKIILITESQLPSMSKYHTEILKIMRIMQRYNKILAKYVNNKVVPYNTNSMTGRLIFKGFMNKATYKWVERLYVKLERKREA", "perc_identity": 21.67}, "gnl|BL_ORD_ID|1032|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 8223, "orf_end": 9251, "orf_from": "BGC0000765.1|Exopolysaccharide_12 ", "model_name": "OXA-23", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "1128", "ARO_accession": "3001418", "ARO_name": "OXA-23", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.72411, "max_identities": 26, "bit_score": 27.335, "cvterm_id": "35507", "query": "DVTVGDKYN-----IYSEDNKKVYIPSFKKELNVKPRVAYDTAE---KKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTE", "match": "D+T+G+        +Y E  +++ +   +KE+    R+ +  AE   + D F    V P     K +  + ++F  ++++T         AN K +  L+E+  Y +  + G  M  K +", "sequence_from_db": "DMTLGEAMKLSAVPVYQELARRIGLDLMQKEVK---RIGFGNAEIGQQVDNFWL--VGP----LKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQ", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGACCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCCCAATTAGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 8559, "query_end": 8894, "hit_start": 345, "hit_end": 678, "orf_dna_sequence": "GTGAATCCAGATATTACTGTTATAGTTCCAATTTATAATGTTGAAAAATATATTAGAAAGTGCTTAGACAGTCTGAAAAGACAGACATACAAGAACTTTGAAGTTTGGGCAATAGATGATGGCTCTCCTGATAATTCTAAAAAGATTGTTCAAGAATATGCTGATAAAGATCCAAGATTTAAATCTATTTTAAAAGAAAATGGTGGCTATGGGTCAGTTTTAGAATATGGAATTAAGAATACAAAAACAAAATATTTTTTAGTTTGTGATCCTGATGATTGGCTAACAGATGATGCATTGGAAAAATTACATAATTTTGCAAAAAATAGTAATTTAGATGTAACTGTTGGTGATAAATATAATATTTATTCAGAAGATAATAAAAAAGTATACATTCCTAGTTTTAAAAAAGAGTTAAATGTAAAACCACGTGTTGCATATGATACGGCTGAAAAAAAGGATAGATTTATTTTTAGTGAAGTATCACCACATGCAAAATTATTTAAAACATCAATTGCAAAAAATATAGATTTTCCTCATAAGATTAGCTATACGGACACTATTTTGTATGTGTTGTCGATTGCTAATGCAAAGAGAGTAGGATATCTGGATGAAGCTCTTGCATACTACTTGATAGATCGTCCTGGTAATACTATGACAGCAAAGACTGAAGCTAAAATTAGGGATACCATTAAAATATGGCATTCCATTTATAATCAGTTGATAAATGGATTTGAGCTAAATCAAATTGAAACATATATATATTTCTTATATTATGAAATGAAAATAATACTTATTACAGAATCTCAGCTACCTTCTATGAGTAAGTATCATACTGAGATTTTAAAAATTATGAGAATAATGCAAAGATATAATAAGATATTAGCTAAATATGTGAATAATAAGGTTGTTCCATATAATACAAATTCTATGACTGGACGCTTAATATTCAAAGGATTTATGAATAAAGCAACATATAAATGGGTAGAGAGATTATATGTTAAATTAGAGAGGAAACGTGAAGCTTAA", "orf_prot_sequence": "MNPDITVIVPIYNVEKYIRKCLDSLKRQTYKNFEVWAIDDGSPDNSKKIVQEYADKDPRFKSILKENGGYGSVLEYGIKNTKTKYFLVCDPDDWLTDDALEKLHNFAKNSNLDVTVGDKYNIYSEDNKKVYIPSFKKELNVKPRVAYDTAEKKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTEAKIRDTIKIWHSIYNQLINGFELNQIETYIYFLYYEMKIILITESQLPSMSKYHTEILKIMRIMQRYNKILAKYVNNKVVPYNTNSMTGRLIFKGFMNKATYKWVERLYVKLERKREA", "perc_identity": 21.67}, "gnl|BL_ORD_ID|2260|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 8223, "orf_end": 9251, "orf_from": "BGC0000765.1|Exopolysaccharide_12 ", "model_name": "OXA-482", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "545", "model_id": "3543", "ARO_accession": "3003639", "ARO_name": "OXA-482", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.73943, "max_identities": 26, "bit_score": 27.335, "cvterm_id": "35507", "query": "DVTVGDKYN-----IYSEDNKKVYIPSFKKELNVKPRVAYDTAE---KKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTE", "match": "D+T+G+        +Y E  +++ +   +KE+    R+ +  AE   + D F    V P     K +  + ++F  ++++T         AN K +  L+E+  Y +  + G  M  K +", "sequence_from_db": "DMTLGEAMKLSAVPVYQELARRIGLDLMQKEVK---RIGFGNAEIGQQVDNFWL--VGP----LKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQ", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVINQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTAATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGACCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCCCAATTAGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 8559, "query_end": 8894, "hit_start": 345, "hit_end": 678, "orf_dna_sequence": "GTGAATCCAGATATTACTGTTATAGTTCCAATTTATAATGTTGAAAAATATATTAGAAAGTGCTTAGACAGTCTGAAAAGACAGACATACAAGAACTTTGAAGTTTGGGCAATAGATGATGGCTCTCCTGATAATTCTAAAAAGATTGTTCAAGAATATGCTGATAAAGATCCAAGATTTAAATCTATTTTAAAAGAAAATGGTGGCTATGGGTCAGTTTTAGAATATGGAATTAAGAATACAAAAACAAAATATTTTTTAGTTTGTGATCCTGATGATTGGCTAACAGATGATGCATTGGAAAAATTACATAATTTTGCAAAAAATAGTAATTTAGATGTAACTGTTGGTGATAAATATAATATTTATTCAGAAGATAATAAAAAAGTATACATTCCTAGTTTTAAAAAAGAGTTAAATGTAAAACCACGTGTTGCATATGATACGGCTGAAAAAAAGGATAGATTTATTTTTAGTGAAGTATCACCACATGCAAAATTATTTAAAACATCAATTGCAAAAAATATAGATTTTCCTCATAAGATTAGCTATACGGACACTATTTTGTATGTGTTGTCGATTGCTAATGCAAAGAGAGTAGGATATCTGGATGAAGCTCTTGCATACTACTTGATAGATCGTCCTGGTAATACTATGACAGCAAAGACTGAAGCTAAAATTAGGGATACCATTAAAATATGGCATTCCATTTATAATCAGTTGATAAATGGATTTGAGCTAAATCAAATTGAAACATATATATATTTCTTATATTATGAAATGAAAATAATACTTATTACAGAATCTCAGCTACCTTCTATGAGTAAGTATCATACTGAGATTTTAAAAATTATGAGAATAATGCAAAGATATAATAAGATATTAGCTAAATATGTGAATAATAAGGTTGTTCCATATAATACAAATTCTATGACTGGACGCTTAATATTCAAAGGATTTATGAATAAAGCAACATATAAATGGGTAGAGAGATTATATGTTAAATTAGAGAGGAAACGTGAAGCTTAA", "orf_prot_sequence": "MNPDITVIVPIYNVEKYIRKCLDSLKRQTYKNFEVWAIDDGSPDNSKKIVQEYADKDPRFKSILKENGGYGSVLEYGIKNTKTKYFLVCDPDDWLTDDALEKLHNFAKNSNLDVTVGDKYNIYSEDNKKVYIPSFKKELNVKPRVAYDTAEKKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTEAKIRDTIKIWHSIYNQLINGFELNQIETYIYFLYYEMKIILITESQLPSMSKYHTEILKIMRIMQRYNKILAKYVNNKVVPYNTNSMTGRLIFKGFMNKATYKWVERLYVKLERKREA", "perc_identity": 21.67}, "gnl|BL_ORD_ID|1049|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 8223, "orf_end": 9251, "orf_from": "BGC0000765.1|Exopolysaccharide_12 ", "model_name": "OXA-169", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "1141", "ARO_accession": "3001469", "ARO_name": "OXA-169", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.75488, "max_identities": 26, "bit_score": 27.335, "cvterm_id": "35507", "query": "DVTVGDKYN-----IYSEDNKKVYIPSFKKELNVKPRVAYDTAE---KKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTE", "match": "D+T+G+        +Y E  +++ +   +KE+    R+ +  AE   + D F    V P     K +  + ++F  ++++T         AN K +  L+E+  Y +  + G  M  K +", "sequence_from_db": "DMTLGEAMKLSAVPVYQELARRIGLDLMQKEVK---RIGFGNAEIGQQVDNFWL--VGP----LKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQ", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDERNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAGAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGACCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCCCAATTAGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 8559, "query_end": 8894, "hit_start": 345, "hit_end": 678, "orf_dna_sequence": "GTGAATCCAGATATTACTGTTATAGTTCCAATTTATAATGTTGAAAAATATATTAGAAAGTGCTTAGACAGTCTGAAAAGACAGACATACAAGAACTTTGAAGTTTGGGCAATAGATGATGGCTCTCCTGATAATTCTAAAAAGATTGTTCAAGAATATGCTGATAAAGATCCAAGATTTAAATCTATTTTAAAAGAAAATGGTGGCTATGGGTCAGTTTTAGAATATGGAATTAAGAATACAAAAACAAAATATTTTTTAGTTTGTGATCCTGATGATTGGCTAACAGATGATGCATTGGAAAAATTACATAATTTTGCAAAAAATAGTAATTTAGATGTAACTGTTGGTGATAAATATAATATTTATTCAGAAGATAATAAAAAAGTATACATTCCTAGTTTTAAAAAAGAGTTAAATGTAAAACCACGTGTTGCATATGATACGGCTGAAAAAAAGGATAGATTTATTTTTAGTGAAGTATCACCACATGCAAAATTATTTAAAACATCAATTGCAAAAAATATAGATTTTCCTCATAAGATTAGCTATACGGACACTATTTTGTATGTGTTGTCGATTGCTAATGCAAAGAGAGTAGGATATCTGGATGAAGCTCTTGCATACTACTTGATAGATCGTCCTGGTAATACTATGACAGCAAAGACTGAAGCTAAAATTAGGGATACCATTAAAATATGGCATTCCATTTATAATCAGTTGATAAATGGATTTGAGCTAAATCAAATTGAAACATATATATATTTCTTATATTATGAAATGAAAATAATACTTATTACAGAATCTCAGCTACCTTCTATGAGTAAGTATCATACTGAGATTTTAAAAATTATGAGAATAATGCAAAGATATAATAAGATATTAGCTAAATATGTGAATAATAAGGTTGTTCCATATAATACAAATTCTATGACTGGACGCTTAATATTCAAAGGATTTATGAATAAAGCAACATATAAATGGGTAGAGAGATTATATGTTAAATTAGAGAGGAAACGTGAAGCTTAA", "orf_prot_sequence": "MNPDITVIVPIYNVEKYIRKCLDSLKRQTYKNFEVWAIDDGSPDNSKKIVQEYADKDPRFKSILKENGGYGSVLEYGIKNTKTKYFLVCDPDDWLTDDALEKLHNFAKNSNLDVTVGDKYNIYSEDNKKVYIPSFKKELNVKPRVAYDTAEKKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTEAKIRDTIKIWHSIYNQLINGFELNQIETYIYFLYYEMKIILITESQLPSMSKYHTEILKIMRIMQRYNKILAKYVNNKVVPYNTNSMTGRLIFKGFMNKATYKWVERLYVKLERKREA", "perc_identity": 21.67}, "gnl|BL_ORD_ID|624|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 8223, "orf_end": 9251, "orf_from": "BGC0000765.1|Exopolysaccharide_12 ", "model_name": "OXA-171", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "677", "ARO_accession": "3001471", "ARO_name": "OXA-171", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.77047, "max_identities": 26, "bit_score": 27.335, "cvterm_id": "35507", "query": "DVTVGDKYN-----IYSEDNKKVYIPSFKKELNVKPRVAYDTAE---KKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTE", "match": "D+T+G+        +Y E  +++ +   +KE+    R+ +  AE   + D F    V P     K +  + ++F  ++++T         AN K +  L+E+  Y +  + G  M  K +", "sequence_from_db": "DMTLGEAMKLSAVPVYQELARRIGLDLMQKEVK---RIGFGNAEIGQQVDNFWL--VGP----LKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQ", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASTRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGACCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCCCAATTAGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCGGCATCTACACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 8559, "query_end": 8894, "hit_start": 345, "hit_end": 678, "orf_dna_sequence": "GTGAATCCAGATATTACTGTTATAGTTCCAATTTATAATGTTGAAAAATATATTAGAAAGTGCTTAGACAGTCTGAAAAGACAGACATACAAGAACTTTGAAGTTTGGGCAATAGATGATGGCTCTCCTGATAATTCTAAAAAGATTGTTCAAGAATATGCTGATAAAGATCCAAGATTTAAATCTATTTTAAAAGAAAATGGTGGCTATGGGTCAGTTTTAGAATATGGAATTAAGAATACAAAAACAAAATATTTTTTAGTTTGTGATCCTGATGATTGGCTAACAGATGATGCATTGGAAAAATTACATAATTTTGCAAAAAATAGTAATTTAGATGTAACTGTTGGTGATAAATATAATATTTATTCAGAAGATAATAAAAAAGTATACATTCCTAGTTTTAAAAAAGAGTTAAATGTAAAACCACGTGTTGCATATGATACGGCTGAAAAAAAGGATAGATTTATTTTTAGTGAAGTATCACCACATGCAAAATTATTTAAAACATCAATTGCAAAAAATATAGATTTTCCTCATAAGATTAGCTATACGGACACTATTTTGTATGTGTTGTCGATTGCTAATGCAAAGAGAGTAGGATATCTGGATGAAGCTCTTGCATACTACTTGATAGATCGTCCTGGTAATACTATGACAGCAAAGACTGAAGCTAAAATTAGGGATACCATTAAAATATGGCATTCCATTTATAATCAGTTGATAAATGGATTTGAGCTAAATCAAATTGAAACATATATATATTTCTTATATTATGAAATGAAAATAATACTTATTACAGAATCTCAGCTACCTTCTATGAGTAAGTATCATACTGAGATTTTAAAAATTATGAGAATAATGCAAAGATATAATAAGATATTAGCTAAATATGTGAATAATAAGGTTGTTCCATATAATACAAATTCTATGACTGGACGCTTAATATTCAAAGGATTTATGAATAAAGCAACATATAAATGGGTAGAGAGATTATATGTTAAATTAGAGAGGAAACGTGAAGCTTAA", "orf_prot_sequence": "MNPDITVIVPIYNVEKYIRKCLDSLKRQTYKNFEVWAIDDGSPDNSKKIVQEYADKDPRFKSILKENGGYGSVLEYGIKNTKTKYFLVCDPDDWLTDDALEKLHNFAKNSNLDVTVGDKYNIYSEDNKKVYIPSFKKELNVKPRVAYDTAEKKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTEAKIRDTIKIWHSIYNQLINGFELNQIETYIYFLYYEMKIILITESQLPSMSKYHTEILKIMRIMQRYNKILAKYVNNKVVPYNTNSMTGRLIFKGFMNKATYKWVERLYVKLERKREA", "perc_identity": 21.67}, "gnl|BL_ORD_ID|4120|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 8223, "orf_end": 9251, "orf_from": "BGC0000765.1|Exopolysaccharide_12 ", "model_name": "OXA-893", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "5190", "ARO_accession": "3006085", "ARO_name": "OXA-893", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.81809, "max_identities": 26, "bit_score": 27.335, "cvterm_id": "35507", "query": "DVTVGDKYN-----IYSEDNKKVYIPSFKKELNVKPRVAYDTAE---KKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTE", "match": "D+T+G+        +Y E  +++ +   +KE+    R+ +  AE   + D F    V P     K +  + ++F  ++++T         AN K +  L+E+  Y +  + G  M  K +", "sequence_from_db": "DMTLGEAMKLSAVPVYQELARRIGLDLMQKEVK---RIGFGNAEIGQQVDNFWL--VGP----LKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQ", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNVLLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGACCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCCCAATTAGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGTATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 8559, "query_end": 8894, "hit_start": 345, "hit_end": 678, "orf_dna_sequence": "GTGAATCCAGATATTACTGTTATAGTTCCAATTTATAATGTTGAAAAATATATTAGAAAGTGCTTAGACAGTCTGAAAAGACAGACATACAAGAACTTTGAAGTTTGGGCAATAGATGATGGCTCTCCTGATAATTCTAAAAAGATTGTTCAAGAATATGCTGATAAAGATCCAAGATTTAAATCTATTTTAAAAGAAAATGGTGGCTATGGGTCAGTTTTAGAATATGGAATTAAGAATACAAAAACAAAATATTTTTTAGTTTGTGATCCTGATGATTGGCTAACAGATGATGCATTGGAAAAATTACATAATTTTGCAAAAAATAGTAATTTAGATGTAACTGTTGGTGATAAATATAATATTTATTCAGAAGATAATAAAAAAGTATACATTCCTAGTTTTAAAAAAGAGTTAAATGTAAAACCACGTGTTGCATATGATACGGCTGAAAAAAAGGATAGATTTATTTTTAGTGAAGTATCACCACATGCAAAATTATTTAAAACATCAATTGCAAAAAATATAGATTTTCCTCATAAGATTAGCTATACGGACACTATTTTGTATGTGTTGTCGATTGCTAATGCAAAGAGAGTAGGATATCTGGATGAAGCTCTTGCATACTACTTGATAGATCGTCCTGGTAATACTATGACAGCAAAGACTGAAGCTAAAATTAGGGATACCATTAAAATATGGCATTCCATTTATAATCAGTTGATAAATGGATTTGAGCTAAATCAAATTGAAACATATATATATTTCTTATATTATGAAATGAAAATAATACTTATTACAGAATCTCAGCTACCTTCTATGAGTAAGTATCATACTGAGATTTTAAAAATTATGAGAATAATGCAAAGATATAATAAGATATTAGCTAAATATGTGAATAATAAGGTTGTTCCATATAATACAAATTCTATGACTGGACGCTTAATATTCAAAGGATTTATGAATAAAGCAACATATAAATGGGTAGAGAGATTATATGTTAAATTAGAGAGGAAACGTGAAGCTTAA", "orf_prot_sequence": "MNPDITVIVPIYNVEKYIRKCLDSLKRQTYKNFEVWAIDDGSPDNSKKIVQEYADKDPRFKSILKENGGYGSVLEYGIKNTKTKYFLVCDPDDWLTDDALEKLHNFAKNSNLDVTVGDKYNIYSEDNKKVYIPSFKKELNVKPRVAYDTAEKKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTEAKIRDTIKIWHSIYNQLINGFELNQIETYIYFLYYEMKIILITESQLPSMSKYHTEILKIMRIMQRYNKILAKYVNNKVVPYNTNSMTGRLIFKGFMNKATYKWVERLYVKLERKREA", "perc_identity": 21.67}, "gnl|BL_ORD_ID|4047|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 8223, "orf_end": 9251, "orf_from": "BGC0000765.1|Exopolysaccharide_12 ", "model_name": "OXA-813", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "5117", "ARO_accession": "3006012", "ARO_name": "OXA-813", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.85053, "max_identities": 26, "bit_score": 27.335, "cvterm_id": "37046", "query": "DVTVGDKYN-----IYSEDNKKVYIPSFKKELNVKPRVAYDTAE---KKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTE", "match": "D+T+G+        +Y E  +++ +   +KE+    R+ +  AE   + D F    V P     K +  + ++F  ++++T         AN K +  L+E+  Y +  + G  M  K +", "sequence_from_db": "DMTLGEAMKLSAVPVYQELARRIGLDLMQKEVK---RIGFGNAEIGQQVDNFWL--VGP----LKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQ", "sequence_from_broadstreet": "MNKYFTCYVFASLFLSGCTVQHNLINETPSQIAQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGTTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGCTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTGTATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCCGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGGCCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCTCAATTGGCGCATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 8559, "query_end": 8894, "hit_start": 345, "hit_end": 678, "orf_dna_sequence": "GTGAATCCAGATATTACTGTTATAGTTCCAATTTATAATGTTGAAAAATATATTAGAAAGTGCTTAGACAGTCTGAAAAGACAGACATACAAGAACTTTGAAGTTTGGGCAATAGATGATGGCTCTCCTGATAATTCTAAAAAGATTGTTCAAGAATATGCTGATAAAGATCCAAGATTTAAATCTATTTTAAAAGAAAATGGTGGCTATGGGTCAGTTTTAGAATATGGAATTAAGAATACAAAAACAAAATATTTTTTAGTTTGTGATCCTGATGATTGGCTAACAGATGATGCATTGGAAAAATTACATAATTTTGCAAAAAATAGTAATTTAGATGTAACTGTTGGTGATAAATATAATATTTATTCAGAAGATAATAAAAAAGTATACATTCCTAGTTTTAAAAAAGAGTTAAATGTAAAACCACGTGTTGCATATGATACGGCTGAAAAAAAGGATAGATTTATTTTTAGTGAAGTATCACCACATGCAAAATTATTTAAAACATCAATTGCAAAAAATATAGATTTTCCTCATAAGATTAGCTATACGGACACTATTTTGTATGTGTTGTCGATTGCTAATGCAAAGAGAGTAGGATATCTGGATGAAGCTCTTGCATACTACTTGATAGATCGTCCTGGTAATACTATGACAGCAAAGACTGAAGCTAAAATTAGGGATACCATTAAAATATGGCATTCCATTTATAATCAGTTGATAAATGGATTTGAGCTAAATCAAATTGAAACATATATATATTTCTTATATTATGAAATGAAAATAATACTTATTACAGAATCTCAGCTACCTTCTATGAGTAAGTATCATACTGAGATTTTAAAAATTATGAGAATAATGCAAAGATATAATAAGATATTAGCTAAATATGTGAATAATAAGGTTGTTCCATATAATACAAATTCTATGACTGGACGCTTAATATTCAAAGGATTTATGAATAAAGCAACATATAAATGGGTAGAGAGATTATATGTTAAATTAGAGAGGAAACGTGAAGCTTAA", "orf_prot_sequence": "MNPDITVIVPIYNVEKYIRKCLDSLKRQTYKNFEVWAIDDGSPDNSKKIVQEYADKDPRFKSILKENGGYGSVLEYGIKNTKTKYFLVCDPDDWLTDDALEKLHNFAKNSNLDVTVGDKYNIYSEDNKKVYIPSFKKELNVKPRVAYDTAEKKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTEAKIRDTIKIWHSIYNQLINGFELNQIETYIYFLYYEMKIILITESQLPSMSKYHTEILKIMRIMQRYNKILAKYVNNKVVPYNTNSMTGRLIFKGFMNKATYKWVERLYVKLERKREA", "perc_identity": 21.67}, "gnl|BL_ORD_ID|4046|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 8223, "orf_end": 9251, "orf_from": "BGC0000765.1|Exopolysaccharide_12 ", "model_name": "OXA-811", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "5116", "ARO_accession": "3006011", "ARO_name": "OXA-811", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.85053, "max_identities": 26, "bit_score": 27.335, "cvterm_id": "39672", "query": "DVTVGDKYN-----IYSEDNKKVYIPSFKKELNVKPRVAYDTAE---KKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTE", "match": "D+T+G+        +Y E  +++ +   +KE+    R+ +  AE   + D F    V P     K +  + ++F  ++++T         AN K +  L+E+  Y +  + G  M  K +", "sequence_from_db": "DMTLGEAMKLSAVPVYQELARRIGLDLMQKEVK---RIGFGNAEIGQQVDNFWL--VGP----LKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQ", "sequence_from_broadstreet": "MNKYFTCYVFASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVAFALNMEMRSGMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGTTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTGTATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGACTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGGCCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCTCAATTGGCGCATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTACTTCTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCACTAAATATGGAAATGCGGTCAGGAATGCCTGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 8559, "query_end": 8894, "hit_start": 345, "hit_end": 678, "orf_dna_sequence": "GTGAATCCAGATATTACTGTTATAGTTCCAATTTATAATGTTGAAAAATATATTAGAAAGTGCTTAGACAGTCTGAAAAGACAGACATACAAGAACTTTGAAGTTTGGGCAATAGATGATGGCTCTCCTGATAATTCTAAAAAGATTGTTCAAGAATATGCTGATAAAGATCCAAGATTTAAATCTATTTTAAAAGAAAATGGTGGCTATGGGTCAGTTTTAGAATATGGAATTAAGAATACAAAAACAAAATATTTTTTAGTTTGTGATCCTGATGATTGGCTAACAGATGATGCATTGGAAAAATTACATAATTTTGCAAAAAATAGTAATTTAGATGTAACTGTTGGTGATAAATATAATATTTATTCAGAAGATAATAAAAAAGTATACATTCCTAGTTTTAAAAAAGAGTTAAATGTAAAACCACGTGTTGCATATGATACGGCTGAAAAAAAGGATAGATTTATTTTTAGTGAAGTATCACCACATGCAAAATTATTTAAAACATCAATTGCAAAAAATATAGATTTTCCTCATAAGATTAGCTATACGGACACTATTTTGTATGTGTTGTCGATTGCTAATGCAAAGAGAGTAGGATATCTGGATGAAGCTCTTGCATACTACTTGATAGATCGTCCTGGTAATACTATGACAGCAAAGACTGAAGCTAAAATTAGGGATACCATTAAAATATGGCATTCCATTTATAATCAGTTGATAAATGGATTTGAGCTAAATCAAATTGAAACATATATATATTTCTTATATTATGAAATGAAAATAATACTTATTACAGAATCTCAGCTACCTTCTATGAGTAAGTATCATACTGAGATTTTAAAAATTATGAGAATAATGCAAAGATATAATAAGATATTAGCTAAATATGTGAATAATAAGGTTGTTCCATATAATACAAATTCTATGACTGGACGCTTAATATTCAAAGGATTTATGAATAAAGCAACATATAAATGGGTAGAGAGATTATATGTTAAATTAGAGAGGAAACGTGAAGCTTAA", "orf_prot_sequence": "MNPDITVIVPIYNVEKYIRKCLDSLKRQTYKNFEVWAIDDGSPDNSKKIVQEYADKDPRFKSILKENGGYGSVLEYGIKNTKTKYFLVCDPDDWLTDDALEKLHNFAKNSNLDVTVGDKYNIYSEDNKKVYIPSFKKELNVKPRVAYDTAEKKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTEAKIRDTIKIWHSIYNQLINGFELNQIETYIYFLYYEMKIILITESQLPSMSKYHTEILKIMRIMQRYNKILAKYVNNKVVPYNTNSMTGRLIFKGFMNKATYKWVERLYVKLERKREA", "perc_identity": 21.67}, "gnl|BL_ORD_ID|4133|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 8223, "orf_end": 9251, "orf_from": "BGC0000765.1|Exopolysaccharide_12 ", "model_name": "OXA-911", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "5203", "ARO_accession": "3006098", "ARO_name": "OXA-911", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.09752, "max_identities": 26, "bit_score": 26.9498, "cvterm_id": "35507", "query": "DVTVGDKYN-----IYSEDNKKVYIPSFKKELNVKPRVAYDTAE---KKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAK", "match": "D+T+G+        +Y E  +++ +   +KE+    R+ +  AE   + D F    V P     K +  + ++F  ++++T         AN K +  L+E+  Y +  + G  M  K", "sequence_from_db": "DMTLGEAMKLSAVPVYQELARRIGLDLMQKEVK---RIGFGNAEIGQQVDNFWL--VGP----LKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIK", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGACCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCCCAATTAGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGGATATAAAAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 8559, "query_end": 8888, "hit_start": 345, "hit_end": 672, "orf_dna_sequence": "GTGAATCCAGATATTACTGTTATAGTTCCAATTTATAATGTTGAAAAATATATTAGAAAGTGCTTAGACAGTCTGAAAAGACAGACATACAAGAACTTTGAAGTTTGGGCAATAGATGATGGCTCTCCTGATAATTCTAAAAAGATTGTTCAAGAATATGCTGATAAAGATCCAAGATTTAAATCTATTTTAAAAGAAAATGGTGGCTATGGGTCAGTTTTAGAATATGGAATTAAGAATACAAAAACAAAATATTTTTTAGTTTGTGATCCTGATGATTGGCTAACAGATGATGCATTGGAAAAATTACATAATTTTGCAAAAAATAGTAATTTAGATGTAACTGTTGGTGATAAATATAATATTTATTCAGAAGATAATAAAAAAGTATACATTCCTAGTTTTAAAAAAGAGTTAAATGTAAAACCACGTGTTGCATATGATACGGCTGAAAAAAAGGATAGATTTATTTTTAGTGAAGTATCACCACATGCAAAATTATTTAAAACATCAATTGCAAAAAATATAGATTTTCCTCATAAGATTAGCTATACGGACACTATTTTGTATGTGTTGTCGATTGCTAATGCAAAGAGAGTAGGATATCTGGATGAAGCTCTTGCATACTACTTGATAGATCGTCCTGGTAATACTATGACAGCAAAGACTGAAGCTAAAATTAGGGATACCATTAAAATATGGCATTCCATTTATAATCAGTTGATAAATGGATTTGAGCTAAATCAAATTGAAACATATATATATTTCTTATATTATGAAATGAAAATAATACTTATTACAGAATCTCAGCTACCTTCTATGAGTAAGTATCATACTGAGATTTTAAAAATTATGAGAATAATGCAAAGATATAATAAGATATTAGCTAAATATGTGAATAATAAGGTTGTTCCATATAATACAAATTCTATGACTGGACGCTTAATATTCAAAGGATTTATGAATAAAGCAACATATAAATGGGTAGAGAGATTATATGTTAAATTAGAGAGGAAACGTGAAGCTTAA", "orf_prot_sequence": "MNPDITVIVPIYNVEKYIRKCLDSLKRQTYKNFEVWAIDDGSPDNSKKIVQEYADKDPRFKSILKENGGYGSVLEYGIKNTKTKYFLVCDPDDWLTDDALEKLHNFAKNSNLDVTVGDKYNIYSEDNKKVYIPSFKKELNVKPRVAYDTAEKKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTEAKIRDTIKIWHSIYNQLINGFELNQIETYIYFLYYEMKIILITESQLPSMSKYHTEILKIMRIMQRYNKILAKYVNNKVVPYNTNSMTGRLIFKGFMNKATYKWVERLYVKLERKREA", "perc_identity": 22.03}, "gnl|BL_ORD_ID|4045|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 8223, "orf_end": 9251, "orf_from": "BGC0000765.1|Exopolysaccharide_12 ", "model_name": "OXA-810", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "5115", "ARO_accession": "3006010", "ARO_name": "OXA-810", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.13681, "max_identities": 26, "bit_score": 26.1794, "cvterm_id": "39672", "query": "DVTVGDKYN-----IYSEDNKKVYIPSFKKELNVKPRVAYDTAE---KKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTE", "match": "D+T+G+        +Y E  +++ +   +KE+    R+ +  AE   + D F    V P     K +  + ++F  ++++T         AN K +  L+E   Y +  + G  M  K +", "sequence_from_db": "DMTLGEAMKLSAVPVYQELARRIGLDLMQKEVK---RIGFGNAEIGQQVDNFWL--VGP----LKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEENNGYKIFGKTGWAMDIKPQ", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEENNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGACCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCCCAATTAGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTACTTCTAGAAGAGAATAATGGCTACAAGATTTTTGGAAAGACTGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTAAATATTATTTAA", "partial": "0", "query_start": 8559, "query_end": 8894, "hit_start": 345, "hit_end": 678, "orf_dna_sequence": "GTGAATCCAGATATTACTGTTATAGTTCCAATTTATAATGTTGAAAAATATATTAGAAAGTGCTTAGACAGTCTGAAAAGACAGACATACAAGAACTTTGAAGTTTGGGCAATAGATGATGGCTCTCCTGATAATTCTAAAAAGATTGTTCAAGAATATGCTGATAAAGATCCAAGATTTAAATCTATTTTAAAAGAAAATGGTGGCTATGGGTCAGTTTTAGAATATGGAATTAAGAATACAAAAACAAAATATTTTTTAGTTTGTGATCCTGATGATTGGCTAACAGATGATGCATTGGAAAAATTACATAATTTTGCAAAAAATAGTAATTTAGATGTAACTGTTGGTGATAAATATAATATTTATTCAGAAGATAATAAAAAAGTATACATTCCTAGTTTTAAAAAAGAGTTAAATGTAAAACCACGTGTTGCATATGATACGGCTGAAAAAAAGGATAGATTTATTTTTAGTGAAGTATCACCACATGCAAAATTATTTAAAACATCAATTGCAAAAAATATAGATTTTCCTCATAAGATTAGCTATACGGACACTATTTTGTATGTGTTGTCGATTGCTAATGCAAAGAGAGTAGGATATCTGGATGAAGCTCTTGCATACTACTTGATAGATCGTCCTGGTAATACTATGACAGCAAAGACTGAAGCTAAAATTAGGGATACCATTAAAATATGGCATTCCATTTATAATCAGTTGATAAATGGATTTGAGCTAAATCAAATTGAAACATATATATATTTCTTATATTATGAAATGAAAATAATACTTATTACAGAATCTCAGCTACCTTCTATGAGTAAGTATCATACTGAGATTTTAAAAATTATGAGAATAATGCAAAGATATAATAAGATATTAGCTAAATATGTGAATAATAAGGTTGTTCCATATAATACAAATTCTATGACTGGACGCTTAATATTCAAAGGATTTATGAATAAAGCAACATATAAATGGGTAGAGAGATTATATGTTAAATTAGAGAGGAAACGTGAAGCTTAA", "orf_prot_sequence": "MNPDITVIVPIYNVEKYIRKCLDSLKRQTYKNFEVWAIDDGSPDNSKKIVQEYADKDPRFKSILKENGGYGSVLEYGIKNTKTKYFLVCDPDDWLTDDALEKLHNFAKNSNLDVTVGDKYNIYSEDNKKVYIPSFKKELNVKPRVAYDTAEKKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTEAKIRDTIKIWHSIYNQLINGFELNQIETYIYFLYYEMKIILITESQLPSMSKYHTEILKIMRIMQRYNKILAKYVNNKVVPYNTNSMTGRLIFKGFMNKATYKWVERLYVKLERKREA", "perc_identity": 21.67}, "gnl|BL_ORD_ID|1545|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 8223, "orf_end": 9251, "orf_from": "BGC0000765.1|Exopolysaccharide_12 ", "model_name": "OXA-49", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "1679", "ARO_accession": "3001671", "ARO_name": "OXA-49", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.6465, "max_identities": 24, "bit_score": 26.1794, "cvterm_id": "35507", "query": "DVTVGDKYN-----IYSEDNKKVYIPSFKKELNVKPRVAYDTAE---KKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPG", "match": "D+T+G+        +Y E  +++ +   +KE+    R+ +  AE   + D F    V P     K +  + ++F  ++++T         AN K +  L+E+  Y +  + G", "sequence_from_db": "DMTLGEAMKLSAVPVYQELARRIGLDLMQKEVE---RIGFGNAEIGQQVDNFWL--VGP----LKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTG", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVERIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAAMDIKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAGAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGACCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCCCAATTAGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 8559, "query_end": 8870, "hit_start": 345, "hit_end": 654, "orf_dna_sequence": "GTGAATCCAGATATTACTGTTATAGTTCCAATTTATAATGTTGAAAAATATATTAGAAAGTGCTTAGACAGTCTGAAAAGACAGACATACAAGAACTTTGAAGTTTGGGCAATAGATGATGGCTCTCCTGATAATTCTAAAAAGATTGTTCAAGAATATGCTGATAAAGATCCAAGATTTAAATCTATTTTAAAAGAAAATGGTGGCTATGGGTCAGTTTTAGAATATGGAATTAAGAATACAAAAACAAAATATTTTTTAGTTTGTGATCCTGATGATTGGCTAACAGATGATGCATTGGAAAAATTACATAATTTTGCAAAAAATAGTAATTTAGATGTAACTGTTGGTGATAAATATAATATTTATTCAGAAGATAATAAAAAAGTATACATTCCTAGTTTTAAAAAAGAGTTAAATGTAAAACCACGTGTTGCATATGATACGGCTGAAAAAAAGGATAGATTTATTTTTAGTGAAGTATCACCACATGCAAAATTATTTAAAACATCAATTGCAAAAAATATAGATTTTCCTCATAAGATTAGCTATACGGACACTATTTTGTATGTGTTGTCGATTGCTAATGCAAAGAGAGTAGGATATCTGGATGAAGCTCTTGCATACTACTTGATAGATCGTCCTGGTAATACTATGACAGCAAAGACTGAAGCTAAAATTAGGGATACCATTAAAATATGGCATTCCATTTATAATCAGTTGATAAATGGATTTGAGCTAAATCAAATTGAAACATATATATATTTCTTATATTATGAAATGAAAATAATACTTATTACAGAATCTCAGCTACCTTCTATGAGTAAGTATCATACTGAGATTTTAAAAATTATGAGAATAATGCAAAGATATAATAAGATATTAGCTAAATATGTGAATAATAAGGTTGTTCCATATAATACAAATTCTATGACTGGACGCTTAATATTCAAAGGATTTATGAATAAAGCAACATATAAATGGGTAGAGAGATTATATGTTAAATTAGAGAGGAAACGTGAAGCTTAA", "orf_prot_sequence": "MNPDITVIVPIYNVEKYIRKCLDSLKRQTYKNFEVWAIDDGSPDNSKKIVQEYADKDPRFKSILKENGGYGSVLEYGIKNTKTKYFLVCDPDDWLTDDALEKLHNFAKNSNLDVTVGDKYNIYSEDNKKVYIPSFKKELNVKPRVAYDTAEKKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTEAKIRDTIKIWHSIYNQLINGFELNQIETYIYFLYYEMKIILITESQLPSMSKYHTEILKIMRIMQRYNKILAKYVNNKVVPYNTNSMTGRLIFKGFMNKATYKWVERLYVKLERKREA", "perc_identity": 21.43}, "gnl|BL_ORD_ID|1632|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 8223, "orf_end": 9251, "orf_from": "BGC0000765.1|Exopolysaccharide_12 ", "model_name": "OXA-146", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "1780", "ARO_accession": "3001779", "ARO_name": "OXA-146", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.21181, "max_identities": 24, "bit_score": 25.7942, "cvterm_id": "35507", "query": "DVTVGDKYN-----IYSEDNKKVYIPSFKKELNVKPRVAYDTAE---KKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPG", "match": "D+T+G+        +Y E  +++ +   +KE+    R+ +  AE   + D F    V P     K +  + ++F  ++++T         AN K +  L+E+  Y +  + G", "sequence_from_db": "DMTLGEAMKLSAVPVYQELARRIGLDLMQKEVK---RIGFGNAEIGQQVDNFWL--VGP----LKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTG", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAAMDIKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGACCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCCCAATTAGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAGAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 8559, "query_end": 8870, "hit_start": 345, "hit_end": 654, "orf_dna_sequence": "GTGAATCCAGATATTACTGTTATAGTTCCAATTTATAATGTTGAAAAATATATTAGAAAGTGCTTAGACAGTCTGAAAAGACAGACATACAAGAACTTTGAAGTTTGGGCAATAGATGATGGCTCTCCTGATAATTCTAAAAAGATTGTTCAAGAATATGCTGATAAAGATCCAAGATTTAAATCTATTTTAAAAGAAAATGGTGGCTATGGGTCAGTTTTAGAATATGGAATTAAGAATACAAAAACAAAATATTTTTTAGTTTGTGATCCTGATGATTGGCTAACAGATGATGCATTGGAAAAATTACATAATTTTGCAAAAAATAGTAATTTAGATGTAACTGTTGGTGATAAATATAATATTTATTCAGAAGATAATAAAAAAGTATACATTCCTAGTTTTAAAAAAGAGTTAAATGTAAAACCACGTGTTGCATATGATACGGCTGAAAAAAAGGATAGATTTATTTTTAGTGAAGTATCACCACATGCAAAATTATTTAAAACATCAATTGCAAAAAATATAGATTTTCCTCATAAGATTAGCTATACGGACACTATTTTGTATGTGTTGTCGATTGCTAATGCAAAGAGAGTAGGATATCTGGATGAAGCTCTTGCATACTACTTGATAGATCGTCCTGGTAATACTATGACAGCAAAGACTGAAGCTAAAATTAGGGATACCATTAAAATATGGCATTCCATTTATAATCAGTTGATAAATGGATTTGAGCTAAATCAAATTGAAACATATATATATTTCTTATATTATGAAATGAAAATAATACTTATTACAGAATCTCAGCTACCTTCTATGAGTAAGTATCATACTGAGATTTTAAAAATTATGAGAATAATGCAAAGATATAATAAGATATTAGCTAAATATGTGAATAATAAGGTTGTTCCATATAATACAAATTCTATGACTGGACGCTTAATATTCAAAGGATTTATGAATAAAGCAACATATAAATGGGTAGAGAGATTATATGTTAAATTAGAGAGGAAACGTGAAGCTTAA", "orf_prot_sequence": "MNPDITVIVPIYNVEKYIRKCLDSLKRQTYKNFEVWAIDDGSPDNSKKIVQEYADKDPRFKSILKENGGYGSVLEYGIKNTKTKYFLVCDPDDWLTDDALEKLHNFAKNSNLDVTVGDKYNIYSEDNKKVYIPSFKKELNVKPRVAYDTAEKKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTEAKIRDTIKIWHSIYNQLINGFELNQIETYIYFLYYEMKIILITESQLPSMSKYHTEILKIMRIMQRYNKILAKYVNNKVVPYNTNSMTGRLIFKGFMNKATYKWVERLYVKLERKREA", "perc_identity": 21.43}, "gnl|BL_ORD_ID|2297|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 8223, "orf_end": 9251, "orf_from": "BGC0000765.1|Exopolysaccharide_12 ", "model_name": "OXA-103", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "3407", "ARO_accession": "3001707", "ARO_name": "OXA-103", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.78375, "max_identities": 25, "bit_score": 25.409, "cvterm_id": "42784", "query": "DVTVGDKYN-----IYSEDNKKVYIPSFKKELNVKPRVAYDTAE---KKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTE", "match": "D+T+G+        +Y E  +++ +   +KE+    R+ +  AE   + D F    + P     K +  + ++F  ++++T         AN K +  L+E+  Y +  + G  M  K +", "sequence_from_db": "DMTLGEAMKLSAVPVYQELARRIGLDLMQKEVE---RIDFGNAEIGQQVDNFWL--IGP----LKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQ", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVERIDFGNAEIGQQVDNFWLIGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCAAGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAGAACGTATTGATTTCGGTAATGCTGAAATTGGACAGCAGGTTGACAATTTCTGGTTGATAGGCCCATTAAAGGTCACGCCTATTCAAGAGGTAGAGTTTGTTTCTCAATTGGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTACTTCTAGAAGAGAGTAATGGCTACAAGATTTTTGGAAAGACTGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCTGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 8559, "query_end": 8894, "hit_start": 345, "hit_end": 678, "orf_dna_sequence": "GTGAATCCAGATATTACTGTTATAGTTCCAATTTATAATGTTGAAAAATATATTAGAAAGTGCTTAGACAGTCTGAAAAGACAGACATACAAGAACTTTGAAGTTTGGGCAATAGATGATGGCTCTCCTGATAATTCTAAAAAGATTGTTCAAGAATATGCTGATAAAGATCCAAGATTTAAATCTATTTTAAAAGAAAATGGTGGCTATGGGTCAGTTTTAGAATATGGAATTAAGAATACAAAAACAAAATATTTTTTAGTTTGTGATCCTGATGATTGGCTAACAGATGATGCATTGGAAAAATTACATAATTTTGCAAAAAATAGTAATTTAGATGTAACTGTTGGTGATAAATATAATATTTATTCAGAAGATAATAAAAAAGTATACATTCCTAGTTTTAAAAAAGAGTTAAATGTAAAACCACGTGTTGCATATGATACGGCTGAAAAAAAGGATAGATTTATTTTTAGTGAAGTATCACCACATGCAAAATTATTTAAAACATCAATTGCAAAAAATATAGATTTTCCTCATAAGATTAGCTATACGGACACTATTTTGTATGTGTTGTCGATTGCTAATGCAAAGAGAGTAGGATATCTGGATGAAGCTCTTGCATACTACTTGATAGATCGTCCTGGTAATACTATGACAGCAAAGACTGAAGCTAAAATTAGGGATACCATTAAAATATGGCATTCCATTTATAATCAGTTGATAAATGGATTTGAGCTAAATCAAATTGAAACATATATATATTTCTTATATTATGAAATGAAAATAATACTTATTACAGAATCTCAGCTACCTTCTATGAGTAAGTATCATACTGAGATTTTAAAAATTATGAGAATAATGCAAAGATATAATAAGATATTAGCTAAATATGTGAATAATAAGGTTGTTCCATATAATACAAATTCTATGACTGGACGCTTAATATTCAAAGGATTTATGAATAAAGCAACATATAAATGGGTAGAGAGATTATATGTTAAATTAGAGAGGAAACGTGAAGCTTAA", "orf_prot_sequence": "MNPDITVIVPIYNVEKYIRKCLDSLKRQTYKNFEVWAIDDGSPDNSKKIVQEYADKDPRFKSILKENGGYGSVLEYGIKNTKTKYFLVCDPDDWLTDDALEKLHNFAKNSNLDVTVGDKYNIYSEDNKKVYIPSFKKELNVKPRVAYDTAEKKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTEAKIRDTIKIWHSIYNQLINGFELNQIETYIYFLYYEMKIILITESQLPSMSKYHTEILKIMRIMQRYNKILAKYVNNKVVPYNTNSMTGRLIFKGFMNKATYKWVERLYVKLERKREA", "perc_identity": 20.83}, "gnl|BL_ORD_ID|1222|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 8223, "orf_end": 9251, "orf_from": "BGC0000765.1|Exopolysaccharide_12 ", "model_name": "OXA-170", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "1326", "ARO_accession": "3001470", "ARO_name": "OXA-170", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.9046, "max_identities": 25, "bit_score": 25.409, "cvterm_id": "35507", "query": "DVTVGDKYN-----IYSEDNKKVYIPSFKKELNVKPRVAYDTAE---KKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTE", "match": "D+T+G+        +Y E  +++ +   +KE+    R+ +  AE   + D F    V P     K +  + ++F  ++++T         AN K +  L+++  Y +  + G  M  K +", "sequence_from_db": "DMTLGEAMKLSAVPVYQELARRIGLDLMQKEVK---RIGFGNAEIGQQVDNFWL--VGP----LKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEKSNGYKIFGKTGWAMDIKPQ", "sequence_from_broadstreet": "MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEKSNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII", "dna_sequence_from_broadstreet": "ATGAATAAATATTTTACTTGCTATGTGGTTGCTTCTCTTTTTCTTTCTGGTTGTACGGTTCAGCATAATTTAATAAATGAAACCCCGAGTCAGATTGTTCAAGGACATAATCAGGTGATTCATCAATACTTTGATGAAAAAAACACCTCAGGTGTGCTGGTTATTCAAACAGATAAAAAAATTAATCTATATGGTAATGCTCTAAGCCGCGCAAATACAGAATATGTGCCAGCCTCTACATTTAAAATGTTGAATGCCCTGATCGGATTGGAGAACCAGAAAACGGATATTAATGAAATATTTAAATGGAAGGGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAGTCCCAGTCTATCAGGAACTTGCGCGACGTATCGGTCTTGATCTCATGCAAAAAGAAGTAAAACGTATTGGTTTCGGTAATGCTGAAATTGGACAGCAGGTTGATAATTTCTGGTTGGTAGGACCATTAAAGGTTACGCCTATTCAAGAGGTAGAGTTTGTTTCCCAATTAGCACATACACAGCTTCCATTTAGTGAAAAAGTGCAGGCTAATGTAAAAAATATGCTTCTTTTAGAAAAGAGTAATGGCTACAAAATTTTTGGAAAGACTGGTTGGGCAATGGATATAAAACCACAAGTGGGCTGGTTGACCGGCTGGGTTGAGCAGCCAGATGGAAAAATTGTCGCTTTTGCATTAAATATGGAAATGCGGTCAGAAATGCCGGCATCTATACGTAATGAATTATTGATGAAATCATTAAAACAGCTGAATATTATTTAA", "partial": "0", "query_start": 8559, "query_end": 8894, "hit_start": 345, "hit_end": 678, "orf_dna_sequence": "GTGAATCCAGATATTACTGTTATAGTTCCAATTTATAATGTTGAAAAATATATTAGAAAGTGCTTAGACAGTCTGAAAAGACAGACATACAAGAACTTTGAAGTTTGGGCAATAGATGATGGCTCTCCTGATAATTCTAAAAAGATTGTTCAAGAATATGCTGATAAAGATCCAAGATTTAAATCTATTTTAAAAGAAAATGGTGGCTATGGGTCAGTTTTAGAATATGGAATTAAGAATACAAAAACAAAATATTTTTTAGTTTGTGATCCTGATGATTGGCTAACAGATGATGCATTGGAAAAATTACATAATTTTGCAAAAAATAGTAATTTAGATGTAACTGTTGGTGATAAATATAATATTTATTCAGAAGATAATAAAAAAGTATACATTCCTAGTTTTAAAAAAGAGTTAAATGTAAAACCACGTGTTGCATATGATACGGCTGAAAAAAAGGATAGATTTATTTTTAGTGAAGTATCACCACATGCAAAATTATTTAAAACATCAATTGCAAAAAATATAGATTTTCCTCATAAGATTAGCTATACGGACACTATTTTGTATGTGTTGTCGATTGCTAATGCAAAGAGAGTAGGATATCTGGATGAAGCTCTTGCATACTACTTGATAGATCGTCCTGGTAATACTATGACAGCAAAGACTGAAGCTAAAATTAGGGATACCATTAAAATATGGCATTCCATTTATAATCAGTTGATAAATGGATTTGAGCTAAATCAAATTGAAACATATATATATTTCTTATATTATGAAATGAAAATAATACTTATTACAGAATCTCAGCTACCTTCTATGAGTAAGTATCATACTGAGATTTTAAAAATTATGAGAATAATGCAAAGATATAATAAGATATTAGCTAAATATGTGAATAATAAGGTTGTTCCATATAATACAAATTCTATGACTGGACGCTTAATATTCAAAGGATTTATGAATAAAGCAACATATAAATGGGTAGAGAGATTATATGTTAAATTAGAGAGGAAACGTGAAGCTTAA", "orf_prot_sequence": "MNPDITVIVPIYNVEKYIRKCLDSLKRQTYKNFEVWAIDDGSPDNSKKIVQEYADKDPRFKSILKENGGYGSVLEYGIKNTKTKYFLVCDPDDWLTDDALEKLHNFAKNSNLDVTVGDKYNIYSEDNKKVYIPSFKKELNVKPRVAYDTAEKKDRFIFSEVSPHAKLFKTSIAKNIDFPHKISYTDTILYVLSIANAKRVGYLDEALAYYLIDRPGNTMTAKTEAKIRDTIKIWHSIYNQLINGFELNQIETYIYFLYYEMKIILITESQLPSMSKYHTEILKIMRIMQRYNKILAKYVNNKVVPYNTNSMTGRLIFKGFMNKATYKWVERLYVKLERKREA", "perc_identity": 20.83}}, "BGC0000765.1|Exopolysaccharide_13 # 9241 # 10359 # 1 # ID=1_13;partial=00;start_type=GTG;rbs_motif=TAG;rbs_spacer=9bp;gc_cont=0.316": {"gnl|BL_ORD_ID|2720|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 9241, "orf_end": 10359, "orf_from": "BGC0000765.1|Exopolysaccharide_13 ", "model_name": "tet(48)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "800", "model_id": "3284", "ARO_accession": "3004581", "ARO_name": "tet(48)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0858028, "max_identities": 18, "bit_score": 31.9574, "cvterm_id": "36791", "query": "LKMTNYLIVGSGLFGAVFAHEVAKRGNKVTVIEKRNHLAGNIYTKEVDGIQV", "match": " KM   L+VG+G+ G    + + + G   T+IEK N L    Y  ++ GI V", "sequence_from_db": "FKMKKVLVVGAGVAGLAVCYWLKEFGFSPTLIEKSNALRKGGYGVDIFGIAV", "sequence_from_broadstreet": "MTFLFKEFKGVFKMKKVLVVGAGVAGLAVCYWLKEFGFSPTLIEKSNALRKGGYGVDIFGIAVDIAKKMSVYEKICAMRTQLEHGFYVNADGHTLVEEQGEKFGFRQGEEVEILREDLIEILKQAIKDIPCHFNQRIKRIKQDGKHVEVTFKDNKTENYDLVIGADGVHSTTRAFTFDKEEYDLIDFGCYSAIFSLPNYLKLRQSEIAFDANQKFISVSSDKNPTIALASLMFHSNRGDNIRNEKDQKSFFKDAFIDLGWETNNLLQYMEESNDFYFDVATQIKMKSWTKGRIALVGDSGYCSTALSGQGTTTALVGAYILAGELKAANGNHITAFERYNMLLHPFVEANQELGAWINETFLLEDAVSKEAVEARTDNIIKKISAISNVIKLPEYSAYK", "dna_sequence_from_broadstreet": "ATGACATTCCTATTTAAGGAATTTAAAGGTGTGTTTAAAATGAAAAAAGTACTAGTGGTTGGTGCAGGGGTTGCTGGATTGGCAGTTTGTTATTGGCTAAAGGAGTTTGGGTTTTCGCCTACATTAATTGAAAAAAGTAATGCTTTAAGGAAGGGTGGTTATGGAGTAGATATCTTTGGTATTGCTGTTGATATTGCTAAAAAAATGAGCGTTTATGAAAAAATATGTGCTATGCGCACCCAGTTAGAACACGGGTTTTATGTGAATGCTGATGGTCATACATTAGTTGAAGAACAAGGGGAAAAATTTGGTTTCAGGCAGGGTGAGGAAGTCGAAATTCTCCGAGAAGATTTAATTGAAATCTTAAAGCAAGCTATTAAAGATATTCCATGCCATTTTAATCAACGTATAAAGCGGATTAAGCAGGATGGTAAACATGTTGAAGTTACTTTTAAGGATAATAAGACTGAAAATTATGATTTAGTTATTGGCGCTGACGGGGTACATTCAACCACTAGAGCTTTTACTTTTGATAAAGAAGAGTATGATCTAATTGATTTTGGATGTTATTCTGCAATATTTAGCCTCCCAAATTATTTAAAATTGAGGCAAAGCGAAATAGCTTTTGATGCGAACCAAAAATTCATTTCTGTCAGTAGCGATAAAAACCCTACTATAGCTCTTGCATCCCTTATGTTCCATTCTAATCGTGGAGACAACATTCGCAATGAGAAGGACCAGAAAAGTTTTTTTAAAGATGCTTTTATTGATCTTGGATGGGAGACAAATAATCTACTTCAGTACATGGAAGAAAGTAATGATTTCTATTTCGATGTTGCTACTCAGATTAAAATGAAATCATGGACAAAAGGAAGAATTGCGTTGGTGGGTGATTCAGGTTATTGTTCAACCGCATTGTCTGGGCAAGGCACCACTACAGCACTTGTTGGAGCTTATATTTTGGCAGGAGAATTAAAAGCTGCAAATGGAAACCATATAACTGCTTTTGAACGCTATAATATGTTGCTACATCCATTTGTTGAAGCTAATCAAGAACTAGGAGCATGGATTAATGAAACGTTTCTTTTAGAAGACGCAGTATCTAAAGAAGCAGTAGAAGCAAGAACAGACAATATCATAAAGAAAATCAGCGCCATCTCGAATGTAATTAAATTACCTGAGTATTCAGCCTATAAATAA", "partial": "0", "query_start": 9247, "query_end": 9402, "hit_start": 33, "hit_end": 189, "orf_dna_sequence": "GTGAAGCTTAAAATGACCAATTATTTAATTGTAGGATCAGGACTTTTCGGAGCAGTATTTGCTCATGAAGTAGCAAAACGAGGCAATAAAGTTACTGTAATTGAAAAAAGAAATCATTTAGCCGGCAATATTTATACTAAAGAAGTTGATGGAATTCAAGTTCATCAATATGGTGCACATATTTTTCATACATCAGACAAAAAAGTATGGGACTATGTACAACAATTTGCTGAATTTAATCGTTACACTAATAGTCCTGTAGCGAATTACTATGGTAAAATGTACAATTTGCCATTTAATATGAATACATTTAGTGAAATGTGGGGAGTAAGAACTCCACAAGAAGCTATGGACAAGATTAATGAACAACGTCAAGAAATGGCAGGAAAAGATCCACAAAATCTTGAAGAACAAGCAATTTCTTTAATTGGACGTGATATTTACGAAAAACTGATTAAGGGATATACAGAAAAGCAATGGGGTAGAAAAGCTACAGAATTGCCAGCATTTATTATTAAAAGACTTCCAGTTCGTTTAACTTATGATAACAATTACTTTAATGATGATTATCAAGGAATTCCTAAGGGTGGTTATACTCAAATAGTAGAAAAAATGCTTGATAATGAGAACATTGAAGTTAAGTTAAATACTGATTTCTTTGATAAAAAGGATGAGTATTTAAAGAATTTTGATAAAATTGTCTACACAGGCATGATTGATAAGTTCTTTGATTATAAGTTAGGCGAACTTGAATATCGTTCTCTTCGTTTTGAGACTGAAGAAAAAGATGTAGATAATTATCAAGGTAATGCAGTAATTAATTATACGGATGCAGAAACTCCATATACACGTGTAATTGAGCACAAACATTTCGAATTTGGTAAAGGCGATAAGGGTAAGACTATCGTTACTCGTGAATATCCTGCTAATTGGAAACGTGGAGATGAGCCATACTATCCAGTTAATAATGAAAGAAACAATAATTTATATAAACAATACAAGGGTCTGGCTGAAAAACAAAATAAAGTAATTTTTGGCGGTAGATTAGGACAATACAAATACTATAATATGGATCAGGTAATTGCTGAGGCATTACGTATGAGTAACAGTGTAGAATAA", "orf_prot_sequence": "MKLKMTNYLIVGSGLFGAVFAHEVAKRGNKVTVIEKRNHLAGNIYTKEVDGIQVHQYGAHIFHTSDKKVWDYVQQFAEFNRYTNSPVANYYGKMYNLPFNMNTFSEMWGVRTPQEAMDKINEQRQEMAGKDPQNLEEQAISLIGRDIYEKLIKGYTEKQWGRKATELPAFIIKRLPVRLTYDNNYFNDDYQGIPKGGYTQIVEKMLDNENIEVKLNTDFFDKKDEYLKNFDKIVYTGMIDKFFDYKLGELEYRSLRFETEEKDVDNYQGNAVINYTDAETPYTRVIEHKHFEFGKGDKGKTIVTREYPANWKRGDEPYYPVNNERNNNLYKQYKGLAEKQNKVIFGGRLGQYKYYNMDQVIAEALRMSNSVE", "perc_identity": 34.62}, "gnl|BL_ORD_ID|318|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 9241, "orf_end": 10359, "orf_from": "BGC0000765.1|Exopolysaccharide_13 ", "model_name": "vanL", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "275", "model_id": "349", "ARO_accession": "3002910", "ARO_name": "vanL", "ARO_category": {"36373": {"category_aro_accession": "3000234", "category_aro_cvterm_id": "36373", "category_aro_name": "glycopeptide resistance gene cluster", "category_aro_description": "Genes that when expressed confer resistance to vancomycin and teicoplanin type antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "39340": {"category_aro_accession": "3002906", "category_aro_cvterm_id": "39340", "category_aro_name": "Van ligase", "category_aro_description": "Van ligases synthesize alternative substrates for peptidoglycan synthesis that reduce vancomycin binding affinity.", "category_aro_class_name": "AMR Gene Family"}, "35947": {"category_aro_accession": "0000028", "category_aro_cvterm_id": "35947", "category_aro_name": "vancomycin", "category_aro_description": "Vancomycin is a glycopeptide antibiotic used in the prophylaxis and treatment of infections caused by Gram-positive bacteria. Vancomycin inhibits the synthesis of peptidoglycan, the major component of the cell wall of gram-positive bacteria. Its mechanism of action is unusual in that it acts by binding precursors of peptidoglycan, rather than by interacting with an enzyme.", "category_aro_class_name": "Antibiotic"}, "36220": {"category_aro_accession": "3000081", "category_aro_cvterm_id": "36220", "category_aro_name": "glycopeptide antibiotic", "category_aro_description": "Glycopeptide antibiotics are natural products produced non-ribosomally by Actinomycetales bacteria. With the exception of bleomycins, they act by binding the terminal D-Ala-D-Ala in peptidoglycan precursors of the growing bacterial cell wall and are generally active against Gram-positive bacteria.  This inhibits transglycosylation leading to cell death due to osmotic stress.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.01149, "max_identities": 13, "bit_score": 28.4906, "cvterm_id": "35918", "query": "EKMLDNENIEVKLNTDFFDKKDEY", "match": "EK+L  E  EV LN+DFFD  ++Y", "sequence_from_db": "EKLLVGECDEVSLNSDFFDYTEKY", "sequence_from_broadstreet": "MMKLKKIAIIFGGQSSEYEVSLKSTVSVLETLSTCNFEIIKIGIDLGGKWYLTTSNNKDIEYDVWQTDPSLQEIIPCFNNRGFYNKTTNKYFRPDVLFPILHGGTGEDGTLQGVFELMNIPYVGCGVTPSAICMDKYLLHEFAQSVGVKSAPTLIIRTRNCKDEIDKFIEKNDFPIFVKPNEAGSSKGINKVNEPDKLEDALTEAFKYSKSVIIQKAIIGREIGCAVLGNEKLLVGECDEVSLNSDFFDYTEKYQMISAKVNIPASISVEFSNEMKKQAQLLYRLLGCSGLARIDFFLSDNNEILLNEINTLPGFTEHSRYPKMMEAVGVTYKEIITKLINLAEEKYYG", "dna_sequence_from_broadstreet": "ATGATGAAATTGAAAAAGATAGCCATAATATTCGGAGGTCAATCTTCGGAATATGAAGTCTCACTTAAATCAACAGTAAGTGTACTAGAAACTCTATCAACTTGTAATTTTGAAATTATAAAAATAGGAATTGATTTAGGCGGAAAGTGGTATCTCACCACAAGCAACAACAAAGATATTGAATATGATGTTTGGCAAACTGATCCTTCATTACAAGAAATAATCCCATGTTTCAATAATCGAGGCTTTTATAACAAAACTACAAATAAATATTTCAGACCAGATGTACTCTTTCCAATTCTTCATGGGGGGACTGGAGAAGATGGAACCCTCCAAGGTGTATTTGAATTAATGAATATTCCTTACGTTGGATGTGGGGTGACGCCTTCGGCTATTTGTATGGACAAATACTTATTGCATGAGTTTGCTCAGAGTGTGGGTGTAAAAAGTGCCCCTACGCTCATAATTCGCACTAGAAACTGCAAAGATGAAATTGACAAGTTCATAGAAAAAAATGACTTCCCTATTTTTGTAAAGCCTAACGAAGCGGGCTCATCAAAAGGAATAAACAAAGTAAATGAGCCAGATAAGCTAGAGGATGCTTTAACAGAAGCGTTTAAGTATAGTAAAAGTGTTATCATTCAGAAAGCTATAATTGGAAGAGAAATTGGCTGTGCTGTCTTAGGTAATGAAAAACTCCTAGTAGGAGAATGTGATGAAGTTTCCCTTAATAGCGATTTTTTTGATTATACCGAGAAATACCAAATGATCTCAGCAAAGGTAAATATACCTGCTTCTATATCTGTAGAATTTTCTAATGAAATGAAGAAACAAGCTCAGCTGTTATATAGGTTACTAGGCTGTTCAGGACTAGCACGAATTGATTTCTTCTTATCAGATAATAACGAAATACTATTAAACGAAATTAATACTTTGCCTGGTTTTACTGAGCATTCCAGATATCCCAAAATGATGGAAGCTGTAGGTGTTACCTATAAAGAGATTATCACGAAGTTAATCAATTTAGCGGAGGAAAAATATTATGGATAA", "partial": "0", "query_start": 9847, "query_end": 9918, "hit_start": 690, "hit_end": 762, "orf_dna_sequence": "GTGAAGCTTAAAATGACCAATTATTTAATTGTAGGATCAGGACTTTTCGGAGCAGTATTTGCTCATGAAGTAGCAAAACGAGGCAATAAAGTTACTGTAATTGAAAAAAGAAATCATTTAGCCGGCAATATTTATACTAAAGAAGTTGATGGAATTCAAGTTCATCAATATGGTGCACATATTTTTCATACATCAGACAAAAAAGTATGGGACTATGTACAACAATTTGCTGAATTTAATCGTTACACTAATAGTCCTGTAGCGAATTACTATGGTAAAATGTACAATTTGCCATTTAATATGAATACATTTAGTGAAATGTGGGGAGTAAGAACTCCACAAGAAGCTATGGACAAGATTAATGAACAACGTCAAGAAATGGCAGGAAAAGATCCACAAAATCTTGAAGAACAAGCAATTTCTTTAATTGGACGTGATATTTACGAAAAACTGATTAAGGGATATACAGAAAAGCAATGGGGTAGAAAAGCTACAGAATTGCCAGCATTTATTATTAAAAGACTTCCAGTTCGTTTAACTTATGATAACAATTACTTTAATGATGATTATCAAGGAATTCCTAAGGGTGGTTATACTCAAATAGTAGAAAAAATGCTTGATAATGAGAACATTGAAGTTAAGTTAAATACTGATTTCTTTGATAAAAAGGATGAGTATTTAAAGAATTTTGATAAAATTGTCTACACAGGCATGATTGATAAGTTCTTTGATTATAAGTTAGGCGAACTTGAATATCGTTCTCTTCGTTTTGAGACTGAAGAAAAAGATGTAGATAATTATCAAGGTAATGCAGTAATTAATTATACGGATGCAGAAACTCCATATACACGTGTAATTGAGCACAAACATTTCGAATTTGGTAAAGGCGATAAGGGTAAGACTATCGTTACTCGTGAATATCCTGCTAATTGGAAACGTGGAGATGAGCCATACTATCCAGTTAATAATGAAAGAAACAATAATTTATATAAACAATACAAGGGTCTGGCTGAAAAACAAAATAAAGTAATTTTTGGCGGTAGATTAGGACAATACAAATACTATAATATGGATCAGGTAATTGCTGAGGCATTACGTATGAGTAACAGTGTAGAATAA", "orf_prot_sequence": "MKLKMTNYLIVGSGLFGAVFAHEVAKRGNKVTVIEKRNHLAGNIYTKEVDGIQVHQYGAHIFHTSDKKVWDYVQQFAEFNRYTNSPVANYYGKMYNLPFNMNTFSEMWGVRTPQEAMDKINEQRQEMAGKDPQNLEEQAISLIGRDIYEKLIKGYTEKQWGRKATELPAFIIKRLPVRLTYDNNYFNDDYQGIPKGGYTQIVEKMLDNENIEVKLNTDFFDKKDEYLKNFDKIVYTGMIDKFFDYKLGELEYRSLRFETEEKDVDNYQGNAVINYTDAETPYTRVIEHKHFEFGKGDKGKTIVTREYPANWKRGDEPYYPVNNERNNNLYKQYKGLAEKQNKVIFGGRLGQYKYYNMDQVIAEALRMSNSVE", "perc_identity": 54.17}, "gnl|BL_ORD_ID|3029|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 9241, "orf_end": 10359, "orf_from": "BGC0000765.1|Exopolysaccharide_13 ", "model_name": "OXA-570", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "470", "model_id": "4056", "ARO_accession": "3005324", "ARO_name": "OXA-570", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.3648, "max_identities": 18, "bit_score": 26.5646, "cvterm_id": "43682", "query": "REYPANWKRGDEPYYPVNNER-NNNLYKQYKGLAEKQNKVI-FGGRLGQYKYYNMDQVIAEALRMSN", "match": "R Y  +  R     +P +  +  N+L     G     ++VI +GG+   +K +  D  + EA+R+SN", "sequence_from_db": "RTYVVDPARAARRIHPASTFKIPNSLIAFDTGAVRDDHEVIPYGGKPQPFKQWEKDMALPEAIRVSN", "sequence_from_broadstreet": "MFARWSKTFALALTACAFVMGATQAHAELIVRDDLKRVFDEAGVTGTFVLMDISGNRTYVVDPARAARRIHPASTFKIPNSLIAFDTGAVRDDHEVIPYGGKPQPFKQWEKDMALPEAIRVSNVPIYQEVARRIGPARMQAYMDAFDYGNRQIGSVIDQFWLRGPLEISAFEEARFTSRLALKQLPVKPRTWDLVHRMLMIERQGDASLYAKTGVATEYQPEIGWWVGWVEREGKVYAFALNIDMPLEADMAKRILLGKRLMQALDVWPTP", "dna_sequence_from_broadstreet": "ATGTTTGCTCGCTGGTCAAAGACCTTTGCGCTGGCCCTCACAGCCTGTGCTTTCGTGATGGGCGCCACTCAAGCGCACGCCGAGTTGATCGTGCGCGATGACCTTAAGCGCGTGTTTGATGAGGCCGGTGTTACGGGCACCTTCGTGCTGATGGACATCAGTGGTAATCGCACCTACGTTGTGGACCCGGCGCGCGCCGCACGGCGCATCCACCCTGCATCAACCTTCAAGATTCCCAACAGCCTGATCGCCTTCGATACGGGTGCCGTGCGTGACGATCACGAGGTGATCCCATACGGTGGCAAGCCACAGCCCTTCAAACAGTGGGAGAAGGACATGGCATTGCCCGAGGCGATCCGTGTATCCAACGTGCCCATCTATCAGGAAGTCGCGCGACGCATTGGCCCTGCGCGCATGCAGGCCTACATGGATGCCTTTGACTACGGCAACCGCCAGATCGGCAGCGTGATTGACCAGTTCTGGCTGCGTGGTCCATTGGAAATTTCCGCATTTGAAGAGGCGCGCTTCACCAGCCGTCTGGCGCTCAAGCAACTGCCGGTGAAGCCGCGCACCTGGGATCTGGTCCACCGCATGCTGATGATCGAGAGACAGGGCGATGCCTCGCTGTACGCCAAGACGGGGGTCGCCACCGAGTATCAGCCCGAGATCGGCTGGTGGGTGGGCTGGGTCGAGCGTGAGGGGAAGGTGTACGCGTTCGCCCTGAACATCGATATGCCGCTTGAGGCCGATATGGCCAAGCGCATCCTGCTGGGCAAACGGCTGATGCAGGCATTGGACGTGTGGCCAACACCCTAG", "partial": "0", "query_start": 10153, "query_end": 10347, "hit_start": 168, "hit_end": 369, "orf_dna_sequence": "GTGAAGCTTAAAATGACCAATTATTTAATTGTAGGATCAGGACTTTTCGGAGCAGTATTTGCTCATGAAGTAGCAAAACGAGGCAATAAAGTTACTGTAATTGAAAAAAGAAATCATTTAGCCGGCAATATTTATACTAAAGAAGTTGATGGAATTCAAGTTCATCAATATGGTGCACATATTTTTCATACATCAGACAAAAAAGTATGGGACTATGTACAACAATTTGCTGAATTTAATCGTTACACTAATAGTCCTGTAGCGAATTACTATGGTAAAATGTACAATTTGCCATTTAATATGAATACATTTAGTGAAATGTGGGGAGTAAGAACTCCACAAGAAGCTATGGACAAGATTAATGAACAACGTCAAGAAATGGCAGGAAAAGATCCACAAAATCTTGAAGAACAAGCAATTTCTTTAATTGGACGTGATATTTACGAAAAACTGATTAAGGGATATACAGAAAAGCAATGGGGTAGAAAAGCTACAGAATTGCCAGCATTTATTATTAAAAGACTTCCAGTTCGTTTAACTTATGATAACAATTACTTTAATGATGATTATCAAGGAATTCCTAAGGGTGGTTATACTCAAATAGTAGAAAAAATGCTTGATAATGAGAACATTGAAGTTAAGTTAAATACTGATTTCTTTGATAAAAAGGATGAGTATTTAAAGAATTTTGATAAAATTGTCTACACAGGCATGATTGATAAGTTCTTTGATTATAAGTTAGGCGAACTTGAATATCGTTCTCTTCGTTTTGAGACTGAAGAAAAAGATGTAGATAATTATCAAGGTAATGCAGTAATTAATTATACGGATGCAGAAACTCCATATACACGTGTAATTGAGCACAAACATTTCGAATTTGGTAAAGGCGATAAGGGTAAGACTATCGTTACTCGTGAATATCCTGCTAATTGGAAACGTGGAGATGAGCCATACTATCCAGTTAATAATGAAAGAAACAATAATTTATATAAACAATACAAGGGTCTGGCTGAAAAACAAAATAAAGTAATTTTTGGCGGTAGATTAGGACAATACAAATACTATAATATGGATCAGGTAATTGCTGAGGCATTACGTATGAGTAACAGTGTAGAATAA", "orf_prot_sequence": "MKLKMTNYLIVGSGLFGAVFAHEVAKRGNKVTVIEKRNHLAGNIYTKEVDGIQVHQYGAHIFHTSDKKVWDYVQQFAEFNRYTNSPVANYYGKMYNLPFNMNTFSEMWGVRTPQEAMDKINEQRQEMAGKDPQNLEEQAISLIGRDIYEKLIKGYTEKQWGRKATELPAFIIKRLPVRLTYDNNYFNDDYQGIPKGGYTQIVEKMLDNENIEVKLNTDFFDKKDEYLKNFDKIVYTGMIDKFFDYKLGELEYRSLRFETEEKDVDNYQGNAVINYTDAETPYTRVIEHKHFEFGKGDKGKTIVTREYPANWKRGDEPYYPVNNERNNNLYKQYKGLAEKQNKVIFGGRLGQYKYYNMDQVIAEALRMSNSVE", "perc_identity": 26.87}, "gnl|BL_ORD_ID|3030|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 9241, "orf_end": 10359, "orf_from": "BGC0000765.1|Exopolysaccharide_13 ", "model_name": "OXA-573", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "450", "model_id": "4057", "ARO_accession": "3005325", "ARO_name": "OXA-573", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.38426, "max_identities": 10, "bit_score": 26.1794, "cvterm_id": "43682", "query": "EKQNKVIFGGRLGQYKYYNMDQVIAEALRMSN", "match": "+ Q  + +GG+   +K +  D  + EA+R+SN", "sequence_from_db": "DDQEVIPYGGKPQPFKQWEKDMALPEAIRVSN", "sequence_from_broadstreet": "MFPRWSKTFALALTAYAFVMGASQAHAELVVRDDLKRVFDEAGVTGTFVLMDIRGDRTYVVDPARAARRIHPASTFKIPNSLIAFDTGAVRDDQEVIPYGGKPQPFKQWEKDMALPEAIRVSNVPIYQEVARRIGPARMQAYVDAFDYGNRQIGSVIDQFWLRGPLEISAFEEARFTSRLALKQLPVKPRTWDLVHRMLLIEKQGDAALYAKTGVATEYQPEIGWWVGWVEREGKVYAFALNIDMPLEADMAKRIPLGKRLMQALEVWPTP", "dna_sequence_from_broadstreet": "ATGTTCCCTCGCTGGTCAAAGACCTTTGCGCTGGCCCTCACAGCCTATGCGTTCGTGATGGGTGCCAGTCAGGCGCACGCCGAGCTGGTCGTGCGCGATGACCTCAAGCGCGTGTTCGACGAAGCCGGTGTTACCGGCACCTTCGTGCTGATGGACATCCGTGGTGATCGCACCTACGTGGTGGACCCGGCACGCGCCGCGCGGCGCATCCACCCTGCATCAACCTTCAAGATTCCCAACAGCCTGATCGCCTTCGATACGGGTGCCGTGCGTGACGACCAGGAGGTGATTCCATACGGTGGCAAGCCACAGCCCTTCAAACAGTGGGAGAAGGACATGGCATTGCCCGAGGCGATCCGCGTGTCGAACGTGCCGATCTACCAGGAGGTTGCGCGCCGTATCGGCCCCGCGCGCATGCAGGCCTATGTGGATGCCTTTGACTACGGCAACCGCCAGATCGGCAGCGTGATTGACCAGTTTTGGCTGCGTGGTCCATTGGAAATTTCCGCATTTGAAGAGGCGCGCTTCACCAGCCGCCTTGCGCTCAAGCAACTGCCGGTGAAGCCGCGCACGTGGGATCTGGTTCACCGCATGCTGCTGATCGAGAAACAGGGCGATGCCGCGCTGTACGCCAAGACGGGGGTCGCTACCGAGTATCAGCCCGAGATCGGCTGGTGGGTGGGCTGGGTCGAGCGTGAGGGGAAGGTGTACGCGTTCGCCCTGAACATCGACATGCCGCTTGAGGCCGACATGGCCAAGCGCATTCCGTTAGGAAAACGGCTGATGCAGGCATTGGAAGTGTGGCCAACACCCTAG", "partial": "0", "query_start": 10252, "query_end": 10347, "hit_start": 273, "hit_end": 369, "orf_dna_sequence": "GTGAAGCTTAAAATGACCAATTATTTAATTGTAGGATCAGGACTTTTCGGAGCAGTATTTGCTCATGAAGTAGCAAAACGAGGCAATAAAGTTACTGTAATTGAAAAAAGAAATCATTTAGCCGGCAATATTTATACTAAAGAAGTTGATGGAATTCAAGTTCATCAATATGGTGCACATATTTTTCATACATCAGACAAAAAAGTATGGGACTATGTACAACAATTTGCTGAATTTAATCGTTACACTAATAGTCCTGTAGCGAATTACTATGGTAAAATGTACAATTTGCCATTTAATATGAATACATTTAGTGAAATGTGGGGAGTAAGAACTCCACAAGAAGCTATGGACAAGATTAATGAACAACGTCAAGAAATGGCAGGAAAAGATCCACAAAATCTTGAAGAACAAGCAATTTCTTTAATTGGACGTGATATTTACGAAAAACTGATTAAGGGATATACAGAAAAGCAATGGGGTAGAAAAGCTACAGAATTGCCAGCATTTATTATTAAAAGACTTCCAGTTCGTTTAACTTATGATAACAATTACTTTAATGATGATTATCAAGGAATTCCTAAGGGTGGTTATACTCAAATAGTAGAAAAAATGCTTGATAATGAGAACATTGAAGTTAAGTTAAATACTGATTTCTTTGATAAAAAGGATGAGTATTTAAAGAATTTTGATAAAATTGTCTACACAGGCATGATTGATAAGTTCTTTGATTATAAGTTAGGCGAACTTGAATATCGTTCTCTTCGTTTTGAGACTGAAGAAAAAGATGTAGATAATTATCAAGGTAATGCAGTAATTAATTATACGGATGCAGAAACTCCATATACACGTGTAATTGAGCACAAACATTTCGAATTTGGTAAAGGCGATAAGGGTAAGACTATCGTTACTCGTGAATATCCTGCTAATTGGAAACGTGGAGATGAGCCATACTATCCAGTTAATAATGAAAGAAACAATAATTTATATAAACAATACAAGGGTCTGGCTGAAAAACAAAATAAAGTAATTTTTGGCGGTAGATTAGGACAATACAAATACTATAATATGGATCAGGTAATTGCTGAGGCATTACGTATGAGTAACAGTGTAGAATAA", "orf_prot_sequence": "MKLKMTNYLIVGSGLFGAVFAHEVAKRGNKVTVIEKRNHLAGNIYTKEVDGIQVHQYGAHIFHTSDKKVWDYVQQFAEFNRYTNSPVANYYGKMYNLPFNMNTFSEMWGVRTPQEAMDKINEQRQEMAGKDPQNLEEQAISLIGRDIYEKLIKGYTEKQWGRKATELPAFIIKRLPVRLTYDNNYFNDDYQGIPKGGYTQIVEKMLDNENIEVKLNTDFFDKKDEYLKNFDKIVYTGMIDKFFDYKLGELEYRSLRFETEEKDVDNYQGNAVINYTDAETPYTRVIEHKHFEFGKGDKGKTIVTREYPANWKRGDEPYYPVNNERNNNLYKQYKGLAEKQNKVIFGGRLGQYKYYNMDQVIAEALRMSNSVE", "perc_identity": 31.25}, "gnl|BL_ORD_ID|4799|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 9241, "orf_end": 10359, "orf_from": "BGC0000765.1|Exopolysaccharide_13 ", "model_name": "tet(47)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "3308", "ARO_accession": "3004613", "ARO_name": "tet(47)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.59115, "max_identities": 12, "bit_score": 26.1794, "cvterm_id": "36791", "query": "KMTNYLIVGSGLFGAVFAHEVAKRGNKVTVIEKRNHLAGNIYTKEVDGIQV", "match": " + N L++G+G+ G    + + + G    +IEK  +L    +  +V G+ +", "sequence_from_db": "SINNILVIGAGIAGPSVCYWLKRFGFSPVLIEKSANLRKGGHALDVRGVAI", "sequence_from_broadstreet": "MRCHFRCNLALPLLVFLNLSRAIKDYQTMSSINNILVIGAGIAGPSVCYWLKRFGFSPVLIEKSANLRKGGHALDVRGVAIDLVKRMGIYEKIGNRRTQVEFGRYMDTQGNILHEEKGERFCYREGEDVEITRGDLVEILIDAIEGVPCYLNQSIDSIKQRDGDVAVRFKDGKIEYYDLIIGADGLHSTTRRMVFDKDEYQLTNLGAYFSVFSIPNYLNLNHTEIQFEANQKLISMTSDKNPKMAEVAFMFRVQNVLNNRRDENEQKRFLRDTFQGFGWETSKILELMSDSDDFYFDSVSQVKMKSWTKGRVALLGDAGYCASPISGQGNNLALVGAYVLAGELKQASDNYHQAFNRYNELLHPFIEANQKLGVLVNESFLVQDEVSKEVAEERSNKIMEEVKIVSNMISLPDYE", "dna_sequence_from_broadstreet": "ATGCGCTGTCATTTCCGATGTAATCTCGCGCTGCCGCTTCTTGTATTCCTCAATCTTAGTAGAGCAATAAAGGATTATCAAACAATGTCTTCTATAAATAATATTCTTGTAATAGGAGCTGGAATTGCTGGACCCTCAGTCTGCTATTGGTTAAAAAGATTTGGTTTTTCTCCCGTTTTAATTGAAAAGTCTGCCAATTTACGAAAAGGAGGGCATGCACTGGATGTTCGAGGTGTTGCAATCGACCTCGTCAAAAGAATGGGCATCTACGAAAAAATAGGCAATAGGCGCACTCAGGTGGAATTTGGACGATACATGGACACTCAAGGCAATATCTTGCATGAAGAAAAGGGTGAAAGATTTTGCTATAGAGAAGGTGAGGATGTTGAAATTACCCGCGGTGATTTAGTTGAGATATTGATAGATGCCATTGAAGGCGTTCCCTGCTATCTCAATCAATCGATTGACAGCATTAAACAGAGGGATGGCGATGTAGCCGTTCGATTTAAAGATGGCAAGATCGAGTATTACGATCTGATTATTGGCGCTGACGGCTTGCATTCAACAACAAGACGCATGGTTTTTGATAAAGATGAATATCAATTAACTAACCTTGGGGCGTACTTTAGCGTTTTTAGTATTCCAAATTATCTCAATTTGAATCACACCGAAATCCAGTTCGAGGCCAATCAAAAACTGATATCTATGACTAGCGACAAGAATCCTAAAATGGCTGAAGTCGCATTCATGTTCCGTGTACAGAATGTCTTGAATAATAGGCGCGATGAAAATGAGCAAAAGAGATTCCTACGCGACACTTTTCAAGGTTTTGGTTGGGAAACGTCGAAAATACTTGAACTGATGTCAGATAGTGATGATTTTTATTTTGATTCAGTCTCCCAAGTGAAAATGAAGTCATGGACTAAGGGTCGAGTTGCCTTATTGGGCGACGCGGGTTACTGCGCATCCCCAATATCTGGTCAAGGTAATAATCTGGCACTAGTTGGTGCTTATGTTTTGGCGGGAGAACTAAAACAGGCAAGCGACAATTATCACCAAGCATTTAATCGTTATAATGAATTGTTACATCCATTCATTGAAGCCAATCAAAAATTGGGAGTCTTGGTTAACGAGTCGTTTCTCGTTCAGGATGAAGTCTCAAAGGAAGTTGCGGAAGAACGATCAAATAAGATAATGGAAGAAGTAAAAATCGTCTCGAATATGATTTCGTTACCGGATTATGAATGA", "partial": "0", "query_start": 9250, "query_end": 9402, "hit_start": 90, "hit_end": 243, "orf_dna_sequence": "GTGAAGCTTAAAATGACCAATTATTTAATTGTAGGATCAGGACTTTTCGGAGCAGTATTTGCTCATGAAGTAGCAAAACGAGGCAATAAAGTTACTGTAATTGAAAAAAGAAATCATTTAGCCGGCAATATTTATACTAAAGAAGTTGATGGAATTCAAGTTCATCAATATGGTGCACATATTTTTCATACATCAGACAAAAAAGTATGGGACTATGTACAACAATTTGCTGAATTTAATCGTTACACTAATAGTCCTGTAGCGAATTACTATGGTAAAATGTACAATTTGCCATTTAATATGAATACATTTAGTGAAATGTGGGGAGTAAGAACTCCACAAGAAGCTATGGACAAGATTAATGAACAACGTCAAGAAATGGCAGGAAAAGATCCACAAAATCTTGAAGAACAAGCAATTTCTTTAATTGGACGTGATATTTACGAAAAACTGATTAAGGGATATACAGAAAAGCAATGGGGTAGAAAAGCTACAGAATTGCCAGCATTTATTATTAAAAGACTTCCAGTTCGTTTAACTTATGATAACAATTACTTTAATGATGATTATCAAGGAATTCCTAAGGGTGGTTATACTCAAATAGTAGAAAAAATGCTTGATAATGAGAACATTGAAGTTAAGTTAAATACTGATTTCTTTGATAAAAAGGATGAGTATTTAAAGAATTTTGATAAAATTGTCTACACAGGCATGATTGATAAGTTCTTTGATTATAAGTTAGGCGAACTTGAATATCGTTCTCTTCGTTTTGAGACTGAAGAAAAAGATGTAGATAATTATCAAGGTAATGCAGTAATTAATTATACGGATGCAGAAACTCCATATACACGTGTAATTGAGCACAAACATTTCGAATTTGGTAAAGGCGATAAGGGTAAGACTATCGTTACTCGTGAATATCCTGCTAATTGGAAACGTGGAGATGAGCCATACTATCCAGTTAATAATGAAAGAAACAATAATTTATATAAACAATACAAGGGTCTGGCTGAAAAACAAAATAAAGTAATTTTTGGCGGTAGATTAGGACAATACAAATACTATAATATGGATCAGGTAATTGCTGAGGCATTACGTATGAGTAACAGTGTAGAATAA", "orf_prot_sequence": "MKLKMTNYLIVGSGLFGAVFAHEVAKRGNKVTVIEKRNHLAGNIYTKEVDGIQVHQYGAHIFHTSDKKVWDYVQQFAEFNRYTNSPVANYYGKMYNLPFNMNTFSEMWGVRTPQEAMDKINEQRQEMAGKDPQNLEEQAISLIGRDIYEKLIKGYTEKQWGRKATELPAFIIKRLPVRLTYDNNYFNDDYQGIPKGGYTQIVEKMLDNENIEVKLNTDFFDKKDEYLKNFDKIVYTGMIDKFFDYKLGELEYRSLRFETEEKDVDNYQGNAVINYTDAETPYTRVIEHKHFEFGKGDKGKTIVTREYPANWKRGDEPYYPVNNERNNNLYKQYKGLAEKQNKVIFGGRLGQYKYYNMDQVIAEALRMSNSVE", "perc_identity": 23.53}, "gnl|BL_ORD_ID|4833|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 9241, "orf_end": 10359, "orf_from": "BGC0000765.1|Exopolysaccharide_13 ", "model_name": "Streptomyces venezuelae rox", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "600", "model_id": "5820", "ARO_accession": "3007209", "ARO_name": "Streptomyces venezuelae rox", "ARO_category": {"36584": {"category_aro_accession": "3000445", "category_aro_cvterm_id": "36584", "category_aro_name": "rifampin monooxygenase", "category_aro_description": "Enzyme responsible for the decolorization of rifampin by monoxygenation.", "category_aro_class_name": "AMR Gene Family"}, "36308": {"category_aro_accession": "3000169", "category_aro_cvterm_id": "36308", "category_aro_name": "rifampin", "category_aro_description": "Rifampin is a semi-synthetic rifamycin, and inhibits RNA synthesis by binding to RNA polymerase. Rifampin is the mainstay agent for the treatment of tuberculosis, leprosy and complicated Gram-positive infections.", "category_aro_class_name": "Antibiotic"}, "36656": {"category_aro_accession": "3000517", "category_aro_cvterm_id": "36656", "category_aro_name": "rifaximin", "category_aro_description": "Rifaximin is a semi-synthetic rifamycin used to treat traveller's diarrhea. Rifaximin inhibits RNA synthesis by binding to the beta subunit of bacterial RNA polymerase.", "category_aro_class_name": "Antibiotic"}, "36673": {"category_aro_accession": "3000534", "category_aro_cvterm_id": "36673", "category_aro_name": "rifapentine", "category_aro_description": "Rifapentine is a semisynthetic rifamycin that inhibits DNA-dependent RNA synthesis. It is often used in the treatment of tuberculosis and leprosy.", "category_aro_class_name": "Antibiotic"}, "36296": {"category_aro_accession": "3000157", "category_aro_cvterm_id": "36296", "category_aro_name": "rifamycin antibiotic", "category_aro_description": "Rifamycin antibiotics are a group of broad-spectrum ansamycin antibiotics that inhibit bacterial RNA polymerase by binding to a highly conserved region, blocking the oligonucleotide exit tunnel, and preventing the extension of nascent mRNAs.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.62391, "max_identities": 12, "bit_score": 25.7942, "cvterm_id": "36873", "query": "MTNYLIVGSGLFGAVFAHEVAKRGNKVTVIEK", "match": "M + ++VG G  G + A E+   G +V V+EK", "sequence_from_db": "MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEK", "sequence_from_broadstreet": "MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG", "dna_sequence_from_broadstreet": "ATGTTTGACGTGATCGTTGTCGGTGGCGGTCCGACCGGCTTGATGCTGGCCGGCGAACTGCGGCTGCACGGCGTGCGCGTACTCGTGCTGGAGAAGGAGACGGAGCCGACGCGGCAGTCCCGCGCGCAGGGGCTGCACGTCCGCAGCATCGAGGTGATGGCCCAGCGCGGGCTCCTGGAGCGCTTCCTCGAACGCGGGCACACGGTCGCGGTCGGCGGCTTCTTCGCCGGTCTGGCGACCTCGTGGCCCGAGCGGCTGGACACCGCGCACTCGTACGTCCTCGCCGTCCCGCAGGTGATCACCGAGCAGCTGCTGGCCGAGCACGCCACCGCACTCGGAGCCGAGATCCGACGCGGCCGGGCACTGGTCGGTCTCCGCCAGGACGAGGACGGCGTGACGGTCGACCTGGCCGACGGCGAACAGCTGCGCGCACGGTACGTCGTCGGCTGCGACGGCGGCCGCAGCACGGTGCGCAAGCTGCTCGGCGTGGCGTTCCCCGGCGAGCCGTCCAGGGTCGAGACCCTGCTCGGCGAGATGGAGATGACCGCCTCCCAGGAGGAGTTGACCTCCGTCATGACCGAGGTCCGCAAGACCCAGCAGCGATTCGGCGCGATGCCCCTGGGGGACGGGGTCTTCCGCGTCGTCGTCCCCGCCGAGGGCGTCGCCGAGGACCGGACGGCCTCCCCGACCCTCGACGAGTTCAAGCAGCAGCTGCGGGCCCACGCCGGGACGGACTTCGGCGTGCACTCGCCCCGGTGGCTCTCCCGCTTCGGCGACGCCACCCGACAGGCCGAGCGCTACCGGGTCGACCGGGTGTTCCTCGCTGGCGACGCGGCGCACATCCACCCGCCGACCGGCGGGCAGGGCCTCAACCTCGGCATCCAGGACGCGTTCAACCTCGGCTGGAAGCTGGCCGCCGAGGTCGACGGCTGGGCGCCGGAGGGACTCCTCGACACGTACCACGCCGAGCGGCACCCGGTGGCCACCGAGGTCCTGGACAACACCCGCGCGCAGATCCAGCTGATGTCGACGGAGCCGGGGCCGCAGGCGGTCCGCCGGCTCATGGCGGAACTCGTGGAGTTCGAGAACGTCAACCGGTACCTGATCGAGAAGATCACGGCGATCTCGGTCCGTTACGACGTCGGCGAGGGCCACGAGCTGCTCGGCCGCCGGATGCGGGACCTCGCGCTCAAGCACGGCCGGCTCTACGAGCGGATGCACGAGGGCCGTGGACTGCTGCTCGACCAGACCGGCCGGCTCTCGGTCGCCGGGTGGGAGGACCGGGTCGACCACGTCGTCGAGGTCAGCGAGGAACTGGACGTGCCCGCGGTGCTGCTGCGTCCCGACGGCCACGTCGTGTGGGCGGGCGAGGACCAGCAGGAGCTGCTCACCCGGATGCCCGCGTGGTTCGGCGCCGCCACGGCCGGCTGA", "partial": "0", "query_start": 9253, "query_end": 9348, "hit_start": 0, "hit_end": 96, "orf_dna_sequence": "GTGAAGCTTAAAATGACCAATTATTTAATTGTAGGATCAGGACTTTTCGGAGCAGTATTTGCTCATGAAGTAGCAAAACGAGGCAATAAAGTTACTGTAATTGAAAAAAGAAATCATTTAGCCGGCAATATTTATACTAAAGAAGTTGATGGAATTCAAGTTCATCAATATGGTGCACATATTTTTCATACATCAGACAAAAAAGTATGGGACTATGTACAACAATTTGCTGAATTTAATCGTTACACTAATAGTCCTGTAGCGAATTACTATGGTAAAATGTACAATTTGCCATTTAATATGAATACATTTAGTGAAATGTGGGGAGTAAGAACTCCACAAGAAGCTATGGACAAGATTAATGAACAACGTCAAGAAATGGCAGGAAAAGATCCACAAAATCTTGAAGAACAAGCAATTTCTTTAATTGGACGTGATATTTACGAAAAACTGATTAAGGGATATACAGAAAAGCAATGGGGTAGAAAAGCTACAGAATTGCCAGCATTTATTATTAAAAGACTTCCAGTTCGTTTAACTTATGATAACAATTACTTTAATGATGATTATCAAGGAATTCCTAAGGGTGGTTATACTCAAATAGTAGAAAAAATGCTTGATAATGAGAACATTGAAGTTAAGTTAAATACTGATTTCTTTGATAAAAAGGATGAGTATTTAAAGAATTTTGATAAAATTGTCTACACAGGCATGATTGATAAGTTCTTTGATTATAAGTTAGGCGAACTTGAATATCGTTCTCTTCGTTTTGAGACTGAAGAAAAAGATGTAGATAATTATCAAGGTAATGCAGTAATTAATTATACGGATGCAGAAACTCCATATACACGTGTAATTGAGCACAAACATTTCGAATTTGGTAAAGGCGATAAGGGTAAGACTATCGTTACTCGTGAATATCCTGCTAATTGGAAACGTGGAGATGAGCCATACTATCCAGTTAATAATGAAAGAAACAATAATTTATATAAACAATACAAGGGTCTGGCTGAAAAACAAAATAAAGTAATTTTTGGCGGTAGATTAGGACAATACAAATACTATAATATGGATCAGGTAATTGCTGAGGCATTACGTATGAGTAACAGTGTAGAATAA", "orf_prot_sequence": "MKLKMTNYLIVGSGLFGAVFAHEVAKRGNKVTVIEKRNHLAGNIYTKEVDGIQVHQYGAHIFHTSDKKVWDYVQQFAEFNRYTNSPVANYYGKMYNLPFNMNTFSEMWGVRTPQEAMDKINEQRQEMAGKDPQNLEEQAISLIGRDIYEKLIKGYTEKQWGRKATELPAFIIKRLPVRLTYDNNYFNDDYQGIPKGGYTQIVEKMLDNENIEVKLNTDFFDKKDEYLKNFDKIVYTGMIDKFFDYKLGELEYRSLRFETEEKDVDNYQGNAVINYTDAETPYTRVIEHKHFEFGKGDKGKTIVTREYPANWKRGDEPYYPVNNERNNNLYKQYKGLAEKQNKVIFGGRLGQYKYYNMDQVIAEALRMSNSVE", "perc_identity": 37.5}}, "BGC0000765.1|Exopolysaccharide_14 # 10365 # 11537 # 1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=TAG;rbs_spacer=10bp;gc_cont=0.252": {"gnl|BL_ORD_ID|2783|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 10365, "orf_end": 11537, "orf_from": "BGC0000765.1|Exopolysaccharide_14 ", "model_name": "ArnT", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "3795", "ARO_accession": "3005053", "ARO_name": "ArnT", "ARO_category": {"41433": {"category_aro_accession": "3004269", "category_aro_cvterm_id": "41433", "category_aro_name": "pmr phosphoethanolamine transferase", "category_aro_description": "This family of phosphoethanolamine transferase catalyze the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine to lipid A, which impedes the binding of colistin to the cell membrane.", "category_aro_class_name": "AMR Gene Family"}, "36966": {"category_aro_accession": "3000622", "category_aro_cvterm_id": "36966", "category_aro_name": "colistin A", "category_aro_description": "Colistin A, or polymyxin E1, has a 6-octanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36968": {"category_aro_accession": "3000624", "category_aro_cvterm_id": "36968", "category_aro_name": "colistin B", "category_aro_description": "Colistin B, or polymyxin E2, has a 6-heptanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36192": {"category_aro_accession": "3000053", "category_aro_cvterm_id": "36192", "category_aro_name": "peptide antibiotic", "category_aro_description": "Peptide antibiotics have a wide range of antibacterial mechanisms, depending on the amino acids that make up the antibiotic, although most act to disrupt the cell membrane in some manner. Subclasses of peptide antibiotics can include additional sidechains of other types, such as lipids in the case of the lipopeptide antibiotics.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.9534, "max_identities": 22, "bit_score": 26.9498, "cvterm_id": "35915", "query": "DILRFKLVKFIILFAFPICFIVLNVLMFWIPKSLFYTLNEALSGRLALNISGLQMWGVKLLG", "match": " I + KL  +I+      CF  L++LM        Y L  A +G  AL I+G+   GV LLG", "sequence_from_db": "SIAKGKLPTYIL-----PCFAPLSILM------ARYALEAAKTGAKALRINGMINLGVGLLG", "sequence_from_broadstreet": "MKSIRYGVSLIALFALYYLLPLNFRLLWQPDETRYAEISREMLATGDWVVPHFLGLRYFEKPIAGYWINSIGQWLFGHNNFGVRFGSVFAITMTALLVAWLAWRIFRDKRVAILSLIIFLTAMLVYAIGTYAVLDPMITLWLALAMCSFWGAVQAHSRSGKILGYVLLGVACGMGVMTKGFLALAVPVVGVLPWVIARKRWREVLTYGWLAVIVCTLVVLPWGLAIAQREPDFWRYFFWVEHIQRFAEKDAQHKAPFWYYIPFLIAGSLPWLALLPGALKRGWLERDEARGALYLLGWVAMPFLFFSIAKGKLPTYILPCFAPLSILMARYALEAAKTGAKALRINGMINLGVGLLGLIAVLVVSPWGFMHKPVWTKIELYKCLLAAIAFAVWALMGWLAMKDSGRRWSLAALCPLGLALLVGFAIPDRVIDSKQPQFLVDIVSESLQPSRYVLTNNVGIAGGLAWELKRSDIIMFDKQGELKYGLDWPDAQGSFVSQAGFADWLAAHRQQGPVSLVLLMDKGESMLDLPLPKPDNAYELGRVVFLQYLPQ", "dna_sequence_from_broadstreet": "ATGAAAAGCATTCGCTATGGCGTCTCTCTGATTGCGCTGTTTGCGCTGTATTATCTGCTGCCGCTCAATTTCCGTTTGCTCTGGCAACCCGACGAAACCCGCTACGCGGAGATCAGCCGTGAAATGCTGGCCACCGGCGACTGGGTGGTACCGCATTTTCTCGGCCTGCGCTACTTCGAAAAACCGATTGCCGGTTACTGGATCAACAGTATCGGTCAGTGGCTGTTTGGCCATAATAACTTCGGCGTACGCTTCGGGTCGGTCTTCGCCATCACCATGACCGCCCTGCTGGTGGCCTGGCTGGCGTGGCGGATCTTTCGTGATAAGCGGGTAGCTATCCTGTCGCTGATTATCTTCCTCACCGCGATGCTGGTGTATGCGATTGGCACCTATGCGGTGCTGGACCCGATGATCACCCTGTGGCTGGCGCTGGCGATGTGCAGCTTCTGGGGCGCGGTGCAGGCGCACAGCCGCAGCGGCAAAATACTGGGCTACGTGCTGCTGGGCGTCGCCTGCGGGATGGGGGTGATGACCAAGGGCTTCCTGGCGCTGGCGGTGCCGGTGGTGGGCGTTCTGCCGTGGGTGATCGCCCGTAAACGCTGGCGTGAAGTGCTGACCTACGGCTGGCTGGCGGTAATCGTCTGTACGCTGGTGGTGCTGCCCTGGGGGCTGGCTATCGCTCAGCGCGAGCCGGACTTCTGGCGCTACTTCTTCTGGGTCGAGCATATTCAGCGTTTTGCTGAAAAAGACGCCCAGCACAAAGCGCCGTTCTGGTACTACATCCCGTTCCTGATCGCCGGCAGTCTGCCGTGGCTGGCCCTGCTGCCGGGGGCGCTAAAGCGCGGCTGGCTTGAGCGCGATGAGGCCCGCGGCGCGCTGTATCTGTTAGGTTGGGTGGCGATGCCGTTCCTGTTCTTCAGTATCGCCAAAGGCAAACTGCCGACCTATATTCTGCCGTGCTTTGCGCCGCTGTCGATCCTGATGGCCCGCTACGCGCTGGAGGCCGCAAAGACCGGCGCGAAAGCGTTGCGCATCAACGGGATGATCAACCTGGGCGTTGGTTTGCTGGGGCTTATCGCCGTGCTGGTGGTCTCGCCGTGGGGCTTCATGCATAAGCCGGTGTGGACCAAGATTGAGCTGTATAAATGTCTGCTGGCGGCGATCGCTTTTGCCGTCTGGGCGCTGATGGGCTGGCTGGCGATGAAAGACTCTGGCCGCCGCTGGAGCCTCGCCGCGCTCTGTCCGCTCGGCCTGGCGCTGCTGGTGGGCTTCGCCATCCCGGACCGGGTTATCGACAGCAAACAGCCGCAGTTCCTCGTGGATATCGTCAGCGAATCCCTGCAGCCCAGCCGTTACGTCCTGACCAACAACGTTGGGATCGCCGGCGGCCTGGCCTGGGAGCTGAAGCGAAGCGATATTATTATGTTCGACAAACAGGGTGAGCTGAAGTACGGTCTCGACTGGCCGGATGCTCAGGGAAGCTTTGTCAGCCAGGCCGGTTTTGCCGACTGGCTGGCCGCGCATCGTCAGCAGGGGCCGGTCTCGCTGGTGCTGTTGATGGATAAAGGAGAGAGTATGCTCGACTTACCGTTACCGAAACCGGATAACGCCTACGAGCTGGGCCGGGTCGTTTTCCTTCAGTACCTGCCGCAATGA", "partial": "0", "query_start": 11031, "query_end": 11216, "hit_start": 918, "hit_end": 1071, "orf_dna_sequence": "ATGGATTTAAAAAAGAAAGAATTAACAAATTTTTTTTGTATAGTTTATTTTATTTGGGGCTTATTTCAACAAATTCAAAATACTGTTAACATAAAATTTAAATTTGAAGAAAGTATAGGACAGATTCTAAATGTTTTTCTTTTAGTAAGTATGTTTTTTTTACTATTATTAGTAATGAAAAATCAAAACTTTGAGGTTAGGATTTGGAATATTATATCTCTGATTTTGTTTTTTGGGCTAATTATTTATTTAAGTAAAAATCAAAATTTCACTTTTATTGCTACGTATGCATTAATTTTGATGGCAGGAAATTTTTATTTTGAAGATATTTTAAAAACTTTCCTTATATTTACCGCCATTATACTGATTTCAACTATATTTTTGTTTAAACTGGGACGTATTCCAAATGCTATAGTCGTAGGTCAGTACCTTAGGGTAAGGTCAAGCCTAGGATTTGGATATTATACATATTCGGCACAGTTGTTATTTTATTTCACATTAGCATACTTAGTTTTTAGAAAACAAAAAATTACGTATGTAGAGCTAATAATTTTAGAAGCCGCAAACTATTTTATTTACTATAGTACTAATACAAGAAACCCATATATTTTATCGACACTTTTTATTTTGTTTGTATTAGTAGATAAGATTTTTAAGTTTAAATTAGATATTTTAAGATTTAAATTGGTAAAATTTATTATATTATTTGCTTTTCCAATATGCTTTATTGTATTAAATGTTTTAATGTTCTGGATTCCTAAATCTTTATTTTATACTTTAAATGAGGCGTTATCGGGTCGATTGGCATTAAATATCTCAGGACTACAAATGTGGGGAGTAAAACTACTTGGACAAAAAATTGATTTTGAAGCGATTAATGTAAATGGAATGGCTACTCAGTATTACAATTTTGTTGATAGTTCATATTTTCAAACATTACTGGTAAGTGGATGTCTATTTTTTATCATAATTATGATATTGCTAATTTATATATGTAATAAATCTATAAAAGAGCATGAACAATATTTAGGAATAGCTTTATTTTTAATTGCCATTCACTCTATGTTTGATCCCCAATTATTATTACCATGGTACTCCCCATTTTGTTTGTTATTAGGACAGTTTTTTGCTGTACACGATTCTTCAATATTTGAAAAAACAATACAAGAATAG", "orf_prot_sequence": "MDLKKKELTNFFCIVYFIWGLFQQIQNTVNIKFKFEESIGQILNVFLLVSMFFLLLLVMKNQNFEVRIWNIISLILFFGLIIYLSKNQNFTFIATYALILMAGNFYFEDILKTFLIFTAIILISTIFLFKLGRIPNAIVVGQYLRVRSSLGFGYYTYSAQLLFYFTLAYLVFRKQKITYVELIILEAANYFIYYSTNTRNPYILSTLFILFVLVDKIFKFKLDILRFKLVKFIILFAFPICFIVLNVLMFWIPKSLFYTLNEALSGRLALNISGLQMWGVKLLGQKIDFEAINVNGMATQYYNFVDSSYFQTLLVSGCLFFIIIMILLIYICNKSIKEHEQYLGIALFLIAIHSMFDPQLLLPWYSPFCLLLGQFFAVHDSSIFEKTIQE", "perc_identity": 35.48}, "gnl|BL_ORD_ID|2509|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 10365, "orf_end": 11537, "orf_from": "BGC0000765.1|Exopolysaccharide_14 ", "model_name": "ICR-Mc", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "600", "model_id": "2902", "ARO_accession": "3004466", "ARO_name": "ICR-Mc", "ARO_category": {"41681": {"category_aro_accession": "3004465", "category_aro_cvterm_id": "41681", "category_aro_name": "intrinsic colistin resistant phosphoethanolamine transferase", "category_aro_description": "Chromosomally-encoded phosphoethanolamine (PEtN) transferases shown to confer resistance to polymyxin antibiotics, including colistin.", "category_aro_class_name": "AMR Gene Family"}, "36966": {"category_aro_accession": "3000622", "category_aro_cvterm_id": "36966", "category_aro_name": "colistin A", "category_aro_description": "Colistin A, or polymyxin E1, has a 6-octanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36968": {"category_aro_accession": "3000624", "category_aro_cvterm_id": "36968", "category_aro_name": "colistin B", "category_aro_description": "Colistin B, or polymyxin E2, has a 6-heptanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36192": {"category_aro_accession": "3000053", "category_aro_cvterm_id": "36192", "category_aro_name": "peptide antibiotic", "category_aro_description": "Peptide antibiotics have a wide range of antibacterial mechanisms, depending on the amino acids that make up the antibiotic, although most act to disrupt the cell membrane in some manner. Subclasses of peptide antibiotics can include additional sidechains of other types, such as lipids in the case of the lipopeptide antibiotics.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.06454, "max_identities": 19, "bit_score": 25.7942, "cvterm_id": "41683", "query": "DILRFKL-VKFIILFAFPICFIVLNVLMFWIPKSLFYTLNEALSGRLALNISGLQMWGVKLLG", "match": "D+L  KL ++ ++L   PIC+I+   L F        TL  +L  RL   +  L + G+ +L ", "sequence_from_db": "DLLSMKLLIRVVLLAGLPICWIIGQPLSFG-------TLKASLMKRLVTYLVALALVGLPILA", "sequence_from_broadstreet": "MSLKHNQTHNTTFTKFLKSNSFWSKGFWSNRHHRTKDLKGLDAYLFMAIVAIFLTTTANVTFFQQVMSVYPLANYAPFIASLAVVLTGVLLLLLVLLGYRHTLKTVAICFILIAAFAGHFTDTYGTVYDTTMLQNALQTDTAETKDLLSMKLLIRVVLLAGLPICWIIGQPLSFGTLKASLMKRLVTYLVALALVGLPILAFSSQYASFFREHKPLRFFTNPVTVMYSAGKLANMSYKNATKPTETIMHANDAIQKTTASTRKPRLVVMVVGETARADHASFNGYQRATFPHMDKLIGLGQVHNFGNVTSCGTSTAYSVPCMFSYLGAEKYDVDTADYHENVIDTLDRLGVAILWRDNNSDSKGVMNRLPAKQYQDYKNSPLQGGNNTICHTNPYDECRDVGMLVDLDDHVKAHANQDILIVLHQMGNHGPAYYKRYDDEFAQFLPVCTSSELAECERQTVINAYDNALLATDDFLKQTIDWLAAQTHADTAMLYLSDHGESLGEKGVYLHGMPKAFAPKEQLSIPALLWLGADTPFAVANSPTAGFSHDAITPTLLNLFDVSTQATADKTAFVNPLD", "dna_sequence_from_broadstreet": "ATGTCCCTTAAACACAACCAAACCCACAACACCACTTTTACCAAATTTTTAAAGTCCAACAGCTTTTGGTCTAAGGGCTTTTGGTCTAACCGCCATCACCGCACCAAAGATTTAAAAGGGTTAGATGCTTATCTGTTTATGGCAATTGTGGCGATATTTTTGACCACAACTGCCAATGTGACATTTTTTCAACAAGTCATGTCAGTATACCCATTGGCAAATTACGCACCTTTTATCGCTTCATTGGCGGTGGTCTTAACAGGCGTTTTGTTGCTCTTATTGGTGTTGCTTGGCTATCGGCATACCTTAAAGACGGTGGCAATTTGTTTTATTTTAATCGCTGCTTTTGCTGGTCATTTTACCGACACCTATGGCACTGTCTACGACACCACCATGCTACAAAATGCCTTACAAACTGACACGGCAGAAACCAAAGATTTATTAAGCATGAAGCTTTTAATCCGTGTTGTGTTGTTGGCTGGTTTGCCCATCTGTTGGATTATTGGGCAGCCATTGTCATTTGGCACACTCAAAGCAAGTTTAATGAAGCGGCTGGTTACCTATCTTGTGGCTTTGGCATTGGTTGGCTTGCCCATTTTGGCATTTAGCAGTCAATACGCCAGTTTTTTTAGGGAACATAAACCGTTGCGATTTTTTACCAATCCTGTAACGGTGATGTATTCAGCAGGCAAACTTGCCAATATGAGTTATAAAAACGCCACCAAACCCACCGAAACCATCATGCACGCCAATGATGCCATACAAAAAACCACCGCTTCCACTCGCAAGCCCAGATTGGTGGTGATGGTGGTGGGTGAGACGGCCCGTGCTGACCATGCGTCTTTTAATGGTTATCAGCGAGCCACTTTCCCTCATATGGACAAACTCATTGGCTTAGGGCAAGTGCATAATTTTGGTAATGTCACTTCTTGTGGCACATCAACGGCATATTCTGTCCCATGTATGTTCAGTTATTTGGGAGCAGAAAAATACGATGTTGATACCGCCGATTACCATGAAAATGTCATTGACACCTTAGACCGCTTGGGTGTGGCGATATTGTGGCGAGATAATAACTCTGATTCAAAAGGCGTGATGAATCGCCTGCCTGCCAAACAGTATCAAGACTACAAAAACAGCCCCCTTCAAGGTGGCAATAACACCATTTGCCACACCAACCCTTATGATGAATGCCGTGATGTGGGCATGTTGGTGGATTTAGATGACCATGTCAAGGCTCATGCCAATCAAGACATATTAATAGTGTTGCATCAAATGGGCAACCATGGCCCTGCTTATTATAAACGCTATGACGATGAATTTGCTCAGTTTTTGCCTGTTTGTACAAGTAGCGAGTTGGCAGAATGTGAGCGACAAACGGTCATTAATGCTTATGACAATGCGTTATTGGCGACTGATGACTTTTTAAAACAAACCATCGATTGGTTGGCAGCACAAACACACGCTGACACCGCCATGTTATATTTAAGCGACCATGGTGAAAGCTTAGGAGAAAAAGGCGTTTATTTACATGGCATGCCTAAGGCGTTTGCCCCAAAAGAACAACTGAGCATTCCTGCGTTACTTTGGTTGGGAGCAGACACTCCATTTGCAGTGGCAAATTCGCCAACGGCTGGCTTTAGCCACGATGCCATCACCCCGACACTGCTCAACTTATTTGATGTCAGCACACAAGCCACGGCAGATAAAACAGCATTTGTTAATCCTTTGGATTGA", "partial": "0", "query_start": 11031, "query_end": 11216, "hit_start": 435, "hit_end": 603, "orf_dna_sequence": "ATGGATTTAAAAAAGAAAGAATTAACAAATTTTTTTTGTATAGTTTATTTTATTTGGGGCTTATTTCAACAAATTCAAAATACTGTTAACATAAAATTTAAATTTGAAGAAAGTATAGGACAGATTCTAAATGTTTTTCTTTTAGTAAGTATGTTTTTTTTACTATTATTAGTAATGAAAAATCAAAACTTTGAGGTTAGGATTTGGAATATTATATCTCTGATTTTGTTTTTTGGGCTAATTATTTATTTAAGTAAAAATCAAAATTTCACTTTTATTGCTACGTATGCATTAATTTTGATGGCAGGAAATTTTTATTTTGAAGATATTTTAAAAACTTTCCTTATATTTACCGCCATTATACTGATTTCAACTATATTTTTGTTTAAACTGGGACGTATTCCAAATGCTATAGTCGTAGGTCAGTACCTTAGGGTAAGGTCAAGCCTAGGATTTGGATATTATACATATTCGGCACAGTTGTTATTTTATTTCACATTAGCATACTTAGTTTTTAGAAAACAAAAAATTACGTATGTAGAGCTAATAATTTTAGAAGCCGCAAACTATTTTATTTACTATAGTACTAATACAAGAAACCCATATATTTTATCGACACTTTTTATTTTGTTTGTATTAGTAGATAAGATTTTTAAGTTTAAATTAGATATTTTAAGATTTAAATTGGTAAAATTTATTATATTATTTGCTTTTCCAATATGCTTTATTGTATTAAATGTTTTAATGTTCTGGATTCCTAAATCTTTATTTTATACTTTAAATGAGGCGTTATCGGGTCGATTGGCATTAAATATCTCAGGACTACAAATGTGGGGAGTAAAACTACTTGGACAAAAAATTGATTTTGAAGCGATTAATGTAAATGGAATGGCTACTCAGTATTACAATTTTGTTGATAGTTCATATTTTCAAACATTACTGGTAAGTGGATGTCTATTTTTTATCATAATTATGATATTGCTAATTTATATATGTAATAAATCTATAAAAGAGCATGAACAATATTTAGGAATAGCTTTATTTTTAATTGCCATTCACTCTATGTTTGATCCCCAATTATTATTACCATGGTACTCCCCATTTTGTTTGTTATTAGGACAGTTTTTTGCTGTACACGATTCTTCAATATTTGAAAAAACAATACAAGAATAG", "orf_prot_sequence": "MDLKKKELTNFFCIVYFIWGLFQQIQNTVNIKFKFEESIGQILNVFLLVSMFFLLLLVMKNQNFEVRIWNIISLILFFGLIIYLSKNQNFTFIATYALILMAGNFYFEDILKTFLIFTAIILISTIFLFKLGRIPNAIVVGQYLRVRSSLGFGYYTYSAQLLFYFTLAYLVFRKQKITYVELIILEAANYFIYYSTNTRNPYILSTLFILFVLVDKIFKFKLDILRFKLVKFIILFAFPICFIVLNVLMFWIPKSLFYTLNEALSGRLALNISGLQMWGVKLLGQKIDFEAINVNGMATQYYNFVDSSYFQTLLVSGCLFFIIIMILLIYICNKSIKEHEQYLGIALFLIAIHSMFDPQLLLPWYSPFCLLLGQFFAVHDSSIFEKTIQE", "perc_identity": 30.16}}, "BGC0000765.1|Exopolysaccharide_15 # 11547 # 12536 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=TAGG;rbs_spacer=8bp;gc_cont=0.320": {"gnl|BL_ORD_ID|1200|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 11547, "orf_end": 12536, "orf_from": "BGC0000765.1|Exopolysaccharide_15 ", "model_name": "vph", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "1223", "ARO_accession": "3003061", "ARO_name": "vph", "ARO_category": {"41425": {"category_aro_accession": "3004261", "category_aro_cvterm_id": "41425", "category_aro_name": "viomycin phosphotransferase", "category_aro_description": "Viomycin family of phosphotransferases confer resistance to viomycin antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35937": {"category_aro_accession": "0000018", "category_aro_cvterm_id": "35937", "category_aro_name": "viomycin", "category_aro_description": "Viomycin sulfate (Viocin) is an polypeptide antibiotic used in the treatment of tuberculosis. It is produced by the actinomycete Streptomyces puniceus and binds to the bacterial ribosome, inhibiting prokaryotic protein synthesis and certain forms of RNA splicing.", "category_aro_class_name": "Antibiotic"}, "36192": {"category_aro_accession": "3000053", "category_aro_cvterm_id": "36192", "category_aro_name": "peptide antibiotic", "category_aro_description": "Peptide antibiotics have a wide range of antibacterial mechanisms, depending on the amino acids that make up the antibiotic, although most act to disrupt the cell membrane in some manner. Subclasses of peptide antibiotics can include additional sidechains of other types, such as lipids in the case of the lipopeptide antibiotics.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.58605, "max_identities": 14, "bit_score": 27.335, "cvterm_id": "39588", "query": "LPHVANAVSHGNMNKVNKMLYKSFDFVSAVSYPMMFGL", "match": "LPH+ +AV HG++   N +L+++ D V     P M G+", "sequence_from_db": "LPHLTSAVVHGDLGGEN-VLWETVDGV-----PRMSGV", "sequence_from_broadstreet": "MRIIETHRDLLSRLLPGDTVGGLAVHEGQFHHVVIGSHRVVCFARTRAAADRLPGRADVLRALAGIDLGFRTPQPLSEGGAQGTDEPPYLVLSRIPGAPLEDDVLTSPEVAEAVARQYATLLSGLAAAGDEEKVRAALPEAPANEWQEFATGVRTELFPLMSDGGRERAERELAALDALPHLTSAVVHGDLGGENVLWETVDGVPRMSGVVDWDEVGIGDPAEDLAAIGASYGEELLGRVLALGGWADNGTAERISAIRGTFALQQALYAQRDGDEEELADGLSGYR", "dna_sequence_from_broadstreet": "ATGAGAATCATTGAGACGCACCGCGATCTGCTGAGCCGGCTCCTGCCCGGGGACACCGTGGGCGGACTCGCCGTCCACGAGGGGCAGTTCCACCATGTGGTGATCGGATCGCACCGGGTGGTCTGCTTCGCCCGCACCCGGGCGGCCGCCGACCGTCTGCCCGGCAGGGCGGACGTCCTGCGCGCTCTTGCCGGGATCGACCTCGGGTTTCGCACGCCGCAGCCGCTGTCCGAGGGCGGCGCCCAGGGCACGGACGAGCCGCCGTACCTGGTGCTGAGCCGCATTCCCGGAGCACCGTTGGAGGACGATGTGCTCACCAGCCCGGAGGTGGCGGAGGCCGTCGCCCGACAGTACGCGACCCTGCTGTCCGGGCTCGCGGCGGCGGGCGACGAGGAGAAGGTGCGCGCCGCGCTGCCGGAGGCTCCCGCGAACGAGTGGCAGGAGTTCGCCACGGGGGTGCGTACCGAACTGTTCCCGCTGATGTCCGACGGCGGCCGGGAGCGTGCCGAGCGCGAGCTCGCCGCGCTCGACGCCCTGCCCCATCTCACCTCCGCGGTGGTCCACGGTGACCTCGGCGGCGAGAACGTCCTGTGGGAGACGGTGGACGGAGTGCCGCGCATGAGCGGCGTCGTCGACTGGGACGAGGTCGGCATCGGCGACCCGGCTGAGGACCTGGCCGCCATCGGGGCGAGCTACGGCGAGGAACTGCTGGGCCGAGTGCTCGCGCTCGGCGGCTGGGCCGACAACGGAACGGCCGAGCGGATCTCGGCGATCCGAGGCACCTTCGCACTCCAGCAGGCCCTCTACGCGCAGCGCGACGGCGACGAGGAGGAACTCGCCGACGGCCTCAGCGGCTACCGGTAG", "partial": "0", "query_start": 12330, "query_end": 12443, "hit_start": 534, "hit_end": 630, "orf_dna_sequence": "ATGAAAGTAATAAAAAACTATTTATATAATGTTGGGTATCAAGTATTGGCAATTATCGTTCCACTTATTACATCTGCCTATGTCAGTAGAGTTTTGCGGCCAGAGGGTGTAGGAGCGAATTCATTTACTAATTCTATAATCCAATATTTTATTCTATTTGCTAATATGGGTATTGGGTATTATGGAAATCGACAAATTGCGTATGTTCGTGAAAAGAAAAGTCAAATGACTAAGACCTTTTGGGAAATTCAAATTGTAAAAACAATCATGACTCTTTACGCATTCGTTGCATTTGAAATTTTTATGATTTTTTACAGTAAGCAACCCGAATATATGTGGGCTCAATCACTAAACTTAGTAGCAGTAGCTTTTGATATATCATGGTTTTATGAAGGCATTGAAGATTTTAAGGTAACTGTTTTAAAGAATTCATTGGTAAAAATTTTATCAATGATTGCAATTTTTATGTTTATCAAAGGACCAAATGATGTCACTTTGTACATAATAGTTCTAGCTTTGTCAACGTTAATTGGAAATCTAACTTTATGGCCTAACATTGTACGTGATTTAGATAGAATAAATATTAAACTCTTAAATCCGTGGCAACACTTTTTCCCTATGGCTGAATTGTTTATTCCTCAAATTGCAACTCAAGTATATGTCCAACTTAATAAAACTATGTTGGGAGTCATGATAAGTGAAACGTCTTCAGGATACTATCAGTATTCTGATAATTTAGTAAAGCTTATTCTTGCATTAGTAACTGCTACGGGAACAGTTATGTTACCCCATGTTGCTAATGCGGTTTCACATGGCAATATGAATAAAGTTAACAAAATGCTTTATAAGTCATTTGATTTTGTATCGGCTGTCTCTTATCCTATGATGTTTGGATTAGCAGCTATTTCATTAACTTTGGCAACGAAATATTACGGTCCTGGTTATGGTCCTGTGGGTCCTGCTATGATGATAGATCAATTGTTATTTTAA", "orf_prot_sequence": "MKVIKNYLYNVGYQVLAIIVPLITSAYVSRVLRPEGVGANSFTNSIIQYFILFANMGIGYYGNRQIAYVREKKSQMTKTFWEIQIVKTIMTLYAFVAFEIFMIFYSKQPEYMWAQSLNLVAVAFDISWFYEGIEDFKVTVLKNSLVKILSMIAIFMFIKGPNDVTLYIIVLALSTLIGNLTLWPNIVRDLDRINIKLLNPWQHFFPMAELFIPQIATQVYVQLNKTMLGVMISETSSGYYQYSDNLVKLILALVTATGTVMLPHVANAVSHGNMNKVNKMLYKSFDFVSAVSYPMMFGLAAISLTLATKYYGPGYGPVGPAMMIDQLLF", "perc_identity": 36.84}, "gnl|BL_ORD_ID|2411|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 11547, "orf_end": 12536, "orf_from": "BGC0000765.1|Exopolysaccharide_15 ", "model_name": "AxyY", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1700", "model_id": "2799", "ARO_accession": "3004144", "ARO_name": "AxyY", "ARO_category": {"36005": {"category_aro_accession": "0010004", "category_aro_cvterm_id": "36005", "category_aro_name": "resistance-nodulation-cell division (RND) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.", "category_aro_class_name": "AMR Gene Family"}, "35925": {"category_aro_accession": "0000006", "category_aro_cvterm_id": "35925", "category_aro_name": "erythromycin", "category_aro_description": "Erythromycin is a macrolide antibiotic with a 14-carbon ring that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people that have an allergy to penicillins. Erythromycin may possess bacteriocidal activity, particularly at higher concentrations by binding to the 50S subunit of the bacterial 70S rRNA complex, inhibiting peptidyl-tRNA translocation. Thus, protein synthesis and subsequently structure/function processes critical for life or replication are inhibited.", "category_aro_class_name": "Antibiotic"}, "35976": {"category_aro_accession": "0000059", "category_aro_cvterm_id": "35976", "category_aro_name": "cefepime", "category_aro_description": "Cefepime (INN) is a fourth-generation cephalosporin antibiotic developed in 1994. It contains an aminothiazolyl group that decreases its affinity with beta-lactamases. Cefepime shows high binding affinity with penicillin-binding proteins and has an extended spectrum of activity against Gram-positive and Gram-negative bacteria, with greater activity against both Gram-negative and Gram-positive organisms than third-generation agents.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35935": {"category_aro_accession": "0000016", "category_aro_cvterm_id": "35935", "category_aro_name": "aminoglycoside antibiotic", "category_aro_description": "Aminoglycosides are a group of antibiotics that are mostly effective against Gram-negative bacteria. These molecules consist of aminated sugars attached to a dibasic cyclitol. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit (some work by binding to the 50S subunit), inhibiting the translocation of the peptidyl-tRNA from the A-site to the P-site and also causing misreading of mRNA, leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.18335, "max_identities": 14, "bit_score": 26.5646, "cvterm_id": "41271", "query": "TKTFWEIQIVKTIMTLYAFVAFEIFMIFY", "match": "T TF EI I K +MTL   VA  +F + Y", "sequence_from_db": "TSTFVEISIKKVLMTLLEAVAL-VFCVMY", "sequence_from_broadstreet": "MARFFIDRPVFAWVISLLIALVGLLSIRALPVAQYPDIAPPVVNIGASYPGASAKVVEEAVTAIIEREMNGAPGLMYTSSSSDSTGWASINLTFKQGTNPDIAAVEVQNRLKAVEPRLPESVRRDGVRVEKAADNIQLVVSLKSDGSLDDMQLGELAASNVLQALRRVEGVGKVQSFGAEAAMRIWPDPAKLTALSLTPGDIVSALRSHNARVTIGELGNQAVPKDAPLNASIVAGESLHTPEQFANIPLRALPDGATLRLKDVARVELGGTDYMYLSRVNGLTGTGLGIKLAPGSNAVETTRRIRETMRELAQYFPPGVTWDIPYETSTFVEISIKKVLMTLLEAVALVFCVMYLFMQNLRATLIPTLVVPVALLGTLGVMLGLGYSINVLTMFGMVLAIGILVDDAIVVVENVERIMAEEGLSPHDATVKAMGQISGAIVGITVVLVSVFVPMAFFDGAVGNIYRQFAVTLAVSIAFSAFLALSLTPALCASLLKPVPAGHHEKRGFFGWFNRAFARLTTRYTARVAGVLARPVRFGLAYALVIGVAALLFARLPSSFLPDEDQGSFMAMVILPQGSPQAETMAVVKDVERYMMEHEPVQYVYSVNGFSQYGSGPNSAMFFVTLKDWKERRDASQHVDAVVKRINKAFADRKNLMVFALNSPPLPDLGSTSGFDFRLQDRGGLGYEALTQARQKLLAKAAEHPALTDVVFAGQEEAPQLQLRVDRDKAQAMGVPIDEINTALAVMYGSDYIGDFMLNGQVRRVMVQADGKRRVDVDDISRLHVRNLQGQMVPLSAFATLTWSMGPPQLNRYNGFPSFTINGSAARGHSSGEAMRAMETLAAELPRGIGFDWSGQSYEERLSGNQAPVLFALSVLIVFLALAALYESWSIPLAVILVVPLGVIGALLGVTVRGMPNDIYFKVGLIATIGLSAKNAILIVEVAKDLVRDGQGILSATLEAARLRLRPIVMTSLAFGVGVLPLALATGAASGAQAAIGTGVLGGIITATVLAVFLVPLFFLIVGRMVGMRARPARPDGREPLETTP", "dna_sequence_from_broadstreet": "ATGGCGCGTTTCTTTATCGATCGCCCCGTTTTCGCGTGGGTGATCTCGCTGCTCATCGCGCTGGTCGGCCTGTTGTCGATCCGCGCGCTGCCGGTGGCGCAGTATCCGGACATCGCTCCGCCCGTCGTCAACATCGGCGCCAGCTATCCCGGCGCCTCGGCCAAGGTGGTCGAGGAAGCCGTCACCGCCATCATCGAACGCGAGATGAACGGCGCCCCGGGCCTGATGTACACCTCGTCCAGCAGCGATTCGACCGGCTGGGCCAGCATCAACCTGACCTTCAAGCAGGGCACCAACCCCGACATCGCGGCGGTGGAAGTGCAGAACCGCCTGAAGGCGGTCGAGCCTCGCCTGCCCGAATCGGTGCGGCGCGATGGCGTGCGCGTGGAAAAGGCGGCCGACAACATCCAGCTGGTGGTGTCGTTGAAGTCGGACGGCAGCCTGGACGACATGCAACTGGGCGAGCTGGCCGCCTCCAATGTGCTGCAGGCGCTGCGGCGGGTCGAAGGCGTGGGCAAGGTGCAGTCGTTCGGCGCGGAAGCGGCGATGCGCATCTGGCCGGACCCGGCCAAGCTCACCGCCCTGTCGCTGACGCCGGGCGACATCGTCTCGGCGCTGCGCAGCCACAACGCGCGCGTCACCATCGGCGAACTGGGCAACCAGGCCGTGCCCAAGGACGCGCCGCTGAACGCCAGCATCGTGGCGGGCGAATCGCTGCACACGCCGGAACAGTTCGCCAACATCCCGCTGCGGGCGCTGCCGGACGGCGCCACGCTGCGCCTGAAGGACGTGGCGCGGGTGGAGCTGGGCGGCACCGACTACATGTACCTGTCGCGCGTCAACGGCCTGACCGGCACCGGCCTGGGCATCAAGCTGGCGCCCGGCTCCAACGCCGTCGAAACCACCCGCCGCATCCGCGAGACCATGCGCGAGCTGGCGCAATACTTCCCGCCGGGCGTGACCTGGGACATTCCGTACGAGACCTCCACCTTCGTCGAGATCTCGATCAAGAAGGTCCTGATGACGCTGCTGGAGGCGGTGGCGCTGGTGTTCTGCGTGATGTACCTGTTCATGCAGAACCTGCGCGCCACGCTGATCCCGACCCTGGTGGTGCCGGTGGCGCTGCTGGGCACGCTGGGGGTGATGCTGGGGCTGGGCTATTCGATCAACGTGCTGACGATGTTCGGCATGGTGCTGGCCATCGGCATCCTGGTGGACGACGCCATCGTGGTGGTCGAGAACGTCGAGCGCATCATGGCCGAGGAAGGCCTGTCGCCGCATGACGCCACGGTCAAGGCCATGGGCCAGATCAGCGGCGCCATCGTCGGCATCACCGTGGTGCTGGTGTCGGTGTTCGTGCCGATGGCGTTCTTCGACGGCGCGGTGGGCAACATCTACCGCCAGTTCGCCGTGACGCTGGCGGTGTCGATCGCCTTCTCGGCCTTCCTGGCGCTGTCGCTGACGCCGGCGCTGTGCGCCAGCCTGCTCAAACCCGTCCCGGCCGGCCACCACGAGAAGCGCGGCTTCTTCGGCTGGTTCAACCGCGCCTTCGCGCGCCTGACCACGCGCTATACGGCGCGGGTGGCCGGCGTGCTGGCGCGGCCGGTACGCTTCGGCCTGGCCTATGCGCTGGTGATCGGCGTGGCGGCGTTGCTGTTCGCGCGGCTGCCATCGTCGTTCCTGCCGGACGAGGACCAGGGCAGCTTCATGGCCATGGTGATCCTGCCGCAGGGCTCGCCGCAGGCCGAGACCATGGCGGTGGTCAAGGACGTCGAACGCTACATGATGGAGCACGAGCCGGTGCAGTACGTGTATTCGGTCAACGGCTTCAGCCAGTACGGCAGCGGCCCGAACTCCGCCATGTTCTTCGTCACGCTGAAGGACTGGAAGGAACGCCGCGATGCCTCGCAACACGTGGACGCGGTGGTCAAGCGCATCAACAAGGCGTTCGCGGATCGCAAGAACCTGATGGTGTTCGCGCTGAACTCGCCGCCGCTGCCTGACCTGGGCTCGACCTCGGGCTTCGACTTCCGGCTGCAGGATCGCGGCGGCCTCGGCTACGAAGCCCTGACGCAGGCGCGCCAGAAGCTGCTGGCCAAGGCGGCCGAGCATCCCGCGCTGACGGACGTGGTGTTCGCCGGCCAGGAAGAGGCGCCGCAGCTGCAACTGCGCGTCGACCGCGACAAGGCGCAGGCCATGGGCGTGCCGATCGACGAGATCAACACCGCGCTGGCTGTGATGTACGGCTCGGACTACATCGGCGACTTCATGCTCAACGGCCAGGTTCGGCGCGTGATGGTGCAGGCCGACGGCAAGCGCCGCGTGGACGTGGACGACATCTCGCGCCTGCACGTGCGCAACCTGCAGGGCCAGATGGTGCCGCTGTCGGCGTTCGCCACGCTGACGTGGTCGATGGGGCCGCCGCAGCTGAACCGCTACAACGGCTTCCCGTCGTTCACCATCAACGGCTCGGCGGCGCGCGGCCACAGCAGCGGCGAGGCCATGCGCGCCATGGAGACGCTGGCGGCCGAGCTGCCGCGCGGCATCGGCTTCGACTGGTCGGGCCAATCGTACGAAGAGCGGCTGTCCGGCAACCAGGCGCCGGTGCTGTTCGCGCTGTCGGTGCTGATCGTGTTCCTGGCGCTGGCGGCGCTGTATGAAAGCTGGTCGATTCCGCTGGCGGTGATCCTGGTGGTGCCGCTGGGCGTGATCGGCGCGCTGCTGGGGGTGACCGTGCGCGGCATGCCCAACGACATCTACTTCAAGGTCGGCCTGATCGCCACCATCGGCCTGTCCGCCAAGAACGCGATCCTGATCGTGGAAGTGGCCAAGGACCTGGTGCGCGACGGCCAGGGCATCCTGTCCGCCACGCTGGAAGCGGCGCGGCTGCGGCTGCGGCCGATCGTGATGACCTCGCTGGCCTTTGGCGTGGGCGTGCTGCCGCTGGCGCTGGCCACTGGCGCCGCCTCGGGCGCGCAGGCCGCCATCGGCACCGGCGTGCTGGGCGGGATCATCACGGCGACCGTGCTGGCGGTGTTCCTGGTGCCGCTGTTCTTTCTCATCGTGGGACGCATGGTCGGCATGCGCGCCCGCCCCGCGCGCCCCGACGGCCGCGAACCGCTGGAGACGACGCCATGA", "partial": "0", "query_start": 11775, "query_end": 11861, "hit_start": 981, "hit_end": 1065, "orf_dna_sequence": "ATGAAAGTAATAAAAAACTATTTATATAATGTTGGGTATCAAGTATTGGCAATTATCGTTCCACTTATTACATCTGCCTATGTCAGTAGAGTTTTGCGGCCAGAGGGTGTAGGAGCGAATTCATTTACTAATTCTATAATCCAATATTTTATTCTATTTGCTAATATGGGTATTGGGTATTATGGAAATCGACAAATTGCGTATGTTCGTGAAAAGAAAAGTCAAATGACTAAGACCTTTTGGGAAATTCAAATTGTAAAAACAATCATGACTCTTTACGCATTCGTTGCATTTGAAATTTTTATGATTTTTTACAGTAAGCAACCCGAATATATGTGGGCTCAATCACTAAACTTAGTAGCAGTAGCTTTTGATATATCATGGTTTTATGAAGGCATTGAAGATTTTAAGGTAACTGTTTTAAAGAATTCATTGGTAAAAATTTTATCAATGATTGCAATTTTTATGTTTATCAAAGGACCAAATGATGTCACTTTGTACATAATAGTTCTAGCTTTGTCAACGTTAATTGGAAATCTAACTTTATGGCCTAACATTGTACGTGATTTAGATAGAATAAATATTAAACTCTTAAATCCGTGGCAACACTTTTTCCCTATGGCTGAATTGTTTATTCCTCAAATTGCAACTCAAGTATATGTCCAACTTAATAAAACTATGTTGGGAGTCATGATAAGTGAAACGTCTTCAGGATACTATCAGTATTCTGATAATTTAGTAAAGCTTATTCTTGCATTAGTAACTGCTACGGGAACAGTTATGTTACCCCATGTTGCTAATGCGGTTTCACATGGCAATATGAATAAAGTTAACAAAATGCTTTATAAGTCATTTGATTTTGTATCGGCTGTCTCTTATCCTATGATGTTTGGATTAGCAGCTATTTCATTAACTTTGGCAACGAAATATTACGGTCCTGGTTATGGTCCTGTGGGTCCTGCTATGATGATAGATCAATTGTTATTTTAA", "orf_prot_sequence": "MKVIKNYLYNVGYQVLAIIVPLITSAYVSRVLRPEGVGANSFTNSIIQYFILFANMGIGYYGNRQIAYVREKKSQMTKTFWEIQIVKTIMTLYAFVAFEIFMIFYSKQPEYMWAQSLNLVAVAFDISWFYEGIEDFKVTVLKNSLVKILSMIAIFMFIKGPNDVTLYIIVLALSTLIGNLTLWPNIVRDLDRINIKLLNPWQHFFPMAELFIPQIATQVYVQLNKTMLGVMISETSSGYYQYSDNLVKLILALVTATGTVMLPHVANAVSHGNMNKVNKMLYKSFDFVSAVSYPMMFGLAAISLTLATKYYGPGYGPVGPAMMIDQLLF", "perc_identity": 48.28}}, "BGC0000765.1|Exopolysaccharide_16 # 12572 # 12973 # 1 # ID=1_16;partial=00;start_type=TTG;rbs_motif=TAGG;rbs_spacer=10bp;gc_cont=0.311": {"gnl|BL_ORD_ID|2186|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 12572, "orf_end": 12973, "orf_from": "BGC0000765.1|Exopolysaccharide_16 ", "model_name": "hmrM", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "900", "model_id": "2425", "ARO_accession": "3003953", "ARO_name": "hmrM", "ARO_category": {"36251": {"category_aro_accession": "3000112", "category_aro_cvterm_id": "36251", "category_aro_name": "multidrug and toxic compound extrusion (MATE) transporter", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Multidrug and toxic compound extrusion (MATE) transporters utilize the cationic gradient across the membrane as an energy source. Although there is a diverse substrate specificity, almost all MATE transporters recognize fluoroquinolones. Arciflavine, ethidium and aminoglycosides are also good substrates.", "category_aro_class_name": "AMR Gene Family"}, "35963": {"category_aro_accession": "0000045", "category_aro_cvterm_id": "35963", "category_aro_name": "acriflavine", "category_aro_description": "Acriflavine is a topical antiseptic. It has the form of an orange or brown powder. It may be harmful in the eyes or if inhaled. Acriflavine is also used as treatment for external fungal infections of aquarium fish.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "43746": {"category_aro_accession": "3005386", "category_aro_cvterm_id": "43746", "category_aro_name": "disinfecting agents and antiseptics", "category_aro_description": "Disinfectants that can also interact with antimicrobial resistance mechanisms, e.g. molecule efflux, and thus are the targets of disinfectant resistance.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.893898, "max_identities": 12, "bit_score": 26.5646, "cvterm_id": "42593", "query": "KDTWLMLGVEVLIGIVVYAVFIVVLKAKIIDQLKDLVGNKLN", "match": "+  WL+LGV + +G+++Y   I +   ++  ++ DL  N L+", "sequence_from_db": "QGIWLVLGVSIPLGLLIYFCEIPLQYMQMESKMSDLARNYLH", "sequence_from_broadstreet": "MNFRLLSQYHTDIKKLIKISLPILLAQIAQNSMGLADTIMAGRVSSTDMAAISIGASIWMPLMFFGQGLLLALPPTISYLNGSGQHHRIAHQVRQGIWLVLGVSIPLGLLIYFCEIPLQYMQMESKMSDLARNYLHAMLWGLPAYLMLINFRCLNDGIEKTKPAMVITFLGLLINIPLNYIFIYGKFGMPAFGAVGCGIATAIVNWAMCLMMIFYSYTNTQERSLKVFSQLIEMPNPKTLKKLLRLGLPIAIAICCEVALYALTSLMLSPLGATIVASHQITLNTSSFIFMFPMSIGMATTILVGQALGAGSPQNAKKIGYAALLLGLTVTIVTALITIFFRYEIASIFVTDEIVIAMAANLLLFAALYQFSDTIQMVVGGILRGYKDTKVILYITLFSYWVIGVPLGYTLGRTDWLVPHIDAKGFWIAFVVSLTFAAFLLSLRMKKMQAMNDNAILQRLEKLK", "dna_sequence_from_broadstreet": "ATGAATTTTCGTCTTTTATCTCAATACCACACTGATATTAAAAAGTTGATTAAAATTTCCTTGCCTATTTTATTAGCGCAAATTGCACAAAACTCAATGGGATTAGCGGATACCATTATGGCGGGGCGAGTGAGTTCCACTGATATGGCAGCCATTTCTATTGGTGCTTCAATTTGGATGCCATTGATGTTTTTTGGGCAAGGTTTATTGTTGGCATTGCCGCCTACAATTTCTTATTTGAATGGTTCAGGCCAACACCATCGCATTGCACATCAAGTTCGCCAAGGCATTTGGCTTGTGTTAGGCGTGAGTATTCCTTTAGGTTTACTGATTTATTTCTGTGAAATTCCGCTGCAATATATGCAAATGGAAAGCAAAATGTCAGATTTAGCACGCAATTATTTACACGCGATGTTGTGGGGATTGCCAGCTTATTTGATGCTGATTAATTTTCGTTGTTTAAATGATGGGATTGAGAAAACCAAGCCTGCGATGGTCATTACCTTTTTAGGTTTATTGATTAATATTCCGCTTAATTACATTTTTATTTATGGAAAATTTGGTATGCCTGCTTTTGGTGCGGTGGGCTGTGGTATTGCGACAGCTATTGTGAACTGGGCAATGTGCTTAATGATGATTTTCTATTCCTACACGAATACTCAAGAACGTTCACTAAAAGTATTTAGTCAATTAATTGAAATGCCAAATCCGAAAACACTTAAAAAATTACTGCGTTTAGGATTACCCATTGCCATTGCAATTTGTTGCGAAGTGGCGTTATATGCACTTACGTCCTTAATGCTTTCTCCGCTGGGTGCAACTATTGTGGCAAGCCATCAAATTACGCTGAATACTAGTTCTTTTATTTTTATGTTCCCTATGTCGATTGGTATGGCAACGACGATTTTAGTTGGACAAGCATTGGGTGCAGGTTCTCCACAAAATGCGAAGAAAATTGGCTATGCCGCATTATTATTAGGGCTAACTGTGACAATTGTTACTGCATTAATTACGATTTTTTTCCGTTATGAAATTGCATCGATCTTCGTGACAGATGAAATTGTCATCGCCATGGCAGCAAATCTATTATTATTTGCCGCACTTTATCAATTTTCAGATACCATTCAAATGGTGGTTGGTGGTATTTTACGTGGTTATAAAGATACTAAAGTCATTTTATACATTACCCTTTTCTCTTATTGGGTAATTGGTGTGCCACTTGGTTATACGCTAGGTCGTACAGATTGGCTTGTGCCACACATTGATGCGAAAGGTTTCTGGATTGCCTTTGTGGTCTCGCTCACTTTTGCGGCATTCTTACTTTCTTTGAGAATGAAAAAAATGCAAGCTATGAACGACAACGCTATTTTACAACGTTTAGAAAAACTTAAATAA", "partial": "0", "query_start": 12842, "query_end": 12967, "hit_start": 282, "hit_end": 408, "orf_dna_sequence": "TTGCTGCCTATGCATAAGCAAAGAGCATTTACTATTTCTGTAACTCTAGGAGCGTTTATTAATTTGGCGTTAAATATTCCTCTTATTAAAATATGGGGATTAAATGGTGCTATGTGGTCTACAGTTTTATCCGAACTTGCTGTAACTCTATATCAACTATGGGCAGTTAAAGATATGTTGAGTATTAGAAGCTTGTTTTCAAGTACGTGGAAGTACTTTTTATCTGGATTGTGTATGTTTATTGTAGTATTTTGGATGAATACGCATTTAAAAGATACATGGCTTATGTTAGGTGTAGAAGTTTTAATAGGAATAGTTGTGTATGCTGTATTTATAGTAGTTTTGAAAGCTAAAATCATTGATCAACTAAAAGATCTAGTAGGAAATAAGTTGAATAGATAA", "orf_prot_sequence": "MLPMHKQRAFTISVTLGAFINLALNIPLIKIWGLNGAMWSTVLSELAVTLYQLWAVKDMLSIRSLFSSTWKYFLSGLCMFIVVFWMNTHLKDTWLMLGVEVLIGIVVYAVFIVVLKAKIIDQLKDLVGNKLNR", "perc_identity": 28.57}}, "BGC0000765.1|Exopolysaccharide_17 # 12987 # 14003 # 1 # ID=1_17;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.261": {"gnl|BL_ORD_ID|4680|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 12987, "orf_end": 14003, "orf_from": "BGC0000765.1|Exopolysaccharide_17 ", "model_name": "vanT gene in vanE cluster", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "200", "model_id": "1308", "ARO_accession": "3002971", "ARO_name": "vanT gene in vanE cluster", "ARO_category": {"36373": {"category_aro_accession": "3000234", "category_aro_cvterm_id": "36373", "category_aro_name": "glycopeptide resistance gene cluster", "category_aro_description": "Genes that when expressed confer resistance to vancomycin and teicoplanin type antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "36511": {"category_aro_accession": "3000372", "category_aro_cvterm_id": "36511", "category_aro_name": "vanT", "category_aro_description": "VanT is a membrane bound serine racemase, converting L-serine to D-serine. It is associated with VanC, which incorporated D-serine into D-Ala-D-Ser terminal end of peptidoglycan subunits that have a decreased binding affinity with vancomycin. It was isolated from Enterococcus gallinarum.", "category_aro_class_name": "AMR Gene Family"}, "35947": {"category_aro_accession": "0000028", "category_aro_cvterm_id": "35947", "category_aro_name": "vancomycin", "category_aro_description": "Vancomycin is a glycopeptide antibiotic used in the prophylaxis and treatment of infections caused by Gram-positive bacteria. Vancomycin inhibits the synthesis of peptidoglycan, the major component of the cell wall of gram-positive bacteria. Its mechanism of action is unusual in that it acts by binding precursors of peptidoglycan, rather than by interacting with an enzyme.", "category_aro_class_name": "Antibiotic"}, "36220": {"category_aro_accession": "3000081", "category_aro_cvterm_id": "36220", "category_aro_name": "glycopeptide antibiotic", "category_aro_description": "Glycopeptide antibiotics are natural products produced non-ribosomally by Actinomycetales bacteria. With the exception of bleomycins, they act by binding the terminal D-Ala-D-Ala in peptidoglycan precursors of the growing bacterial cell wall and are generally active against Gram-positive bacteria.  This inhibits transglycosylation leading to cell death due to osmotic stress.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.0092e-09, "max_identities": 49, "bit_score": 55.8398, "cvterm_id": "35918", "query": "KHRNYGLDLVKILACILVLCLHSLVPTSPVVK--NSLLNLSVYYAGAIAIPIFFMASSYFVLNKRMMSYSY-VMRRVGEILFIIIGWVLIYSIV----------HLCIKHNFIFLEELKGTAFVGIPNQHFYHFWFFWALIIMLLLSPLL", "match": "KHR  G+DL +I A  +V+ +H+  P   +    + ++ L+V+    +A+P FFM + YF+L +  +++SY   +RV + L+  IG + +YSI+           + +K N + L  LK   F G     FYH W+F A II  +L  LL", "sequence_from_db": "KHRANGIDLFRIFAATMVVAIHTF-PFQSIAPFLDEVITLTVF---RVAVPFFFMITGYFLLGRLSLNFSYNNNQRVKKYLY-KIGMIYLYSILLYFPLSLLNGTISLKMNILLL--LKVFIFDGT----FYHLWYFPASIIGTILVTLL", "sequence_from_broadstreet": "MKHRANGIDLFRIFAATMVVAIHTFPFQSIAPFLDEVITLTVFRVAVPFFFMITGYFLLGRLSLNFSYNNNQRVKKYLYKIGMIYLYSILLYFPLSLLNGTISLKMNILLLLKVFIFDGTFYHLWYFPASIIGTILVTLLLRSIGFKLTVAFSTCLYLVGLGGDSWYGITNQVPLLNKLYTFIFSWSDYTRSGVFFTPVFLCLGIFAYRVSKKLTASKILNLLFYVFIIGMTFESIFLHRFTNVKHDSMYLLLPSCALILFLMLLNWQPKLKVKESADLTLLVYILHPLVIVIVHSISKYIPILKNSLLNFLLVVVCSFILAQLLLNLKRKLRVSKQKIPFERASKEISASAIHHNINEIRKIIPKNTNIMGVVKANAYGCGMVEVAYELEKIGISFFCVATIEEAIALRKSGNQGDILILGYTHPNRINDIKKYNLIQSIVSEEHGKVLNLKKIPIRCHLQVDTGMHRLGVTPNVTIIQQMYLFSNLKIEGIYSHLGSSDSLEQESIARTNTQIFLFNNILSDLEQMGISYGYTHIQSSYGILNYPELSFDFVRIGILCYGFLSDYNSPTKIPIDLQPIVKVKASLITERIVEAGEYVGYGLGAKVEKRTRIGVVSIGYADGIPRALSNAKLTLEFKGQSIKQIGNICMDMMLVDLSEVEDISLNDELIVLPNISKIADEEQTITNELLSRLGSRLGTELN", "dna_sequence_from_broadstreet": "ATGAAGCATAGAGCTAACGGCATTGATCTATTTCGAATATTCGCTGCTACTATGGTTGTTGCTATCCATACATTCCCTTTTCAATCAATAGCACCTTTTTTAGACGAAGTCATAACGTTAACTGTGTTTCGGGTAGCTGTCCCTTTTTTCTTTATGATTACAGGATATTTTTTGTTAGGAAGATTGTCATTAAATTTTTCGTATAATAATAATCAGAGAGTGAAAAAATATCTATACAAAATTGGAATGATTTATTTATATTCTATTTTATTGTATTTCCCATTATCTTTACTAAATGGCACTATTTCATTAAAAATGAACATACTTTTACTTTTAAAGGTTTTCATTTTTGACGGTACCTTTTATCACCTATGGTACTTTCCAGCTAGTATAATTGGAACGATTTTAGTAACCCTACTGTTACGTAGTATAGGATTTAAATTAACAGTCGCATTTTCTACATGTCTATATCTAGTTGGACTTGGTGGAGACAGCTGGTACGGGATAACCAATCAAGTTCCATTGCTAAATAAACTGTATACATTTATTTTTAGTTGGTCGGACTATACGCGTTCAGGTGTTTTCTTTACGCCTGTGTTTCTTTGCCTAGGAATATTTGCCTATAGAGTATCTAAAAAGTTAACTGCATCAAAGATATTAAACTTGCTTTTTTATGTGTTTATCATAGGTATGACTTTTGAGAGTATATTTCTACACCGATTTACGAACGTCAAACACGATAGTATGTATCTCTTATTGCCTTCATGTGCATTAATTTTGTTTTTAATGTTATTAAACTGGCAACCAAAACTAAAGGTAAAAGAATCAGCCGATTTAACGTTACTGGTTTATATTCTCCATCCATTAGTTATTGTAATTGTCCATTCTATAAGTAAGTATATTCCGATATTAAAAAACAGTTTGCTAAATTTCTTGTTAGTAGTCGTGTGCAGCTTTATACTAGCTCAGCTTCTGTTAAACTTAAAAAGAAAGCTAAGAGTTAGTAAGCAAAAAATACCATTTGAACGTGCTAGTAAAGAAATATCAGCTAGTGCAATACACCATAATATTAATGAAATACGAAAGATAATTCCCAAAAATACAAATATTATGGGTGTTGTGAAGGCAAATGCGTATGGCTGTGGCATGGTAGAGGTAGCTTATGAATTAGAAAAAATCGGTATTTCATTTTTCTGCGTAGCTACTATAGAAGAAGCAATTGCTTTAAGGAAATCAGGAAACCAAGGGGATATTTTAATTTTAGGGTATACACATCCCAATCGCATTAATGATATAAAAAAATATAATTTGATTCAATCGATTGTAAGTGAAGAACATGGGAAAGTGTTGAATCTAAAAAAAATACCTATTCGTTGTCATTTACAGGTTGATACTGGGATGCATCGTTTAGGTGTTACACCGAACGTAACAATTATTCAGCAGATGTATCTTTTTTCCAATCTTAAGATTGAGGGGATATACTCACACTTAGGTTCTTCAGACTCATTAGAGCAAGAATCAATCGCTCGAACAAATACTCAAATTTTTTTATTCAATAATATACTAAGTGATTTGGAACAAATGGGTATTTCCTACGGTTATACTCATATCCAAAGCAGCTATGGTATTTTAAATTACCCAGAATTAAGCTTTGATTTTGTGAGAATAGGAATTCTCTGTTATGGATTTTTAAGTGACTATAATAGTCCGACTAAAATCCCTATAGATTTACAACCTATAGTAAAAGTAAAAGCCTCTTTGATTACAGAAAGAATTGTGGAGGCAGGTGAATATGTTGGCTATGGATTAGGCGCTAAAGTTGAAAAAAGAACAAGAATAGGTGTCGTTAGTATTGGGTATGCGGACGGTATACCAAGGGCATTATCCAATGCTAAACTTACGTTAGAGTTTAAAGGTCAATCAATAAAACAGATTGGGAATATTTGTATGGATATGATGCTTGTTGATCTGTCCGAAGTGGAAGATATTTCCTTGAATGATGAACTAATCGTGTTACCTAATATTAGTAAAATCGCTGATGAAGAACAAACAATTACCAATGAGCTATTGAGTCGATTAGGTTCGAGGTTAGGTACAGAGTTAAATTGA", "partial": "0", "query_start": 12999, "query_end": 13409, "hit_start": 3, "hit_end": 420, "orf_dna_sequence": "TTGAGTAATAGAAAACATAGAAATTATGGTTTAGATTTAGTAAAAATCCTAGCATGTATTTTAGTATTGTGTCTTCATTCTTTAGTTCCAACAAGTCCAGTAGTTAAAAATAGTTTACTTAATTTAAGTGTTTATTATGCTGGGGCAATTGCAATTCCTATATTTTTTATGGCAAGCAGTTATTTTGTTTTAAATAAAAGAATGATGTCATATTCTTATGTTATGAGAAGAGTGGGAGAAATTCTTTTTATAATAATTGGCTGGGTATTAATATATAGTATAGTTCATTTATGTATAAAACATAATTTTATTTTTCTTGAAGAACTGAAGGGGACTGCTTTTGTAGGAATTCCAAATCAGCATTTTTATCACTTTTGGTTCTTTTGGGCACTTATTATTATGCTGTTGTTATCCCCATTATTATGGTATCTTTTGCAAAAAAGTTTTGTAGGATATTTAATTTTGACAAGTATAGTTACTTTGATTTGTATAGGTATTGATATTTCGATGCATTTTGGCAACAGTTCTAATATTCGGAACATACCACAGATTTTTAGACTATATTTATATATTGAATACTATCTTTTAGGTGGCTTAATTGGAAATACTAATTTTGAGAAAATAAAAAATTTTTGCAAGCAACATTTTGTAATGACATGCATTGTAGCTAGTTTTTTATATGTTGGAGTGATCGCATATTCAATTTGGAATAGAAATATAATTCATTGGTTTTATGCTGAGGCAAATTATGGAAATGCTCTGATTATATTTACTTCAGTATTGATACTTATAATTTTTTCTATTTCTTCTCCACCTAATAAAAGTACAATTGAATTTATTATTCCTGCAACAATGGGAATATATATGCTTCATCCATTTTTTATTGGTAAATTAATGAAGATTCATATTTTATATAATTATCCTATTTTTATGATTCCCGTTTTGTTCATTCTATGTTTGATAATTGTAGAAATTGCTCTACGTATTCCAATTATTAATCGTTTCTTTAAATTATAA", "orf_prot_sequence": "MSNRKHRNYGLDLVKILACILVLCLHSLVPTSPVVKNSLLNLSVYYAGAIAIPIFFMASSYFVLNKRMMSYSYVMRRVGEILFIIIGWVLIYSIVHLCIKHNFIFLEELKGTAFVGIPNQHFYHFWFFWALIIMLLLSPLLWYLLQKSFVGYLILTSIVTLICIGIDISMHFGNSSNIRNIPQIFRLYLYIEYYLLGGLIGNTNFEKIKNFCKQHFVMTCIVASFLYVGVIAYSIWNRNIIHWFYAEANYGNALIIFTSVLILIIFSISSPPNKSTIEFIIPATMGIYMLHPFFIGKLMKIHILYNYPIFMIPVLFILCLIIVEIALRIPIINRFFKL", "perc_identity": 32.67}, "gnl|BL_ORD_ID|4729|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 12987, "orf_end": 14003, "orf_from": "BGC0000765.1|Exopolysaccharide_17 ", "model_name": "vanTm gene in vanL cluster", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "175", "model_id": "229", "ARO_accession": "3002973", "ARO_name": "vanTm gene in vanL cluster", "ARO_category": {"36373": {"category_aro_accession": "3000234", "category_aro_cvterm_id": "36373", "category_aro_name": "glycopeptide resistance gene cluster", "category_aro_description": "Genes that when expressed confer resistance to vancomycin and teicoplanin type antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "36511": {"category_aro_accession": "3000372", "category_aro_cvterm_id": "36511", "category_aro_name": "vanT", "category_aro_description": "VanT is a membrane bound serine racemase, converting L-serine to D-serine. It is associated with VanC, which incorporated D-serine into D-Ala-D-Ser terminal end of peptidoglycan subunits that have a decreased binding affinity with vancomycin. It was isolated from Enterococcus gallinarum.", "category_aro_class_name": "AMR Gene Family"}, "35947": {"category_aro_accession": "0000028", "category_aro_cvterm_id": "35947", "category_aro_name": "vancomycin", "category_aro_description": "Vancomycin is a glycopeptide antibiotic used in the prophylaxis and treatment of infections caused by Gram-positive bacteria. Vancomycin inhibits the synthesis of peptidoglycan, the major component of the cell wall of gram-positive bacteria. Its mechanism of action is unusual in that it acts by binding precursors of peptidoglycan, rather than by interacting with an enzyme.", "category_aro_class_name": "Antibiotic"}, "36220": {"category_aro_accession": "3000081", "category_aro_cvterm_id": "36220", "category_aro_name": "glycopeptide antibiotic", "category_aro_description": "Glycopeptide antibiotics are natural products produced non-ribosomally by Actinomycetales bacteria. With the exception of bleomycins, they act by binding the terminal D-Ala-D-Ala in peptidoglycan precursors of the growing bacterial cell wall and are generally active against Gram-positive bacteria.  This inhibits transglycosylation leading to cell death due to osmotic stress.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.76005e-05, "max_identities": 50, "bit_score": 41.9726, "cvterm_id": "35918", "query": "KHRNYGLDLVKILACILVLCLHSLVPTSPVVK--NSLLNLSVYYAGAIAIPIFFMASSYFVLNKRMMSYS-------YVMRRVGEILFIIIGWVLIYSIVHLCIKHNFIFLEELKGTAFVGIPNQHFYHFWFFWALIIMLLLSPLLWYLLQKSFVGYLILTSIVTLICIGIDISMHFGNS--SNIRNIPQIFRLY", "match": "K +N G++  +++A  +V+ +H   P   + K  ++L+ L+V+    IA+P FFM S Y++L     S +       Y+ +++    F I+ ++ + +     I  +   +  +K   F G     FYH WFF A ++ LL+   L  L + +    L +T +  LI +G       G+S    ++ +P  FR Y", "sequence_from_db": "KKQNTGVNNFRLIAAAMVVAIHCF-PFQTISKELDTLVTLTVF---RIAVPFFFMVSGYYLLGPIPSSATNTYQINNYIKKQLKVYTFAIVLYLPL-AFYSQSITLDMSIISFIKQLLFNGF----FYHLWFFPAWVLGLLIVQFL--LKRMNIQTVLFITFVAYLIGLG-------GDSWWGIVKQVPFFFRFY", "sequence_from_broadstreet": "MKKQNTGVNNFRLIAAAMVVAIHCFPFQTISKELDTLVTLTVFRIAVPFFFMVSGYYLLGPIPSSATNTYQINNYIKKQLKVYTFAIVLYLPLAFYSQSITLDMSIISFIKQLLFNGFFYHLWFFPAWVLGLLIVQFLLKRMNIQTVLFITFVAYLIGLGGDSWWGIVKQVPFFFRFYNAIFQLFGYTRNGLFYAPLFFALGAYLYKMNIKNFNSARNNYLLLLFSIEMILESYFLHLFNIPKHDSMYLFLPFVMTLVFIKIYNWSPKNNLLNSSQLSLGVYLIHPYIIAVIHSISIYVSIFTNSIINYLSVLLISYLTIRLILKRKEW", "dna_sequence_from_broadstreet": "ATGAAAAAACAAAATACGGGTGTAAATAATTTCCGTTTAATCGCTGCTGCCATGGTAGTAGCGATTCATTGCTTTCCATTTCAAACAATCAGTAAAGAACTAGATACATTGGTTACGCTAACTGTCTTTCGTATTGCCGTTCCTTTTTTCTTCATGGTTTCTGGGTACTACCTACTAGGTCCAATTCCAAGTTCAGCCACAAATACTTATCAAATTAATAACTATATAAAGAAACAGCTTAAAGTTTATACTTTCGCTATAGTTCTGTATCTACCTTTAGCGTTTTATAGTCAATCTATCACTTTGGATATGTCAATTATTAGTTTTATAAAACAACTACTTTTTAACGGTTTTTTTTACCATCTTTGGTTTTTCCCTGCATGGGTATTAGGATTATTAATTGTTCAATTTTTATTAAAAAGAATGAATATACAGACTGTATTGTTTATAACATTTGTGGCTTATTTAATAGGACTAGGAGGGGATAGTTGGTGGGGAATAGTTAAACAAGTTCCCTTTTTTTTCAGATTTTACAATGCTATATTTCAATTATTTGGTTATACACGAAATGGTCTATTTTATGCGCCGTTATTCTTTGCACTGGGAGCATATCTATACAAGATGAATATTAAAAACTTTAATTCCGCAAGAAATAACTATCTTTTACTGCTTTTTAGTATAGAAATGATTTTAGAAAGTTATTTCTTACATCTCTTTAACATTCCTAAACATGACAGTATGTATTTGTTTTTACCGTTTGTAATGACTTTGGTGTTTATCAAAATATACAATTGGTCACCAAAAAATAATTTATTGAACAGCTCTCAGCTATCTCTAGGAGTATATCTTATACATCCATATATCATCGCAGTAATTCACTCTATCTCAATTTACGTTTCTATTTTTACTAATAGCATAATTAATTATTTAAGTGTGCTATTGATAAGTTACCTAACTATAAGACTAATACTAAAAAGGAAGGAATGGTAG", "partial": "0", "query_start": 12999, "query_end": 13550, "hit_start": 3, "hit_end": 534, "orf_dna_sequence": "TTGAGTAATAGAAAACATAGAAATTATGGTTTAGATTTAGTAAAAATCCTAGCATGTATTTTAGTATTGTGTCTTCATTCTTTAGTTCCAACAAGTCCAGTAGTTAAAAATAGTTTACTTAATTTAAGTGTTTATTATGCTGGGGCAATTGCAATTCCTATATTTTTTATGGCAAGCAGTTATTTTGTTTTAAATAAAAGAATGATGTCATATTCTTATGTTATGAGAAGAGTGGGAGAAATTCTTTTTATAATAATTGGCTGGGTATTAATATATAGTATAGTTCATTTATGTATAAAACATAATTTTATTTTTCTTGAAGAACTGAAGGGGACTGCTTTTGTAGGAATTCCAAATCAGCATTTTTATCACTTTTGGTTCTTTTGGGCACTTATTATTATGCTGTTGTTATCCCCATTATTATGGTATCTTTTGCAAAAAAGTTTTGTAGGATATTTAATTTTGACAAGTATAGTTACTTTGATTTGTATAGGTATTGATATTTCGATGCATTTTGGCAACAGTTCTAATATTCGGAACATACCACAGATTTTTAGACTATATTTATATATTGAATACTATCTTTTAGGTGGCTTAATTGGAAATACTAATTTTGAGAAAATAAAAAATTTTTGCAAGCAACATTTTGTAATGACATGCATTGTAGCTAGTTTTTTATATGTTGGAGTGATCGCATATTCAATTTGGAATAGAAATATAATTCATTGGTTTTATGCTGAGGCAAATTATGGAAATGCTCTGATTATATTTACTTCAGTATTGATACTTATAATTTTTTCTATTTCTTCTCCACCTAATAAAAGTACAATTGAATTTATTATTCCTGCAACAATGGGAATATATATGCTTCATCCATTTTTTATTGGTAAATTAATGAAGATTCATATTTTATATAATTATCCTATTTTTATGATTCCCGTTTTGTTCATTCTATGTTTGATAATTGTAGAAATTGCTCTACGTATTCCAATTATTAATCGTTTCTTTAAATTATAA", "orf_prot_sequence": "MSNRKHRNYGLDLVKILACILVLCLHSLVPTSPVVKNSLLNLSVYYAGAIAIPIFFMASSYFVLNKRMMSYSYVMRRVGEILFIIIGWVLIYSIVHLCIKHNFIFLEELKGTAFVGIPNQHFYHFWFFWALIIMLLLSPLLWYLLQKSFVGYLILTSIVTLICIGIDISMHFGNSSNIRNIPQIFRLYLYIEYYLLGGLIGNTNFEKIKNFCKQHFVMTCIVASFLYVGVIAYSIWNRNIIHWFYAEANYGNALIIFTSVLILIIFSISSPPNKSTIEFIIPATMGIYMLHPFFIGKLMKIHILYNYPIFMIPVLFILCLIIVEIALRIPIINRFFKL", "perc_identity": 25.64}, "gnl|BL_ORD_ID|4675|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 12987, "orf_end": 14003, "orf_from": "BGC0000765.1|Exopolysaccharide_17 ", "model_name": "vanT gene in vanC cluster", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "200", "model_id": "734", "ARO_accession": "3002970", "ARO_name": "vanT gene in vanC cluster", "ARO_category": {"36373": {"category_aro_accession": "3000234", "category_aro_cvterm_id": "36373", "category_aro_name": "glycopeptide resistance gene cluster", "category_aro_description": "Genes that when expressed confer resistance to vancomycin and teicoplanin type antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "36511": {"category_aro_accession": "3000372", "category_aro_cvterm_id": "36511", "category_aro_name": "vanT", "category_aro_description": "VanT is a membrane bound serine racemase, converting L-serine to D-serine. It is associated with VanC, which incorporated D-serine into D-Ala-D-Ser terminal end of peptidoglycan subunits that have a decreased binding affinity with vancomycin. It was isolated from Enterococcus gallinarum.", "category_aro_class_name": "AMR Gene Family"}, "35947": {"category_aro_accession": "0000028", "category_aro_cvterm_id": "35947", "category_aro_name": "vancomycin", "category_aro_description": "Vancomycin is a glycopeptide antibiotic used in the prophylaxis and treatment of infections caused by Gram-positive bacteria. Vancomycin inhibits the synthesis of peptidoglycan, the major component of the cell wall of gram-positive bacteria. Its mechanism of action is unusual in that it acts by binding precursors of peptidoglycan, rather than by interacting with an enzyme.", "category_aro_class_name": "Antibiotic"}, "36220": {"category_aro_accession": "3000081", "category_aro_cvterm_id": "36220", "category_aro_name": "glycopeptide antibiotic", "category_aro_description": "Glycopeptide antibiotics are natural products produced non-ribosomally by Actinomycetales bacteria. With the exception of bleomycins, they act by binding the terminal D-Ala-D-Ala in peptidoglycan precursors of the growing bacterial cell wall and are generally active against Gram-positive bacteria.  This inhibits transglycosylation leading to cell death due to osmotic stress.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00263844, "max_identities": 34, "bit_score": 36.5798, "cvterm_id": "36781", "query": "RNYGLDLVKILACILVLCLHSLV-----PTSPVVKNSLLNLSVYYAGAIAIPIFFMASSYFVLNKRMMSYSYVMRRVGEILFIIIGWVLIYSIVHLCIKHNFIFLEELKGTAFVG------IPNQHFYHFWFFWALI", "match": "+N G+D  +++A ++V+ +H L      P   +    L+ L+++    +A+P FFM S Y+V  +  ++ SY  R+   +   I   + +Y +  L      ++ + +     VG      + N   YH W+F ALI", "sequence_from_db": "KNKGIDQFRVIAAMMVVAIHCLPLHYLWPEGDI----LITLTIF---RVAVPFFFMISGYYVFAELAVANSYPSRQ--RVFNFIKKQLKVYLLATLMFLPLALYSQTIGFDLPVGTLVQVLLVNGILYHLWYFPALI", "sequence_from_broadstreet": "MKNKGIDQFRVIAAMMVVAIHCLPLHYLWPEGDILITLTIFRVAVPFFFMISGYYVFAELAVANSYPSRQRVFNFIKKQLKVYLLATLMFLPLALYSQTIGFDLPVGTLVQVLLVNGILYHLWYFPALITGSLLLTSLLIHVSFKKVFWLAAGLYLIGLGGDSWFGLIQQTPIEPFYTAVFHLLDGTRNGIFFTPLFLCLGVLVRKQSEKRSLSKTALFFLISLIGLLIESAYLHGFSIPKHDSMYLFLPVVLFFLFPLILRWHPHRTWKHPGQLSLWLYLLHPYTIAGTHFLSQKISILQNNLINYLVVLILTIGFICLFLRQKHSWFRHKQTTPVKRAVKEFSKTALLHNLQEIQRIISPKTKVMAVVKADAYGCGAKEVAPVLEQAGIDFFAVATIDEGIRLRKNAVKSPILVLGYTSPKRIKELRRYSLTQSIISEGHAVALSQRKVAIDCHLAIDTGMHRLGVTPTIDSILSIFDLPFLTISGVYSHLGSADRLNPDSMIRTQKQIACFDQILLELDQRQISYGITHLQSSYGILNYPDLNYDYVRPGILLTGSLSDTNEPTKQRVSLQPILTLKAQLITKRVVAKGEAIGYGQTAVANQETTVGVVSIGYCDGLPRSLSNQEFCLSYRGQSLPQIGLICMDMLLIDLSHCPTIPIESEIEILTDWSDTAEQVQTITNELICRIGPRVSARIK", "dna_sequence_from_broadstreet": "ATGAAAAATAAAGGAATCGATCAATTTCGTGTGATTGCAGCCATGATGGTGGTTGCGATCCATTGTCTTCCCCTTCACTATTTATGGCCAGAAGGCGATATCCTAATCACATTGACGATTTTTCGAGTAGCTGTTCCTTTCTTTTTTATGATCAGTGGTTACTATGTGTTTGCAGAACTTGCTGTGGCCAATAGTTATCCTTCGCGACAACGAGTATTCAACTTTATCAAAAAACAGCTAAAAGTCTATCTATTAGCCACACTAATGTTTTTACCATTAGCACTCTATAGTCAAACGATCGGCTTCGATCTACCAGTTGGAACATTAGTACAAGTACTTTTGGTCAATGGCATTCTTTATCATCTTTGGTACTTTCCGGCTTTGATTACTGGGAGCCTGCTCCTAACAAGTTTGCTGATACATGTCTCCTTCAAAAAAGTGTTCTGGCTTGCGGCTGGATTGTACCTGATTGGATTAGGTGGTGATAGTTGGTTTGGACTGATCCAACAGACACCAATCGAACCATTCTATACTGCTGTGTTCCACCTATTAGATGGTACCCGCAACGGTATTTTCTTTACACCATTGTTTTTGTGCTTAGGTGTGCTGGTCAGAAAACAATCAGAGAAAAGAAGTTTATCCAAAACAGCTCTCTTCTTTTTGATCAGTCTTATCGGATTGCTTATTGAGAGTGCGTACTTGCATGGGTTTTCTATACCTAAACATGACAGTATGTATCTCTTCTTGCCTGTTGTACTCTTTTTCTTATTTCCGCTGATCTTGCGCTGGCATCCCCACAGGACTTGGAAGCATCCAGGACAGCTATCTTTGTGGCTTTACCTTTTACATCCTTATACAATTGCCGGCACACACTTTTTGAGCCAAAAAATCAGCATTCTGCAAAACAATCTAATCAACTATTTGGTTGTTTTGATCTTGACGATTGGATTCATTTGCCTCTTTTTAAGACAAAAACACTCATGGTTTAGACACAAACAAACAACGCCCGTTAAAAGGGCCGTAAAAGAATTCTCAAAGACAGCCCTTTTGCATAATCTACAGGAGATCCAGCGGATCATCTCACCGAAAACAAAAGTGATGGCAGTCGTTAAAGCCGATGCCTACGGCTGTGGTGCCAAGGAAGTTGCTCCTGTTTTAGAACAAGCCGGAATTGATTTTTTTGCGGTGGCTACGATTGATGAAGGTATTCGATTGCGGAAAAATGCTGTCAAAAGCCCCATCTTGGTCTTGGGATATACCTCTCCAAAACGCATAAAAGAACTTCGTCGCTACTCATTGACCCAATCGATCATCAGCGAAGGTCATGCTGTAGCATTGTCACAAAGAAAAGTAGCGATTGACTGTCATTTAGCCATCGATACTGGGATGCATCGGTTAGGTGTAACACCGACTATCGATTCGATTCTTTCGATTTTCGATTTGCCCTTCTTGACGATCAGTGGTGTTTATTCTCATCTTGGTTCGGCAGATCGCTTAAATCCTGATAGTATGATTCGCACTCAGAAGCAGATTGCCTGCTTCGATCAGATTCTCCTAGAGTTGGATCAGAGACAGATTTCTTATGGTATCACACACTTACAAAGCAGTTATGGTATTTTGAATTATCCAGACTTAAACTATGATTATGTGCGTCCGGGGATTTTATTGACAGGATCCCTCAGTGATACGAACGAGCCTACAAAACAACGAGTAAGCTTACAGCCTATTCTGACCCTCAAAGCACAGTTGATCACTAAGCGAGTCGTTGCCAAAGGGGAAGCGATCGGTTATGGGCAAACCGCCGTCGCGAATCAAGAAACAACTGTTGGTGTTGTGAGCATCGGCTATTGTGACGGACTGCCCCGTTCTCTATCAAATCAAGAGTTTTGTCTTTCCTATCGCGGTCAGTCCTTGCCGCAGATCGGCTTGATCTGCATGGACATGCTTTTGATAGACTTGAGCCATTGTCCTACGATCCCAATTGAAAGTGAAATTGAAATTCTGACAGATTGGAGCGATACTGCCGAGCAAGTACAAACTATAACCAATGAGTTGATTTGTCGGATCGGTCCACGAGTCAGTGCTAGGATCAAATAG", "partial": "0", "query_start": 13005, "query_end": 13382, "hit_start": 3, "hit_end": 387, "orf_dna_sequence": "TTGAGTAATAGAAAACATAGAAATTATGGTTTAGATTTAGTAAAAATCCTAGCATGTATTTTAGTATTGTGTCTTCATTCTTTAGTTCCAACAAGTCCAGTAGTTAAAAATAGTTTACTTAATTTAAGTGTTTATTATGCTGGGGCAATTGCAATTCCTATATTTTTTATGGCAAGCAGTTATTTTGTTTTAAATAAAAGAATGATGTCATATTCTTATGTTATGAGAAGAGTGGGAGAAATTCTTTTTATAATAATTGGCTGGGTATTAATATATAGTATAGTTCATTTATGTATAAAACATAATTTTATTTTTCTTGAAGAACTGAAGGGGACTGCTTTTGTAGGAATTCCAAATCAGCATTTTTATCACTTTTGGTTCTTTTGGGCACTTATTATTATGCTGTTGTTATCCCCATTATTATGGTATCTTTTGCAAAAAAGTTTTGTAGGATATTTAATTTTGACAAGTATAGTTACTTTGATTTGTATAGGTATTGATATTTCGATGCATTTTGGCAACAGTTCTAATATTCGGAACATACCACAGATTTTTAGACTATATTTATATATTGAATACTATCTTTTAGGTGGCTTAATTGGAAATACTAATTTTGAGAAAATAAAAAATTTTTGCAAGCAACATTTTGTAATGACATGCATTGTAGCTAGTTTTTTATATGTTGGAGTGATCGCATATTCAATTTGGAATAGAAATATAATTCATTGGTTTTATGCTGAGGCAAATTATGGAAATGCTCTGATTATATTTACTTCAGTATTGATACTTATAATTTTTTCTATTTCTTCTCCACCTAATAAAAGTACAATTGAATTTATTATTCCTGCAACAATGGGAATATATATGCTTCATCCATTTTTTATTGGTAAATTAATGAAGATTCATATTTTATATAATTATCCTATTTTTATGATTCCCGTTTTGTTCATTCTATGTTTGATAATTGTAGAAATTGCTCTACGTATTCCAATTATTAATCGTTTCTTTAAATTATAA", "orf_prot_sequence": "MSNRKHRNYGLDLVKILACILVLCLHSLVPTSPVVKNSLLNLSVYYAGAIAIPIFFMASSYFVLNKRMMSYSYVMRRVGEILFIIIGWVLIYSIVHLCIKHNFIFLEELKGTAFVGIPNQHFYHFWFFWALIIMLLLSPLLWYLLQKSFVGYLILTSIVTLICIGIDISMHFGNSSNIRNIPQIFRLYLYIEYYLLGGLIGNTNFEKIKNFCKQHFVMTCIVASFLYVGVIAYSIWNRNIIHWFYAEANYGNALIIFTSVLILIIFSISSPPNKSTIEFIIPATMGIYMLHPFFIGKLMKIHILYNYPIFMIPVLFILCLIIVEIALRIPIINRFFKL", "perc_identity": 24.82}, "gnl|BL_ORD_ID|1522|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 12987, "orf_end": 14003, "orf_from": "BGC0000765.1|Exopolysaccharide_17 ", "model_name": "vanT gene in vanG cluster", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "175", "model_id": "1561", "ARO_accession": "3002972", "ARO_name": "vanT gene in vanG cluster", "ARO_category": {"36373": {"category_aro_accession": "3000234", "category_aro_cvterm_id": "36373", "category_aro_name": "glycopeptide resistance gene cluster", "category_aro_description": "Genes that when expressed confer resistance to vancomycin and teicoplanin type antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "36511": {"category_aro_accession": "3000372", "category_aro_cvterm_id": "36511", "category_aro_name": "vanT", "category_aro_description": "VanT is a membrane bound serine racemase, converting L-serine to D-serine. It is associated with VanC, which incorporated D-serine into D-Ala-D-Ser terminal end of peptidoglycan subunits that have a decreased binding affinity with vancomycin. It was isolated from Enterococcus gallinarum.", "category_aro_class_name": "AMR Gene Family"}, "35947": {"category_aro_accession": "0000028", "category_aro_cvterm_id": "35947", "category_aro_name": "vancomycin", "category_aro_description": "Vancomycin is a glycopeptide antibiotic used in the prophylaxis and treatment of infections caused by Gram-positive bacteria. Vancomycin inhibits the synthesis of peptidoglycan, the major component of the cell wall of gram-positive bacteria. Its mechanism of action is unusual in that it acts by binding precursors of peptidoglycan, rather than by interacting with an enzyme.", "category_aro_class_name": "Antibiotic"}, "36220": {"category_aro_accession": "3000081", "category_aro_cvterm_id": "36220", "category_aro_name": "glycopeptide antibiotic", "category_aro_description": "Glycopeptide antibiotics are natural products produced non-ribosomally by Actinomycetales bacteria. With the exception of bleomycins, they act by binding the terminal D-Ala-D-Ala in peptidoglycan precursors of the growing bacterial cell wall and are generally active against Gram-positive bacteria.  This inhibits transglycosylation leading to cell death due to osmotic stress.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00969389, "max_identities": 38, "bit_score": 35.039, "cvterm_id": "35918", "query": "KHRNY-GLDLVKILACILVLCLHSLVPTSPVVKNSLLNLSVYYA--GAIAIPIFFMASSYFVLNKRMMSYSYVMRRVGEILFIIIGWVLIYSI-----VHLCIKHNFIFLEEL-----KGTAFVGIPNQHFYHFWFFWALIIMLLLSPLLWYLLQK", "match": "K+ +Y G+D  + +A +L++ +H    TSP+   S     ++      +A+P FFM S +F++++    Y+    ++G     I    LIY +     + + + + +  ++ L     K   F G      YH W+  A II    + + WYL++K", "sequence_from_db": "KNESYSGIDYFRFIAALLIVAIH----TSPLSSFSETGNFIFTRIVARVAVPFFFMTSGFFLISR----YTCNAEKLGA---FIKKTTLIYGVAILLYIPINVYNGYFKMDNLLPNIIKDIVFDGT----LYHLWYLPASIIG---AAIAWYLVKK", "sequence_from_broadstreet": "MTKNESYSGIDYFRFIAALLIVAIHTSPLSSFSETGNFIFTRIVARVAVPFFFMTSGFFLISRYTCNAEKLGAFIKKTTLIYGVAILLYIPINVYNGYFKMDNLLPNIIKDIVFDGTLYHLWYLPASIIGAAIAWYLVKKVHYRKAFLIASILYIIGLFGDSYYGIVKSVSCLNVFYNLIFQLTDYTRNGIFFAPIFFVLGGYISDSQNRLSLKRSIVGFIVCFALMFGEALTLHHFDIQKHDSMYVLLLPSVYCLFNLLLHFRGKRRTGLRTISLIIYIIHPFMIVVIRLFAKLLHLQSLLVENSLVHYIAVCFASVVLAVVITALLSSLKPKKAKHTADTDRAYLEINLNNLEHNVNTLQKAMSPKCELMAVVKAEAYGHGMYEVTTYLEQIGVSSFAVATIDEGIRLRKYGISSEILILGYTSPSRAKELCKYELTQTLIDYRYSLLLNKQGYDIKAHIKIDTGMHRLGFSTEDKDKILAAFSLKHIKVAGIFTHLCAADSLEENDVAFTNKQIGSFYKVLDWLKSSGLNIPKVHIQSSYGLLNYPELECDYIRVGVALYGVLSSTNDKTKLELDLRPVLSLKAKVVLIRKIKQGESVGYSRAFTATRDSLIAILPIGYADGFPRNLSCGNSYVLIGGRQAPIVGKICMDQLAVDVTDIPNVKTGSIATLIGKDGKEEITAPMVAESAESITNELLSRMGHRLNIIRRA", "dna_sequence_from_broadstreet": "ATGACTAAAAACGAAAGCTATTCTGGCATTGATTATTTTAGATTTATTGCAGCCTTATTGATTGTTGCTATTCATACTTCGCCTCTCTCTTCTTTTAGTGAAACAGGCAACTTTATATTTACACGCATTGTAGCCCGTGTAGCCGTTCCGTTCTTTTTTATGACATCTGGATTTTTTCTGATTTCCAGATATACCTGTAATGCCGAAAAGCTGGGAGCTTTTATAAAAAAGACAACCTTAATTTACGGGGTTGCAATACTCTTATACATACCTATCAATGTTTATAACGGTTATTTCAAAATGGACAACCTTTTGCCAAATATCATAAAAGATATTGTATTTGATGGTACTTTATATCACTTGTGGTATCTTCCTGCATCTATTATCGGAGCTGCGATTGCTTGGTATCTGGTAAAGAAAGTTCATTATCGCAAAGCCTTTTTGATAGCTTCTATACTCTATATCATAGGCTTATTTGGAGATAGTTATTATGGAATTGTGAAAAGCGTTTCCTGCTTAAATGTTTTTTACAATCTAATCTTCCAATTAACAGATTACACAAGAAACGGAATATTTTTTGCCCCAATCTTTTTTGTGCTTGGTGGATATATCTCTGATAGTCAAAACAGACTATCGTTAAAAAGAAGTATAGTAGGATTTATAGTTTGTTTTGCCCTTATGTTTGGAGAAGCCCTTACTTTACATCATTTTGATATACAGAAACATGACAGTATGTATGTGCTTTTACTTCCGAGTGTGTATTGCTTATTTAATCTTCTTCTGCACTTTAGAGGAAAACGCCGCACAGGATTACGGACAATATCATTGATTATCTATATCATTCATCCGTTTATGATTGTTGTAATACGATTGTTTGCCAAATTACTGCATCTGCAAAGCCTGCTTGTTGAAAACAGCCTTGTTCATTATATTGCGGTCTGCTTTGCATCGGTAGTATTAGCAGTGGTTATAACAGCGTTATTGAGCAGTCTGAAACCGAAAAAGGCAAAACATACCGCCGATACGGATAGAGCGTATCTGGAAATCAACCTAAATAATTTAGAGCATAATGTAAACACTTTGCAAAAAGCAATGTCACCTAAATGTGAATTGATGGCGGTTGTAAAAGCGGAAGCCTATGGTCACGGTATGTATGAAGTGACGACATATCTTGAGCAGATAGGAGTTTCTTCATTTGCGGTAGCTACCATTGATGAAGGTATCCGATTGAGAAAATATGGCATCTCTAGCGAAATCCTAATTTTAGGCTATACATCGCCTTCAAGGGCAAAAGAACTTTGTAAGTATGAGCTGACACAAACCTTGATAGATTATAGGTATTCGTTGCTTTTGAATAAACAGGGATATGACATTAAAGCACATATTAAAATTGACACAGGTATGCATAGACTTGGATTTAGCACAGAAGATAAGGATAAAATCCTTGCAGCTTTTTCTTTGAAGCACATCAAAGTTGCGGGAATTTTTACACATTTGTGTGCGGCTGACAGCCTTGAAGAAAATGATGTTGCATTTACAAACAAGCAAATAGGCAGTTTCTATAAAGTGCTTGATTGGCTGAAAAGCAGCGGTTTGAATATACCTAAAGTACATATCCAAAGTAGTTATGGATTATTGAATTATCCAGAGCTTGAATGTGATTATATCAGAGTGGGTGTTGCTCTGTATGGTGTTTTAAGCTCTACTAATGACAAAACAAAATTAGAACTTGATTTAAGACCTGTACTTTCTTTGAAAGCAAAAGTTGTTTTAATTCGGAAGATAAAGCAGGGCGAAAGTGTTGGTTATAGCAGGGCTTTTACTGCAACCCGAGATAGTTTAATTGCCATATTACCAATTGGATATGCAGATGGTTTTCCAAGAAATCTGTCTTGTGGAAATAGTTATGTGCTGATTGGTGGACGACAAGCCCCTATTGTCGGAAAAATCTGTATGGATCAACTTGCAGTTGATGTAACAGATATTCCCAATGTTAAGACTGGAAGTATTGCAACGCTGATTGGTAAAGATGGAAAGGAAGAAATTACAGCACCGATGGTAGCTGAAAGTGCAGAAAGCATAACCAATGAATTGTTAAGCCGTATGGGACACAGATTAAATATTATTCGTAGAGCGTAA", "partial": "0", "query_start": 12999, "query_end": 13427, "hit_start": 6, "hit_end": 420, "orf_dna_sequence": "TTGAGTAATAGAAAACATAGAAATTATGGTTTAGATTTAGTAAAAATCCTAGCATGTATTTTAGTATTGTGTCTTCATTCTTTAGTTCCAACAAGTCCAGTAGTTAAAAATAGTTTACTTAATTTAAGTGTTTATTATGCTGGGGCAATTGCAATTCCTATATTTTTTATGGCAAGCAGTTATTTTGTTTTAAATAAAAGAATGATGTCATATTCTTATGTTATGAGAAGAGTGGGAGAAATTCTTTTTATAATAATTGGCTGGGTATTAATATATAGTATAGTTCATTTATGTATAAAACATAATTTTATTTTTCTTGAAGAACTGAAGGGGACTGCTTTTGTAGGAATTCCAAATCAGCATTTTTATCACTTTTGGTTCTTTTGGGCACTTATTATTATGCTGTTGTTATCCCCATTATTATGGTATCTTTTGCAAAAAAGTTTTGTAGGATATTTAATTTTGACAAGTATAGTTACTTTGATTTGTATAGGTATTGATATTTCGATGCATTTTGGCAACAGTTCTAATATTCGGAACATACCACAGATTTTTAGACTATATTTATATATTGAATACTATCTTTTAGGTGGCTTAATTGGAAATACTAATTTTGAGAAAATAAAAAATTTTTGCAAGCAACATTTTGTAATGACATGCATTGTAGCTAGTTTTTTATATGTTGGAGTGATCGCATATTCAATTTGGAATAGAAATATAATTCATTGGTTTTATGCTGAGGCAAATTATGGAAATGCTCTGATTATATTTACTTCAGTATTGATACTTATAATTTTTTCTATTTCTTCTCCACCTAATAAAAGTACAATTGAATTTATTATTCCTGCAACAATGGGAATATATATGCTTCATCCATTTTTTATTGGTAAATTAATGAAGATTCATATTTTATATAATTATCCTATTTTTATGATTCCCGTTTTGTTCATTCTATGTTTGATAATTGTAGAAATTGCTCTACGTATTCCAATTATTAATCGTTTCTTTAAATTATAA", "orf_prot_sequence": "MSNRKHRNYGLDLVKILACILVLCLHSLVPTSPVVKNSLLNLSVYYAGAIAIPIFFMASSYFVLNKRMMSYSYVMRRVGEILFIIIGWVLIYSIVHLCIKHNFIFLEELKGTAFVGIPNQHFYHFWFFWALIIMLLLSPLLWYLLQKSFVGYLILTSIVTLICIGIDISMHFGNSSNIRNIPQIFRLYLYIEYYLLGGLIGNTNFEKIKNFCKQHFVMTCIVASFLYVGVIAYSIWNRNIIHWFYAEANYGNALIIFTSVLILIIFSISSPPNKSTIEFIIPATMGIYMLHPFFIGKLMKIHILYNYPIFMIPVLFILCLIIVEIALRIPIINRFFKL", "perc_identity": 24.36}, "gnl|BL_ORD_ID|4745|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 12987, "orf_end": 14003, "orf_from": "BGC0000765.1|Exopolysaccharide_17 ", "model_name": "vanT gene in vanN cluster", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "200", "model_id": "1983", "ARO_accession": "3002975", "ARO_name": "vanT gene in vanN cluster", "ARO_category": {"36373": {"category_aro_accession": "3000234", "category_aro_cvterm_id": "36373", "category_aro_name": "glycopeptide resistance gene cluster", "category_aro_description": "Genes that when expressed confer resistance to vancomycin and teicoplanin type antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "36511": {"category_aro_accession": "3000372", "category_aro_cvterm_id": "36511", "category_aro_name": "vanT", "category_aro_description": "VanT is a membrane bound serine racemase, converting L-serine to D-serine. It is associated with VanC, which incorporated D-serine into D-Ala-D-Ser terminal end of peptidoglycan subunits that have a decreased binding affinity with vancomycin. It was isolated from Enterococcus gallinarum.", "category_aro_class_name": "AMR Gene Family"}, "35947": {"category_aro_accession": "0000028", "category_aro_cvterm_id": "35947", "category_aro_name": "vancomycin", "category_aro_description": "Vancomycin is a glycopeptide antibiotic used in the prophylaxis and treatment of infections caused by Gram-positive bacteria. Vancomycin inhibits the synthesis of peptidoglycan, the major component of the cell wall of gram-positive bacteria. Its mechanism of action is unusual in that it acts by binding precursors of peptidoglycan, rather than by interacting with an enzyme.", "category_aro_class_name": "Antibiotic"}, "36220": {"category_aro_accession": "3000081", "category_aro_cvterm_id": "36220", "category_aro_name": "glycopeptide antibiotic", "category_aro_description": "Glycopeptide antibiotics are natural products produced non-ribosomally by Actinomycetales bacteria. With the exception of bleomycins, they act by binding the terminal D-Ala-D-Ala in peptidoglycan precursors of the growing bacterial cell wall and are generally active against Gram-positive bacteria.  This inhibits transglycosylation leading to cell death due to osmotic stress.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.92844, "max_identities": 17, "bit_score": 27.335, "cvterm_id": "36779", "query": "YHFWFFWALIIMLLLSPLLWYLLQK-SFVGYLILTSIVTLICIGID", "match": "YH W+F ALI+ +L   +++ LLQ+ +    L++T +  L+C+G D", "sequence_from_db": "YHLWYFPALILGVL---IVYCLLQRFTLRQVLLVTFLFYLLCLGGD", "sequence_from_broadstreet": "MKNVNTGINQFRLIAAFMVVAIHCFPFQSFSKTLDILITLTLFRTAVPFFLMVTGFYLIGPIATKRGYPAYLKIKKFLKKQVKLYVLATLIYLPLAFYSGVITFKTSVIQFFQLIFFEGVLYHLWYFPALILGVLIVYCLLQRFTLRQVLLVTFLFYLLCLGGDSWWGLARQIPVLEKSYQGIFTLMIHTRNGLFFAPFFLTLGASFHQSEWNMRTSKAKYFLLIASLGMLVESYLLHSFSSPKHDSAYLFLPVVMFFLFPLILNWQPTRVIADASTISLGIYVLHPYVIAVVHTLAKKITILNNSLIYYLCVSLLTSLIILYVHSKKKKTTKNQATFVPRTKKVLSKQAVIHNLAQINQVIPKTTKIMAVIKANAYGTDDTEFARILEQQGVDFFAVATIDEGIRLRENGIKSKILILGYTPSIRIKELAHYTLIQTIVSKEHAYSLNQQKIPISCHLKIDTGMHRLGVEPVVQEVSSLYRLPYLNIQGIYSHLGSADDRSDKGMKRTRKQISIFDYLLHELELQKIDVGVTHLQSSYGILNYPELVYDYVRPGILLYGYLSEHNGDSKINLNLQPILDVQALLVSKKWVAAGEYLGYSLDTKLVSPKLIGIVSIGYADGVPRELSHNEFYLAYQGQNLPQIGRICMDMLLVDLTDSPEIKVESQISIFPELEQTANQTNTLTNEIISRLGNRFYTEWS", "dna_sequence_from_broadstreet": "ATGAAAAACGTAAATACCGGGATCAATCAATTTCGATTGATCGCTGCTTTCATGGTCGTTGCGATTCACTGTTTTCCTTTTCAGTCGTTTAGTAAAACTCTTGATATATTGATTACTTTGACACTCTTTCGAACTGCCGTACCTTTTTTCTTAATGGTCACAGGTTTTTATTTAATTGGACCGATTGCCACTAAGAGAGGCTATCCAGCCTATTTAAAGATAAAAAAATTTTTAAAAAAGCAAGTGAAGCTATATGTGCTTGCTACGCTCATTTATCTTCCACTAGCTTTTTATAGTGGTGTGATCACTTTCAAGACGAGTGTCATTCAATTTTTTCAACTCATCTTTTTCGAAGGAGTTCTTTACCACTTGTGGTATTTTCCAGCATTGATTTTAGGTGTTCTCATCGTTTACTGCTTATTACAGCGGTTCACGCTTCGACAAGTTTTATTAGTGACTTTTCTATTCTATTTACTATGTTTGGGCGGCGATAGCTGGTGGGGGTTAGCTAGACAAATTCCTGTGTTAGAAAAAAGTTATCAAGGGATATTTACGCTCATGATCCATACTCGAAATGGACTATTTTTTGCCCCTTTCTTTTTAACACTCGGTGCTTCGTTCCATCAATCAGAGTGGAACATGCGTACATCTAAAGCCAAGTATTTTTTGTTGATTGCTAGTTTAGGCATGCTAGTGGAAAGCTATTTGCTACACTCCTTTAGTTCACCAAAACATGATAGTGCATACCTATTCTTGCCTGTGGTGATGTTTTTTCTTTTTCCACTTATTTTGAACTGGCAGCCTACACGTGTCATTGCCGACGCTTCGACAATCAGTTTAGGTATTTATGTCCTTCATCCTTATGTCATTGCTGTTGTCCATACTTTAGCCAAAAAAATAACGATACTAAACAATAGTTTAATTTATTATCTCTGCGTTTCCCTTTTAACTAGTTTGATTATTCTTTATGTACACTCTAAGAAAAAGAAAACGACAAAAAATCAGGCTACGTTTGTCCCTAGAACAAAAAAAGTACTCTCTAAGCAAGCAGTTATCCATAATTTGGCACAAATCAATCAAGTGATTCCGAAAACAACGAAAATAATGGCTGTCATAAAAGCCAACGCTTATGGAACTGATGATACAGAATTTGCTCGAATCTTAGAACAACAAGGAGTTGATTTTTTTGCTGTCGCTACCATTGATGAAGGCATTCGTTTGCGAGAAAATGGAATTAAAAGCAAAATCTTAATTCTAGGCTATACACCATCGATACGAATAAAAGAATTAGCTCACTACACATTAATACAAACAATCGTTAGCAAAGAACATGCTTATTCATTAAATCAACAAAAGATACCTATTTCGTGCCATCTAAAAATTGATACTGGCATGCATCGTTTAGGTGTTGAGCCTGTGGTTCAGGAGGTTTCATCCTTATATCGATTACCCTACTTAAATATTCAAGGTATTTATTCTCATCTCGGTTCAGCTGATGATCGAAGTGACAAAGGAATGAAACGCACGAGAAAACAAATTTCGATTTTTGATTATTTATTACATGAACTAGAACTTCAAAAAATCGATGTCGGTGTTACGCATCTGCAAAGTAGCTATGGTATTTTGAATTATCCTGAACTGGTCTATGATTATGTTCGTCCTGGTATTCTTTTATACGGTTATTTAAGTGAACATAATGGAGATTCAAAAATCAACTTAAATTTGCAACCAATTTTAGATGTCCAAGCACTGCTCGTATCAAAAAAATGGGTTGCTGCTGGTGAATATCTTGGCTATAGCCTTGATACTAAACTAGTTTCTCCAAAGCTGATTGGTATCGTCAGCATCGGCTATGCAGACGGTGTTCCTAGAGAGTTATCTCACAATGAGTTTTATCTTGCTTATCAGGGACAAAATCTACCACAAATCGGACGAATTTGTATGGATATGCTATTAGTGGATTTGACTGATTCTCCAGAAATCAAAGTAGAGTCACAAATTAGTATCTTCCCAGAACTAGAACAAACTGCTAATCAAACGAATACATTGACTAACGAAATCATCAGTCGCTTAGGTAATCGTTTCTACACCGAATGGTCCTAA", "partial": "0", "query_start": 13353, "query_end": 13487, "hit_start": 363, "hit_end": 492, "orf_dna_sequence": "TTGAGTAATAGAAAACATAGAAATTATGGTTTAGATTTAGTAAAAATCCTAGCATGTATTTTAGTATTGTGTCTTCATTCTTTAGTTCCAACAAGTCCAGTAGTTAAAAATAGTTTACTTAATTTAAGTGTTTATTATGCTGGGGCAATTGCAATTCCTATATTTTTTATGGCAAGCAGTTATTTTGTTTTAAATAAAAGAATGATGTCATATTCTTATGTTATGAGAAGAGTGGGAGAAATTCTTTTTATAATAATTGGCTGGGTATTAATATATAGTATAGTTCATTTATGTATAAAACATAATTTTATTTTTCTTGAAGAACTGAAGGGGACTGCTTTTGTAGGAATTCCAAATCAGCATTTTTATCACTTTTGGTTCTTTTGGGCACTTATTATTATGCTGTTGTTATCCCCATTATTATGGTATCTTTTGCAAAAAAGTTTTGTAGGATATTTAATTTTGACAAGTATAGTTACTTTGATTTGTATAGGTATTGATATTTCGATGCATTTTGGCAACAGTTCTAATATTCGGAACATACCACAGATTTTTAGACTATATTTATATATTGAATACTATCTTTTAGGTGGCTTAATTGGAAATACTAATTTTGAGAAAATAAAAAATTTTTGCAAGCAACATTTTGTAATGACATGCATTGTAGCTAGTTTTTTATATGTTGGAGTGATCGCATATTCAATTTGGAATAGAAATATAATTCATTGGTTTTATGCTGAGGCAAATTATGGAAATGCTCTGATTATATTTACTTCAGTATTGATACTTATAATTTTTTCTATTTCTTCTCCACCTAATAAAAGTACAATTGAATTTATTATTCCTGCAACAATGGGAATATATATGCTTCATCCATTTTTTATTGGTAAATTAATGAAGATTCATATTTTATATAATTATCCTATTTTTATGATTCCCGTTTTGTTCATTCTATGTTTGATAATTGTAGAAATTGCTCTACGTATTCCAATTATTAATCGTTTCTTTAAATTATAA", "orf_prot_sequence": "MSNRKHRNYGLDLVKILACILVLCLHSLVPTSPVVKNSLLNLSVYYAGAIAIPIFFMASSYFVLNKRMMSYSYVMRRVGEILFIIIGWVLIYSIVHLCIKHNFIFLEELKGTAFVGIPNQHFYHFWFFWALIIMLLLSPLLWYLLQKSFVGYLILTSIVTLICIGIDISMHFGNSSNIRNIPQIFRLYLYIEYYLLGGLIGNTNFEKIKNFCKQHFVMTCIVASFLYVGVIAYSIWNRNIIHWFYAEANYGNALIIFTSVLILIIFSISSPPNKSTIEFIIPATMGIYMLHPFFIGKLMKIHILYNYPIFMIPVLFILCLIIVEIALRIPIINRFFKL", "perc_identity": 36.96}, "gnl|BL_ORD_ID|596|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 12987, "orf_end": 14003, "orf_from": "BGC0000765.1|Exopolysaccharide_17 ", "model_name": "Clostridium butyricum catB", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "492", "ARO_accession": "3002674", "ARO_name": "Clostridium butyricum catB", "ARO_category": {"36261": {"category_aro_accession": "3000122", "category_aro_cvterm_id": "36261", "category_aro_name": "chloramphenicol acetyltransferase (CAT)", "category_aro_description": "Inactivates chloramphenicol by addition of an acyl group. CAT is used to describe many variants of the chloramphenicol acetyltransferase gene in a range of organisms including Acinetobacter calcoaceticus, Agrobacterium tumefaciens, Alkalihalobacillus clausii, Bacillus subtilis, Campylobacter coli, Enterococcus faecalis, Enterococcus faecium, Lactococcus lactis, Listeria monocytogenes, Listonella anguillarum, Morganella morganii, Photobacterium damselae subsp. piscicida, Proteus mirabilis, Salmonella typhi, Serratia marcescens, Shigella flexneri, Staphylococcus aureus, Staphylococcus haemolyticus, Staphylococcus intermedius, Streptococcus agalactiae, Streptococcus suis and Streptomyces acrimycini.", "category_aro_class_name": "AMR Gene Family"}, "36521": {"category_aro_accession": "3000382", "category_aro_cvterm_id": "36521", "category_aro_name": "azidamfenicol", "category_aro_description": "Azidamfenicol is a water soluble derivative of chloramphenicol, sharing the same mode of action of inhibiting peptide synthesis by interacting with the 23S RNA of the 50S ribosomal subunit.", "category_aro_class_name": "Antibiotic"}, "36524": {"category_aro_accession": "3000385", "category_aro_cvterm_id": "36524", "category_aro_name": "chloramphenicol", "category_aro_description": "Chloramphenicol is a bacteriostatic antimicrobial originally derived from the bacterium Streptomyces venezuelae. It was the first antibiotic to be manufactured synthetically on a large scale. It functions by inhibiting peptidyl transferase activity of the bacterial ribosome, binding to A2451 and A2452 residues in the 23S rRNA of the 50S ribosomal subunit and preventing peptide bond formation.", "category_aro_class_name": "Antibiotic"}, "36595": {"category_aro_accession": "3000456", "category_aro_cvterm_id": "36595", "category_aro_name": "thiamphenicol", "category_aro_description": "Derivative of Chloramphenicol. The nitro group (-NO2) is substituted by a sulfomethyl group (-SO2CH3).", "category_aro_class_name": "Antibiotic"}, "36526": {"category_aro_accession": "3000387", "category_aro_cvterm_id": "36526", "category_aro_name": "phenicol antibiotic", "category_aro_description": "Phenicols are broad spectrum bacteriostatic antibiotics acting on bacterial protein synthesis. More specifically, the phenicols block peptide elongation by binding to the peptidyltansferase centre of the 70S ribosome.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.26419, "max_identities": 20, "bit_score": 26.9498, "cvterm_id": "36845", "query": "LDLVKILACILVLCLHSLVPTS-------PVVKNSLLNLSVYYAGAIAIPIFFMASSYFVLNKRM", "match": "LD +K    I+     S  P +       P V  +  NL+VY  G   IPI F A  YF    ++", "sequence_from_db": "LDDIKNYGNIMKFTPKSNEPDNTFSVSSIPWVSFTGFNLNVYNEGTYLIPI-FTAGKYFKQENKI", "sequence_from_broadstreet": "MNFNLIDINHWSRKPYFEHYLNNVKCTYSMTANIEITDLLYEIKLKNIKFYPTLIYMIATVVNNHKEFRICFDHKGSLGYWDSMNPSYTIFHKENETFSSIWTEYNKSFLRFYSDYLDDIKNYGNIMKFTPKSNEPDNTFSVSSIPWVSFTGFNLNVYNEGTYLIPIFTAGKYFKQENKIFIPISIQVHHAICDGYHASRFINEMQELAFSFQEWLENK", "dna_sequence_from_broadstreet": "ATGAATTTTAATTTAATAGATATTAATCATTGGAGTAGAAAGCCATACTTTGAACATTATTTAAACAATGTGAAATGTACTTACAGTATGACTGCCAATATAGAAATAACTGATTTATTGTATGAAATTAAACTTAAAAATATTAAATTTTATCCTACACTTATTTATATGATTGCAACTGTGGTTAATAATCATAAAGAATTCCGTATTTGTTTTGATCATAAAGGTAGTTTAGGATATTGGGATAGCATGAATCCAAGCTATACTATTTTTCATAAAGAAAACGAAACATTTTCAAGTATTTGGACGGAATATAACAAAAGTTTTTTACGTTTTTATAGTGATTATCTTGACGATATAAAAAACTATGGAAATATCATGAAGTTTACTCCGAAATCAAATGAACCTGACAATACATTTTCTGTATCAAGTATTCCTTGGGTGAGTTTTACAGGATTTAACTTGAATGTTTATAATGAAGGAACATATTTAATTCCTATTTTTACTGCAGGAAAGTATTTCAAACAAGAAAATAAAATATTTATTCCTATATCAATACAAGTACATCATGCTATCTGTGACGGTTATCATGCTAGTAGATTTATTAATGAAATGCAAGAATTAGCATTTAGTTTTCAAGAATGGTTAGAAAATAAATAA", "partial": "0", "query_start": 13017, "query_end": 13190, "hit_start": 348, "hit_end": 540, "orf_dna_sequence": "TTGAGTAATAGAAAACATAGAAATTATGGTTTAGATTTAGTAAAAATCCTAGCATGTATTTTAGTATTGTGTCTTCATTCTTTAGTTCCAACAAGTCCAGTAGTTAAAAATAGTTTACTTAATTTAAGTGTTTATTATGCTGGGGCAATTGCAATTCCTATATTTTTTATGGCAAGCAGTTATTTTGTTTTAAATAAAAGAATGATGTCATATTCTTATGTTATGAGAAGAGTGGGAGAAATTCTTTTTATAATAATTGGCTGGGTATTAATATATAGTATAGTTCATTTATGTATAAAACATAATTTTATTTTTCTTGAAGAACTGAAGGGGACTGCTTTTGTAGGAATTCCAAATCAGCATTTTTATCACTTTTGGTTCTTTTGGGCACTTATTATTATGCTGTTGTTATCCCCATTATTATGGTATCTTTTGCAAAAAAGTTTTGTAGGATATTTAATTTTGACAAGTATAGTTACTTTGATTTGTATAGGTATTGATATTTCGATGCATTTTGGCAACAGTTCTAATATTCGGAACATACCACAGATTTTTAGACTATATTTATATATTGAATACTATCTTTTAGGTGGCTTAATTGGAAATACTAATTTTGAGAAAATAAAAAATTTTTGCAAGCAACATTTTGTAATGACATGCATTGTAGCTAGTTTTTTATATGTTGGAGTGATCGCATATTCAATTTGGAATAGAAATATAATTCATTGGTTTTATGCTGAGGCAAATTATGGAAATGCTCTGATTATATTTACTTCAGTATTGATACTTATAATTTTTTCTATTTCTTCTCCACCTAATAAAAGTACAATTGAATTTATTATTCCTGCAACAATGGGAATATATATGCTTCATCCATTTTTTATTGGTAAATTAATGAAGATTCATATTTTATATAATTATCCTATTTTTATGATTCCCGTTTTGTTCATTCTATGTTTGATAATTGTAGAAATTGCTCTACGTATTCCAATTATTAATCGTTTCTTTAAATTATAA", "orf_prot_sequence": "MSNRKHRNYGLDLVKILACILVLCLHSLVPTSPVVKNSLLNLSVYYAGAIAIPIFFMASSYFVLNKRMMSYSYVMRRVGEILFIIIGWVLIYSIVHLCIKHNFIFLEELKGTAFVGIPNQHFYHFWFFWALIIMLLLSPLLWYLLQKSFVGYLILTSIVTLICIGIDISMHFGNSSNIRNIPQIFRLYLYIEYYLLGGLIGNTNFEKIKNFCKQHFVMTCIVASFLYVGVIAYSIWNRNIIHWFYAEANYGNALIIFTSVLILIIFSISSPPNKSTIEFIIPATMGIYMLHPFFIGKLMKIHILYNYPIFMIPVLFILCLIIVEIALRIPIINRFFKL", "perc_identity": 30.77}}, "BGC0000765.1|Exopolysaccharide_19 # 14758 # 14988 # 1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=14bp;gc_cont=0.411": {"gnl|BL_ORD_ID|3103|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 14758, "orf_end": 14988, "orf_from": "BGC0000765.1|Exopolysaccharide_19 ", "model_name": "ACT-50", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "4141", "ARO_accession": "3006245", "ARO_name": "ACT-50", "ARO_category": {"36211": {"category_aro_accession": "3000072", "category_aro_cvterm_id": "36211", "category_aro_name": "ACT beta-lactamase", "category_aro_description": "ACT beta-lactamases, also known as AmpC beta-lactamases, are cephalosporinases that cannot be inhibited by clavulanate. These enzymes are encoded by genes located on the chromosome and can be induced by the presence of beta-lactam antibiotics. However recently, these genes have been found on plasmids and expressed at high constitutive levels in Escherichia coli and Klebsiella pneumoniae.", "category_aro_class_name": "AMR Gene Family"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35962": {"category_aro_accession": "0000044", "category_aro_cvterm_id": "35962", "category_aro_name": "cephamycin", "category_aro_description": "Cephamycins are a group of beta-lactam antibiotics, very similar to cephalosporins. Together with cephalosporins, they form a sub-group of antibiotics known as cephems. Cephamycins are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. The 7-alpha-methoxy group increases resistance to beta-lactamases.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.36755, "max_identities": 12, "bit_score": 22.7126, "cvterm_id": "35506", "query": "MSQENLEKIISQQATTIQNLTDEIKLLREQVAYLTQKHY", "match": "MS++ L K++ +  T + N    I  +   V Y  Q HY", "sequence_from_db": "MSEKQLAKVVERAVTPLMN-AQAIPGMAVAVIYQGQPHY", "sequence_from_broadstreet": "MMKKSLSCALLLSVACSAFAAPMSEKQLAKVVERAVTPLMNAQAIPGMAVAVIYQGQPHYFTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTRYWPELTGKQWQGIRMLDLATYTAGGLPLQVPDDVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGALAVKPSGMSFEEAMTKRVFKPLRLDHTWINVPKAEEAHYAWGYRDGKAVHVSPGMLDAEAYGIKTNVKDMASWVVANMAPDALQDSSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDAKTVVGGSDNKVALAPLPAREVNPPVPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLANKSYPNPARVETAYRILDALQ", "dna_sequence_from_broadstreet": "ATGATGAAAAAATCCCTAAGTTGTGCCCTGCTGCTCAGCGTTGCCTGCTCTGCCTTCGCCGCCCCCATGTCAGAAAAACAGCTGGCTAAGGTGGTGGAGCGTGCCGTTACGCCGCTGATGAACGCGCAGGCCATTCCGGGTATGGCGGTGGCGGTAATTTATCAGGGTCAGCCGCACTACTTTACCTTTGGTAAAGCGGATGTCGCGGCGAATAAACCTGTTACGCCTCAAACCTTGTTCGAGCTGGGCTCTATAAGTAAAACCTTCACCGGCGTATTGGGTGGCGATGCGATTGCTCGCGGTGAAATCTCACTGGGTGATCCAGTGACAAGGTACTGGCCTGAACTGACAGGAAAACAGTGGCAGGGCATTCGCATGCTGGATCTGGCAACCTATACCGCAGGGGGGTTGCCGTTACAGGTACCGGATGACGTCACTGATAACGCCTCTCTGCTGCGCTTTTATCAAAACTGGCAGCCGCAGTGGAAGCCGGGCACCACGCGTCTTTATGCCAACGCCAGCATCGGTCTTTTTGGTGCTCTCGCGGTTAAACCCTCCGGCATGAGTTTTGAAGAGGCCATGACGAAGCGGGTCTTTAAGCCGCTCAGGCTCGACCATACGTGGATTAACGTACCAAAAGCGGAAGAGGCGCATTACGCCTGGGGATACCGTGACGGTAAAGCGGTACACGTTTCTCCAGGGATGCTGGACGCTGAAGCCTATGGCATAAAAACCAACGTGAAAGATATGGCGAGCTGGGTGGTGGCAAACATGGCCCCCGATGCCCTTCAGGATAGCTCTCTCAAACAAGGGATAGCCCTGGCACAGTCCCGCTACTGGCGCGTGGGTGCCATGTATCAGGGGTTAGGCTGGGAAATGCTGAACTGGCCGGTCGATGCCAAAACCGTGGTCGGGGGCAGCGACAATAAGGTGGCGCTGGCGCCGTTGCCTGCCAGAGAAGTCAATCCCCCGGTACCGCCGGTTAAGGCCTCCTGGGTACACAAAACGGGTTCAACCGGTGGGTTTGGGAGCTACGTGGCATTTATTCCTGAAAAACAGCTCGGCATTGTGATGCTGGCGAATAAAAGCTATCCGAATCCGGCACGCGTTGAGACGGCATACCGTATCCTCGACGCGCTGCAGTAA", "partial": "0", "query_start": 14758, "query_end": 14874, "hit_start": 66, "hit_end": 180, "orf_dna_sequence": "ATGTCACAAGAAAATTTGGAAAAGATTATTTCCCAACAGGCAACTACCATTCAAAACCTAACTGATGAGATCAAGCTTCTCCGTGAACAAGTAGCTTACTTAACGCAAAAGCATTACGGCAAGTCTTCAGAACAAATGTCCTTGAATGGCCAAACAAGTTTATTTGATGAGTCTGAAGCTCAAGATGACGGAGAGCGTCCCCGACGCCGCCATTCAGACTATTACTTATAG", "orf_prot_sequence": "MSQENLEKIISQQATTIQNLTDEIKLLREQVAYLTQKHYGKSSEQMSLNGQTSLFDESEAQDDGERPRRRHSDYYL", "perc_identity": 30.77}}, "BGC0000765.1|Exopolysaccharide_20 # 14942 # 15046 # 1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.505": {"gnl|BL_ORD_ID|307|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 14942, "orf_end": 15046, "orf_from": "BGC0000765.1|Exopolysaccharide_20 ", "model_name": "adeC", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "850", "model_id": "337", "ARO_accession": "3003811", "ARO_name": "adeC", "ARO_category": {"36005": {"category_aro_accession": "0010004", "category_aro_cvterm_id": "36005", "category_aro_name": "resistance-nodulation-cell division (RND) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.", "category_aro_class_name": "AMR Gene Family"}, "35949": {"category_aro_accession": "0000030", "category_aro_cvterm_id": "35949", "category_aro_name": "tigecycline", "category_aro_description": "Tigecycline is an glycylcycline antibiotic. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35960": {"category_aro_accession": "0000042", "category_aro_cvterm_id": "35960", "category_aro_name": "glycylcycline", "category_aro_description": "Glycylcyclines are a new class of antibiotics derived from tetracycline. These tetracycline analogues are specifically designed to overcome two common mechanisms of tetracycline resistance. Presently, there is only one glycylcycline antibiotic for clinical use: tigecycline. It works by inhibiting action of the prokaryotic 30S ribosome, preventing the binding of aminoacyl-tRNA.", "category_aro_class_name": "Drug Class"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.07424, "max_identities": 10, "bit_score": 22.3274, "cvterm_id": "35507", "query": "VPDAAIQTITYRRQAHTRKRADLL", "match": "+PD AIQ IT+ +       +DLL", "sequence_from_db": "LPDHAIQNITFEKNFAAGLPSDLL", "sequence_from_broadstreet": "MSKSTIVSRGLILSTLSIALVACVNMQAPQPAITSHIPQNFSQNHSGKMIAEKSYKEFISDPKLLQVIEISLNNNRDLRTATLNIERVQQEYQITKNSQLPTIGVTGNAVRQVSPSINPNNPVSTFQVGLGMTAYELDFWGRVQNLKDAALNNYLATQSAKEAVQIGLISNITQVWLNYAFAQANLNLAEQTLKAQVDAYNLNKKRFDVGIDSEVPLKQAQISVETARNDVATYKTQIQQAKNLLDLLAGHPVPQNLLPDHAIQNITFEKNFAAGLPSDLLNHRPDLKAAEYELRVAGANIGAAKARMFPTISLTGSTGYASSELKDLFKTGNFAWSIGPNIDLPIFDWGTRKTNIKIAETDQKIALAKYEKAIQSAFREVNDALATHAHIGERLDAQRRLVSATAATYKLSMARYKAGVDSYFTVLDAQRSAYAAQQGLLALEQIKLNNQIEIYKVLGGGISKV", "dna_sequence_from_broadstreet": "ATGTCTAAATCGACAATCGTATCTCGTGGACTCATTCTTTCTACACTCTCAATTGCACTCGTTGCATGTGTCAATATGCAAGCGCCACAGCCTGCAATTACATCTCATATTCCTCAAAATTTTAGTCAAAATCATTCTGGAAAAATGATTGCAGAAAAAAGTTATAAAGAATTTATTTCTGATCCGAAATTATTACAGGTCATTGAAATCAGTTTAAATAACAACCGTGATTTACGGACTGCTACGCTTAATATTGAACGTGTACAGCAAGAATACCAAATCACAAAAAATAGCCAGCTCCCAACCATTGGTGTAACGGGAAATGCAGTGCGGCAGGTTAGCCCATCGATTAACCCCAATAACCCAGTTTCTACATTTCAAGTTGGCTTGGGAATGACTGCCTATGAGCTAGATTTTTGGGGCCGTGTTCAAAATTTAAAAGATGCTGCATTAAATAACTATCTTGCAACTCAAAGTGCAAAAGAAGCTGTACAAATTGGTTTAATCAGTAATATTACACAGGTCTGGTTAAATTATGCTTTTGCACAAGCAAATTTAAACCTTGCCGAGCAAACCTTAAAAGCACAAGTCGATGCTTATAACCTTAACAAGAAGCGCTTTGATGTTGGTATTGATAGTGAAGTGCCATTAAAACAAGCACAAATTTCGGTAGAGACTGCTCGAAATGATGTTGCAACTTATAAAACTCAAATTCAACAGGCAAAAAATTTACTGGATTTGTTAGCAGGTCATCCTGTTCCGCAAAATTTACTTCCGGATCATGCTATTCAAAATATTACCTTTGAGAAAAACTTTGCAGCCGGTTTACCAAGTGATTTATTAAATCATCGTCCAGACCTTAAAGCTGCCGAATATGAGTTACGTGTTGCAGGAGCAAATATTGGTGCTGCTAAAGCACGGATGTTCCCAACCATAAGCTTGACAGGCTCGACGGGTTATGCATCATCTGAACTGAAAGATTTATTTAAAACAGGCAATTTTGCATGGTCGATTGGACCTAATATCGATCTACCAATTTTTGATTGGGGAACAAGAAAAACTAATATTAAAATTGCGGAAACTGACCAGAAAATTGCTTTAGCTAAATATGAAAAAGCCATTCAATCAGCTTTTCGTGAAGTTAATGATGCACTTGCTACACATGCACATATTGGTGAACGATTAGACGCTCAGCGTCGCTTAGTCTCTGCGACTGCTGCAACCTATAAACTCTCAATGGCACGTTACAAAGCTGGAGTGGATAGTTATTTTACGGTTTTAGATGCTCAGCGTTCTGCTTATGCTGCACAACAAGGCTTACTTGCACTTGAACAAATAAAATTAAATAACCAAATTGAAATTTATAAAGTTTTAGGAGGAGGAATATCAAAAGTCTAA", "partial": "0", "query_start": 14954, "query_end": 15025, "hit_start": 771, "hit_end": 843, "orf_dna_sequence": "ATGACGGAGAGCGTCCCCGACGCCGCCATTCAGACTATTACTTATAGAAGACAAGCTCACACGAGAAAAAGAGCCGACCTGTTAGCAGGCTTTCCTGCTGAGTAA", "orf_prot_sequence": "MTESVPDAAIQTITYRRQAHTRKRADLLAGFPAE", "perc_identity": 41.67}, "gnl|BL_ORD_ID|3424|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 14942, "orf_end": 15046, "orf_from": "BGC0000765.1|Exopolysaccharide_20 ", "model_name": "CTX-M-150", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4493", "ARO_accession": "3002007", "ARO_name": "CTX-M-150", "ARO_category": {"36025": {"category_aro_accession": "3000016", "category_aro_cvterm_id": "36025", "category_aro_name": "CTX-M beta-lactamase", "category_aro_description": "These enzymes were named for their greater activity against cefotaxime than other oxyimino-beta-lactam substrates (eg, ceftazidime, ceftriaxone, or cefepime). Rather than arising by mutation, they represent examples of plasmid acquisition of beta-lactamase genes normally found on the chromosome of Kluyvera species, a group of rarely pathogenic commensal organisms. These enzymes are not very closely related to TEM or SHV beta-lactamases in that they show only approximately 40% identity with these two commonly isolated beta-lactamases. Despite their name, a few are more active on ceftazidime than cefotaxime.  CTX-M-15 was recently found in bacterial strains expressing NDM-1 and were responsible for resistance to aztreonam.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.9356, "max_identities": 9, "bit_score": 20.0162, "cvterm_id": "35914", "query": "QTITYRRQAHTRKRADLLAGFPAE", "match": "Q +T+ +  HT   A + AG PA ", "sequence_from_db": "QLVTWMK-GHTHGAASIQAGLPAS", "sequence_from_broadstreet": "MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGHTHGAASIQAGLPASWVVGDKTGSGGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL", "dna_sequence_from_broadstreet": "ATGGTTAAAAAATCACTGCGCCAGTTCACGCTGATGGCGACGGCAACCGTCACGCTGTTGTTAGGAAGTGTGCCGCTGTATGCGCAAACGGCGGACGTACAGCAAAAACTTGCCGAATTAGAGCGGCAGTCGGGAGGCAGACTGGGTGTGGCATTGATTAACACAGCAGATAATTCGCAAATACTTTATCGTGCTGATGAGCGCTTTGCGATGTGCAGCACCAGTAAAGTGATGGCCGCGGCCGCGGTGCTGAAGAAAAGTGAAAGCGAACCGAATCTGTTAAATCAGCGAGTTGAGATCAAAAAATCTGACCTTGTTAACTATAATCCGATTGCGGAAAAGCACGTCAATGGGACGATGTCACTGGCTGAGCTTAGCGCGGCCGCGCTACAGTACAGCGATAACGTGGCGATGAATAAGCTGATTGCTCACGTTGGCGGCCCGGCTAGCGTCACCGCGTTCGCCCGACAGCTGGGAGACGAAACGTTCCGTCTCGACCGTACCGAGCCGACGTTAAACACCGCCATTCCGGGCGATCCGCGTGATACCACTTCACCTCGGGCAATGGCGCAAACTCTGCGGAATCTGACGCTGGGTAAAGCATTGGGCGACAGCCAACGGGCGCAGCTGGTGACATGGATGAAAGGCCATACCCACGGTGCAGCGAGCATTCAGGCTGGACTGCCTGCTTCCTGGGTTGTGGGGGATAAAACCGGCAGCGGTGGCTATGGCACCACCAACGATATCGCGGTGATCTGGCCAAAAGATCGTGCGCCGCTAATTCTGGTCACTTACTTCACCCAGCCTCAACCTAAGGCAGAAAGCCGTCGCGATGTATTAGCGTCGGCGGCTAAAATCGTCACCGACGGTTTGTAA", "partial": "0", "query_start": 14972, "query_end": 15043, "hit_start": 624, "hit_end": 693, "orf_dna_sequence": "ATGACGGAGAGCGTCCCCGACGCCGCCATTCAGACTATTACTTATAGAAGACAAGCTCACACGAGAAAAAGAGCCGACCTGTTAGCAGGCTTTCCTGCTGAGTAA", "orf_prot_sequence": "MTESVPDAAIQTITYRRQAHTRKRADLLAGFPAE", "perc_identity": 37.5}, "gnl|BL_ORD_ID|1914|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 14942, "orf_end": 15046, "orf_from": "BGC0000765.1|Exopolysaccharide_20 ", "model_name": "AAC(6')-Ib7", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "475", "model_id": "2117", "ARO_accession": "3002578", "ARO_name": "AAC(6')-Ib7", "ARO_category": {"36484": {"category_aro_accession": "3000345", "category_aro_cvterm_id": "36484", "category_aro_name": "AAC(6')", "category_aro_description": "A category of aminoglycoside N-acetyltransferase enzymes with modification regiospecificity based at the 6'-amino group of the respective antibiotic. These enzymes inactivate aminoglycoside antibiotics through acetylation of the 6-amino group of the compound.", "category_aro_class_name": "AMR Gene Family"}, "35932": {"category_aro_accession": "0000013", "category_aro_cvterm_id": "35932", "category_aro_name": "amikacin", "category_aro_description": "Amikacin is an aminoglycoside antibiotic that works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35966": {"category_aro_accession": "0000049", "category_aro_cvterm_id": "35966", "category_aro_name": "kanamycin A", "category_aro_description": "Kanamycin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Kanamycin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35969": {"category_aro_accession": "0000052", "category_aro_cvterm_id": "35969", "category_aro_name": "tobramycin", "category_aro_description": "Tobramycin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Tobramycin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35935": {"category_aro_accession": "0000016", "category_aro_cvterm_id": "35935", "category_aro_name": "aminoglycoside antibiotic", "category_aro_description": "Aminoglycosides are a group of antibiotics that are mostly effective against Gram-negative bacteria. These molecules consist of aminated sugars attached to a dibasic cyclitol. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit (some work by binding to the 50S subunit), inhibiting the translocation of the peptidyl-tRNA from the A-site to the P-site and also causing misreading of mRNA, leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.47775, "max_identities": 9, "bit_score": 20.0162, "cvterm_id": "35906", "query": "TESVPDAAIQTITYRRQAHTRKRAD", "match": "T + PD     +   RQA  R R+D", "sequence_from_db": "TVTTPDGPAVYMVQTRQAFERTRSD", "sequence_from_broadstreet": "MRSRNWSRTLTERSGGNGAVAVFMACYDCFFVQSMPRASKQQARYAVGRCLMLWSSNDVTQQGSRPKTKLGITKYSIVTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQLLANASQLGKGLGTKLVRALVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERTRSDA", "dna_sequence_from_broadstreet": "ATGCGCTCACGCAACTGGTCCAGAACCTTGACCGAACGCAGCGGTGGTAACGGCGCAGTGGCGGTTTTCATGGCTTGTTATGACTGTTTTTTTGTACAGTCTATGCCTCGGGCATCCAAGCAGCAAGCGCGTTACGCCGTGGGTCGATGTTTGATGTTATGGAGCAGCAACGATGTTACGCAGCAGGGCAGTCGCCCTAAAACAAAGTTAGGCATCACAAAGTACAGCATCGTGACCAACAGCAACGATTCCGTCACACTGCGCCTCATGACTGAGCATGACCTTGCGATGCTCTATGAGTGGCTAAATCGATCTCATATCGTCGAGTGGTGGGGCGGAGAAGAAGCACGCCCGACACTTGCTGACGTACAGGAACAGTACTTGCCAAGCGTTTTAGCGCAAGAGTCCGTCACTCCATACATTGCAATGCTGAATGGAGAGCCGATTGGGTATGCCCAGTCGTACGTTGCTCTTGGAAGCGGGGACGGATGGTGGGAAGAAGAAACCGATCCAGGAGTACGCGGAATAGACCAGTTACTGGCGAATGCATCACAACTGGGCAAAGGCTTGGGAACCAAGCTGGTTCGAGCTCTGGTTGAGTTGCTGTTCAATGATCCCGAGGTCACCAAGATCCAAACGGACCCGTCGCCGAGCAACTTGCGAGCGATCCGATGCTACGAGAAAGCGGGGTTTGAGAGGCAAGGTACCGTAACCACCCCAGATGGTCCAGCCGTGTACATGGTTCAAACACGCCAGGCATTCGAGCGAACACGCAGTGATGCCTAA", "partial": "0", "query_start": 14945, "query_end": 15019, "hit_start": 705, "hit_end": 780, "orf_dna_sequence": "ATGACGGAGAGCGTCCCCGACGCCGCCATTCAGACTATTACTTATAGAAGACAAGCTCACACGAGAAAAAGAGCCGACCTGTTAGCAGGCTTTCCTGCTGAGTAA", "orf_prot_sequence": "MTESVPDAAIQTITYRRQAHTRKRADLLAGFPAE", "perc_identity": 36.0}}, "BGC0000765.1|Exopolysaccharide_21 # 15059 # 15934 # 1 # ID=1_21;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.428": {"gnl|BL_ORD_ID|2587|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15059, "orf_end": 15934, "orf_from": "BGC0000765.1|Exopolysaccharide_21 ", "model_name": "vmlR", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1000", "model_id": "2907", "ARO_accession": "3004476", "ARO_name": "vmlR", "ARO_category": {"45630": {"category_aro_accession": "3007068", "category_aro_cvterm_id": "45630", "category_aro_name": "Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins", "category_aro_description": "ABC-F subfamily ATP-binding cassette ribosomal protection proteins of unknown, unclear or miscellaneous classification which nevertheless confer resistance to antibiotics through ribosomal protection and not through antibiotic efflux. These proteins should be further reviewed to elucidate associated genes, their function, origin and classification.", "category_aro_class_name": "AMR Gene Family"}, "35964": {"category_aro_accession": "0000046", "category_aro_cvterm_id": "35964", "category_aro_name": "lincomycin", "category_aro_description": "Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. It binds to the 23s portion of the 50S subunit of bacterial ribosomes and inhibit early elongation of peptide chain by inhibiting transpeptidase reaction.", "category_aro_class_name": "Antibiotic"}, "37021": {"category_aro_accession": "3000677", "category_aro_cvterm_id": "37021", "category_aro_name": "virginiamycin S2", "category_aro_description": "Virginiamycin S2 is a streptogramin B antibiotic.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35967": {"category_aro_accession": "0000050", "category_aro_cvterm_id": "35967", "category_aro_name": "streptogramin B antibiotic", "category_aro_description": "Streptogramin B antibiotics are are cyclic hepta- or hexa-depsipeptides.  Type B streptogramins block the peptide exit tunnel of the 50S bacterial ribosome. The general composition of group B streptogramins is 3-hydroxypicolinic acid-L-Thr-D-aminobutyric acid (or D-Ala)-L-Pro-L-Phe (or 4-N-,N-(dimethylamino)-L-Phe)-X-L-phenylglycine. Used alone, streptogramin B antibiotics are bacteriostatic, but is bactericidal when used with streptogramin A antibiotics.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.39476, "max_identities": 21, "bit_score": 29.261, "cvterm_id": "39579", "query": "LLNRPILHADETYYTVLESETIKTYYWVFLSGKHDRYGITLYHHDP-HRSGQVALDFLGNYSGYL", "match": "LL+ P  H DE     L  + +K Y    +   HDRY +            Q  ++F GNYSGY+", "sequence_from_db": "LLDEPTNHLDEKSLQFL-IQQLKHYNGTVILVSHDRYFLDEAATKIWSLEDQTLIEFKGNYSGYM", "sequence_from_broadstreet": "MKEIVTLTNVSYEVKDQTVFKHVNASVQQGDIIGIIGKNGAGKSTLLHLIHNDLAPAQGQILRKDIKLALVEQETAAYSFADQTPAEKKLLEKWHVPLRDFHQLSGGEKLKARLAKGLSEDADLLLLDEPTNHLDEKSLQFLIQQLKHYNGTVILVSHDRYFLDEAATKIWSLEDQTLIEFKGNYSGYMKFREKKRLTQQREYEKQQKMVERIEAQMNGLASWSEKAHAQSTKKEGFKEYHRVKAKRTDAQIKSKQKRLEKELEKAKAEPVTPEYTVRFSIDTTHKTGKRFLEVQNVTKAFGERTLFKNANFTIQHGEKVAIIGPNGSGKTTLLNIILGQETAEGSVWVSPSANIGYLTQEVFDLPLEQTPEELFENETFKARGHVQNLMRHLGFTAAQWTEPIKHMSMGERVKIKLMAYILEEKDVLILDEPTNHLDLPSREQLEETLSQYSGTLLAVSHDRYFLEKTTNSKLVISNNGIEKQLNDVPSERNEREELRLKLETERQEVLGKLSFMTPNDKGYKELDQAFNELTKRIKELDHQDKKD", "dna_sequence_from_broadstreet": "ATGAAAGAGATCGTAACATTAACAAACGTTAGCTATGAAGTAAAGGATCAAACTGTTTTTAAACATGTAAACGCCAGTGTTCAGCAAGGAGATATCATTGGGATTATCGGCAAAAACGGCGCTGGGAAATCTACGTTGCTGCACCTCATTCACAATGACTTAGCCCCTGCACAGGGTCAAATCCTTCGGAAGGATATAAAACTGGCTTTGGTTGAACAGGAAACCGCGGCGTATTCCTTTGCGGATCAGACACCTGCCGAAAAGAAGTTACTGGAGAAATGGCATGTGCCTCTTCGTGATTTTCATCAGTTAAGCGGCGGTGAAAAACTGAAAGCGCGGCTGGCGAAAGGACTATCAGAGGATGCAGATCTGCTGCTGTTAGATGAACCGACAAACCACCTTGATGAAAAAAGCTTGCAATTTCTCATCCAACAGCTGAAACATTATAACGGCACTGTGATTCTCGTTTCTCACGATCGATATTTTTTAGACGAAGCCGCAACAAAAATATGGTCGCTTGAGGATCAGACGCTGATTGAATTCAAAGGGAATTACTCCGGGTATATGAAGTTCCGGGAGAAGAAAAGACTCACCCAGCAGCGTGAATATGAAAAGCAGCAAAAAATGGTTGAACGGATTGAAGCACAAATGAATGGGCTCGCTTCTTGGTCGGAAAAAGCCCATGCTCAATCGACGAAAAAGGAAGGGTTTAAAGAATATCACCGGGTAAAAGCGAAGCGTACGGATGCCCAGATAAAATCCAAGCAGAAGCGGCTTGAAAAAGAGCTTGAAAAAGCAAAGGCGGAACCCGTTACCCCAGAATATACAGTCCGCTTTTCAATCGATACAACCCACAAAACAGGAAAACGTTTTTTAGAAGTTCAGAATGTAACAAAAGCGTTTGGAGAAAGGACTCTCTTTAAAAACGCAAACTTTACAATTCAGCACGGCGAAAAGGTTGCGATCATAGGCCCCAATGGCAGCGGAAAAACGACATTACTGAACATCATTCTGGGACAGGAAACAGCAGAAGGAAGTGTATGGGTGTCGCCGTCCGCAAACATCGGCTATTTAACGCAGGAGGTGTTTGATTTGCCTTTAGAACAAACACCGGAAGAGTTATTTGAGAATGAAACATTCAAAGCAAGGGGGCACGTTCAAAATCTGATGAGGCACTTAGGTTTTACAGCCGCCCAATGGACTGAACCGATCAAGCATATGAGTATGGGTGAGCGTGTAAAGATCAAGCTGATGGCATATATTCTGGAGGAAAAAGACGTGCTGATTTTAGATGAGCCGACAAACCATCTCGACCTGCCGTCACGCGAACAGCTGGAAGAAACACTGTCACAATACAGCGGCACATTGCTGGCGGTTTCACATGACCGATACTTTCTCGAAAAAACAACAAACAGTAAACTCGTCATCTCAAACAACGGCATCGAAAAGCAGTTAAACGACGTTCCTTCAGAAAGAAATGAGCGGGAGGAGCTTCGGTTAAAGCTTGAGACAGAAAGACAAGAAGTGCTGGGAAAGCTCAGTTTTATGACGCCAAATGATAAAGGGTATAAGGAGCTTGATCAGGCTTTCAATGAGCTTACGAAACGAATAAAAGAGCTGGATCATCAAGACAAAAAAGACTGA", "partial": "0", "query_start": 15452, "query_end": 15643, "hit_start": 375, "hit_end": 567, "orf_dna_sequence": "TTGGACGATAAGCACTGCCCTAATTGTCATCATGAGTTGAAAGAAATTGGCGCTTATCCGATAAGACAGGAATTGCTTTTCATTCCCGCTCAGCTTAAGCGCTTGAATCACATCCAACATGCTTTCAAATGCCAATACTGCAGTCAGAGAAGTCTTAGCGACAAGATCATTAAAGCCGCAGTACCTAAGGCACCATTGAATCACGGCCTAGGATCACCTTCGCTTATTGCCCATACTTTATATCAAAAGTATGAGTTGAAGATCCCAGATTATCGGCAAGAAAGCGACTGGAAAAAGATGGGGCTAGAAGTTTCTCGACAAATGTTAAATCACTGGGGACTGAAGAGTAGCGAATATTACTTTAAGCCGTTATATGACGTGCTTAAACAAAAGCTGTTAAACCGACCAATCTTGCATGCCGATGAAACCTATTACACCGTGCTGGAAAGTGAGACAATTAAAACCTATTATTGGGTCTTTCTTTCTGGCAAGCATGATCGCTATGGGATTACACTGTATCATCATGATCCGCACCGCAGCGGCCAAGTAGCACTTGATTTTTTAGGCAACTATTCTGGCTATCTGCACTGCGATATGTGGCAGGCTTATGAACAGCTGCCTGAGGCAACCTTGGTTGGCTGCTGGGCTCATGTTAGGAGAAAGTTTCATGAAGCTATGCCACAAAATGCTTCTGGCAAGTGCATTGCCAGGCAAGGGCTTAACTATTGCAATCGGATGTTCTGCTTGGAAAAAGCTTGGGAATCTTTAGATTGTCAAACACGTTATCAAGCTAGAAAAGAAGAACTCAGGCCATTAATGCAGGAGTTTTTTGAATGGTGCAGGAAAAATAAAGCAACTGTTTTTGCCTGGTTCTAA", "orf_prot_sequence": "MDDKHCPNCHHELKEIGAYPIRQELLFIPAQLKRLNHIQHAFKCQYCSQRSLSDKIIKAAVPKAPLNHGLGSPSLIAHTLYQKYELKIPDYRQESDWKKMGLEVSRQMLNHWGLKSSEYYFKPLYDVLKQKLLNRPILHADETYYTVLESETIKTYYWVFLSGKHDRYGITLYHHDPHRSGQVALDFLGNYSGYLHCDMWQAYEQLPEATLVGCWAHVRRKFHEAMPQNASGKCIARQGLNYCNRMFCLEKAWESLDCQTRYQARKEELRPLMQEFFEWCRKNKATVFAWF", "perc_identity": 32.31}, "gnl|BL_ORD_ID|2587|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15059, "orf_end": 15934, "orf_from": "BGC0000765.1|Exopolysaccharide_21 ", "model_name": "vmlR", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1000", "model_id": "2907", "ARO_accession": "3004476", "ARO_name": "vmlR", "ARO_category": {"45630": {"category_aro_accession": "3007068", "category_aro_cvterm_id": "45630", "category_aro_name": "Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins", "category_aro_description": "ABC-F subfamily ATP-binding cassette ribosomal protection proteins of unknown, unclear or miscellaneous classification which nevertheless confer resistance to antibiotics through ribosomal protection and not through antibiotic efflux. These proteins should be further reviewed to elucidate associated genes, their function, origin and classification.", "category_aro_class_name": "AMR Gene Family"}, "35964": {"category_aro_accession": "0000046", "category_aro_cvterm_id": "35964", "category_aro_name": "lincomycin", "category_aro_description": "Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. It binds to the 23s portion of the 50S subunit of bacterial ribosomes and inhibit early elongation of peptide chain by inhibiting transpeptidase reaction.", "category_aro_class_name": "Antibiotic"}, "37021": {"category_aro_accession": "3000677", "category_aro_cvterm_id": "37021", "category_aro_name": "virginiamycin S2", "category_aro_description": "Virginiamycin S2 is a streptogramin B antibiotic.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35967": {"category_aro_accession": "0000050", "category_aro_cvterm_id": "35967", "category_aro_name": "streptogramin B antibiotic", "category_aro_description": "Streptogramin B antibiotics are are cyclic hepta- or hexa-depsipeptides.  Type B streptogramins block the peptide exit tunnel of the 50S bacterial ribosome. The general composition of group B streptogramins is 3-hydroxypicolinic acid-L-Thr-D-aminobutyric acid (or D-Ala)-L-Pro-L-Phe (or 4-N-,N-(dimethylamino)-L-Phe)-X-L-phenylglycine. Used alone, streptogramin B antibiotics are bacteriostatic, but is bactericidal when used with streptogramin A antibiotics.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.26076, "max_identities": 17, "bit_score": 25.0238, "cvterm_id": "39579", "query": "DVLKQKLLNRPILHADETYYTVLESETIKTYYWVFLSGKHDRY", "match": "DVL   +L+ P  H D      LE ET+  Y    L+  HDRY", "sequence_from_db": "DVL---ILDEPTNHLDLPSREQLE-ETLSQYSGTLLAVSHDRY", "sequence_from_broadstreet": "MKEIVTLTNVSYEVKDQTVFKHVNASVQQGDIIGIIGKNGAGKSTLLHLIHNDLAPAQGQILRKDIKLALVEQETAAYSFADQTPAEKKLLEKWHVPLRDFHQLSGGEKLKARLAKGLSEDADLLLLDEPTNHLDEKSLQFLIQQLKHYNGTVILVSHDRYFLDEAATKIWSLEDQTLIEFKGNYSGYMKFREKKRLTQQREYEKQQKMVERIEAQMNGLASWSEKAHAQSTKKEGFKEYHRVKAKRTDAQIKSKQKRLEKELEKAKAEPVTPEYTVRFSIDTTHKTGKRFLEVQNVTKAFGERTLFKNANFTIQHGEKVAIIGPNGSGKTTLLNIILGQETAEGSVWVSPSANIGYLTQEVFDLPLEQTPEELFENETFKARGHVQNLMRHLGFTAAQWTEPIKHMSMGERVKIKLMAYILEEKDVLILDEPTNHLDLPSREQLEETLSQYSGTLLAVSHDRYFLEKTTNSKLVISNNGIEKQLNDVPSERNEREELRLKLETERQEVLGKLSFMTPNDKGYKELDQAFNELTKRIKELDHQDKKD", "dna_sequence_from_broadstreet": "ATGAAAGAGATCGTAACATTAACAAACGTTAGCTATGAAGTAAAGGATCAAACTGTTTTTAAACATGTAAACGCCAGTGTTCAGCAAGGAGATATCATTGGGATTATCGGCAAAAACGGCGCTGGGAAATCTACGTTGCTGCACCTCATTCACAATGACTTAGCCCCTGCACAGGGTCAAATCCTTCGGAAGGATATAAAACTGGCTTTGGTTGAACAGGAAACCGCGGCGTATTCCTTTGCGGATCAGACACCTGCCGAAAAGAAGTTACTGGAGAAATGGCATGTGCCTCTTCGTGATTTTCATCAGTTAAGCGGCGGTGAAAAACTGAAAGCGCGGCTGGCGAAAGGACTATCAGAGGATGCAGATCTGCTGCTGTTAGATGAACCGACAAACCACCTTGATGAAAAAAGCTTGCAATTTCTCATCCAACAGCTGAAACATTATAACGGCACTGTGATTCTCGTTTCTCACGATCGATATTTTTTAGACGAAGCCGCAACAAAAATATGGTCGCTTGAGGATCAGACGCTGATTGAATTCAAAGGGAATTACTCCGGGTATATGAAGTTCCGGGAGAAGAAAAGACTCACCCAGCAGCGTGAATATGAAAAGCAGCAAAAAATGGTTGAACGGATTGAAGCACAAATGAATGGGCTCGCTTCTTGGTCGGAAAAAGCCCATGCTCAATCGACGAAAAAGGAAGGGTTTAAAGAATATCACCGGGTAAAAGCGAAGCGTACGGATGCCCAGATAAAATCCAAGCAGAAGCGGCTTGAAAAAGAGCTTGAAAAAGCAAAGGCGGAACCCGTTACCCCAGAATATACAGTCCGCTTTTCAATCGATACAACCCACAAAACAGGAAAACGTTTTTTAGAAGTTCAGAATGTAACAAAAGCGTTTGGAGAAAGGACTCTCTTTAAAAACGCAAACTTTACAATTCAGCACGGCGAAAAGGTTGCGATCATAGGCCCCAATGGCAGCGGAAAAACGACATTACTGAACATCATTCTGGGACAGGAAACAGCAGAAGGAAGTGTATGGGTGTCGCCGTCCGCAAACATCGGCTATTTAACGCAGGAGGTGTTTGATTTGCCTTTAGAACAAACACCGGAAGAGTTATTTGAGAATGAAACATTCAAAGCAAGGGGGCACGTTCAAAATCTGATGAGGCACTTAGGTTTTACAGCCGCCCAATGGACTGAACCGATCAAGCATATGAGTATGGGTGAGCGTGTAAAGATCAAGCTGATGGCATATATTCTGGAGGAAAAAGACGTGCTGATTTTAGATGAGCCGACAAACCATCTCGACCTGCCGTCACGCGAACAGCTGGAAGAAACACTGTCACAATACAGCGGCACATTGCTGGCGGTTTCACATGACCGATACTTTCTCGAAAAAACAACAAACAGTAAACTCGTCATCTCAAACAACGGCATCGAAAAGCAGTTAAACGACGTTCCTTCAGAAAGAAATGAGCGGGAGGAGCTTCGGTTAAAGCTTGAGACAGAAAGACAAGAAGTGCTGGGAAAGCTCAGTTTTATGACGCCAAATGATAAAGGGTATAAGGAGCTTGATCAGGCTTTCAATGAGCTTACGAAACGAATAAAAGAGCTGGATCATCAAGACAAAAAAGACTGA", "partial": "0", "query_start": 15434, "query_end": 15562, "hit_start": 1275, "hit_end": 1392, "orf_dna_sequence": "TTGGACGATAAGCACTGCCCTAATTGTCATCATGAGTTGAAAGAAATTGGCGCTTATCCGATAAGACAGGAATTGCTTTTCATTCCCGCTCAGCTTAAGCGCTTGAATCACATCCAACATGCTTTCAAATGCCAATACTGCAGTCAGAGAAGTCTTAGCGACAAGATCATTAAAGCCGCAGTACCTAAGGCACCATTGAATCACGGCCTAGGATCACCTTCGCTTATTGCCCATACTTTATATCAAAAGTATGAGTTGAAGATCCCAGATTATCGGCAAGAAAGCGACTGGAAAAAGATGGGGCTAGAAGTTTCTCGACAAATGTTAAATCACTGGGGACTGAAGAGTAGCGAATATTACTTTAAGCCGTTATATGACGTGCTTAAACAAAAGCTGTTAAACCGACCAATCTTGCATGCCGATGAAACCTATTACACCGTGCTGGAAAGTGAGACAATTAAAACCTATTATTGGGTCTTTCTTTCTGGCAAGCATGATCGCTATGGGATTACACTGTATCATCATGATCCGCACCGCAGCGGCCAAGTAGCACTTGATTTTTTAGGCAACTATTCTGGCTATCTGCACTGCGATATGTGGCAGGCTTATGAACAGCTGCCTGAGGCAACCTTGGTTGGCTGCTGGGCTCATGTTAGGAGAAAGTTTCATGAAGCTATGCCACAAAATGCTTCTGGCAAGTGCATTGCCAGGCAAGGGCTTAACTATTGCAATCGGATGTTCTGCTTGGAAAAAGCTTGGGAATCTTTAGATTGTCAAACACGTTATCAAGCTAGAAAAGAAGAACTCAGGCCATTAATGCAGGAGTTTTTTGAATGGTGCAGGAAAAATAAAGCAACTGTTTTTGCCTGGTTCTAA", "orf_prot_sequence": "MDDKHCPNCHHELKEIGAYPIRQELLFIPAQLKRLNHIQHAFKCQYCSQRSLSDKIIKAAVPKAPLNHGLGSPSLIAHTLYQKYELKIPDYRQESDWKKMGLEVSRQMLNHWGLKSSEYYFKPLYDVLKQKLLNRPILHADETYYTVLESETIKTYYWVFLSGKHDRYGITLYHHDPHRSGQVALDFLGNYSGYLHCDMWQAYEQLPEATLVGCWAHVRRKFHEAMPQNASGKCIARQGLNYCNRMFCLEKAWESLDCQTRYQARKEELRPLMQEFFEWCRKNKATVFAWF", "perc_identity": 39.53}, "gnl|BL_ORD_ID|1891|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15059, "orf_end": 15934, "orf_from": "BGC0000765.1|Exopolysaccharide_21 ", "model_name": "msrC", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "950", "model_id": "2054", "ARO_accession": "3002819", "ARO_name": "msrC", "ARO_category": {"41695": {"category_aro_accession": "3004471", "category_aro_cvterm_id": "41695", "category_aro_name": "msr-type ABC-F protein", "category_aro_description": "msr-type ABC-F subfamily ribosomal protection proteins expression in Staphylococci species and confer resistance to erythromycin and streptogramin B antibiotics through antibiotic target protection mechanisms.", "category_aro_class_name": "AMR Gene Family"}, "35925": {"category_aro_accession": "0000006", "category_aro_cvterm_id": "35925", "category_aro_name": "erythromycin", "category_aro_description": "Erythromycin is a macrolide antibiotic with a 14-carbon ring that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people that have an allergy to penicillins. Erythromycin may possess bacteriocidal activity, particularly at higher concentrations by binding to the 50S subunit of the bacterial 70S rRNA complex, inhibiting peptidyl-tRNA translocation. Thus, protein synthesis and subsequently structure/function processes critical for life or replication are inhibited.", "category_aro_class_name": "Antibiotic"}, "36723": {"category_aro_accession": "3000584", "category_aro_cvterm_id": "36723", "category_aro_name": "quinupristin", "category_aro_description": "Quinupristin is a type B streptogramin and a semisynthetic derivative of pristinamycin 1A. It is a component of the drug Synercid and interacts with the 50S subunit of the bacterial ribosome to inhibit protein synthesis.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35967": {"category_aro_accession": "0000050", "category_aro_cvterm_id": "35967", "category_aro_name": "streptogramin B antibiotic", "category_aro_description": "Streptogramin B antibiotics are are cyclic hepta- or hexa-depsipeptides.  Type B streptogramins block the peptide exit tunnel of the 50S bacterial ribosome. The general composition of group B streptogramins is 3-hydroxypicolinic acid-L-Thr-D-aminobutyric acid (or D-Ala)-L-Pro-L-Phe (or 4-N-,N-(dimethylamino)-L-Phe)-X-L-phenylglycine. Used alone, streptogramin B antibiotics are bacteriostatic, but is bactericidal when used with streptogramin A antibiotics.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.57018, "max_identities": 24, "bit_score": 27.335, "cvterm_id": "36779", "query": "LLNRPILHADETYYTVLESETIKTYYWVFLSGKHDRYGITLYHHD--PHRSGQVALDFLGNYSGYLHCDMWQAYEQLPEA", "match": "LL+ P  H D      L  E ++ YY   +   HDRY +          + G++  +F  NYS YL     +   QL EA", "sequence_from_db": "LLDEPTTHLDRKSMDRL-IEELRYYYGTLIFVSHDRYFLDELATKVWEVKDGEIR-EFPENYSAYLTQRELEKKTQLREA", "sequence_from_broadstreet": "MENLAVNITNLQVRFGNQLELSIDSLRVYQQDRIGIIGENGVGKTTLLKLIVGELIPNQGKIQTEITFNYLPQLTYLAEAKDLNLELASHFQLKLEETSERKWSGGEERKIELIRLLSSYEQGMLLDEPTTHLDRKSMDRLIEELRYYYGTLIFVSHDRYFLDELATKVWEVKDGEIREFPENYSAYLTQRELEKKTQLREAESIMKEKKRLEKSIQEKKKQAEKLEKVSSKKKKQQIRPDRLSSSKQKDSVQKAIQKNTKTLERRLQKIGETTKPQQMKQIRFPVPKSLELHNRYPIMGQNIQLERSGRTLLINSDFQFSLGKKIAIVGENGSGKTTLLEHIRKQGEGILLSPKVSFQVYQQKDYQMTSEESVIRFVMRQTEFSESLVRSLLNHLGFAQETLTKPLCTLSGGEATRLTIALLFTKPSNVLLLDEPTNFIDVATIEALEQLMQVYPGTILFTSHDSYFVERTADEVYEIKGQKIKKVLTRNF", "dna_sequence_from_broadstreet": "ATGGAAAATTTAGCAGTAAATATAACAAACCTGCAAGTTCGTTTTGGTAACCAGTTAGAATTATCTATTGATTCTCTTCGTGTCTATCAGCAAGATCGGATAGGAATCATAGGGGAAAATGGAGTCGGTAAAACAACGTTGCTGAAACTGATAGTCGGTGAACTTATCCCCAATCAAGGGAAAATCCAAACAGAGATCACTTTCAACTATCTGCCTCAATTAACCTATCTTGCTGAGGCAAAGGACCTAAATTTGGAATTAGCCAGTCATTTCCAGTTGAAACTGGAAGAAACTTCGGAACGGAAATGGAGTGGAGGGGAAGAACGAAAGATCGAGTTGATACGTCTTCTTTCTTCTTATGAACAAGGGATGCTTCTAGACGAGCCGACAACCCATCTAGATAGAAAAAGTATGGATCGACTAATTGAAGAGCTTCGTTATTATTATGGCACGCTGATTTTTGTTAGTCATGACCGCTATTTTCTAGATGAGTTGGCAACGAAAGTCTGGGAAGTAAAAGACGGAGAAATCCGAGAGTTTCCGGAGAATTATAGTGCCTATCTCACTCAAAGGGAATTGGAGAAAAAGACTCAGCTACGAGAAGCAGAGTCGATCATGAAAGAGAAAAAACGATTGGAAAAATCGATCCAAGAAAAGAAAAAACAAGCGGAAAAGTTAGAAAAAGTGTCCAGTAAAAAGAAAAAGCAACAAATCAGACCGGATCGGTTGTCTTCCTCTAAACAAAAAGACAGTGTACAAAAAGCCATCCAAAAGAATACGAAAACATTAGAGAGAAGACTCCAAAAAATAGGAGAAACAACCAAACCGCAACAGATGAAACAAATCCGTTTTCCAGTACCAAAATCTCTTGAACTCCACAATCGTTATCCAATCATGGGACAAAATATCCAATTGGAAAGAAGCGGAAGAACATTACTGATAAATAGCGATTTTCAATTTTCTTTAGGTAAAAAAATCGCGATTGTCGGCGAAAATGGATCAGGTAAGACAACTTTATTGGAACATATCCGCAAACAAGGAGAAGGAATCCTTCTCTCTCCGAAAGTAAGCTTTCAAGTATATCAGCAAAAGGATTATCAAATGACATCTGAAGAATCCGTCATTCGTTTTGTCATGAGACAAACAGAGTTTTCGGAATCACTTGTCCGCAGTTTGTTGAATCATTTAGGGTTTGCTCAGGAAACTCTGACGAAACCGTTGTGTACGTTAAGTGGGGGAGAAGCGACTCGTTTGACGATTGCTTTGCTTTTTACTAAGCCAAGTAATGTGTTGCTGTTAGATGAACCGACTAATTTCATTGATGTGGCAACGATCGAAGCTTTAGAGCAGCTGATGCAAGTATATCCGGGAACGATTTTGTTTACTTCACATGATTCCTACTTTGTCGAGCGTACGGCTGATGAAGTTTATGAAATAAAAGGGCAGAAAATAAAAAAAGTACTTACGAGAAATTTTTAA", "partial": "0", "query_start": 15452, "query_end": 15685, "hit_start": 372, "hit_end": 606, "orf_dna_sequence": "TTGGACGATAAGCACTGCCCTAATTGTCATCATGAGTTGAAAGAAATTGGCGCTTATCCGATAAGACAGGAATTGCTTTTCATTCCCGCTCAGCTTAAGCGCTTGAATCACATCCAACATGCTTTCAAATGCCAATACTGCAGTCAGAGAAGTCTTAGCGACAAGATCATTAAAGCCGCAGTACCTAAGGCACCATTGAATCACGGCCTAGGATCACCTTCGCTTATTGCCCATACTTTATATCAAAAGTATGAGTTGAAGATCCCAGATTATCGGCAAGAAAGCGACTGGAAAAAGATGGGGCTAGAAGTTTCTCGACAAATGTTAAATCACTGGGGACTGAAGAGTAGCGAATATTACTTTAAGCCGTTATATGACGTGCTTAAACAAAAGCTGTTAAACCGACCAATCTTGCATGCCGATGAAACCTATTACACCGTGCTGGAAAGTGAGACAATTAAAACCTATTATTGGGTCTTTCTTTCTGGCAAGCATGATCGCTATGGGATTACACTGTATCATCATGATCCGCACCGCAGCGGCCAAGTAGCACTTGATTTTTTAGGCAACTATTCTGGCTATCTGCACTGCGATATGTGGCAGGCTTATGAACAGCTGCCTGAGGCAACCTTGGTTGGCTGCTGGGCTCATGTTAGGAGAAAGTTTCATGAAGCTATGCCACAAAATGCTTCTGGCAAGTGCATTGCCAGGCAAGGGCTTAACTATTGCAATCGGATGTTCTGCTTGGAAAAAGCTTGGGAATCTTTAGATTGTCAAACACGTTATCAAGCTAGAAAAGAAGAACTCAGGCCATTAATGCAGGAGTTTTTTGAATGGTGCAGGAAAAATAAAGCAACTGTTTTTGCCTGGTTCTAA", "orf_prot_sequence": "MDDKHCPNCHHELKEIGAYPIRQELLFIPAQLKRLNHIQHAFKCQYCSQRSLSDKIIKAAVPKAPLNHGLGSPSLIAHTLYQKYELKIPDYRQESDWKKMGLEVSRQMLNHWGLKSSEYYFKPLYDVLKQKLLNRPILHADETYYTVLESETIKTYYWVFLSGKHDRYGITLYHHDPHRSGQVALDFLGNYSGYLHCDMWQAYEQLPEATLVGCWAHVRRKFHEAMPQNASGKCIARQGLNYCNRMFCLEKAWESLDCQTRYQARKEELRPLMQEFFEWCRKNKATVFAWF", "perc_identity": 30.0}, "gnl|BL_ORD_ID|4750|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15059, "orf_end": 15934, "orf_from": "BGC0000765.1|Exopolysaccharide_21 ", "model_name": "msr(I)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "600", "model_id": "5744", "ARO_accession": "3007043", "ARO_name": "msr(I)", "ARO_category": {"41695": {"category_aro_accession": "3004471", "category_aro_cvterm_id": "41695", "category_aro_name": "msr-type ABC-F protein", "category_aro_description": "msr-type ABC-F subfamily ribosomal protection proteins expression in Staphylococci species and confer resistance to erythromycin and streptogramin B antibiotics through antibiotic target protection mechanisms.", "category_aro_class_name": "AMR Gene Family"}, "35944": {"category_aro_accession": "0000025", "category_aro_cvterm_id": "35944", "category_aro_name": "fosfomycin", "category_aro_description": "Fosfomycin (also known as phosphomycin and phosphonomycin) is a broad-spectrum antibiotic produced by certain Streptomyces species. It is effective on gram positive and negative bacteria as it targets the cell wall, an essential feature shared by both bacteria. Its specific target is MurA (MurZ in E.coli), which attaches phosphoenolpyruvate (PEP) to UDP-N-acetylglucosamine, a step of commitment to cell wall synthesis. In the active site of MurA, the active cysteine molecule is alkylated which stops the catalytic reaction.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "45731": {"category_aro_accession": "3007149", "category_aro_cvterm_id": "45731", "category_aro_name": "phosphonic acid antibiotic", "category_aro_description": "A group of antibiotics derived from phosphonic acids.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.93205, "max_identities": 25, "bit_score": 27.335, "cvterm_id": "36764", "query": "LLNRPILHADETYYTVLESETIKTYYWVFLSGKHDRYGI-----TLYHHDPHRSGQVALDFLGNYSGYLH------CDMWQAYEQ", "match": "L++ P  H D+   + L  E +K YY   +   HDRY +     T++  D    G+V + + G+YS Y+           QA+EQ", "sequence_from_db": "LIDEPTTHLDQEGISFL-IEELKYYYGALVLISHDRYVLDELVTTIWEVD---DGKVKV-YSGDYSEYIEQKKLERSKQTQAHEQ", "sequence_from_broadstreet": "MEQICFELEKIEVTYLDKKVLEIDRLAVHQFDRIGIVGKNGVGKSTLLKLLAGHIQPTVGKVKRQVEYGYFEQVEGPKDISTDPKLLSQLHVDENSKGLSGGEQTRLKLAQLFTDYYESLLIDEPTTHLDQEGISFLIEELKYYYGALVLISHDRYVLDELVTTIWEVDDGKVKVYSGDYSEYIEQKKLERSKQTQAHEQFLKEKKRLEKAAEEKMKKAEKIAKSSAKSKDSKVKANRMFESKSKGTTQKALQRAAKAVEQRVKKLEVIDAPKKEQTIRFHQTNIILELHNKFPIMADQLTITVGNKILLNNVNFQFALGETIAITGKNGSGKSTLIHHILQREKGITISPKAVIGSYEQMGYQFKTDETVMDFMKNRSDYGESKIRSVLYAMSFTGNDLKKSVQKLSGGEATRLVLCQLFLGRYNVLILDEPTNFLDVFCIEALETFLKGYEGTVILISHDKTFLDRVADSEYVLENQNLKKNR", "dna_sequence_from_broadstreet": "ATGGAACAAATTTGTTTTGAATTAGAAAAAATTGAAGTAACTTATTTAGATAAAAAAGTATTAGAGATAGATCGTTTAGCAGTTCATCAATTTGATAGAATTGGTATTGTTGGAAAAAATGGTGTTGGTAAGAGTACTCTGCTAAAATTACTTGCAGGTCATATTCAACCTACAGTTGGAAAAGTAAAGCGTCAAGTAGAATATGGTTATTTTGAACAGGTAGAAGGTCCTAAAGATATATCAACAGATCCTAAGTTACTTAGCCAATTACATGTTGATGAGAATTCGAAAGGGCTAAGTGGTGGTGAACAAACAAGATTAAAACTTGCACAGTTATTTACGGACTATTATGAATCTTTATTAATTGATGAGCCAACTACACATTTGGACCAAGAAGGTATATCATTTTTAATAGAAGAGTTGAAATACTATTATGGGGCACTGGTATTAATAAGTCATGACCGATATGTTTTAGATGAACTTGTGACTACAATTTGGGAAGTTGATGATGGGAAAGTAAAAGTATATTCAGGAGATTACAGTGAATATATCGAGCAAAAGAAACTTGAAAGATCAAAACAAACTCAGGCTCATGAACAGTTCTTAAAGGAAAAAAAACGTTTAGAAAAAGCAGCAGAAGAAAAAATGAAAAAAGCAGAAAAAATTGCTAAATCTTCTGCTAAATCAAAAGACTCTAAAGTAAAAGCAAATCGTATGTTTGAATCAAAATCAAAGGGTACAACTCAAAAAGCGTTACAACGTGCTGCTAAGGCTGTTGAACAAAGAGTAAAAAAACTTGAAGTTATAGATGCGCCTAAAAAAGAACAAACTATCCGTTTTCATCAAACAAATATCATACTTGAGTTACATAACAAGTTTCCAATTATGGCTGATCAATTAACGATTACAGTAGGAAATAAGATACTTTTAAACAATGTTAACTTTCAATTTGCATTAGGTGAAACGATTGCTATTACTGGTAAAAATGGTTCTGGGAAATCAACATTAATTCACCACATATTACAACGTGAAAAAGGAATTACTATTTCTCCAAAGGCTGTTATAGGCTCTTATGAGCAGATGGGATATCAATTTAAAACTGATGAAACTGTAATGGACTTTATGAAAAATAGAAGCGATTATGGAGAAAGTAAAATACGTTCTGTACTATATGCTATGAGTTTTACTGGGAATGATTTAAAAAAGAGTGTTCAAAAATTAAGTGGTGGCGAGGCGACTCGTTTAGTCCTATGTCAATTATTTCTAGGAAGATACAACGTTTTGATTTTAGATGAACCTACTAACTTTTTAGATGTTTTTTGTATTGAAGCTTTAGAAACATTTTTAAAAGGCTATGAAGGAACAGTTATACTAATATCACATGATAAAACATTTTTAGATCGTGTAGCTGATAGTGAATACGTTCTAGAAAATCAGAACCTTAAAAAAAATAGATAG", "partial": "0", "query_start": 15452, "query_end": 15673, "hit_start": 360, "hit_end": 600, "orf_dna_sequence": "TTGGACGATAAGCACTGCCCTAATTGTCATCATGAGTTGAAAGAAATTGGCGCTTATCCGATAAGACAGGAATTGCTTTTCATTCCCGCTCAGCTTAAGCGCTTGAATCACATCCAACATGCTTTCAAATGCCAATACTGCAGTCAGAGAAGTCTTAGCGACAAGATCATTAAAGCCGCAGTACCTAAGGCACCATTGAATCACGGCCTAGGATCACCTTCGCTTATTGCCCATACTTTATATCAAAAGTATGAGTTGAAGATCCCAGATTATCGGCAAGAAAGCGACTGGAAAAAGATGGGGCTAGAAGTTTCTCGACAAATGTTAAATCACTGGGGACTGAAGAGTAGCGAATATTACTTTAAGCCGTTATATGACGTGCTTAAACAAAAGCTGTTAAACCGACCAATCTTGCATGCCGATGAAACCTATTACACCGTGCTGGAAAGTGAGACAATTAAAACCTATTATTGGGTCTTTCTTTCTGGCAAGCATGATCGCTATGGGATTACACTGTATCATCATGATCCGCACCGCAGCGGCCAAGTAGCACTTGATTTTTTAGGCAACTATTCTGGCTATCTGCACTGCGATATGTGGCAGGCTTATGAACAGCTGCCTGAGGCAACCTTGGTTGGCTGCTGGGCTCATGTTAGGAGAAAGTTTCATGAAGCTATGCCACAAAATGCTTCTGGCAAGTGCATTGCCAGGCAAGGGCTTAACTATTGCAATCGGATGTTCTGCTTGGAAAAAGCTTGGGAATCTTTAGATTGTCAAACACGTTATCAAGCTAGAAAAGAAGAACTCAGGCCATTAATGCAGGAGTTTTTTGAATGGTGCAGGAAAAATAAAGCAACTGTTTTTGCCTGGTTCTAA", "orf_prot_sequence": "MDDKHCPNCHHELKEIGAYPIRQELLFIPAQLKRLNHIQHAFKCQYCSQRSLSDKIIKAAVPKAPLNHGLGSPSLIAHTLYQKYELKIPDYRQESDWKKMGLEVSRQMLNHWGLKSSEYYFKPLYDVLKQKLLNRPILHADETYYTVLESETIKTYYWVFLSGKHDRYGITLYHHDPHRSGQVALDFLGNYSGYLHCDMWQAYEQLPEATLVGCWAHVRRKFHEAMPQNASGKCIARQGLNYCNRMFCLEKAWESLDCQTRYQARKEELRPLMQEFFEWCRKNKATVFAWF", "perc_identity": 29.41}}, "BGC0000765.1|Exopolysaccharide_25 # 16758 # 18083 # 1 # ID=1_25;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.295": {"gnl|BL_ORD_ID|4619|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 16758, "orf_end": 18083, "orf_from": "BGC0000765.1|Exopolysaccharide_25 ", "model_name": "VHW-1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "550", "model_id": "5690", "ARO_accession": "3007004", "ARO_name": "VHW-1", "ARO_category": {"43916": {"category_aro_accession": "3005456", "category_aro_cvterm_id": "43916", "category_aro_name": "VHW beta-lactamase", "category_aro_description": "VHW beta-lactamases are class A beta-lactamases found Vibrio harveyi.", "category_aro_class_name": "AMR Gene Family"}, "36981": {"category_aro_accession": "3000637", "category_aro_cvterm_id": "36981", "category_aro_name": "ampicillin", "category_aro_description": "Ampicillin is a penicillin derivative that is highly acid stable, with its activity similar to benzylpenicillin.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.59699, "max_identities": 21, "bit_score": 26.9498, "cvterm_id": "36785", "query": "RLNNLNPKKRKDKIKINSKVRILS---QSDYKKYRSHIR---QHQDNK--------GIPQGSSIS", "match": "RLN  NP  ++D    N+ V  L    + D   Y S I+     QDNK         +P+G SI+", "sequence_from_db": "RLNEANPGDKRDTTTPNAMVNTLHTLLEGDALSYESRIQLKIWMQDNKVSDSLMRSVLPKGWSIA", "sequence_from_broadstreet": "MKKLFLLLGLLACSSATYAAKLNEDISAIEEHISGRIGVSVWDTQTDEHWDYRGDERFPMMSTFKTLACATMLSDMDNEKLDKNATAKVEERNMVVWSPVMDRMAGQTTRFEHACEAAMLMSDNSAAHIVLRSIWGVHAGGTSFLRSIGDKATRLDRFEPRLNEANPGDKRDTTTPNAMVNTLHTLLEGDALSYESRIQLKIWMQDNKVSDSLMRSVLPKGWSIADRSGAGGFGSRGITAMIWKENHKPVYISIYITETDLSLQARDQVIAQVSQLILDEVQYYLALAKY", "dna_sequence_from_broadstreet": "ATGAAAAAGCTATTTCTGCTACTTGGATTGTTAGCCTGTTCGAGTGCAACGTACGCCGCCAAACTTAATGAAGACATCTCCGCGATTGAAGAGCATATTTCGGGTCGAATCGGTGTGTCTGTCTGGGATACTCAAACCGATGAACATTGGGACTATAGAGGCGACGAGCGCTTCCCGATGATGAGCACATTCAAAACGCTTGCATGTGCAACGATGCTTAGTGACATGGATAATGAAAAGCTCGATAAAAACGCCACTGCCAAAGTAGAAGAGCGCAATATGGTGGTTTGGTCACCAGTAATGGATCGTATGGCAGGTCAAACAACGCGTTTTGAACATGCTTGTGAAGCCGCAATGCTTATGAGCGACAATTCCGCAGCCCACATTGTTTTGCGTAGCATTTGGGGGGTCCACGCGGGGGGCACTTCGTTCTTGCGTTCTATCGGTGATAAAGCAACGCGCCTTGACCGTTTTGAACCAAGACTGAACGAGGCGAACCCGGGCGACAAGCGAGACACCACAACACCTAATGCCATGGTAAATACGCTGCATACGTTGTTAGAAGGTGATGCGCTATCCTACGAATCACGCATTCAATTAAAAATCTGGATGCAGGATAACAAAGTCTCTGATTCTTTGATGCGCTCTGTGTTACCAAAGGGTTGGTCGATTGCCGATCGTTCTGGCGCAGGTGGCTTTGGATCACGCGGTATCACAGCAATGATCTGGAAAGAGAATCATAAACCGGTCTACATCAGCATTTACATTACTGAAACCGATTTATCCTTGCAGGCGCGCGATCAGGTTATCGCTCAAGTGAGCCAGTTAATACTGGATGAAGTACAATACTATTTAGCGCTCGCTAAATACTAA", "partial": "0", "query_start": 17331, "query_end": 17483, "hit_start": 480, "hit_end": 675, "orf_dna_sequence": "ATGAATATTAATGAATGGTTTGAAGACCCAAAAGTATTTGAAAAGAGTAAAAGAGAATATGCACATTTTGATCTTCGAACTGATTTAGCTAAATGCAAGAAATATATTACTAATTCTAAAAATATTGAGCGACATGGTTTTTATCCGTTTATAAAATATGATCTTGAATATCATAAATATAATAGGGCGGAAGGAAGAAAAACAAAGAAGCGTACCATTTGTTATGCATCTCATATTGATAGTTGTATTTTTCAATATTATAGTTTTTTAATTAATAAAAAATATAATGCACGTCTAAAACAAGATGGCATTTACGAAGTGCCAATAGCATATCGAACAGATCTACATACAGATACTATTGCTGAATTTAGAAAAATGCATCAGTTCATGATTCAGCATCCTTCTTCTTATGTTATGATTGGCGATTTTACAAGCTTTTTTGACAAAATTGACCATCAATATTTAAAAGAGCGCTTATGTGATTTATTACAAGTCGATAAGCTTAATTCCGATTATTATGCGATATTTAAACGAATTACCAAATATGATTATTGGGATTTAACAGATCTCTATCGATTAAATAATCTTAATCCAAAGAAGAGAAAAGATAAGATTAAGATAAATTCTAAAGTAAGAATTCTCTCTCAAAGTGATTATAAGAAATATCGATCACACATTAGGCAACATCAAGACAATAAAGGAATTCCGCAAGGCTCATCAATTAGTGCATGTCTAGCAAATGTTTATATGTTAGAAATTGATCGGCTGATTAATGAATTTGTAGTTGCACGTGGCGGTATTTATAGAAAATACAGTGACGATTTTATAATTATCTTACCTATGGATACTAGTTCAACTGATGATATTGAAAAAATAATTCTAAAATTTGGAGCATTTAAAGATAAAGGTATTTTGGAATTACAACCAGAAAAGACGCAAGTTTATAAATTACAAGACCATTCAGTCGTGAATATCGGTCATCTTTTTACTCCGAGCTTGAATGAAAAGAACAAAACAATTAATTTTATTGGCTTTACTTTTGACGGTAATGCAATAAAAATACGCGAAAAAACAACAAGTAAATATTATTATCGAATGCATCATAAAGCTAAAGGTGTCGCTCATCAATATTATCGTAATAAGTATTACAAGGGTGCAGATAAGTTATATCAACTGTATTCTCCAAATGGTCAGTATGGAAAAGGTAATTATTTTACTTATTTAAGTAGAGTTCAGAATGCTTTCCCCAACCAATCTATTATGATTTCAGAGGATAGGATTATGACGAATATTAGGCTGACTTTGAAGAAAAATAGGTGGGGATAG", "orf_prot_sequence": "MNINEWFEDPKVFEKSKREYAHFDLRTDLAKCKKYITNSKNIERHGFYPFIKYDLEYHKYNRAEGRKTKKRTICYASHIDSCIFQYYSFLINKKYNARLKQDGIYEVPIAYRTDLHTDTIAEFRKMHQFMIQHPSSYVMIGDFTSFFDKIDHQYLKERLCDLLQVDKLNSDYYAIFKRITKYDYWDLTDLYRLNNLNPKKRKDKIKINSKVRILSQSDYKKYRSHIRQHQDNKGIPQGSSISACLANVYMLEIDRLINEFVVARGGIYRKYSDDFIIILPMDTSSTDDIEKIILKFGAFKDKGILELQPEKTQVYKLQDHSVVNIGHLFTPSLNEKNKTINFIGFTFDGNAIKIREKTTSKYYYRMHHKAKGVAHQYYRNKYYKGADKLYQLYSPNGQYGKGNYFTYLSRVQNAFPNQSIMISEDRIMTNIRLTLKKNRWG", "perc_identity": 32.31}, "gnl|BL_ORD_ID|4618|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 16758, "orf_end": 18083, "orf_from": "BGC0000765.1|Exopolysaccharide_25 ", "model_name": "VHH-1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "550", "model_id": "5689", "ARO_accession": "3007003", "ARO_name": "VHH-1", "ARO_category": {"43915": {"category_aro_accession": "3005455", "category_aro_cvterm_id": "43915", "category_aro_name": "VHH beta-lactamase", "category_aro_description": "VHH beta-lactamases are class A beta-lactamases found in Vibrio harveyi.", "category_aro_class_name": "AMR Gene Family"}, "36981": {"category_aro_accession": "3000637", "category_aro_cvterm_id": "36981", "category_aro_name": "ampicillin", "category_aro_description": "Ampicillin is a penicillin derivative that is highly acid stable, with its activity similar to benzylpenicillin.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.38329, "max_identities": 21, "bit_score": 26.1794, "cvterm_id": "36785", "query": "RLNNLNPKKRKDKIKINSKVRILS---QSDYKKYRSHIR---QHQDNK--------GIPQGSSIS", "match": "RLN  NP  ++D    N+ V  L    + D   Y S I+     QDNK         +P+G SI+", "sequence_from_db": "RLNEANPGDKRDTTTPNAMVNTLHTLLEGDALSYESRIQLKIWMQDNKVSDSLMRSVLPKGWSIA", "sequence_from_broadstreet": "MKKLFLLLGLLACSSATYAANLMKTSPRLKKHISGRIGVSVWDTQTDEHWDYRGDERFPMMSTFKTLACATMLSDMDNEKLDKNATAKVEERNMVVWSPVMDRMASQTTRIEHACEAAMLMSDNTAANIVLRSIGGPRGVTTFLRSIGDKATRLDRFEPRLNEANPGDKRDTTTPNAMVNTLHTLLEGDALSYESRIQLKIWMQDNKVSDSLMRSVLPKGWSIADRSGAGGFGSRGITAMIWKENHKPVYISIYITETDLSLQARDQVIAQVSQLILDEYNTI", "dna_sequence_from_broadstreet": "ATGAAAAAGCTATTTCTGCTACTTGGATTGTTAGCCTGTTCGAGTGCAACGTACGCCGCAAACTTAATGAAAACATCTCCGCGATTGAAGAAGCATATTTCGGGTCGAATCGGTGTGTCTGTCTGGGATACTCAAACCGATGAACATTGGGACTATAGAGGCGACGAGCGCTTCCCGATGATGAGCACATTCAAAACGCTTGCATGTGCAACGATGCTTAGTGACATGGATAATGAAAAGCTCGATAAAAACGCCACTGCCAAAGTAGAAGAGCGCAATATGGTGGTTTGGTCACCAGTAATGGATCGTATGGCAAGTCAAACAACGCGTATTGAACATGCTTGTGAAGCCGCAATGCTGATGAGCGACAATACCGCAGCCAACATTGTTTTGCGTAGCATTGGGGGTCCACGCGGTGTCACTACGTTCTTGCGTTCTATCGGTGATAAAGCAACGCGCCTTGACCGTTTTGAACCAAGACTGAACGAGGCGAACCCGGGCGACAAGCGAGACACCACAACACCTAATGCCATGGTAAATACGCTGCATACGTTGTTAGAAGGTGATGCGCTATCCTACGAATCACGCATTCAATTAAAAATCTGGATGCAGGATAACAAAGTCTCTGATTCTTTGATGCGCTCTGTGTTACCAAAGGGTTGGTCGATTGCCGATCGTTCTGGCGCAGGTGGCTTTGGATCACGCGGTATCACAGCAATGATCTGGAAAGAGAATCATAAACCGGTCTACATCAGCATTTACATTACTGAAACCGATTTATCCTTGCAGGCGCGCGATCAGGTTATCGCTCAAGTGAGCCAGTTAATACTGGATGAGTACAATACTATTTAG", "partial": "0", "query_start": 17331, "query_end": 17483, "hit_start": 477, "hit_end": 672, "orf_dna_sequence": "ATGAATATTAATGAATGGTTTGAAGACCCAAAAGTATTTGAAAAGAGTAAAAGAGAATATGCACATTTTGATCTTCGAACTGATTTAGCTAAATGCAAGAAATATATTACTAATTCTAAAAATATTGAGCGACATGGTTTTTATCCGTTTATAAAATATGATCTTGAATATCATAAATATAATAGGGCGGAAGGAAGAAAAACAAAGAAGCGTACCATTTGTTATGCATCTCATATTGATAGTTGTATTTTTCAATATTATAGTTTTTTAATTAATAAAAAATATAATGCACGTCTAAAACAAGATGGCATTTACGAAGTGCCAATAGCATATCGAACAGATCTACATACAGATACTATTGCTGAATTTAGAAAAATGCATCAGTTCATGATTCAGCATCCTTCTTCTTATGTTATGATTGGCGATTTTACAAGCTTTTTTGACAAAATTGACCATCAATATTTAAAAGAGCGCTTATGTGATTTATTACAAGTCGATAAGCTTAATTCCGATTATTATGCGATATTTAAACGAATTACCAAATATGATTATTGGGATTTAACAGATCTCTATCGATTAAATAATCTTAATCCAAAGAAGAGAAAAGATAAGATTAAGATAAATTCTAAAGTAAGAATTCTCTCTCAAAGTGATTATAAGAAATATCGATCACACATTAGGCAACATCAAGACAATAAAGGAATTCCGCAAGGCTCATCAATTAGTGCATGTCTAGCAAATGTTTATATGTTAGAAATTGATCGGCTGATTAATGAATTTGTAGTTGCACGTGGCGGTATTTATAGAAAATACAGTGACGATTTTATAATTATCTTACCTATGGATACTAGTTCAACTGATGATATTGAAAAAATAATTCTAAAATTTGGAGCATTTAAAGATAAAGGTATTTTGGAATTACAACCAGAAAAGACGCAAGTTTATAAATTACAAGACCATTCAGTCGTGAATATCGGTCATCTTTTTACTCCGAGCTTGAATGAAAAGAACAAAACAATTAATTTTATTGGCTTTACTTTTGACGGTAATGCAATAAAAATACGCGAAAAAACAACAAGTAAATATTATTATCGAATGCATCATAAAGCTAAAGGTGTCGCTCATCAATATTATCGTAATAAGTATTACAAGGGTGCAGATAAGTTATATCAACTGTATTCTCCAAATGGTCAGTATGGAAAAGGTAATTATTTTACTTATTTAAGTAGAGTTCAGAATGCTTTCCCCAACCAATCTATTATGATTTCAGAGGATAGGATTATGACGAATATTAGGCTGACTTTGAAGAAAAATAGGTGGGGATAG", "orf_prot_sequence": "MNINEWFEDPKVFEKSKREYAHFDLRTDLAKCKKYITNSKNIERHGFYPFIKYDLEYHKYNRAEGRKTKKRTICYASHIDSCIFQYYSFLINKKYNARLKQDGIYEVPIAYRTDLHTDTIAEFRKMHQFMIQHPSSYVMIGDFTSFFDKIDHQYLKERLCDLLQVDKLNSDYYAIFKRITKYDYWDLTDLYRLNNLNPKKRKDKIKINSKVRILSQSDYKKYRSHIRQHQDNKGIPQGSSISACLANVYMLEIDRLINEFVVARGGIYRKYSDDFIIILPMDTSSTDDIEKIILKFGAFKDKGILELQPEKTQVYKLQDHSVVNIGHLFTPSLNEKNKTINFIGFTFDGNAIKIREKTTSKYYYRMHHKAKGVAHQYYRNKYYKGADKLYQLYSPNGQYGKGNYFTYLSRVQNAFPNQSIMISEDRIMTNIRLTLKKNRWG", "perc_identity": 32.31}}, "BGC0000765.1|Exopolysaccharide_26 # 18452 # 19378 # 1 # ID=1_26;partial=00;start_type=GTG;rbs_motif=TAG;rbs_spacer=8bp;gc_cont=0.347": {"gnl|BL_ORD_ID|586|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 18452, "orf_end": 19378, "orf_from": "BGC0000765.1|Exopolysaccharide_26 ", "model_name": "mecR1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1100", "model_id": "645", "ARO_accession": "3000215", "ARO_name": "mecR1", "ARO_category": {"37589": {"category_aro_accession": "3001208", "category_aro_cvterm_id": "37589", "category_aro_name": "methicillin resistant PBP2", "category_aro_description": "In methicillin sensitive S. aureus (MSSA), beta-lactams bind to native penicillin-binding proteins (PBPs) and disrupt synthesis of the cell membrane's peptidoglycan layer. In methicillin resistant S. aureus (MRSA), foreign PBP2a acquired by lateral gene transfer is able to perform peptidoglycan synthesis in the presence of beta-lactams.", "category_aro_class_name": "AMR Gene Family"}, "35934": {"category_aro_accession": "0000015", "category_aro_cvterm_id": "35934", "category_aro_name": "methicillin", "category_aro_description": "Derived from penicillin to combat penicillin-resistance, methicillin is insensitive to beta-lactamases (also known as penicillinases) secreted by many penicillin-resistant bacteria. Methicillin is bactericidal, and acts by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Antibiotic"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "35998": {"category_aro_accession": "0001002", "category_aro_cvterm_id": "35998", "category_aro_name": "antibiotic target replacement", "category_aro_description": "Replacement or substitution of antibiotic action target, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.133405, "max_identities": 12, "bit_score": 30.8018, "cvterm_id": "35519", "query": "ASLALTQGLLNMMNKKEVQGVIGHELSHIRNYD", "match": "+ + L   ++  MN KE++ +I HELSH++++D", "sequence_from_db": "SQIVLPTVVVETMNDKEIEYIILHELSHVKSHD", "sequence_from_broadstreet": "MLSSFLMLSIISSLLTICVIFLVRMLYIKYTQNIMSHKIWLLVLVSTLIPLIPFYKISNFTFSKDMMNRNVSDTTSSVSHMLDGQQSSVTKDLAINVNQFETSNITYMILLIWVFGSLLCLFYMIKAFRQIDVIKSSSLESSYLNERLKVCQSKMQFYKKHITISYSSNIDNPMVFGLVKSQIVLPTVVVETMNDKEIEYIILHELSHVKSHDLIFNQLYVVFKMIFWFNPALYISKTMMDNDCEKVCDRNVLKILNRHEHIRYGESILKCSILKSQHINNVAAQYLLGFNSNIKERVKYIALYDSMPKPNRNKRIVAYIVCSISLLIQAPLLSAHVQQDKYETNVSYKKLNQLAPYFKGFDGSFVLYNEREQAYSIYNEPESKQRYSPNSTYKIYLALMAFDQNLLSLNHTEQQWDKHQYPFKEWNQDQNLNSSMKYSVNWYYENLNKHLRQDEVKSYLDLIEYGNEEISGNENYWNESSLKISAIEQVNLLKNMKQHNMHFDNKAIEKVENSMTLKQKDTYKYVGKTGTGIVNHKEANGWFVGYVETKDNTYYFATHLKGEDNANGEKAQQISERILKEMELI", "dna_sequence_from_broadstreet": "GTGTTATCATCTTTTTTAATGTTAAGTATAATCAGTTCATTGCTCACGATATGTGTAATTTTTTTAGTGAGAATGCTCTATATAAAATATACTCAAAATATTATGTCACATAAGATTTGGTTATTAGTGCTCGTCTCCACGTTAATTCCATTAATACCATTTTACAAAATATCGAATTTTACATTTTCAAAAGATATGATGAATCGAAATGTATCTGACACGACTTCTTCGGTTAGTCATATGTTAGATGGTCAACAATCATCTGTTACGAAAGACTTAGCAATTAATGTTAATCAGTTTGAGACCTCAAATATAACGTATATGATTCTTTTGATATGGGTATTTGGTAGTTTGTTGTGCTTATTTTATATGATTAAGGCATTCCGACAAATTGATGTTATTAAAAGTTCGTCATTGGAATCGTCATATCTTAATGAACGACTTAAAGTATGTCAAAGTAAGATGCAGTTCTACAAAAAGCATATAACAATTAGTTATAGTTCAAACATTGATAATCCGATGGTATTTGGTTTAGTGAAATCCCAAATTGTACTACCAACTGTCGTAGTCGAAACCATGAATGACAAAGAAATTGAATATATTATTCTACATGAACTATCACATGTGAAAAGTCATGACTTAATATTCAACCAGCTTTATGTTGTTTTTAAAATGATATTCTGGTTTAATCCTGCACTATATATAAGTAAAACAATGATGGACAATGACTGTGAAAAAGTATGTGATAGAAACGTTTTAAAAATTTTGAATCGCCATGAACATATACGTTATGGTGAATCGATATTAAAATGCTCTATTTTAAAATCTCAGCACATAAATAATGTGGCAGCACAATATTTACTAGGTTTTAATTCAAATATTAAAGAACGTGTTAAGTATATTGCACTTTATGATTCAATGCCTAAACCTAATCGAAACAAGCGTATTGTTGCGTATATTGTATGTAGTATATCGCTTTTAATACAAGCACCGTTACTATCTGCACATGTTCAACAAGACAAATATGAAACAAATGTATCATATAAAAAATTAAATCAACTAGCTCCGTATTTCAAAGGATTTGATGGAAGTTTTGTGCTTTATAATGAACGGGAGCAAGCTTATTCTATTTATAATGAACCAGAAAGTAAACAACGATATTCACCTAATTCTACTTACAAAATTTATTTAGCGTTAATGGCATTCGACCAAAATTTACTCTCATTAAATCATACTGAACAACAATGGGATAAACATCAATATCCATTTAAAGAATGGAACCAAGATCAAAATTTAAATTCTTCAATGAAATATTCAGTAAATTGGTATTACGAAAATTTAAACAAACATTTAAGACAAGATGAGGTTAAATCTTATTTAGATCTAATTGAATATGGTAATGAAGAAATATCAGGGAATGAAAATTATTGGAATGAATCTTCATTAAAAATTTCTGCAATAGAACAGGTTAATTTGTTGAAAAATATGAAACAACATAACATGCATTTTGATAATAAGGCTATTGAAAAAGTTGAAAATAGTATGACTTTGAAACAAAAAGATACTTATAAATATGTAGGTAAAACTGGAACAGGAATCGTGAATCACAAAGAAGCAAATGGATGGTTCGTAGGTTATGTTGAAACGAAAGATAATACGTATTATTTTGCTACACATTTAAAAGGCGAAGACAATGCGAATGGCGAAAAAGCACAACAAATTTCTGAGCGTATTTTAAAAGAAATGGAATTAATATAA", "partial": "0", "query_start": 18809, "query_end": 18907, "hit_start": 540, "hit_end": 639, "orf_dna_sequence": "GTGAAAAGAATGCTTTATAAACAAATTGAACAGAATAAACGAAATACTTGGATTATTTTAGGTCTATACACCTTGTTGATACTAATAATAAGTATTTTTCTTGGGATGCTTTTTACAGTTTATATTGGAGGGTTATTCTTTGTTATAGGTTTGATTTACATTGCACACGTCTACTTTGATGCAACTCGCCATCTTATGAAAGTAACAAATGCTGTTGAAATCACTAAAGAAACAGAGCCCCAAATTTATGAATTAGTTGAAGAACTCTGTTTAGCCGGTGGGTTGCCAGTTCCAAAATTATATATTACTCCTGATCAGGCGCCAAATGCGTTTGCTACCGGACGCGATCCACAACATGCAAGTTTAGCTTTAACGCAAGGACTATTGAATATGATGAATAAAAAGGAAGTTCAAGGTGTCATTGGCCATGAACTTTCTCATATTCGAAACTATGATACTCGTATTACAGTTTTAGCCAGTGCGCTAACTAGTTTAATTACAATGACTGGTATAGGAATCGTTGTATTTGGATGGGGTGTATTAACTAGTGAGAGTAAAGGTTTGTTAGGTCTTCTCATCAAATTTTTTGCCTTATTTTTGATTATTGTAGGTGGAATTATTTCTATTATTGGAATTCCTATAGCAAAGTTGCTATTTTTACTAGTATCACGTCAGAGAGAATATTTAGCGGATATTGGTTCAGTTGATTTGACACGTGAACCAAGCGGCTTAATTTCTGCTCTGTCTAAACTTGAAAAGCTAGAAGAAGGAGAGAGTATTCCACAAATTGGATCACAAGATTTAGCCCTACAACATTTGTATTTTAATTTTCCGAGTGCTCATAATTGGATTAACCGCCTTTTCTCCGATCATCCACCTTTGGATAAAAGAATTGAACGCCTAGAAAATAGTAATCGGATAAAATAA", "orf_prot_sequence": "MKRMLYKQIEQNKRNTWIILGLYTLLILIISIFLGMLFTVYIGGLFFVIGLIYIAHVYFDATRHLMKVTNAVEITKETEPQIYELVEELCLAGGLPVPKLYITPDQAPNAFATGRDPQHASLALTQGLLNMMNKKEVQGVIGHELSHIRNYDTRITVLASALTSLITMTGIGIVVFGWGVLTSESKGLLGLLIKFFALFLIIVGGIISIIGIPIAKLLFLLVSRQREYLADIGSVDLTREPSGLISALSKLEKLEEGESIPQIGSQDLALQHLYFNFPSAHNWINRLFSDHPPLDKRIERLENSNRIK", "perc_identity": 36.36}, "gnl|BL_ORD_ID|2016|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 18452, "orf_end": 19378, "orf_from": "BGC0000765.1|Exopolysaccharide_26 ", "model_name": "MexK", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1900", "model_id": "2206", "ARO_accession": "3003693", "ARO_name": "MexK", "ARO_category": {"36005": {"category_aro_accession": "0010004", "category_aro_cvterm_id": "36005", "category_aro_name": "resistance-nodulation-cell division (RND) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.", "category_aro_class_name": "AMR Gene Family"}, "35925": {"category_aro_accession": "0000006", "category_aro_cvterm_id": "35925", "category_aro_name": "erythromycin", "category_aro_description": "Erythromycin is a macrolide antibiotic with a 14-carbon ring that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people that have an allergy to penicillins. Erythromycin may possess bacteriocidal activity, particularly at higher concentrations by binding to the 50S subunit of the bacterial 70S rRNA complex, inhibiting peptidyl-tRNA translocation. Thus, protein synthesis and subsequently structure/function processes critical for life or replication are inhibited.", "category_aro_class_name": "Antibiotic"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "37250": {"category_aro_accession": "3000870", "category_aro_cvterm_id": "37250", "category_aro_name": "triclosan", "category_aro_description": "Triclosan is a common antibacterial agent added to many consumer products as a biocide.  It is an inhibitor of fatty acid biosynthesis by blocking enoyl-carrier protein reductase (FabI).", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "43746": {"category_aro_accession": "3005386", "category_aro_cvterm_id": "43746", "category_aro_name": "disinfecting agents and antiseptics", "category_aro_description": "Disinfectants that can also interact with antimicrobial resistance mechanisms, e.g. molecule efflux, and thus are the targets of disinfectant resistance.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.58295, "max_identities": 12, "bit_score": 25.409, "cvterm_id": "36804", "query": "HNW-INRLFSDHPPLDKRIERLEN", "match": "  W I R+  D P L  RI RLEN", "sequence_from_db": "RKWLIERMNEDFPHLRSRISRLEN", "sequence_from_broadstreet": "MSFNLSAWALQNRQIVLYLMILLGAVGALSYSKLGQSEDPPFTFKAMVVQTNWPGASAEEVARQVTERIEKKLMETGDYDRIVSFSRPGVSQVTFMAREDIHSSEIPELWYQIRKKISDIRATLPQSIQGPFFNDEFGTTYGNIYALTGKGFDYAVMKDYADRLQLQLQRIRNVGKVELIGLQDEKIWIDLSNTKLATLGLPLAAVQKALEEQNAVASSGFFETASDRVQLRVSGRFDSVEEIRDFPIRVGDRTFRIGDVAEVRRGFNDPPAPRMRFMGEDAIGLAVAMKPGGDILVLGKALETEFARLQQSLPAGLELRKVSDQPAAVRTGVGEFIRVLAEALVIVLLVSFFSLGLRTGLVVALSIPLVLAMTFAAMHYFGIGLHKISLGALVLALGLLVDDAIIAVEMMAVKMEQGYDRLKAASFAWTSTAFPMLTGTLITAAGFLPIATAQSGTGEYTRSLFQVVTIALVVSWFAAVVFVPYLGAKLLPDLARLHAQKHGGSADGYDPYATAFYQRFRRLVEWCVRYRKTVIVLTLAAFVGALLLFRLVPQQFFPPSARLELLLDIKLAEGASLRSTGEEVQRLEKMLQGHDGIDNYVAYVGTGSPRFYLPLDQQLPAASFAQVVVLAKDLESREALRKWLIERMNEDFPHLRSRISRLENGPPVGYPVQFRVSGEDIPQVRELARKVADKMRENPHVVNVHLDWEEPSKVVYLSIDQERARALGVSTASLSQFLQSALTGSHVSFFREDNELIEILLRGTEQERRDLSLLPSLAVPTENGRSVALSQIATLEYGFEEGIIWHRNRLPTVTVRADIYDDSLPATLVAQIAPTLEPIRAELPDGYLLEVGGTVEDAAKGQSSVNAGVPLFIVVVLSLLMVQLRSFSRMAMVFLTAPLGLIGVTLFLLLFRQPFGFVAMLGTIALAGMIMRNSVILVDQIEQDISHGLDRWHAIIEATVRRFRPIVLTALAAVLAMIPLSRSVFFGPMAVAIMGGLIVATVLTLLFLPALYAAWFRVKKDEARA", "dna_sequence_from_broadstreet": "ATGTCCTTCAACCTTTCCGCCTGGGCGTTGCAGAATCGCCAGATCGTCCTGTACCTGATGATCCTGCTTGGCGCGGTCGGCGCGCTGTCCTACAGCAAGCTGGGGCAGAGCGAAGACCCGCCGTTCACCTTCAAGGCCATGGTGGTGCAGACCAACTGGCCGGGCGCCAGCGCCGAAGAGGTGGCCCGGCAGGTCACCGAGCGTATCGAGAAGAAGCTGATGGAAACCGGCGACTACGATCGCATCGTGTCCTTCTCCCGCCCCGGCGTCTCGCAGGTGACCTTCATGGCCCGCGAGGACATCCATTCCAGCGAGATCCCCGAACTCTGGTACCAGATCCGCAAGAAGATCAGCGACATTCGCGCCACCTTGCCGCAAAGCATCCAGGGCCCGTTCTTCAACGACGAGTTCGGCACCACCTACGGCAACATCTATGCGCTCACCGGCAAGGGCTTCGACTACGCGGTGATGAAGGACTATGCCGACCGCCTGCAACTGCAATTGCAGCGGATCAGGAACGTCGGCAAGGTCGAGCTGATCGGCCTGCAGGACGAGAAGATCTGGATCGACCTGTCCAACACCAAGCTGGCCACCCTCGGCCTGCCCCTGGCGGCGGTACAGAAGGCGCTGGAGGAACAGAACGCGGTGGCCTCCTCCGGGTTCTTCGAGACCGCCAGCGACCGCGTGCAGTTGCGCGTTTCCGGGCGTTTCGATTCGGTGGAGGAGATCCGCGACTTCCCCATCCGCGTCGGCGACCGCACCTTCCGCATCGGCGACGTGGCCGAGGTTCGCCGCGGCTTCAACGATCCGCCGGCGCCGCGCATGCGCTTCATGGGCGAGGACGCCATCGGCCTGGCGGTAGCGATGAAGCCGGGCGGCGACATCCTGGTGCTGGGCAAGGCCCTGGAAACCGAGTTCGCCCGCCTGCAGCAGTCGCTGCCGGCCGGACTGGAACTGCGCAAGGTGTCCGACCAGCCGGCGGCGGTACGTACCGGGGTCGGCGAGTTCATCCGGGTGCTGGCCGAGGCGCTGGTGATCGTCCTGCTGGTGAGCTTCTTCTCCCTCGGCCTGCGCACCGGCCTGGTGGTGGCGCTGTCGATCCCGCTGGTGCTGGCGATGACCTTCGCCGCCATGCATTACTTCGGCATCGGCCTGCACAAGATCTCCCTCGGCGCCCTGGTGCTGGCGCTGGGATTACTGGTGGACGACGCGATCATCGCGGTGGAGATGATGGCGGTGAAGATGGAGCAGGGCTACGACCGCCTCAAGGCGGCCAGCTTCGCCTGGACCAGCACCGCCTTCCCGATGCTCACCGGCACCCTGATCACCGCCGCCGGCTTCCTGCCGATCGCCACCGCGCAGTCCGGCACCGGCGAATACACCCGCTCGTTGTTCCAGGTGGTGACCATCGCCCTGGTGGTCTCCTGGTTCGCCGCGGTGGTCTTCGTTCCCTACCTGGGGGCCAAGCTGCTGCCGGACCTGGCCAGGTTGCACGCGCAGAAGCACGGCGGCAGCGCCGATGGCTACGATCCCTATGCTACGGCCTTCTACCAGCGCTTCCGGCGTCTGGTGGAGTGGTGCGTGCGCTACCGCAAGACGGTGATCGTCCTGACTCTCGCGGCCTTCGTCGGCGCGCTGCTGCTGTTCCGCCTGGTGCCGCAGCAGTTCTTCCCGCCCTCGGCGCGCCTGGAGCTGCTGCTGGACATCAAGCTGGCGGAGGGTGCCTCACTGCGCTCTACCGGCGAGGAAGTCCAGCGCCTGGAAAAAATGCTGCAGGGCCATGACGGCATCGACAACTACGTGGCCTACGTCGGCACCGGCTCGCCCCGCTTCTACCTGCCGCTGGACCAGCAATTGCCGGCGGCCAGCTTCGCCCAGGTGGTGGTGCTGGCCAAGGACCTGGAGAGCCGCGAGGCGCTGCGCAAGTGGCTGATCGAGCGGATGAACGAGGACTTCCCGCACCTGCGCAGCCGCATCAGTCGCCTGGAGAACGGGCCGCCGGTGGGCTATCCGGTGCAGTTCCGGGTTTCCGGCGAGGACATCCCGCAGGTTCGCGAACTGGCGCGCAAGGTCGCCGACAAGATGCGCGAGAACCCGCACGTGGTGAATGTGCACCTGGATTGGGAAGAGCCGAGCAAGGTGGTGTACCTGAGCATCGACCAGGAGCGCGCCCGTGCCCTGGGGGTGAGCACCGCCAGCCTGTCGCAGTTCCTGCAGAGCGCGCTGACCGGCTCGCACGTGAGCTTCTTCCGCGAAGACAACGAGCTGATCGAGATCCTCCTGCGCGGCACCGAGCAGGAGCGTCGTGACCTGTCGTTGCTGCCGAGCCTGGCGGTGCCGACCGAGAATGGCCGGAGCGTGGCGCTGTCGCAGATCGCTACGCTCGAATACGGCTTCGAAGAGGGCATCATCTGGCACCGCAACCGCCTGCCGACGGTCACCGTGCGCGCCGATATCTACGACGATTCGCTGCCGGCGACCCTGGTCGCGCAGATCGCCCCGACCCTGGAACCGATCCGCGCCGAGTTGCCGGACGGCTACCTGCTGGAGGTGGGCGGCACGGTGGAGGACGCGGCGAAGGGCCAGAGTTCGGTGAACGCCGGCGTGCCGCTGTTCATCGTGGTGGTGTTGAGCCTGCTGATGGTGCAGTTGCGCAGCTTCTCGCGGATGGCGATGGTATTCCTCACCGCACCGCTGGGCCTGATCGGCGTGACCCTGTTCCTGCTGCTGTTCCGCCAGCCGTTCGGCTTCGTGGCGATGCTCGGGACCATCGCCCTGGCCGGCATGATCATGCGCAACTCGGTGATCCTGGTGGACCAGATCGAACAGGACATCAGCCATGGACTGGATCGCTGGCACGCCATCATCGAGGCTACCGTGCGGCGTTTCAGGCCCATCGTGCTGACCGCGCTGGCGGCGGTGCTGGCGATGATCCCGCTGTCGCGCAGCGTGTTCTTCGGGCCGATGGCGGTGGCGATCATGGGCGGGCTGATCGTCGCCACCGTGCTCACCCTGCTGTTCCTGCCGGCGCTCTATGCCGCCTGGTTCCGCGTGAAGAAGGACGAGGCGCGGGCCTGA", "partial": "0", "query_start": 19292, "query_end": 19360, "hit_start": 1920, "hit_end": 1992, "orf_dna_sequence": "GTGAAAAGAATGCTTTATAAACAAATTGAACAGAATAAACGAAATACTTGGATTATTTTAGGTCTATACACCTTGTTGATACTAATAATAAGTATTTTTCTTGGGATGCTTTTTACAGTTTATATTGGAGGGTTATTCTTTGTTATAGGTTTGATTTACATTGCACACGTCTACTTTGATGCAACTCGCCATCTTATGAAAGTAACAAATGCTGTTGAAATCACTAAAGAAACAGAGCCCCAAATTTATGAATTAGTTGAAGAACTCTGTTTAGCCGGTGGGTTGCCAGTTCCAAAATTATATATTACTCCTGATCAGGCGCCAAATGCGTTTGCTACCGGACGCGATCCACAACATGCAAGTTTAGCTTTAACGCAAGGACTATTGAATATGATGAATAAAAAGGAAGTTCAAGGTGTCATTGGCCATGAACTTTCTCATATTCGAAACTATGATACTCGTATTACAGTTTTAGCCAGTGCGCTAACTAGTTTAATTACAATGACTGGTATAGGAATCGTTGTATTTGGATGGGGTGTATTAACTAGTGAGAGTAAAGGTTTGTTAGGTCTTCTCATCAAATTTTTTGCCTTATTTTTGATTATTGTAGGTGGAATTATTTCTATTATTGGAATTCCTATAGCAAAGTTGCTATTTTTACTAGTATCACGTCAGAGAGAATATTTAGCGGATATTGGTTCAGTTGATTTGACACGTGAACCAAGCGGCTTAATTTCTGCTCTGTCTAAACTTGAAAAGCTAGAAGAAGGAGAGAGTATTCCACAAATTGGATCACAAGATTTAGCCCTACAACATTTGTATTTTAATTTTCCGAGTGCTCATAATTGGATTAACCGCCTTTTCTCCGATCATCCACCTTTGGATAAAAGAATTGAACGCCTAGAAAATAGTAATCGGATAAAATAA", "orf_prot_sequence": "MKRMLYKQIEQNKRNTWIILGLYTLLILIISIFLGMLFTVYIGGLFFVIGLIYIAHVYFDATRHLMKVTNAVEITKETEPQIYELVEELCLAGGLPVPKLYITPDQAPNAFATGRDPQHASLALTQGLLNMMNKKEVQGVIGHELSHIRNYDTRITVLASALTSLITMTGIGIVVFGWGVLTSESKGLLGLLIKFFALFLIIVGGIISIIGIPIAKLLFLLVSRQREYLADIGSVDLTREPSGLISALSKLEKLEEGESIPQIGSQDLALQHLYFNFPSAHNWINRLFSDHPPLDKRIERLENSNRIK", "perc_identity": 50.0}}, "BGC0000765.1|Exopolysaccharide_27 # 19507 # 19686 # -1 # ID=1_27;partial=00;start_type=ATG;rbs_motif=TAG;rbs_spacer=10bp;gc_cont=0.411": {"gnl|BL_ORD_ID|913|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 19507, "orf_end": 19686, "orf_from": "BGC0000765.1|Exopolysaccharide_27 ", "model_name": "baeS", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "850", "model_id": "986", "ARO_accession": "3000829", "ARO_name": "baeS", "ARO_category": {"36005": {"category_aro_accession": "0010004", "category_aro_cvterm_id": "36005", "category_aro_name": "resistance-nodulation-cell division (RND) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.", "category_aro_class_name": "AMR Gene Family"}, "36250": {"category_aro_accession": "3000111", "category_aro_cvterm_id": "36250", "category_aro_name": "novobiocin", "category_aro_description": "Novobiocin is an aminocoumarin antibiotic produced by Streptomyces spheroides and Streptomyces niveus, and binds DNA gyrase subunit B inhibiting ATP-dependent DNA supercoiling.", "category_aro_class_name": "Antibiotic"}, "35935": {"category_aro_accession": "0000016", "category_aro_cvterm_id": "35935", "category_aro_name": "aminoglycoside antibiotic", "category_aro_description": "Aminoglycosides are a group of antibiotics that are mostly effective against Gram-negative bacteria. These molecules consist of aminated sugars attached to a dibasic cyclitol. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit (some work by binding to the 50S subunit), inhibiting the translocation of the peptidyl-tRNA from the A-site to the P-site and also causing misreading of mRNA, leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Drug Class"}, "36242": {"category_aro_accession": "3000103", "category_aro_cvterm_id": "36242", "category_aro_name": "aminocoumarin antibiotic", "category_aro_description": "Aminocoumarin antibiotics bind DNA gyrase subunit B to inhibit ATP-dependent DNA supercoiling.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36590": {"category_aro_accession": "3000451", "category_aro_cvterm_id": "36590", "category_aro_name": "protein(s) and two-component regulatory system modulating antibiotic efflux", "category_aro_description": "Protein(s) and two component regulatory systems that directly or indirectly change rates of antibiotic efflux.", "category_aro_class_name": "Efflux Regulator"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.44238, "max_identities": 8, "bit_score": 21.9422, "cvterm_id": "36839", "query": "PTPLFMGLPPQTWRT", "match": "P P   G+PP  WRT", "sequence_from_db": "PGP---GMPPHGWRT", "sequence_from_broadstreet": "MKFWRPGITGKLFLAIFATCIVLLISMHWAVRISFERGFIDYIKHGNEQRLQLLSDALGEQYAQHGNWRFLRNNDRFVFQILRSFEHDNSEDKPGPGMPPHGWRTQFWVVDQNNKVLVGPRAPIPPDGTRRPILVNGAEVGAVIASPVERLTRNTDINFDKQQRQTSWLIVALATLLAALATFLLARGLLAPVKRLVDGTHKLAAGDFTTRVTPTSEDELGKLAQDFNQLASTLEKNQQMRRDFMADISHELRTPLAVLRGELEAIQDGVRKFTPETVASLQAEVGTLTKLVDDLHQLSMSDEGALAYQKAPVDLIPLLEVAGGAFRERFASRGLKLQFSLPDSITVFGDRDRLMQLFNNLLENSLRYTDSGGSLQISAGQRDKTVRLTFADSAPGVSDDQLQKLFERFYRTEGSRNRASGGSGLGLAICLNIVEAHNGRIIAAHSPFGGVSITVELPLERDLQREV", "dna_sequence_from_broadstreet": "ATGAAGTTCTGGCGACCCGGTATTACCGGCAAACTGTTTCTGGCGATTTTCGCCACCTGCATTGTCTTGCTGATCAGTATGCACTGGGCGGTGCGTATCAGTTTTGAGCGTGGCTTTATTGATTACATCAAGCATGGTAATGAACAGCGATTACAACTGTTAAGTGATGCGCTTGGCGAGCAGTATGCGCAGCATGGCAACTGGCGCTTCCTGCGCAACAATGATCGCTTTGTCTTTCAGATCCTGCGTTCATTTGAACACGATAATTCGGAAGATAAACCCGGCCCGGGTATGCCACCGCACGGCTGGCGTACCCAGTTCTGGGTGGTTGATCAAAACAACAAAGTGCTGGTTGGTCCGCGAGCGCCGATTCCACCTGACGGTACACGGCGACCCATTCTGGTCAACGGTGCGGAAGTTGGCGCGGTGATCGCCTCCCCCGTTGAGCGGTTAACGCGCAATACTGATATCAATTTCGATAAACAACAGCGGCAAACCAGCTGGTTGATTGTCGCCCTGGCAACGTTACTCGCGGCACTTGCCACTTTTCTGCTGGCGCGCGGTTTACTGGCACCGGTAAAACGACTTGTCGATGGCACGCACAAACTGGCGGCGGGCGATTTCACTACCCGCGTAACGCCCACCAGTGAAGATGAACTGGGCAAACTGGCGCAAGACTTCAACCAGCTTGCCAGCACACTGGAGAAAAACCAGCAAATGCGGCGCGATTTTATGGCCGATATTTCTCACGAACTGCGTACGCCATTAGCGGTGCTGCGCGGTGAACTGGAAGCCATTCAGGATGGCGTGCGTAAATTCACGCCGGAGACGGTGGCGTCTTTACAGGCGGAGGTCGGTACACTGACCAAACTGGTTGACGATCTCCATCAGTTGTCGATGTCTGATGAAGGCGCTCTCGCCTATCAAAAAGCACCGGTAGATTTGATCCCACTGCTGGAAGTGGCGGGCGGCGCATTTCGCGAACGATTCGCCAGTCGTGGCCTGAAACTGCAATTTTCCCTGCCAGACAGTATTACCGTATTTGGCGATCGCGACCGTTTAATGCAGTTATTCAATAACTTACTGGAAAACAGCCTGCGCTACACTGACAGCGGCGGCAGCCTGCAAATCTCTGCCGGGCAGCGCGACAAAACGGTGCGCCTGACCTTTGCCGACAGTGCGCCAGGTGTCAGTGACGATCAGCTACAAAAATTGTTTGAACGTTTTTATCGCACCGAAGGTTCCCGCAACCGTGCCAGCGGCGGTTCCGGGCTGGGGCTGGCGATTTGCCTGAACATTGTTGAAGCACATAATGGTCGCATTATTGCTGCCCATTCGCCTTTTGGCGGGGTAAGCATTACAGTAGAGTTACCGCTGGAACGGGATTTACAGAGAGAAGTATGA", "partial": "0", "query_start": 19555, "query_end": 19599, "hit_start": 279, "hit_end": 315, "orf_dna_sequence": "ATGATGTGGCATTTTTTATTTACTGGAGAATACGAGTTAGTAATTTTGCCAACACCACTTTTCATGGGATTACCTCCACAAACATGGAGAACACCAAGGCACTGCGAAATCTTCATACTTGGGGGGCATCAGAAGCAGCTCCACTTACGTGGAGAATACACTAAAAGATCTCTGATATAA", "orf_prot_sequence": "MMWHFLFTGEYELVILPTPLFMGLPPQTWRTPRHCEIFILGGHQKQLHLRGEYTKRSLI", "perc_identity": 53.33}, "gnl|BL_ORD_ID|325|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 19507, "orf_end": 19686, "orf_from": "BGC0000765.1|Exopolysaccharide_27 ", "model_name": "ErmU", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "356", "ARO_accession": "3001305", "ARO_name": "ErmU", "ARO_category": {"36699": {"category_aro_accession": "3000560", "category_aro_cvterm_id": "36699", "category_aro_name": "Erm 23S ribosomal RNA methyltransferase", "category_aro_description": "Erm proteins are part of the RNA methyltransferase family and methylate A2058 (E. coli nomenclature) of the 23S ribosomal RNA conferring degrees of resistance to Macrolides, Lincosamides and Streptogramin b. This is called the MLSb phenotype.", "category_aro_class_name": "AMR Gene Family"}, "35964": {"category_aro_accession": "0000046", "category_aro_cvterm_id": "35964", "category_aro_name": "lincomycin", "category_aro_description": "Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. It binds to the 23s portion of the 50S subunit of bacterial ribosomes and inhibit early elongation of peptide chain by inhibiting transpeptidase reaction.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.2118, "max_identities": 8, "bit_score": 21.557, "cvterm_id": "36862", "query": "GLPPQTWRTPR", "match": "GLPP+T R PR", "sequence_from_db": "GLPPRTSRGPR", "sequence_from_broadstreet": "MPSRYGSRQDLGQNFLVDPDIIKLIRRAPNERKVPSLIWRRRGHVTLPLSRLGRPVTAVELDPRRVKRLSARAPENVKVVGEDILRFRLPTVPHTVVGNIPFHVTTATMRRILVAPAWVSAVLVVQWEVARRRAGIGGCSLVTAESWPWFDFSVLKRVPRFAFRPAPSVDGGILVIERRPEPLVRERREYQAFVRQVFTGRGHGLREILQRIGRVQDSDLSAWFRAHGVSPQALPKDLTAEQWASLWGMARGGRSVPRTRRPRGLPPRTSRGPRRNSG", "dna_sequence_from_broadstreet": "GTGCCCAGCCGGTACGGCAGCCGGCAGGACCTCGGTCAGAACTTCCTCGTCGACCCCGACATCATCAAGCTGATCCGCCGAGCGCCGAACGAGCGGAAGGTCCCATCGTTGATCTGGCGCCGGAGAGGGCACGTGACGCTGCCCTTGAGTCGCTTGGGCCGCCCGGTCACCGCGGTTGAGCTCGACCCCCGCCGGGTCAAACGGCTCTCGGCGCGTGCCCCGGAAAACGTCAAGGTCGTCGGCGAGGACATCCTGCGCTTCCGGCTCCCGACCGTTCCGCACACCGTCGTGGGGAACATCCCCTTCCATGTCACGACGGCCACGATGCGCCGGATCCTCGTGGCTCCCGCATGGGTGTCGGCCGTCCTCGTGGTGCAGTGGGAAGTGGCGCGCCGCCGGGCCGGCATCGGCGGCTGCTCGCTGGTCACGGCGGAGTCCTGGCCGTGGTTCGACTTCTCGGTGCTCAAGCGGGTGCCGAGGTTCGCCTTCCGGCCCGCGCCCTCCGTGGACGGCGGGATCCTCGTCATCGAGCGGCGGCCCGAGCCACTGGTGCGGGAGCGCAGGGAGTACCAGGCATTCGTCAGACAGGTCTTCACCGGGCGCGGTCACGGGCTGCGGGAGATCCTCCAACGCATCGGGCGGGTCCAGGACAGCGACCTGTCCGCGTGGTTCAGGGCACATGGAGTCTCGCCGCAGGCGCTGCCGAAGGACCTCACCGCCGAGCAGTGGGCGTCGCTCTGGGGCATGGCGCGTGGCGGCCGGTCCGTGCCGCGGACGCGGCGACCCCGGGGCCTGCCGCCCCGCACGTCCCGCGGGCCGCGGCGCAACAGCGGCTGA", "partial": "0", "query_start": 19573, "query_end": 19605, "hit_start": 789, "hit_end": 822, "orf_dna_sequence": "ATGATGTGGCATTTTTTATTTACTGGAGAATACGAGTTAGTAATTTTGCCAACACCACTTTTCATGGGATTACCTCCACAAACATGGAGAACACCAAGGCACTGCGAAATCTTCATACTTGGGGGGCATCAGAAGCAGCTCCACTTACGTGGAGAATACACTAAAAGATCTCTGATATAA", "orf_prot_sequence": "MMWHFLFTGEYELVILPTPLFMGLPPQTWRTPRHCEIFILGGHQKQLHLRGEYTKRSLI", "perc_identity": 72.73}}, "BGC0000765.1|Exopolysaccharide_28 # 20564 # 20758 # 1 # ID=1_28;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.374": {"gnl|BL_ORD_ID|4672|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 20564, "orf_end": 20758, "orf_from": "BGC0000765.1|Exopolysaccharide_28 ", "model_name": "vanS gene in vanB cluster", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "499", "ARO_accession": "3002932", "ARO_name": "vanS gene in vanB cluster", "ARO_category": {"36210": {"category_aro_accession": "3000071", "category_aro_cvterm_id": "36210", "category_aro_name": "vanS", "category_aro_description": "VanS is similar to histidine protein kinases like EnvZ and acts as a response regulator by activating VanR. VanS is required for high level transcription of other van glycopeptide resistance genes.", "category_aro_class_name": "AMR Gene Family"}, "36373": {"category_aro_accession": "3000234", "category_aro_cvterm_id": "36373", "category_aro_name": "glycopeptide resistance gene cluster", "category_aro_description": "Genes that when expressed confer resistance to vancomycin and teicoplanin type antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35947": {"category_aro_accession": "0000028", "category_aro_cvterm_id": "35947", "category_aro_name": "vancomycin", "category_aro_description": "Vancomycin is a glycopeptide antibiotic used in the prophylaxis and treatment of infections caused by Gram-positive bacteria. Vancomycin inhibits the synthesis of peptidoglycan, the major component of the cell wall of gram-positive bacteria. Its mechanism of action is unusual in that it acts by binding precursors of peptidoglycan, rather than by interacting with an enzyme.", "category_aro_class_name": "Antibiotic"}, "36220": {"category_aro_accession": "3000081", "category_aro_cvterm_id": "36220", "category_aro_name": "glycopeptide antibiotic", "category_aro_description": "Glycopeptide antibiotics are natural products produced non-ribosomally by Actinomycetales bacteria. With the exception of bleomycins, they act by binding the terminal D-Ala-D-Ala in peptidoglycan precursors of the growing bacterial cell wall and are generally active against Gram-positive bacteria.  This inhibits transglycosylation leading to cell death due to osmotic stress.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.00542, "max_identities": 11, "bit_score": 21.9422, "cvterm_id": "35918", "query": "NAKESVDPTSYFSNHLKVMEKGGKATHDLVLVTTDIENELTPWGNQIKEGRKKVGLI", "match": "N  +  D + Y    +K+M++ GK   +++ + +  +  + P    +  GR    L+", "sequence_from_db": "NIGDYKDHSKYLRECIKMMDRQGKTISEILELVSLNDGRIVPIAEPLDIGRTVAELL", "sequence_from_broadstreet": "MERKGIFIKVFSYTIIVLLLLVGVTATLFAQQFVSYFRAMEAQQTVKSYQPLVELIQNSDRLDMQEVAGLFHYNNQSFEFYIEDKEGSVLYATPNADTSNSVRPDFLYVVHRDDNISIVAQSKAGVGLLYQGLTIRGIVMIAIMVVFSLLCAYIFARQMTTPIKALADSANKMANLKEVPPPLERKDELGALAHDMHSMYIRLKETIARLEDEIAREHELEETQRYFFAAASHELKTPIAAVSVLLEGMLENIGDYKDHSKYLRECIKMMDRQGKTISEILELVSLNDGRIVPIAEPLDIGRTVAELLPDFQTLAEANNQRFVTDIPAGQIVLSDPKLIQKALSNVILNAVQNTPQGGEVRIWSEPGAEKYRLSVLNMGVHIDDTALSKLFIPFYRIDQARSRKSGRSGLGLAIVQKTLDAMSLQYALENTSDGVLFWLDLPPTSTL", "dna_sequence_from_broadstreet": "ATGGAAAGAAAAGGGATTTTCATTAAGGTTTTTTCCTATACGATCATTGTCCTGTTACTGCTTGTCGGTGTAACGGCAACACTGTTTGCACAGCAATTTGTGTCTTATTTCAGAGCGATGGAAGCACAGCAAACAGTAAAATCCTATCAGCCATTGGTGGAACTGATTCAGAATAGCGATAGGCTTGATATGCAAGAGGTGGCAGGGCTGTTTCACTACAATAACCAATCCTTTGAGTTTTATATTGAAGATAAAGAGGGAAGCGTACTCTATGCCACACCGAATGCCGATACATCAAATAGTGTTAGGCCCGACTTTCTTTATGTGGTACATAGAGATGATAATATTTCGATTGTTGCTCAAAGCAAGGCAGGTGTGGGATTGCTTTATCAAGGGCTGACAATTCGGGGAATTGTTATGATTGCGATAATGGTTGTATTCAGCCTTTTATGCGCGTATATCTTTGCGCGGCAAATGACAACGCCGATCAAAGCCTTAGCGGACAGTGCGAATAAAATGGCAAACCTGAAAGAAGTACCGCCGCCGCTGGAGCGAAAGGATGAGCTTGGCGCACTGGCTCACGACATGCATTCCATGTATATCAGGCTGAAAGAAACCATCGCAAGGCTGGAGGATGAAATCGCAAGGGAACATGAGTTGGAGGAAACACAGCGATATTTCTTTGCGGCAGCCTCTCATGAGTTAAAAACGCCCATCGCGGCTGTAAGCGTTCTGTTGGAGGGAATGCTTGAAAATATCGGTGACTACAAAGACCATTCTAAGTATCTGCGCGAATGCATCAAAATGATGGACAGGCAGGGCAAAACCATTTCCGAAATACTGGAGCTTGTCAGCCTGAACGATGGGAGAATCGTACCCATAGCCGAACCGCTGGACATAGGGCGCACGGTTGCCGAGCTGCTACCCGATTTTCAAACCTTGGCAGAGGCAAACAACCAGCGGTTCGTCACAGATATTCCAGCCGGACAAATTGTCCTGTCCGATCCGAAGCTGATCCAAAAGGCGCTATCCAATGTCATATTGAATGCGGTTCAGAACACGCCCCAGGGAGGTGAGGTACGGATATGGAGTGAGCCTGGGGCTGAAAAATACCGTCTTTCCGTTTTGAACATGGGCGTTCACATTGATGATACTGCACTTTCAAAGCTGTTCATCCCATTCTATCGCATTGATCAGGCGCGAAGCAGAAAAAGTGGGCGAAGCGGTTTGGGGCTTGCCATCGTACAAAAAACGCTGGATGCCATGAGCCTCCAATATGCGCTGGAAAACACCTCAGATGGCGTTTTGTTCTGGCTGGATTTACCGCCCACATCAACACTATAA", "partial": "0", "query_start": 20585, "query_end": 20755, "hit_start": 753, "hit_end": 924, "orf_dna_sequence": "GTGCAAGGAACTTTCACTAATAATGCTAAAGAAAGCGTTGATCCAACATCTTACTTTAGTAACCACTTAAAAGTAATGGAGAAAGGTGGCAAAGCTACTCATGATCTTGTTTTGGTCACTACAGACATTGAAAATGAATTAACACCTTGGGGAAACCAGATTAAGGAAGGTCGTAAGAAGGTTGGCCTAATATGA", "orf_prot_sequence": "MQGTFTNNAKESVDPTSYFSNHLKVMEKGGKATHDLVLVTTDIENELTPWGNQIKEGRKKVGLI", "perc_identity": 19.3}}, "BGC0000765.1|Exopolysaccharide_30 # 21063 # 21908 # -1 # ID=1_30;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=9bp;gc_cont=0.323": {"gnl|BL_ORD_ID|2202|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 21063, "orf_end": 21908, "orf_from": "BGC0000765.1|Exopolysaccharide_30 ", "model_name": "lin", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "900", "model_id": "3361", "ARO_accession": "3004651", "ARO_name": "lin", "ARO_category": {"36360": {"category_aro_accession": "3000221", "category_aro_cvterm_id": "36360", "category_aro_name": "lincosamide nucleotidyltransferase (LNU)", "category_aro_description": "Resistance to the lincosamide antibiotic by ATP-dependent modification of the 3' and/or 4'-hydroxyl groups of the methylthiolincosamide sugar.", "category_aro_class_name": "AMR Gene Family"}, "35964": {"category_aro_accession": "0000046", "category_aro_cvterm_id": "35964", "category_aro_name": "lincomycin", "category_aro_description": "Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. It binds to the 23s portion of the 50S subunit of bacterial ribosomes and inhibit early elongation of peptide chain by inhibiting transpeptidase reaction.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.47545, "max_identities": 16, "bit_score": 28.8758, "cvterm_id": "42702", "query": "NALNNTNSKLDNLSEQNKQLMQQNKELQSAINTYKQDQNKE", "match": "N LN T S L+N+SE + Q  Q N+E+  +++  + D +KE", "sequence_from_db": "NGLNQTKSLLENISEISVQTKQVNREVLGSMHFKESDLHKE", "sequence_from_broadstreet": "MSTIEINQLKIEVADRVLVEIPHLLVSKKARIGIIGQNGLGKTTLMEVIAGAKEATSGTVTTQGKLAYIKQLSTDTSTKSGGEKTRKATQHAMRQNPSVLLADEPTSNLDVESVKHLERQWSDFHGALIIISHDRAFLDALCTEIWEIKNQKIHVYKGNYHAYLEQKQQQENQAELAYKEFKNKKKQLQASQTHHEIEAGRIVKPGKRLNNKEASAFKAGKGTQQKKQHSTIKALEKRIERLGNVEKPHTTKPIKIITPDNRVIKKGNTILSAKETAYEIAGRKLFETKAFSIKAGDKVALIGENASGKTTFLKEIIQENPNLLCNPQAKIAYFDQELNGLNQTKSLLENISEISVQTKQVNREVLGSMHFKESDLHKEVRMLSGGERVKLLLSMLLLSDANFLILDEPTNYLDIYAMEALETLIKQFAGTVLFVSHDRTFVNHVAEQLLVIENNEMNFHRMTFAEYEESKAPSRITEEDKLILEMRMSEIAAKLMQPNLKPTEKAILEQDYQEIITKRQQFS", "dna_sequence_from_broadstreet": "ATGTCTACAATCGAAATAAATCAATTAAAAATAGAAGTAGCAGATAGAGTTTTAGTAGAAATTCCTCATCTGCTAGTTAGTAAAAAAGCAAGAATCGGCATCATCGGTCAAAATGGTCTAGGAAAAACAACACTAATGGAAGTGATTGCTGGCGCTAAAGAAGCGACATCTGGCACGGTGACTACACAAGGAAAACTTGCTTACATCAAACAACTTTCCACGGATACAAGTACGAAAAGCGGTGGTGAAAAAACAAGAAAAGCTACTCAACACGCGATGCGCCAAAATCCAAGTGTTCTCCTAGCAGACGAACCAACAAGCAATCTTGATGTCGAAAGCGTCAAACATTTAGAACGTCAGTGGAGCGATTTCCACGGTGCGCTCATAATTATCTCGCATGACCGCGCTTTTTTAGATGCACTTTGTACAGAAATATGGGAAATCAAAAACCAAAAAATTCACGTGTACAAAGGAAACTACCACGCGTATTTAGAACAAAAACAACAACAAGAAAACCAAGCAGAACTTGCATACAAAGAATTTAAAAACAAAAAGAAACAATTGCAAGCATCTCAAACACATCACGAAATCGAAGCAGGTCGTATCGTTAAACCCGGGAAACGCTTAAACAACAAAGAAGCCAGCGCATTTAAAGCTGGAAAAGGAACACAACAAAAGAAACAACATAGTACAATCAAAGCTTTAGAAAAACGAATTGAACGGCTTGGTAATGTCGAAAAACCACATACAACTAAACCAATCAAAATTATCACCCCAGACAATCGCGTTATAAAAAAAGGCAACACGATACTAAGTGCCAAAGAAACAGCTTACGAAATTGCCGGACGAAAACTATTTGAAACAAAAGCTTTTTCTATTAAAGCAGGGGATAAAGTGGCGCTGATCGGTGAAAATGCAAGTGGGAAAACTACATTTTTAAAAGAAATAATCCAAGAAAATCCTAATCTCTTATGTAATCCCCAAGCGAAAATTGCTTATTTCGACCAAGAATTGAATGGATTAAACCAAACGAAATCCCTATTAGAAAACATCTCGGAAATTAGCGTTCAAACCAAGCAAGTAAACAGAGAAGTACTAGGTAGTATGCATTTTAAAGAAAGCGATTTGCATAAGGAAGTGCGCATGCTCTCTGGCGGGGAACGAGTGAAGTTGCTGCTCAGTATGCTCCTTCTTAGTGACGCCAATTTCTTGATTCTTGATGAACCAACCAACTATTTGGATATCTACGCAATGGAAGCGCTGGAAACGTTAATCAAACAATTTGCGGGGACGGTACTCTTCGTTTCTCATGATAGAACTTTTGTTAATCATGTGGCAGAACAGTTACTTGTTATCGAAAATAATGAAATGAATTTCCACCGGATGACTTTTGCAGAATATGAAGAAAGTAAAGCACCAAGCCGGATTACAGAAGAAGATAAGTTGATTTTAGAAATGCGTATGTCAGAAATTGCGGCAAAACTCATGCAACCCAATTTAAAGCCCACAGAAAAAGCCATACTCGAACAAGATTATCAAGAAATTATCACAAAAAGACAGCAATTTAGTTAA", "partial": "0", "query_start": 21537, "query_end": 21659, "hit_start": 1014, "hit_end": 1137, "orf_dna_sequence": "ATGACATTACAAATCAATACCAGAGTAGACTCAATTACCTGGCCTCTTAATCAGAATTTGACCAATCAAGAAATAATCTCTCAATTGGAACTTACAGTTACAGAAAATGGCCATCTTATTTCAAATGATAATCTTAGTATAAATAAAAAGGCCGTTAACCGGTCTGAAGCAGGAGTATATCCTGTAATTATTACAGCGATTGGCACTAATAACGAATATGGGACCAAAAAAATTCAAGCCTGGGTAACAGATAAAAATAATATGGTTGATTCTTCCCCTACTCCTCAACCAGCTCCAGTAAAAACAGCACAATATACTTCTTCTCCTAATAAAGCTGCTAGTCCTAAAAAGAAAGGCAAGAAAAAGATAGTATATATTGTTCTTGGAGTGCTTGTTTTATTAATTGCCATCATCTTTGGTATTTCAGCTTGTCAGGCTCATAATGATACGGTTCAAAATGAGCAAGCTCAAAGTAATGCCCTCAATAATACTAACAGTAAATTAGATAATCTGTCTGAACAAAACAAGCAATTAATGCAACAAAATAAAGAGTTGCAAAGTGCTATCAATACCTATAAGCAGGATCAAAATAAAGAAGAATTACAAAACCAATTAAACCAAATCAAAACGGAAAATGAACAATTGAAAAATAATGCTGCTAATAATCAAGCCTTACAAAATCAAATTGATCAATTGGGCTCTACTATCGACCAAATCAAACAAAATCCAAATCAGGCCGATTCATTATTAGATCAAATGAAAAATAATCAAAACGAATTTATGCAGAATTTAAATGCAACTTTTCAAAAACTAGTTAGCGATTTCCAGCAACTAATTGGACAATAA", "orf_prot_sequence": "MTLQINTRVDSITWPLNQNLTNQEIISQLELTVTENGHLISNDNLSINKKAVNRSEAGVYPVIITAIGTNNEYGTKKIQAWVTDKNNMVDSSPTPQPAPVKTAQYTSSPNKAASPKKKGKKKIVYIVLGVLVLLIAIIFGISACQAHNDTVQNEQAQSNALNNTNSKLDNLSEQNKQLMQQNKELQSAINTYKQDQNKEELQNQLNQIKTENEQLKNNAANNQALQNQIDQLGSTIDQIKQNPNQADSLLDQMKNNQNEFMQNLNATFQKLVSDFQQLIGQ", "perc_identity": 39.02}, "gnl|BL_ORD_ID|694|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 21063, "orf_end": 21908, "orf_from": "BGC0000765.1|Exopolysaccharide_30 ", "model_name": "KPC-9", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "550", "model_id": "755", "ARO_accession": "3002319", "ARO_name": "KPC-9", "ARO_category": {"36198": {"category_aro_accession": "3000059", "category_aro_cvterm_id": "36198", "category_aro_name": "KPC beta-lactamase", "category_aro_description": "Klebsiella pneumoniae carbapenem resistant (KPC) beta-lactamases are notorious for their ability to efficiently hydrolyze carbapenems, unlike other Ambler Class A beta-lactamases.  There are currently 9 variants reported worldwide.  These enzymes were first isolated from Klebsiella pneumoniae strains in 2001 in the United States.  Hospital outbreaks have since been reported in Greece and Israel and KPC carrying strains are now endemic to New York facilities.  KPC-1 and KPC-2 have been shown to be identical and are now referred to as KPC-2.", "category_aro_class_name": "AMR Gene Family"}, "35923": {"category_aro_accession": "0000004", "category_aro_cvterm_id": "35923", "category_aro_name": "monobactam", "category_aro_description": "Monobactams are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Unlike penams and cephems, monobactams do not have any ring fused to its four-member lactam structure. Monobactam antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.93415, "max_identities": 16, "bit_score": 24.6386, "cvterm_id": "35914", "query": "GTNNEYGTKKIQAWVTDKNNMVDSSPTPQPAPVKTAQYTSSPNK", "match": "GT   YGT          N+     PT + AP+  A YT +PNK", "sequence_from_db": "GTCGAYGTA---------NDYAVVWPTGR-APIVLAVYTRAPNK", "sequence_from_broadstreet": "RLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYRAEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAELSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTSSPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGAYGTANDYAVVWPTGRAPIVLAVYTRAPNKDDKYSEAVIAAAARLALEGLG", "dna_sequence_from_broadstreet": "CGTCTAGTTCTGCTGTCTTGTCTCTCATGGCCGCTGGCTGGCTTTTCTGCCACCGCGCTGACCAACCTCGTCGCGGAACCATTCGCTAAACTCGAACAGGACTTTGGCGGCTCCATCGGTGTGTACGCGATGGATACCGGCTCAGGCGCAACTGTAAGTTACCGCGCTGAGGAGCGCTTCCCACTGTGCAGCTCATTCAAGGGCTTTCTTGCTGCCGCTGTGCTGGCTCGCAGCCAGCAGCAGGCCGGCTTGCTGGACACACCCATCCGTTACGGCAAAAATGCGCTGGTTCCGTGGTCACCCATCTCGGAAAAATATCTGACAACAGGCATGACGGTGGCGGAGCTGTCCGCGGCCGCCGTGCAATACAGTGATAACGCCGCCGCCAATTTGTTGCTGAAGGAGTTGGGCGGCCCGGCCGGGCTGACGGCCTTCATGCGCTCTATCGGCGATACCACGTTCCGTCTGGACCGCTGGGAGCTGGAGCTGAACTCCGCCATCCCAGGCGATGCGCGCGATACCTCATCGCCGCGCGCCGTGACGGAAAGCTTACAAAAACTGACACTGGGCTCTGCACTGGCTGCGCCGCAGCGGCAGCAGTTTGTTGATTGGCTAAAGGGAAACACGACCGGCAACCACCGCATCCGCGCGGCGGTGCCGGCAGACTGGGCAGTCGGAGACAAAACCGGAACCTGCGGAGCGTATGGCACGGCAAATGACTATGCCGTCGTCTGGCCCACTGGGCGCGCACCTATTGTGTTGGCCGTCTACACCCGGGCGCCTAACAAGGATGACAAGTACAGCGAGGCCGTCATCGCCGCTGCGGCTAGACTCGCGCTCGAGGGATTGGGC", "partial": "1", "query_start": 21264, "query_end": 21395, "hit_start": 687, "hit_end": 789, "orf_dna_sequence": "ATGACATTACAAATCAATACCAGAGTAGACTCAATTACCTGGCCTCTTAATCAGAATTTGACCAATCAAGAAATAATCTCTCAATTGGAACTTACAGTTACAGAAAATGGCCATCTTATTTCAAATGATAATCTTAGTATAAATAAAAAGGCCGTTAACCGGTCTGAAGCAGGAGTATATCCTGTAATTATTACAGCGATTGGCACTAATAACGAATATGGGACCAAAAAAATTCAAGCCTGGGTAACAGATAAAAATAATATGGTTGATTCTTCCCCTACTCCTCAACCAGCTCCAGTAAAAACAGCACAATATACTTCTTCTCCTAATAAAGCTGCTAGTCCTAAAAAGAAAGGCAAGAAAAAGATAGTATATATTGTTCTTGGAGTGCTTGTTTTATTAATTGCCATCATCTTTGGTATTTCAGCTTGTCAGGCTCATAATGATACGGTTCAAAATGAGCAAGCTCAAAGTAATGCCCTCAATAATACTAACAGTAAATTAGATAATCTGTCTGAACAAAACAAGCAATTAATGCAACAAAATAAAGAGTTGCAAAGTGCTATCAATACCTATAAGCAGGATCAAAATAAAGAAGAATTACAAAACCAATTAAACCAAATCAAAACGGAAAATGAACAATTGAAAAATAATGCTGCTAATAATCAAGCCTTACAAAATCAAATTGATCAATTGGGCTCTACTATCGACCAAATCAAACAAAATCCAAATCAGGCCGATTCATTATTAGATCAAATGAAAAATAATCAAAACGAATTTATGCAGAATTTAAATGCAACTTTTCAAAAACTAGTTAGCGATTTCCAGCAACTAATTGGACAATAA", "orf_prot_sequence": "MTLQINTRVDSITWPLNQNLTNQEIISQLELTVTENGHLISNDNLSINKKAVNRSEAGVYPVIITAIGTNNEYGTKKIQAWVTDKNNMVDSSPTPQPAPVKTAQYTSSPNKAASPKKKGKKKIVYIVLGVLVLLIAIIFGISACQAHNDTVQNEQAQSNALNNTNSKLDNLSEQNKQLMQQNKELQSAINTYKQDQNKEELQNQLNQIKTENEQLKNNAANNQALQNQIDQLGSTIDQIKQNPNQADSLLDQMKNNQNEFMQNLNATFQKLVSDFQQLIGQ", "perc_identity": 36.36}, "gnl|BL_ORD_ID|3059|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 21063, "orf_end": 21908, "orf_from": "BGC0000765.1|Exopolysaccharide_30 ", "model_name": "KPC-23", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "550", "model_id": "4088", "ARO_accession": "3005356", "ARO_name": "KPC-23", "ARO_category": {"36198": {"category_aro_accession": "3000059", "category_aro_cvterm_id": "36198", "category_aro_name": "KPC beta-lactamase", "category_aro_description": "Klebsiella pneumoniae carbapenem resistant (KPC) beta-lactamases are notorious for their ability to efficiently hydrolyze carbapenems, unlike other Ambler Class A beta-lactamases.  There are currently 9 variants reported worldwide.  These enzymes were first isolated from Klebsiella pneumoniae strains in 2001 in the United States.  Hospital outbreaks have since been reported in Greece and Israel and KPC carrying strains are now endemic to New York facilities.  KPC-1 and KPC-2 have been shown to be identical and are now referred to as KPC-2.", "category_aro_class_name": "AMR Gene Family"}, "35923": {"category_aro_accession": "0000004", "category_aro_cvterm_id": "35923", "category_aro_name": "monobactam", "category_aro_description": "Monobactams are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Unlike penams and cephems, monobactams do not have any ring fused to its four-member lactam structure. Monobactam antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.01809, "max_identities": 16, "bit_score": 24.6386, "cvterm_id": "35915", "query": "GTNNEYGTKKIQAWVTDKNNMVDSSPTPQPAPVKTAQYTSSPNK", "match": "GT   YGT          N+     PT + AP+  A YT +PNK", "sequence_from_db": "GTCGAYGTA---------NDYAVVWPTGR-APIVLAVYTRAPNK", "sequence_from_broadstreet": "MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYRAEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAELSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTSSPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGAYGTANDYAVVWPTGRAPIVLAVYTRAPNKDDKYSEAVIAAAARLALEGLGVNGQ", "dna_sequence_from_broadstreet": "ATGTCACTGTATCGCCGTCTAGTTCTGCTGTCTTGTCTCTCATGGCCGCTGGCTGGCTTTTCTGCCACCGCGCTGACCAACCTCGTCGCGGAACCATTCGCTAAACTCGAACAGGACTTTGGCGGCTCCATCGGTGTGTACGCGATGGATACCGGCTCAGGCGCAACTGTAAGTTACCGCGCTGAGGAGCGCTTCCCACTGTGCAGCTCATTCAAGGGCTTTCTTGCTGCCGCTGTGCTGGCTCGCAGCCAGCAGCAGGCCGGCTTGCTGGACACACCCATCCGTTACGGCAAAAATGCGCTGGTTCCGTGGTCACCCATCTCGGAAAAATATCTGACAACAGGCATGACGGTGGCGGAGCTGTCCGCGGCCGCCGTGCAATACAGTGATAACGCCGCCGCCAATTTGTTGCTGAAGGAGTTGGGCGGCCCGGCCGGGCTGACGGCCTTCATGCGCTCTATCGGCGATACCACGTTCCGTCTGGACCGCTGGGAGCTGGAGCTGAACTCCGCCATCCCAGGCGATGCGCGCGATACCTCATCGCCGCGCGCCGTGACGGAAAGCTTACAAAAACTGACACTGGGCTCTGCACTGGCTGCGCCGCAGCGGCAGCAGTTTGTTGATTGGCTAAAGGGAAACACGACCGGCAACCACCGCATCCGCGCGGCGGTGCCGGCAGACTGGGCAGTCGGAGACAAAACCGGAACCTGCGGAGCGTATGGCACGGCAAATGACTATGCCGTCGTCTGGCCCACTGGGCGCGCACCTATTGTGTTGGCCGTCTACACCCGGGCGCCTAACAAGGATGACAAGTACAGCGAGGCCGTCATCGCCGCTGCGGCTAGACTCGCGCTCGAGGGATTGGGCGTCAACGGGCAGTAA", "partial": "0", "query_start": 21264, "query_end": 21395, "hit_start": 702, "hit_end": 804, "orf_dna_sequence": "ATGACATTACAAATCAATACCAGAGTAGACTCAATTACCTGGCCTCTTAATCAGAATTTGACCAATCAAGAAATAATCTCTCAATTGGAACTTACAGTTACAGAAAATGGCCATCTTATTTCAAATGATAATCTTAGTATAAATAAAAAGGCCGTTAACCGGTCTGAAGCAGGAGTATATCCTGTAATTATTACAGCGATTGGCACTAATAACGAATATGGGACCAAAAAAATTCAAGCCTGGGTAACAGATAAAAATAATATGGTTGATTCTTCCCCTACTCCTCAACCAGCTCCAGTAAAAACAGCACAATATACTTCTTCTCCTAATAAAGCTGCTAGTCCTAAAAAGAAAGGCAAGAAAAAGATAGTATATATTGTTCTTGGAGTGCTTGTTTTATTAATTGCCATCATCTTTGGTATTTCAGCTTGTCAGGCTCATAATGATACGGTTCAAAATGAGCAAGCTCAAAGTAATGCCCTCAATAATACTAACAGTAAATTAGATAATCTGTCTGAACAAAACAAGCAATTAATGCAACAAAATAAAGAGTTGCAAAGTGCTATCAATACCTATAAGCAGGATCAAAATAAAGAAGAATTACAAAACCAATTAAACCAAATCAAAACGGAAAATGAACAATTGAAAAATAATGCTGCTAATAATCAAGCCTTACAAAATCAAATTGATCAATTGGGCTCTACTATCGACCAAATCAAACAAAATCCAAATCAGGCCGATTCATTATTAGATCAAATGAAAAATAATCAAAACGAATTTATGCAGAATTTAAATGCAACTTTTCAAAAACTAGTTAGCGATTTCCAGCAACTAATTGGACAATAA", "orf_prot_sequence": "MTLQINTRVDSITWPLNQNLTNQEIISQLELTVTENGHLISNDNLSINKKAVNRSEAGVYPVIITAIGTNNEYGTKKIQAWVTDKNNMVDSSPTPQPAPVKTAQYTSSPNKAASPKKKGKKKIVYIVLGVLVLLIAIIFGISACQAHNDTVQNEQAQSNALNNTNSKLDNLSEQNKQLMQQNKELQSAINTYKQDQNKEELQNQLNQIKTENEQLKNNAANNQALQNQIDQLGSTIDQIKQNPNQADSLLDQMKNNQNEFMQNLNATFQKLVSDFQQLIGQ", "perc_identity": 36.36}}, "BGC0000765.1|Exopolysaccharide_31 # 22060 # 22197 # 1 # ID=1_31;partial=01;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.333": {"gnl|BL_ORD_ID|1708|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 22060, "orf_end": 22197, "orf_from": "BGC0000765.1|Exopolysaccharide_31 ", "model_name": "FomB", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "1850", "ARO_accession": "3000449", "ARO_name": "FomB", "ARO_category": {"41410": {"category_aro_accession": "3004246", "category_aro_cvterm_id": "41410", "category_aro_name": "Fom phosphotransferase family", "category_aro_description": "Two members of the Fom family have been identified, FomA and FomB. FomB must interact with FomA confer resistance to fosfomycin, however FomA is capable of conferring resistance alone.", "category_aro_class_name": "AMR Gene Family"}, "35944": {"category_aro_accession": "0000025", "category_aro_cvterm_id": "35944", "category_aro_name": "fosfomycin", "category_aro_description": "Fosfomycin (also known as phosphomycin and phosphonomycin) is a broad-spectrum antibiotic produced by certain Streptomyces species. It is effective on gram positive and negative bacteria as it targets the cell wall, an essential feature shared by both bacteria. Its specific target is MurA (MurZ in E.coli), which attaches phosphoenolpyruvate (PEP) to UDP-N-acetylglucosamine, a step of commitment to cell wall synthesis. In the active site of MurA, the active cysteine molecule is alkylated which stops the catalytic reaction.", "category_aro_class_name": "Antibiotic"}, "45731": {"category_aro_accession": "3007149", "category_aro_cvterm_id": "45731", "category_aro_name": "phosphonic acid antibiotic", "category_aro_description": "A group of antibiotics derived from phosphonic acids.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.740015, "max_identities": 13, "bit_score": 23.483, "cvterm_id": "39587", "query": "MCMIKDKDKI---LVLNRTDPVWPGLTFPGGHVESH", "match": "+C+  D+D I   L  +RTD  + G  F GG+   H", "sequence_from_db": "VCVDLDRDDIPAELYADRTDRTFRGKRFKGGYYLVH", "sequence_from_broadstreet": "MLENLTIRSSRVVDLNLVKVRLSTNLEDFAAYSYFSAFAEDESAPADYEVVCVDLDRDDIPAELYADRTDRTFRGKRFKGGYYLVHYFGEPAHLITVGRTFYVFGRSLEKTVWPYFVKHILTVHSADHGFLHLKAAGFELPGAGATLLVGRNGAGKTVFLAQACLNGARFLSNTHTLVRDGVAHGVPSSIRVRRDQCFGELIDKHDLTAHMESGDYVTDSSTLFESPQISTARVRNVVIVDYDPARPQGLMPISPAAAGTFMEQFSFAVTTYGLKDDLLAHHGDFDTYVDSLARMRAQLTELVEGARCYRANADMLAKEVRDSTLKQLAE", "dna_sequence_from_broadstreet": "ATGCTGGAAAACCTCACGATCCGCAGCAGCCGCGTCGTCGACCTCAACCTGGTCAAGGTCAGGCTGTCCACCAACCTCGAGGACTTCGCGGCGTACTCCTACTTCTCGGCCTTCGCCGAGGACGAGTCCGCGCCCGCCGACTACGAGGTCGTCTGCGTCGACCTGGACCGGGACGACATCCCGGCCGAGCTGTACGCCGACCGGACCGACCGGACCTTCCGCGGCAAGCGGTTCAAGGGCGGCTACTACCTCGTCCACTACTTCGGGGAGCCCGCCCACCTCATCACGGTGGGCCGCACGTTCTACGTGTTCGGCAGGTCCCTCGAGAAGACCGTCTGGCCCTACTTCGTCAAGCACATCCTGACCGTCCACTCCGCGGACCACGGCTTCCTGCACCTGAAGGCGGCGGGCTTCGAACTGCCCGGCGCCGGAGCCACCCTGCTCGTCGGGCGCAACGGCGCGGGGAAGACCGTCTTCCTGGCCCAGGCGTGCCTCAACGGCGCCCGGTTCCTCAGCAACACCCACACGCTGGTCCGGGACGGGGTCGCGCACGGCGTCCCCTCCTCGATCCGGGTGCGCCGCGACCAGTGCTTCGGTGAACTCATCGACAAGCACGACCTGACGGCGCACATGGAGTCGGGCGACTACGTCACCGACTCCTCGACTCTCTTCGAGAGTCCGCAGATCAGCACGGCACGCGTCCGGAACGTCGTCATCGTCGACTACGACCCCGCACGCCCCCAGGGCCTCATGCCGATCTCGCCGGCCGCGGCCGGCACCTTCATGGAGCAGTTCTCCTTCGCGGTCACCACCTACGGCCTCAAGGACGATCTGCTCGCCCACCACGGGGACTTCGACACCTACGTCGACTCCCTGGCCCGGATGCGGGCGCAGCTGACCGAACTGGTCGAGGGCGCGCGCTGCTACCGGGCCAACGCAGACATGCTGGCCAAGGAAGTCCGGGATTCGACGCTCAAGCAGCTTGCCGAATGA", "partial": "0", "query_start": 22093, "query_end": 22191, "hit_start": 150, "hit_end": 258, "orf_dna_sequence": "ATGAAAAGATCAGAAAATGTGACTTTAACTAATATGTGTATGATAAAAGATAAAGATAAAATTTTAGTTCTAAATAGAACTGATCCAGTTTGGCCTGGTTTAACTTTTCCAGGCGGCCACGTCGAATCTCATGAAGCT", "orf_prot_sequence": "MKRSENVTLTNMCMIKDKDKILVLNRTDPVWPGLTFPGGHVESHEA", "perc_identity": 36.11}, "gnl|BL_ORD_ID|428|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 22060, "orf_end": 22197, "orf_from": "BGC0000765.1|Exopolysaccharide_31 ", "model_name": "amrB", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1750", "model_id": "476", "ARO_accession": "3002983", "ARO_name": "amrB", "ARO_category": {"36005": {"category_aro_accession": "0010004", "category_aro_cvterm_id": "36005", "category_aro_name": "resistance-nodulation-cell division (RND) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.", "category_aro_class_name": "AMR Gene Family"}, "35935": {"category_aro_accession": "0000016", "category_aro_cvterm_id": "35935", "category_aro_name": "aminoglycoside antibiotic", "category_aro_description": "Aminoglycosides are a group of antibiotics that are mostly effective against Gram-negative bacteria. These molecules consist of aminated sugars attached to a dibasic cyclitol. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit (some work by binding to the 50S subunit), inhibiting the translocation of the peptidyl-tRNA from the A-site to the P-site and also causing misreading of mRNA, leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.44634, "max_identities": 9, "bit_score": 22.3274, "cvterm_id": "41211", "query": "IKDKDKILVLNRTDPVWPGLTFPG", "match": "+  ++K+L   R DPV   L F G", "sequence_from_db": "VAAREKLLAEGRKDPVLTDLMFAG", "sequence_from_broadstreet": "MARFFIDRPVFAWVISLFIMLGGIFAIRALPVAQYPDIAPPVVSLYATYPGASAQVVEESVTAVIEREMNGVPGLLYTSATSSAGQASLSLTFKQGVSADLAAVDVQNRLKIVEARLPEPVRRDGISIEKAADNAQIIVSLTSEDGRLSGVELGEYASANVLQALRRVEGVGKVQFWGAEYAMRIWPDPVKMAALGLTASDIASAVRAHNARVTIGDVGRSAVPDSAPIAATVLADAPLTTPDAFGAIALRARADGSTLYLRDVARIEFGGNDYNYPSFVNGKTATGMGIKLAPGSNAVATEKRVRATMEELAKFFPPGVKYQIPYETASFVRVSMSKVVTTLVEAGVLVFAVMFLFMQNFRATLIPTLVVPVALLGTFGAMLAAGFSINVLTMFGMVLAIGILVDDAIVVVENVERLMVEEKLPPYEATVKAMKQISGAIVGITVVLTSVFVPMAFFGGAVGNIYRQFAFALAVSIGFSAFLALSLTPALCATLLKPVADDHHEKDGFFGWFNRFVARSTHRYTRRVGRVLERPLRWLVVYGALTAAAALLITKLPAAFLPDEDQGNFMVMVIRPQGTPLAETMQSVRRVEEYVRTHSPSAYTFALGGYNLYGEGPNGGMIFVTMKDWKERKRARDQVQAIIAEINAHFAGTPNTMVFAINMPALPDLGLTGGFDFRLQDRGGLGYGAFVAAREKLLAEGRKDPVLTDLMFAGTQDAPQLKLDIDRAKASALGVSMEEINATLAVMFGSDYIGDFMHGSQVRRVIVQADGRHRLDAADVTKLRVRNAKGEMVPLAAFATLHWTMGPPQLTRYNGFPSFTINGAASAGHSSGEAMAAIERIASTLPAGTGYAWSGQSYEERLSGAQAPMLFALSVLVVFLALAALYESWSIPFAVMLVVPLGVIGAVAGVTLRGMPNDIYFKVGLIATIGLSAKNAILIVEVAKDLVAQRMSLADAALEAARLRLRPIVMTSLAFGVGVLPLAFATGAASGAQIAIGTGVLGGVISATLFAIFLVPLFFVCVGRVFDVVPRRRGGAQAALEAK", "dna_sequence_from_broadstreet": "ATGGCTCGTTTCTTCATCGATCGCCCGGTGTTCGCATGGGTGATCTCCTTGTTCATCATGCTGGGCGGCATCTTCGCGATCCGCGCGCTGCCCGTCGCGCAGTATCCGGACATCGCGCCGCCCGTCGTCAGCCTCTATGCGACGTATCCGGGCGCGTCCGCGCAGGTCGTCGAGGAATCGGTCACCGCCGTGATCGAGCGCGAGATGAACGGCGTGCCCGGCCTGCTGTACACGTCGGCGACGAGCAGCGCCGGCCAGGCGTCGCTGTCGCTCACGTTCAAGCAGGGCGTGAGCGCCGATCTCGCGGCCGTCGACGTGCAGAACCGCCTGAAAATCGTCGAGGCGCGGCTGCCCGAGCCCGTGCGGCGCGACGGCATCTCGATCGAGAAGGCGGCCGACAACGCGCAGATCATCGTGTCGCTCACGTCGGAGGACGGACGGTTATCGGGCGTGGAGCTCGGCGAATACGCGTCGGCGAACGTGTTGCAGGCGCTGCGGCGCGTCGAGGGCGTCGGCAAGGTGCAGTTCTGGGGCGCCGAGTATGCGATGCGGATCTGGCCGGACCCCGTGAAGATGGCGGCGCTCGGCCTGACGGCGTCCGATATCGCGTCGGCCGTGCGCGCGCACAACGCGCGCGTGACGATCGGCGACGTCGGCCGCAGCGCGGTGCCCGACAGCGCGCCGATCGCGGCGACCGTGCTCGCCGACGCGCCGCTCACGACGCCCGACGCGTTCGGCGCGATCGCGCTGCGCGCGCGCGCCGACGGCTCGACGCTGTACCTGCGCGACGTCGCGAGAATCGAGTTCGGCGGCAACGATTACAACTACCCGTCGTTCGTGAACGGCAAGACGGCGACGGGCATGGGCATCAAGCTCGCGCCCGGTTCGAATGCGGTCGCCACCGAAAAGCGCGTGCGCGCGACGATGGAGGAGCTCGCGAAGTTCTTTCCGCCGGGCGTCAAGTACCAGATTCCGTACGAGACGGCGTCGTTCGTGCGCGTGTCGATGAGCAAGGTCGTCACGACGCTCGTCGAGGCGGGCGTGCTCGTGTTCGCGGTGATGTTCCTCTTCATGCAGAACTTCCGCGCGACGCTGATTCCGACGCTCGTCGTGCCCGTCGCGCTGCTCGGCACGTTCGGCGCGATGCTCGCCGCGGGCTTCTCGATCAACGTGCTGACGATGTTCGGGATGGTGCTCGCGATCGGCATCCTCGTCGACGACGCGATCGTCGTCGTCGAGAACGTCGAGCGGCTGATGGTCGAGGAGAAGCTGCCGCCGTACGAGGCCACCGTGAAGGCGATGAAGCAGATCAGCGGCGCGATCGTCGGGATCACCGTCGTGCTCACGTCGGTGTTCGTGCCGATGGCGTTCTTCGGCGGCGCGGTCGGCAACATCTACCGGCAGTTCGCGTTCGCGCTGGCGGTGTCGATCGGCTTCTCGGCGTTTCTCGCGCTGTCGCTCACGCCGGCGCTCTGCGCGACGCTGCTCAAGCCCGTCGCCGACGACCATCACGAGAAGGACGGCTTCTTCGGCTGGTTCAACCGTTTCGTCGCGCGCTCGACGCACCGCTACACGCGGCGCGTCGGGCGGGTGCTCGAGCGCCCGCTGCGCTGGCTCGTCGTCTACGGCGCGCTGACGGCCGCCGCCGCGCTGCTGATCACGAAGCTGCCGGCCGCGTTCCTGCCCGACGAGGATCAGGGCAACTTCATGGTGATGGTGATTCGCCCGCAGGGCACGCCGCTCGCCGAGACGATGCAGAGCGTGCGGCGCGTCGAGGAATACGTGCGCACGCATTCGCCGAGCGCGTACACGTTCGCGCTCGGCGGCTACAACCTGTACGGCGAAGGGCCGAACGGCGGGATGATCTTCGTCACGATGAAGGACTGGAAGGAGCGCAAGCGGGCGCGGGACCAGGTGCAGGCGATCATCGCGGAGATCAACGCGCATTTCGCCGGCACGCCGAACACGATGGTGTTCGCGATCAACATGCCGGCGCTGCCGGACCTCGGCCTGACGGGCGGCTTCGACTTCCGGCTGCAGGACCGCGGCGGGCTCGGCTACGGCGCGTTCGTCGCCGCGCGCGAGAAGCTGCTCGCCGAGGGGCGCAAGGACCCCGTCCTGACCGATTTGATGTTCGCCGGCACGCAGGACGCGCCGCAGCTGAAGCTCGACATCGATCGCGCGAAGGCGTCGGCGCTCGGCGTATCGATGGAGGAAATCAACGCGACGCTCGCTGTGATGTTCGGCTCGGACTACATCGGCGATTTCATGCACGGCTCGCAGGTGCGCCGCGTGATCGTGCAGGCGGACGGGCGGCACCGGCTCGACGCCGCCGACGTGACGAAGCTGCGCGTGCGCAACGCGAAGGGCGAGATGGTGCCGCTCGCGGCGTTCGCGACGCTGCACTGGACGATGGGCCCGCCGCAGTTGACGCGCTACAACGGCTTTCCGTCGTTTACGATCAACGGCGCGGCGTCGGCCGGGCACAGCAGCGGCGAGGCGATGGCGGCGATCGAGCGGATCGCGTCGACGCTGCCCGCCGGCACCGGCTACGCGTGGTCCGGCCAGTCGTACGAGGAGCGGCTGTCGGGCGCGCAGGCGCCGATGCTGTTCGCGCTGTCGGTGCTCGTCGTGTTCCTCGCGCTCGCGGCGCTGTACGAGAGCTGGTCGATTCCGTTCGCGGTGATGCTCGTCGTGCCGCTCGGCGTGATCGGCGCGGTCGCGGGCGTCACGCTGCGCGGGATGCCGAACGACATCTATTTCAAGGTGGGGCTGATCGCGACGATCGGTTTGTCCGCGAAGAACGCGATCCTGATCGTCGAGGTCGCGAAGGATCTGGTCGCGCAGCGCATGTCGCTCGCCGACGCGGCGCTCGAGGCCGCGCGGCTGCGGCTGCGGCCGATCGTGATGACCTCGCTCGCGTTCGGCGTCGGCGTGCTGCCGCTCGCGTTCGCGACGGGCGCCGCATCCGGCGCGCAGATCGCGATCGGCACGGGGGTGCTCGGCGGCGTGATCAGCGCGACGCTGTTCGCGATCTTCCTCGTCCCGCTCTTTTTCGTCTGCGTCGGGCGCGTGTTCGACGTCGTTCCGCGCCGCCGAGGCGGCGCGCAAGCGGCACTGGAGGCCAAGTGA", "partial": "0", "query_start": 22102, "query_end": 22173, "hit_start": 2070, "hit_end": 2142, "orf_dna_sequence": "ATGAAAAGATCAGAAAATGTGACTTTAACTAATATGTGTATGATAAAAGATAAAGATAAAATTTTAGTTCTAAATAGAACTGATCCAGTTTGGCCTGGTTTAACTTTTCCAGGCGGCCACGTCGAATCTCATGAAGCT", "orf_prot_sequence": "MKRSENVTLTNMCMIKDKDKILVLNRTDPVWPGLTFPGGHVESHEA", "perc_identity": 37.5}, "gnl|BL_ORD_ID|1073|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 22060, "orf_end": 22197, "orf_from": "BGC0000765.1|Exopolysaccharide_31 ", "model_name": "lsaB", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1000", "model_id": "1161", "ARO_accession": "3003111", "ARO_name": "lsaB", "ARO_category": {"41696": {"category_aro_accession": "3004472", "category_aro_cvterm_id": "41696", "category_aro_name": "lsa-type ABC-F protein", "category_aro_description": "A subgroup of the ABC-F protein subfamily of ATP-binding cassette proteins. lsa-type ABC-F proteins confer resistance to streptogramin, lincosamide and pleuromutilin antibiotics through antibiotic target protection of the ribosome.", "category_aro_class_name": "AMR Gene Family"}, "35983": {"category_aro_accession": "0000066", "category_aro_cvterm_id": "35983", "category_aro_name": "clindamycin", "category_aro_description": "Clindamycin is a lincosamide antibiotic that blocks A-site aminoacyl-tRNA binding. It is usually used to treat infections with anaerobic bacteria but can also be used to treat some protozoal diseases, such as malaria.", "category_aro_class_name": "Antibiotic"}, "37716": {"category_aro_accession": "3001317", "category_aro_cvterm_id": "37716", "category_aro_name": "pleuromutilin", "category_aro_description": "Pleuromutilin is a natural product antibiotic produced by Clitopilus passeckerianus. Related antibiotics of clinical significance, such as tiamulin and retapamulin, are semi-synthetic derivatives of this compound.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "37014": {"category_aro_accession": "3000670", "category_aro_cvterm_id": "37014", "category_aro_name": "pleuromutilin antibiotic", "category_aro_description": "Pleuromutilins are natural fungal products that target bacterial protein translation by binding the the 23S rRNA, blocking the ribosome P site at the 50S subunit. They are mostly used for agriculture and veterinary purposes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.89243, "max_identities": 9, "bit_score": 20.7866, "cvterm_id": "36794", "query": "MKRSENVTLTNMCMIKDKDKIL", "match": "MKRS+N+       I++K K+L", "sequence_from_db": "MKRSKNLEARQQKSIEEKSKLL", "sequence_from_broadstreet": "MSMIHVQNLTFSYPSSFDNIFEDVSFQIDTDWKLGFIGRNGRGKTTLFNLLLDKFEYRGKIISSVDFNYFPYPVEDKSKYTHEILEEICPQAEDWEFLREIAYLNVDAEAMYRPFETLSNGEQTKVLLVALFLNEGQFLLIDEPTNHLDTEARKTVSNYLRKKKGNILISHDRNFLDGSVDHILSINRADIEVQSGNYSSWKLNFDRQQGHEQATNERLQKDIGRLEQSTKRSAGWSNRVEASKNGTTNSGSKLDKGFVGHKAAKMMKRSKNLEARQQKSIEEKSKLLKNIEKTESLQFEPVEYKSKELIQLTDVSVIYDGQVVNKPISFNVEQGDRIVLDGKNGSGKSSILKLILGDPIQYTGTLNTGSNLITSYVQQDTSHLKGMLADFIEENEIDESLFKAILRKLDFDRVQFEKDISHYSGGQKKKLLIAKSLCEKAHLYIWDEPLNFIDIYSRMQIEELIQTFNPTMVFVEHDQTFQETISTKIIKI", "dna_sequence_from_broadstreet": "ATGTCAATGATACATGTACAAAATTTAACTTTCTCTTATCCGAGTAGTTTTGATAATATCTTTGAAGATGTAAGCTTTCAAATTGATACAGATTGGAAGCTTGGATTTATTGGTCGAAATGGACGAGGGAAAACAACCCTTTTTAATTTATTACTAGATAAATTTGAATATAGGGGGAAAATCATTTCTTCGGTCGATTTTAACTACTTCCCATATCCAGTAGAAGATAAAAGTAAGTATACACATGAAATTTTAGAAGAAATATGCCCTCAAGCTGAGGACTGGGAATTTCTTCGAGAAATAGCTTATTTAAATGTGGATGCCGAAGCCATGTACCGTCCTTTTGAAACTTTATCAAACGGTGAACAAACAAAGGTATTGCTTGTTGCTCTATTTTTAAACGAAGGACAATTTTTATTAATTGATGAACCAACAAATCATTTAGATACTGAAGCTCGTAAGACGGTTTCGAATTACTTGAGGAAGAAAAAAGGGAATATTTTAATTTCTCATGACCGTAACTTTTTAGATGGCAGTGTTGATCATATCTTGTCTATAAATAGAGCAGATATTGAGGTTCAAAGTGGAAATTATTCCTCATGGAAGTTGAACTTTGACCGACAGCAGGGACATGAACAAGCAACAAATGAACGCTTGCAGAAGGATATTGGAAGGTTAGAACAATCTACAAAACGTTCGGCTGGTTGGTCTAACCGAGTCGAAGCTTCAAAAAATGGAACAACGAATTCTGGTTCTAAATTGGACAAAGGTTTTGTAGGACATAAAGCAGCAAAAATGATGAAACGATCTAAGAACCTTGAGGCTCGACAGCAAAAATCGATTGAAGAAAAGTCAAAGCTTCTAAAAAACATTGAAAAAACGGAGTCCCTACAGTTTGAACCAGTGGAATATAAATCGAAGGAACTCATTCAATTAACAGATGTGTCTGTCATATATGATGGGCAAGTTGTCAACAAACCAATAAGTTTTAATGTTGAACAAGGAGATAGAATTGTACTGGATGGAAAGAACGGCAGTGGAAAAAGTAGTATTTTAAAATTAATCTTAGGCGATCCAATACAGTATACAGGCACGTTAAATACGGGTTCTAACCTGATAACTTCTTATGTTCAGCAAGACACCTCTCATTTAAAGGGGATGCTAGCTGACTTTATTGAAGAAAATGAGATTGATGAATCGTTGTTTAAGGCCATCCTGAGAAAGCTAGATTTTGACCGAGTACAGTTTGAAAAAGATATATCTCATTATTCAGGTGGTCAGAAGAAAAAATTGCTTATCGCTAAAAGTTTATGTGAAAAAGCTCACCTATATATTTGGGATGAACCATTAAACTTTATTGATATTTACTCTCGAATGCAAATTGAAGAGCTTATTCAAACCTTTAATCCGACTATGGTTTTTGTTGAACATGACCAGACCTTCCAAGAGACAATATCAACAAAAATAATAAAAATATAA", "partial": "0", "query_start": 22060, "query_end": 22125, "hit_start": 798, "hit_end": 864, "orf_dna_sequence": "ATGAAAAGATCAGAAAATGTGACTTTAACTAATATGTGTATGATAAAAGATAAAGATAAAATTTTAGTTCTAAATAGAACTGATCCAGTTTGGCCTGGTTTAACTTTTCCAGGCGGCCACGTCGAATCTCATGAAGCT", "orf_prot_sequence": "MKRSENVTLTNMCMIKDKDKILVLNRTDPVWPGLTFPGGHVESHEA", "perc_identity": 40.91}, "gnl|BL_ORD_ID|4935|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 22060, "orf_end": 22197, "orf_from": "BGC0000765.1|Exopolysaccharide_31 ", "model_name": "almE", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1000", "model_id": "5928", "ARO_accession": "3007433", "ARO_name": "almE", "ARO_category": {"46184": {"category_aro_accession": "3007428", "category_aro_cvterm_id": "46184", "category_aro_name": "polymyxin resistance operon", "category_aro_description": "Operon or gene clusters confering resistance to polymyxin antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "46188": {"category_aro_accession": "3007432", "category_aro_cvterm_id": "46188", "category_aro_name": "alm glycyltransferase", "category_aro_description": "Glycyl transferase associated with polymyxin resistance operons not interacting with lipid A.", "category_aro_class_name": "AMR Gene Family"}, "36966": {"category_aro_accession": "3000622", "category_aro_cvterm_id": "36966", "category_aro_name": "colistin A", "category_aro_description": "Colistin A, or polymyxin E1, has a 6-octanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36968": {"category_aro_accession": "3000624", "category_aro_cvterm_id": "36968", "category_aro_name": "colistin B", "category_aro_description": "Colistin B, or polymyxin E2, has a 6-heptanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36192": {"category_aro_accession": "3000053", "category_aro_cvterm_id": "36192", "category_aro_name": "peptide antibiotic", "category_aro_description": "Peptide antibiotics have a wide range of antibacterial mechanisms, depending on the amino acids that make up the antibiotic, although most act to disrupt the cell membrane in some manner. Subclasses of peptide antibiotics can include additional sidechains of other types, such as lipids in the case of the lipopeptide antibiotics.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.8652, "max_identities": 13, "bit_score": 20.4014, "cvterm_id": "36789", "query": "VTLTNM-CMIKDKDKILVLNRTDPV--WPGLTF", "match": "V+ +N+ C I   DK+  LN  D V  +  LTF", "sequence_from_db": "VSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTF", "sequence_from_broadstreet": "MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH", "dna_sequence_from_broadstreet": "ATGCCATACAATTCTGCGACAGATTTGTTACAGAGAGAGGGTTATGGTGTCGTGCATAACCAATTTATCAATAAAATGGCGATGTGCTGCGAGACAAGACACTCTATTTTGGCGGCCATTCAGGCTAACCGACATGCCCCTGCATTATGGGTTAAACAGAAAACCTACACCTATCAAGAGATGACCGATATGGCACTCTCATTGAGTGACTATTGGCATTTACAGGGCGTGCAGCGAGTTGCGATCCTTTCGGTACGCGATCTCGCGGCTTATTCTGCGATTTGGGCGAGCTATTTGGGCGGTATGACTTATATTCCGCTCAATGCGCGAGCAACAACAGAACAGATCCAAGAGACGCTGATCGCGACACAATGTGATTCCATCATGGTAGACGCGCAGCAATTGAGTCGTTTGTCCTCCTTACTAGATACTTGCATTGACCGATTACACATTTATGCGCTGCCTGATGTGGATATGGAACCGTTACGTCAGCAATATCCTCAGCACACTTTTCACACAGTGCAAATAACCGAACAAGATGTGGAATTACTGGTAGCGAAATACCATTTAGACAATGAACATGAGTACGCTTATATCATGCAAACCTCAGGTTCGACTGGTAAACCCAAACGTATTGCGGTCAGCTACAGTAATTTGCATTGCTATATCAGTCAAATTGACAAACTATTTCCACTCAATGCGCAAGATCGAGTGGGGCAATATTCTGATTTGACTTTTGATCTTTCGGTACATGATATTTTTTACAGTTTGATCTCTGGTGCTTGTTTATATGTTGTGCCTGAATTAGCGAAATTAAGTCCAGCGGAATTTATTCGTCACCATCAATTAACGGTATGGCTTTCTGTGCCTACTGTTATTGAGTTGGCCCTACAAAGACAAACCTTAACCCCACACAGTTTACCTTCTCTGCGACTGAGTTTTTTCTGCGGACAAGCCTTGCTGCATGATTTAGCCGAACAATGGCAACAGGCCACCCAGCAGCCGGTGATCAATCTGTATGGTCCAACAGAGTGCACGATTGCTATTACCTATCATCGATTTGTCGCCCATTCAGGTATGGCATCGGTGCCGATTGGCCGTGCTTTTGAAGAGGAGTGTTTAGCCATCATCAACGAACAAGGTGAATTGATGCGCTTTGAATCTGCACCCGAGGGGTATCGCGGAGAATTACTTCTGTCGGGCAAACAATTAGTCAATGGTTATCTGAATGATCCGCTGAATACGCAAAGTGCCTTTTTCCAGCACGAAGGGCGTATTTGGTATCGTTCAGGTGACATTGTCACTAAATCAAATGGCGTGCTGATTCATCTTGGGCGTCGCGATCACCAAGTGAAAATTGCCGGACAACGGGTGGAATTAGAAGAGATTGAAACCGTTGTTCGCCGCGTGACTCAAGCGCACAGCGTGGCGATAGTGCCTTGGCCTTTAAGTGAGTCGGGCTATGCCAGCGGCACGGTGGCGTTTGTGGATACCCATACCCAATGGCAACCAGATCTGTGGTTGAGCCAATGCAAACAACAATTAAATCCAACTTTTGTGCCTAAGCGTTGGTATGCCATTGAACAATTACCAAGAAATGCCAATGGCAAAACCGATATTAAAGCTTTACAACAACAATTAGCGAGTCAGACATATGAAACAAGCCATTGA", "partial": "0", "query_start": 22078, "query_end": 22167, "hit_start": 639, "hit_end": 738, "orf_dna_sequence": "ATGAAAAGATCAGAAAATGTGACTTTAACTAATATGTGTATGATAAAAGATAAAGATAAAATTTTAGTTCTAAATAGAACTGATCCAGTTTGGCCTGGTTTAACTTTTCCAGGCGGCCACGTCGAATCTCATGAAGCT", "orf_prot_sequence": "MKRSENVTLTNMCMIKDKDKILVLNRTDPVWPGLTFPGGHVESHEA", "perc_identity": 39.39}}}